,Approval,Class,Drug Class,Drug Name,EntryName,Gene,INDEX,Indication(s),LigandType,Phase,PhaseDate,ClinicalStatus,Status,Subfamily,Target class,Target_novelty,Trial name,Uniprot,ModeOfAction,Note
0,0,Class A (Rhodopsin),small molecule,apd791,5ht2a_human,HTR2A,195,antithrombotic,Aminergic ,1,2008.0,Completed,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,apd791,P28223,agonist,
1,0,Class A (Rhodopsin),small molecule,apd916,hrh3_human,HRH3,196,sleep disorders; narcolepsy,Aminergic ,1,2010.0,Completed,in trial,Histamine receptors,GPCR;Rhodopsin,established,apd916,Q9Y5N1,agonist,
2,0,Class A (Rhodopsin),small molecule,cpb-307,s1pr1_human,S1PR1,MMAmar2016_0127,autoimmune diseases,Lipid ,1,2014.0,Completed,in trial,Lysophospholipid (S1P) receptors,GPCR;Rhodopsin,established,cpb-307,P21453,agonist,
3,0,Class A (Rhodopsin),peptide,peptide yy,npy2r_human,NPY2R,699,Appetite suppressant,Peptide ,1,2009.0,Completed,in trial,Neuropeptide Y receptors,GPCR;Rhodopsin,not established,eligen pyy-3-36 + glp-1,P49146,agonist,
4,0,Class A (Rhodopsin),small molecule,gc021109,p2ry6_human,P2RY6,MMAfeb2016_0055,Alzheimer's disease,Nucleotide ,1,2015.0,Completed,in trial,P2Y receptors,GPCR;Rhodopsin,not established,gc021109,Q15077,agonist,
5,0,Class A (Rhodopsin),small molecule,HTL18318,acm1_human,OPRM,ASH_Mar2017_2,dementia ; schizophrenia,Aminergic ,1,2016.0,Completed,in trial,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,HTL18318,P11229,agonist,
6,0,Class A (Rhodopsin),small molecule,int-767,gpbar_human,GPBAR1,MMAapril2016_0196,Treatment of liver fibrosis,Steroid ,1,2011.0,Completed,in trial,Bile acid receptors,GPCR;Rhodopsin,not established,int-767,Q8TDU6,agonist,Appears to be heading to phase 2 trials as of 2015
7,0,Class A (Rhodopsin),small molecule,int-767,gpbar_human,GPBAR1,MMAapril2016_0196,Treatment of liver fibrosis,Steroid ,1,2011.0,Completed,in trial,Bile acid receptors,GPCR;Rhodopsin,not established,int-767,Q8TDU6,agonist,Appears to be heading to phase 2 trials as of 2015
8,0,Class C (Glutamate) ,small molecule,"deuterium containing analog of sodium oxybate, gamma hydroxybutyric acid",gabr1_human,GABBR1,MMAmay2016_0773,sleep disorders; narcolepsy,Amino acid ,1,2014.0,Completed,in trial,GABAB receptors,GPCR;Glutamate,established,jzp-386,Q9UBS5,agonist,
9,0,Class C (Glutamate) ,small molecule,"deuterium containing analog of sodium oxybate, gamma hydroxybutyric acid",gabr2_human,GABBR2,MMAmay2016_0771,sleep disorders; narcolepsy,Amino acid ,1,2014.0,Completed,in trial,GABAB receptors,GPCR;Glutamate,established,jzp-386,O75899,agonist,
10,0,Class B1 (Secretin),peptide,ormd-0901,glp1r_human,GLP1R,1519,Antidiabetic,Peptide ,1,2016.0,Completed,in trial,Glucagon receptor family,GPCR;Secretin,established,"ormd-0901, oral glp-1 analog",P43220,agonist,
11,0,Class A (Rhodopsin),small molecule,trv734,oprk_human,OPRK1,MMAapril2016_0140,Analgesics,Peptide ,1,2015.0,Completed,in trial,Opioid receptors,GPCR;Rhodopsin,established,trv734,P41145,agonist,
12,0,Class B1 (Secretin),unknown,glp1 agonist ,glp1r_human,GLP1R,2155,Antidiabetic,Peptide ,1,2010.0,Completed,in trial,Glucagon receptor family,GPCR;Secretin,established,viaderm-glp1 agonist,P43220,agonist,
13,0,Class B1 (Secretin),peptide,zyd1,glp1r_human,GLP1R,2256,Antidiabetic,Peptide ,1,2012.0,Completed,in trial,Glucagon receptor family,GPCR;Secretin,established,zyd1,P43220,agonist,
14,0,Class A (Rhodopsin),small molecule,ari-3037mo,hcar2_human,HCAR2,226,Vitamin B analog; for treatment for hyperlipidemia,Alicarboxylic acid ,2,2015.0,Completed,in trial,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,ari-3037mo,Q8TDS4,agonist,
15,0,Class A (Rhodopsin),small molecule,ari-3037mo,hcar3_human,HCAR3,226,Vitamin B analog; for treatment for hyperlipidemia,Alicarboxylic acid ,2,2015.0,Completed,in trial,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,ari-3037mo,P49019,agonist,
16,0,Class A (Rhodopsin),small molecule,ati-7505,5ht4r_human,HTR4,265,Parasympathomimetic,Aminergic ,2,2009.0,Completed,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,ati-7505,Q13639,agonist,
17,0,Class B1 (Secretin),peptide,"efpeglenatide, hm11260c",glp1r_human,GLP1R,MMAmar2016_0245,Antidiabetic,Peptide ,2,2014.0,Completed,in trial,Glucagon receptor family,GPCR;Secretin,established,"efpeglenatide, hm11260c",P43220,agonist,
18,0,Class B1 (Secretin),peptide,glp,glp1r_human,GLP1R,699,Appetite suppressant,Peptide ,2,2009.0,Completed,in trial,Glucagon receptor family,GPCR;Secretin,established,eligen pyy-3-36 + glp-1,P43220,agonist,
19,0,Class A (Rhodopsin),small molecule,gsk-961081,adrb2_human,ADRB2,881,Bronchodilator,Aminergic ,2,2015.0,Completed,in trial,Adrenoceptors,GPCR;Rhodopsin,established,gsk-961081,P07550,agonist,
20,0,Class A (Rhodopsin),small molecule,kp201,oprd_human,OPRD1,1079,Analgesics,Peptide ,2,2015.0,Completed,in trial,Opioid receptors,GPCR;Rhodopsin,established,kp201 (prodrug of hydrocodone),P41143,agonist,Difficult to get good clinical trial info for
21,0,Class A (Rhodopsin),small molecule,kp201,oprk_human,OPRK1,1079,Analgesics,Peptide ,2,2015.0,Completed,in trial,Opioid receptors,GPCR;Rhodopsin,established,kp201 (prodrug of hydrocodone),P41145,agonist,Difficult to get good clinical trial info for
22,0,Class A (Rhodopsin),small molecule,kp201,oprm_human,OPRM1,1079,Analgesics,Peptide ,2,2015.0,Completed,in trial,Opioid receptors,GPCR;Rhodopsin,established,kp201 (prodrug of hydrocodone),P35372,agonist,Difficult to get good clinical trial info for
23,0,Class A (Rhodopsin),small molecule,las-100977,adrb2_human,ADRB2,1092,Bronchodilator,Aminergic ,2,2011.0,Completed,in trial,Adrenoceptors,GPCR;Rhodopsin,established,las-100977,P07550,agonist,
24,0,Class A (Rhodopsin),small molecule,"min-001,  cyr-101",5ht2a_human,HTR2A,MMAapril2016_0202,schizophrenia,Aminergic ,2,2009.0,Completed,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"min-001,  cyr-101",P28223,agonist,Can't find information if discontinued or not
25,0,Class A (Rhodopsin),unknown,mn-221,adrb2_human,ADRB2,1317,Anti-Asthmatic,Aminergic ,2,2008.0,Completed,in trial,Adrenoceptors,GPCR;Rhodopsin,established,mn-221,P07550,agonist,no information on next phase plans
26,0,Class A (Rhodopsin),small molecule,opa-6566,aa2ar_human,ADORA2A,MMAmay2016_0512,Antiglaucomic,Nucleotide ,2,2011.0,Completed,in trial,Adenosine receptors,GPCR;Rhodopsin,established,opa-6566,P29274,agonist,
27,0,Class B1 (Secretin),protein,pb1023,glp1r_human,GLP1R,1569,Antidiabetic,Peptide ,2,2012.0,Completed,in trial,Glucagon receptor family,GPCR;Secretin,established,"pb1023, glp-1-elp-120,glymera",P43220,agonist,
28,0,Class A (Rhodopsin),small molecule,"pd-6735, tik-301",mtr1a_human,MTNR1A,1575,Hypnotics and Sedatives,Melatonin ,2,2004.0,Completed,in trial,Melatonin,GPCR;Rhodopsin,established,"pd-6735, ly-156735, tik-301",P48039,agonist,May still be researched
29,0,Class A (Rhodopsin),small molecule,"pd-6735, tik-301",mtr1b_human,MTNR1B,1575,Hypnotics and Sedatives,Melatonin ,2,2004.0,Completed,in trial,Melatonin,GPCR;Rhodopsin,established,"pd-6735, ly-156735, tik-301",P49286,agonist,May still be researched
30,0,Class A (Rhodopsin),small molecule,opc-14523,5ht1a_human,HTR1A,1662,Anti-depressant,Aminergic ,2,2009.0,Completed,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"prs-013, opc-14523",P08908,agonist,No development reported
31,0,Class A (Rhodopsin),small molecule,prx-3140,5ht4r_human,HTR4,1671,Alzheimer's disease,Aminergic ,2,2013.0,Completed,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,prx-3140,Q13639,agonist,
32,0,Class A (Rhodopsin),small molecule,ser100,oprx_human,OPRL1,MMAmay2016_0735,Antihypertensive,Peptide ,2,2013.0,Completed,in trial,Opioid receptors,GPCR;Rhodopsin,not established,ser100,P41146,agonist,
33,0,Class A (Rhodopsin),small molecule,obinepitide,npy2r_human,NPY2R,2027,Anti-obesity,Peptide ,2,2010.0,Completed,in trial,Neuropeptide Y receptors,GPCR;Rhodopsin,not established,"tm30338,obinepitide",P49146,agonist,Sweden
34,0,Class A (Rhodopsin),small molecule,obinepitide,npy4r_human,PPYR1,2027,Anti-obesity,Peptide ,2,2010.0,Completed,in trial,Neuropeptide Y receptors,GPCR;Rhodopsin,not established,"tm30338,obinepitide",P50391,agonist,Sweden
35,0,Class B1 (Secretin),peptide,tt-401,glr_human,GCGR,MMAmay2016_0612,Antidiabetic,Peptide ,2,2014.0,Completed,in trial,Glucagon receptor family,GPCR;Secretin,established,"tt-401, Pegapamodutide, LY2944876",P47871,agonist,
36,0,Class B1 (Secretin),peptide,tt-401,glp1r_human,GLP1R,MMAmay2016_0613,Antidiabetic,Peptide ,2,2014.0,Completed,in trial,Glucagon receptor family,GPCR;Secretin,established,"tt-401, Pegapamodutide, LY2944876",P43220,agonist,
37,0,Class B1 (Secretin),small molecule,ttp273,glp1r_human,GLP1R,MMAmar2016_0255,Antidiabetic,Peptide ,2,2016.0,Completed,in trial,Glucagon receptor family,GPCR;Secretin,established,ttp273,P43220,agonist,
38,0,Class A (Rhodopsin),small molecule,tzp-101,ghsr_human,GHSR,2095,gastroparesis,Peptide ,2,2016.0,Completed,in trial,Ghrelin receptors,GPCR;Rhodopsin,not established,"tzp-101, Ulimorelin",Q92847,agonist,
39,0,Class A (Rhodopsin),small molecule,xp21279,drd1_human,DRD1,2223,Antiparkinson,Aminergic ,2,2010.0,Completed,in trial,Dopamine receptors,GPCR;Rhodopsin,established,xp21279,P21728,agonist,
40,0,Class A (Rhodopsin),small molecule,xp21279,drd2_human,DRD2,2223,Antiparkinson,Aminergic ,2,2010.0,Completed,in trial,Dopamine receptors,GPCR;Rhodopsin,established,xp21279,P14416,agonist,
41,0,Class A (Rhodopsin),small molecule,xp21279,drd3_human,DRD3,2223,Antiparkinson,Aminergic ,2,2010.0,Completed,in trial,Dopamine receptors,GPCR;Rhodopsin,established,xp21279,P35462,agonist,
42,0,Class A (Rhodopsin),small molecule,xp21279,drd4_human,DRD4,2223,Antiparkinson,Aminergic ,2,2010.0,Completed,in trial,Dopamine receptors,GPCR;Rhodopsin,established,xp21279,P21917,agonist,
43,0,Class A (Rhodopsin),small molecule,xp21279,drd5_human,DRD5,2223,Antiparkinson,Aminergic ,2,2010.0,Completed,in trial,Dopamine receptors,GPCR;Rhodopsin,established,xp21279,P21918,agonist,
44,0,Class A (Rhodopsin),small molecule,ykp10811,5ht4r_human,HTR4,MMAmay2016_0641,for chronic or functional constipation,Aminergic ,2,2014.0,Completed,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,ykp10811,Q13639,agonist,
45,0,Class B1 (Secretin),peptide,elsiglutide,glp2r_human,GLP2R,2464,Antidiuretic,Peptide ,2,2012.0,Completed,in trial,Glucagon receptor family,GPCR;Secretin,established,zp1846,O95838,agonist,
46,0,Class A (Rhodopsin),small molecule,carbetocin,oxyr_human,OXTR,NRDD078,Labor Inducing,Peptide ,3,2016.0,Completed,in trial,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,-,P30559,agonist,Approved in Europe but not FDA
47,0,Class A (Rhodopsin),small molecule,anamorelin,ghsr_human,GHSR,175,Appetite stimulant,Peptide ,3,2011.0,Completed,in trial,Ghrelin receptors,GPCR;Rhodopsin,not established,"anamorelin, rc-1291",Q92847,agonist,
48,0,Class C (Glutamate) ,small molecule,arbaclofen,gabr1_human,GABBR1,216,Fragile X syndrome,Amino acid ,3,2011.0,Completed,in trial,GABAB receptors,GPCR;Glutamate,established,arbaclofen,Q9UBS5,agonist,
49,0,Class C (Glutamate) ,small molecule,arbaclofen,gabr2_human,GABBR2,216,Fragile X syndrome,Amino acid ,3,2011.0,Completed,in trial,GABAB receptors,GPCR;Glutamate,established,arbaclofen,O75899,agonist,
50,0,Class A (Rhodopsin),peptide,ljpc-501,agtr1_human,AGTR1,MMA2015_0090,Hepatorenal syndrome-catecholamine-resistant hypotension (CRH),Peptide ,3,2015.0,Completed,in trial,Angiotensin receptors,GPCR;Rhodopsin,established,athos-3,P30556,agonist,
51,0,Class A (Rhodopsin),peptide,ljpc-501,agtr2_human,AGTR2,MMA2015_0091,Hepatorenal syndrome-catecholamine-resistant hypotension (CRH),Peptide ,3,2015.0,Completed,in trial,Angiotensin receptors,GPCR;Rhodopsin,not established,athos-3,P50052,agonist,
52,0,Class A (Rhodopsin),small molecule,binodenoson,aa2ar_human,ADORA2A,363,Diagnostic,Nucleotide ,3,2009.0,Completed,in trial,Adenosine receptors,GPCR;Rhodopsin,established,"binodenoson, mre 0470,corvue",P29274,agonist,No development reported
53,0,Class A (Rhodopsin),small molecule,ino-8875,aa1r_human,ADORA1,985,Antiglaucomic,Nucleotide ,3,2015.0,Completed,in trial,Adenosine receptors,GPCR;Rhodopsin,established,ino-8875,P30542,agonist,
54,0,Class A (Rhodopsin),small molecule,kuc-7483,adrb3_human,ADRB3,1082,overactive bladder,Aminergic ,3,2009.0,Completed,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"kuc-7483, Ritobegron",P13945,agonist,"Article from 2012 suggests may be worth more research, but also possibly discontinued"
55,0,Class A (Rhodopsin),peptide,"macimorelin,  aezs-130",ghsr_human,GHSR,MMAmay2016_0080,"growth hormone deficiency, cancer cachexia",Peptide ,3,2015.0,Completed,in trial,Ghrelin receptors,GPCR;Rhodopsin,not established,"macimorelin,  aezs-130",Q92847,agonist,Applied for fda approval in 2013 and rejected in 2014
56,0,Class B1 (Secretin),protein,alx1-11,pth1r_human,PTH1R,1646,Anti-osteoporotic,Peptide ,3,2005.0,Completed,in trial,Parathyroid hormone receptors,GPCR;Secretin,established,preos,Q03431,agonist,
57,0,Class B1 (Secretin),protein,alx1-11,pth2r_human,PTH2R,1646,Anti-osteoporotic,Peptide ,3,2005.0,Completed,in trial,Parathyroid hormone receptors,GPCR;Secretin,established,preos,P49190,agonist,
58,0,Class B1 (Secretin),protein,alx1-11,pth2r_human,PTH2R,1646,Anti-osteoporotic,Peptide ,3,2005.0,Completed,in trial,Parathyroid hormone receptors,GPCR;Secretin,established,preos,P49190,agonist,
59,0,Class A (Rhodopsin),small molecule,abediterol,adrb2_human,ADRB2,ASH_Sep2016_190,Anti-Asthmatic,Aminergic ,2,2016.0,Completed,in trial,Adrenoceptors,GPCR;Rhodopsin,established,abediterol,P07550,agonist,
60,0,Class A (Rhodopsin),small molecule,batefenterol,adrb2_human,ADRB2,ASH_Sep2016_188,chronic obstructive pulmonary disease (COPD),Aminergic ,2,2016.0,Completed,in trial,Adrenoceptors,GPCR;Rhodopsin,established,batefenterol,P07550,agonist,
61,0,Class A (Rhodopsin),small molecule,batefenterol,acm2_human,CHRM2,ASH_Sep2016_56,chronic obstructive pulmonary disease (COPD),Aminergic ,2,2015.0,Completed,in trial,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,batefenterol,P08172,agonist,
62,0,Class A (Rhodopsin),small molecule,batefenterol,acm3_human,CHRM3,ASH_Sep2016_82,chronic obstructive pulmonary disease (COPD),Aminergic ,2,2016.0,Completed,in trial,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,batefenterol,P20309,agonist,
63,0,Class A (Rhodopsin),small molecule,bedoradrine,adrb2_human,ADRB2,ASH_Sep2016_189,Anti-Asthmatic,Aminergic ,2,2009.0,Completed,in trial,Adrenoceptors,GPCR;Rhodopsin,established,bedoradrine,P07550,agonist,No development reported
64,0,Class A (Rhodopsin),small molecule,camicinal,mtlr_human,MLNR,ASH_Sep2016_262,gastroparesis,Peptide ,2,2014.0,Completed,in trial,Motilin receptors,GPCR;Rhodopsin,not established,camicinal,O43193,agonist,
65,0,Class A (Rhodopsin),protein,fsh-gex,fshr_human,FSHR,825,Fertility,Protein ,2,2013.0,Completed,in trial,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,fsh-gex,P23945,agonist,
66,0,Class A (Rhodopsin),small molecule,naronapride,5ht4r_human,HTR4,ASH_Sep2016_41,constipation,Aminergic ,2,2009.0,Completed,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,naronapride,Q13639,agonist,
67,0,Class A (Rhodopsin),small molecule,ulimorelin,ghsr_human,GHSR,ASH_Sep2016_254,digestive system disease,Peptide ,3,2012.0,Completed,in trial,Ghrelin receptors,GPCR;Rhodopsin,not established,ulimorelin,Q92847,agonist,
68,0,Class A (Rhodopsin),small molecule,aiko-150,oprm_human,OPRM1,92,opioid antagonist,Peptide ,1,2009.0,Completed,in trial,Opioid receptors,GPCR;Rhodopsin,established,aiko-150,P35372,antagonist,
69,0,Class A (Rhodopsin),small molecule,avn-101,5ht6r_human,HTR6,290,Alzheimer's disease,Aminergic ,1,2009.0,Completed,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,avn-101,P50406,antagonist,
70,0,Class C (Glutamate) ,small molecule,bci-838,grm2_human,GRM2,MMAmay2016_0306,Anti-depressant,Amino acid ,1,2012.0,Completed,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,bci-838,Q14416,antagonist,No development reported
71,0,Class C (Glutamate) ,small molecule,bci-838,grm3_human,GRM3,MMAmay2016_0307,Anti-depressant,Amino acid ,1,2012.0,Completed,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,bci-838,Q14832,antagonist,No development reported
72,0,Class A (Rhodopsin),small molecule,ccx507,ccr9_human,CCR9,MMAmay2016_0216,ulcerative colitis; inflammatory bowel disease,Protein ,1,2014.0,Completed,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,ccx507,P51686,antagonist,
73,0,Class F (Frizzled),small molecule,cur-61414,smo_human,SMO,2823,Antineoplastic,Protein ,1,2010.0,Completed,in trial,Frizzled,GPCR;Frizzled,established,cur-61414,Q99835,antagonist,
74,0,Class A (Rhodopsin),small molecule,cvt-6883,aa2br_human,ADORA2B,569,Anti-Asthmatic,Nucleotide ,1,2008.0,Completed,in trial,Adenosine receptors,GPCR;Rhodopsin,established,cvt-6883,P29275,antagonist,
75,0,Class A (Rhodopsin),peptide,pdc31,pf2r_human,PTGFR,MMAmay2016_0526,pre-term labor; dysmenorrhea,Lipid ,1,2010.0,Completed,in trial,Prostanoid receptors,GPCR;Rhodopsin,established,pdc31,P43088,antagonist,
76,0,Class A (Rhodopsin),small molecule,prx-07034,5ht6r_human,HTR6,1667,Anti-obesity ; nootropic,Aminergic ,1,2007.0,Completed,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,prx-07034,P50406,antagonist,Sold to undisclosed company in 2009
77,0,Class A (Rhodopsin),small molecule,q-122,cxcr4_human,CXCR4,MMAmar2016_0157,Anti-inflammatory ; hot flashes,Protein ,1,2014.0,Completed,in trial,Chemokine receptors,GPCR;Rhodopsin,established,q-122,P61073,antagonist,
78,0,Class A (Rhodopsin),small molecule,tm38837,cnr1_human,CNR1,2029,Anti-obesity,Lipid ,1,2013.0,Completed,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,tm38837,P21554,antagonist,
79,0,Class A (Rhodopsin),small molecule,alks 33,oprd_human,OPRD1,116,alcohol dependance; Anti-depressant,Peptide ,2,2009.0,Completed,in trial,Opioid receptors,GPCR;Rhodopsin,established,"alks 33, samidorphan",P41143,antagonist,
80,0,Class A (Rhodopsin),small molecule,alks 33,oprk_human,OPRK1,116,alcohol dependance; Anti-depressant,Peptide ,2,2009.0,Completed,in trial,Opioid receptors,GPCR;Rhodopsin,established,"alks 33, samidorphan",P41145,antagonist,
81,0,Class A (Rhodopsin),small molecule,alks 33,oprm_human,OPRM1,116,alcohol dependance; Anti-depressant,Peptide ,2,2009.0,Completed,in trial,Opioid receptors,GPCR;Rhodopsin,established,"alks 33, samidorphan",P35372,antagonist,
82,0,Class A (Rhodopsin),small molecule,am1030,5ht2b_human,HTR2B,MMAmar2016_0116,Anti-inflammatory ; atopic dermatitis,Aminergic ,2,2015.0,Completed,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,am1030,P41595,antagonist,
83,0,Class A (Rhodopsin),small molecule,am-152,lpar1_human,LPAR1,144,Anti-inflammatory ; antifibrotic,Lipid ,2,2015.0,Completed,in trial,Lysophospholipid (LPA) receptors,GPCR;Rhodopsin,not established,"am-152, BMS 986020",Q92633,antagonist,
84,0,Class A (Rhodopsin),small molecule,amap102,5ht2b_human,HTR2B,148,Anti-inflammatory ; DMARD,Aminergic ,2,2014.0,Completed,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,amap102,P41595,antagonist,Phase 2 in Europe
85,0,Class A (Rhodopsin),small molecule,amap102,5ht2c_human,HTR2C,148,Anti-inflammatory ; DMARD,Aminergic ,2,2014.0,Completed,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,amap102,P28335,antagonist,
86,0,Class A (Rhodopsin),small molecule,"api246,  srx246",v1ar_human,AVPR1A,MMAjun2016_0005,Treatment of affective and anger disorders,Peptide ,2,2016.0,Completed,in trial,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,"api246,  srx246",P37288,antagonist,
87,0,Class A (Rhodopsin),small molecule,arry-502,pd2r2_human,GPR44,MMAapril2016_0314,Anti-Allergic,Lipid ,2,2012.0,Completed,in trial,Prostanoid receptors,GPCR;Rhodopsin,not established,arry-502,Q9Y5Y4,antagonist,
88,0,Class A (Rhodopsin),small molecule,budiodarone,adrb1_human,ADRB1,404,Anti-Arrhythmia,Aminergic ,2,2005.0,Completed,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"budiodarone, ati-2042",P08588,antagonist,
89,0,Class A (Rhodopsin),small molecule,ccx140,ccr2_human,CCR2,447,Anti-inflammatory ; Antidiabetic,Protein ,2,2011.0,Completed,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,ccx140,P41597,antagonist,
90,0,Class A (Rhodopsin),small molecule,ccx354,ccr1_human,CCR1,450,Anti-inflammatory ; DMARD,Protein ,2,2010.0,Completed,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,ccx354,P32246,antagonist,
91,0,Class A (Rhodopsin),small molecule,cannabidiol,cnr1_human,CNR1,MMAapril2016_0328,schizophrenia,Lipid ,2,2013.0,Completed,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,"epidiolex, oral liquid cannabidiol, gwp42003",P21554,antagonist,
92,0,Class A (Rhodopsin),small molecule,cannabidiol,cnr2_human,CNR2,MMAapril2016_0328,schizophrenia,Lipid ,2,2013.0,Completed,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,"epidiolex, oral liquid cannabidiol, gwp42003",P34972,antagonist,
93,0,Class A (Rhodopsin),small molecule,glpg0974,ffar2_human,FFAR2,MMAmay2016_0156,Anti-inflammatory ; neutrophil driven inflammation; ulcerative colitis,Lipid ,2,2013.0,Completed,in trial,Free fatty acid receptors,GPCR;Rhodopsin,not established,glpg0974,O15552,antagonist,
94,0,Class A (Rhodopsin),small molecule,glpg1205,gpr84_human,GPR84,MMAapril2016_0323,for ulcerative colitis; IBS,Orphan ,2,2015.0,Completed,in trial,Class A orphans,GPCR;Rhodopsin,not established,glpg1205,Q9NQS5,antagonist,
95,0,Class A (Rhodopsin),small molecule,gsk-961081,acm3_human,CHRM3,881,Bronchodilator,Aminergic ,2,2015.0,Completed,in trial,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,gsk-961081,P20309,antagonist,
96,0,Class A (Rhodopsin),small molecule,tetrahydrocannabivarin (thcv),cnr1_human,CNR1,MMAapril2016_0329,Antidiabetic,Lipid ,2,2014.0,Completed,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,"gwp42004, Tetrahydrocannabivarin-9",P21554,antagonist,
97,0,Class A (Rhodopsin),small molecule,jnj-37822681,drd2_human,DRD2,1054,schizophrenia,Aminergic ,2,2013.0,Completed,in trial,Dopamine receptors,GPCR;Rhodopsin,established,jnj-37822681,P14416,antagonist,
98,0,Class A (Rhodopsin),small molecule,min-117,5ht1a_human,HTR1A,MMAapril2016_0204,Anti-depressant,Aminergic ,2,2016.0,Completed,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,min-117,P08908,antagonist,
99,0,Class A (Rhodopsin),small molecule,min-117,5ht2a_human,HTR2A,MMAapril2016_0203,Anti-depressant,Aminergic ,2,2016.0,Completed,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,min-117,P28223,antagonist,
100,0,Class A (Rhodopsin),small molecule,"min-202, jnj-42847922",ox2r_human,HCRTR2,MMA2016_0029,Anti-depressant and sleep disorder therapy,Peptide ,2,2015.0,Completed,in trial,Orexin receptors,GPCR;Rhodopsin,established,"min-202, jnj-42847922",O43614,antagonist,
101,0,Class A (Rhodopsin),small molecule,ncx 1510,hrh1_human,HRH1,1390,Anti-Allergic,Aminergic ,2,2009.0,Completed,in trial,Histamine receptors,GPCR;Rhodopsin,established,"ncx 1510, ox-nla",P35367,antagonist,
102,0,Class C (Glutamate) ,small molecule,npsp795,casr_human,CASR,MMAmar2016_0202,hypocalcaemia,Ion ,2,2014.0,Completed,in trial,Calcium-sensing receptors,GPCR;Glutamate,established,npsp795,P41180,antagonist,
103,0,Class A (Rhodopsin),small molecule,prx-08066,5ht2b_human,HTR2B,1668,Antihypertensive,Aminergic ,2,2008.0,Completed,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,prx-08066,P41595,antagonist,
104,0,Class A (Rhodopsin),small molecule,"re-021, sparsentan",agtr1_human,AGTR1,MMAapril2016_0044,kidney disease; nephropathy,Peptide ,2,2012.0,Completed,in trial,Angiotensin receptors,GPCR;Rhodopsin,established,"re-021, sparsentan",P30556,antagonist,
105,0,Class A (Rhodopsin),small molecule,"re-021, sparsentan",ednra_human,EDNRA,MMAapril2016_0045,kidney disease; nephropathy,Peptide ,2,2012.0,Completed,in trial,Endothelin receptors,GPCR;Rhodopsin,established,"re-021, sparsentan",P25101,antagonist,
106,0,Class A (Rhodopsin),small molecule,svt-40776,acm3_human,CHRM3,1921,incontinence,Aminergic ,2,2011.0,Completed,in trial,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"svt-40776, tarafenacin",P20309,antagonist,
107,0,Class A (Rhodopsin),sirna,syl040012,adrb2_human,ADRB2,1922,Antiglaucomic,Aminergic ,2,2014.0,Completed,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"syl040012, Bamosiran",P07550,antagonist,
108,0,Class A (Rhodopsin),small molecule,syn120,5ht2a_human,HTR2A,MMAapril2016_0310,cognitive disorders,Aminergic ,2,2014.0,Completed,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"syn120, Landipirdine",P28223,antagonist,
109,0,Class A (Rhodopsin),small molecule,syn120,5ht6r_human,HTR6,MMAapril2016_0309,cognitive disorders,Aminergic ,2,2014.0,Completed,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"syn120, Landipirdine",P50406,antagonist,
110,0,Class A (Rhodopsin),small molecule,td-1211,oprm_human,OPRM1,1971,opioid-induced gastrointestinal side-effects,Peptide ,2,2012.0,Completed,in trial,Opioid receptors,GPCR;Rhodopsin,established,"td-1211, Axelopran",P35372,antagonist,
111,0,Class A (Rhodopsin),small molecule,tg-0054,cxcr4_human,CXCR4,2002,adjuvant to stem cell transplantation,Protein ,2,2014.0,Completed,in trial,Chemokine receptors,GPCR;Rhodopsin,established,"tg-0054, Burixafor",P61073,antagonist,
112,0,Class A (Rhodopsin),peptide,luteinizing hormone-releasing hormone,gnrhr_human,GNRHR,2097,Antineoplastic,Peptide ,2,2005.0,Completed,in trial,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,"tztx-001,teverelix la",P30968,antagonist,"Seems to be planning Phase 3, but can't find recent dated information"
113,0,Class A (Rhodopsin),peptide,luteinizing hormone-releasing hormone,gnrr2_human,GNRHR2,2097,Antineoplastic,Peptide ,2,2005.0,Completed,in trial,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,"tztx-001,teverelix la",Q96P88,antagonist,"Seems to be planning Phase 3, but can't find recent dated information"
114,0,Class A (Rhodopsin),small molecule,v81444,aa2ar_human,ADORA2A,MMAmay2016_0766,Antiparkinson,Nucleotide ,2,2014.0,Completed,in trial,Adenosine receptors,GPCR;Rhodopsin,established,"v81444, CPI 444",P29274,antagonist,
115,0,Class A (Rhodopsin),small molecule,va111913,v1ar_human,AVPR1A,2116,dysmenorrhea,Peptide ,2,2010.0,Completed,in trial,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,va111913,P37288,antagonist,
116,0,Class A (Rhodopsin),small molecule,va111913,v1br_human,AVPR1B,2116,dysmenorrhea,Peptide ,2,2010.0,Completed,in trial,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,va111913,P47901,antagonist,
117,0,Class A (Rhodopsin),small molecule,va111913,v2r_human,AVPR2,2116,dysmenorrhea,Peptide ,2,2010.0,Completed,in trial,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,va111913,P30518,antagonist,
118,0,Class A (Rhodopsin),small molecule,vapitadine,hrh1_human,HRH1,2123,"Anti-Allergic, pruritus",Aminergic ,2,2006.0,Completed,in trial,Histamine receptors,GPCR;Rhodopsin,established,"vapitadine dihydrochloride,hivenyl",P35367,antagonist,No development reported
119,0,Class B1 (Secretin),small molecule,"verucerfont, nbi-77860",crfr1_human,CRHR1,MMA2016_0047,Congenital Adrenal Hyperplasia,Peptide ,2,2013.0,Completed,in trial,Corticotropin-releasing factor receptors,GPCR;Secretin,not established,"verucerfont, nbi-77860, 561679",P34998,antagonist,
120,0,Class A (Rhodopsin),unknown,ykp-1358,drd2_human,DRD2,2226,schizophrenia,Aminergic ,2,2008.0,Completed,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"ykp-1358, Relenopride",P14416,antagonist,Inferred dates
121,0,Class A (Rhodopsin),unknown,ykp-1358,5ht2a_human,HTR2A,2226,schizophrenia,Aminergic ,2,2008.0,Completed,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"ykp-1358, Relenopride",P28223,antagonist,Inferred dates
122,0,Class A (Rhodopsin),small molecule,"zpl-389, zpl-3893787",hrh4_human,HRH4,MMAmar2016_0120,Anti-inflammatory ; atopic dermatitis,Aminergic ,2,2015.0,Completed,in trial,Histamine receptors,GPCR;Rhodopsin,established,"zpl-389, zpl-3893787",Q9H3N8,antagonist,
123,0,Class A (Rhodopsin),small molecule,"alks 33, alks 5461",oprd_human,OPRD1,118,alcohol dependance; Anti-depressant,Peptide ,3,2014.0,Completed,in trial,Opioid receptors,GPCR;Rhodopsin,established,"alks 33, alks 5461, Buprenorphine+samidorphan",P41143,antagonist,
124,0,Class A (Rhodopsin),small molecule,"alks 33, alks 5461",oprk_human,OPRK1,118,alcohol dependance; Anti-depressant,Peptide ,3,2014.0,Completed,in trial,Opioid receptors,GPCR;Rhodopsin,established,"alks 33, alks 5461, Buprenorphine+samidorphan",P41145,antagonist,
125,0,Class A (Rhodopsin),small molecule,"alks 33, alks 5461",oprm_human,OPRM1,118,alcohol dependance; Anti-depressant,Peptide ,3,2014.0,Completed,in trial,Opioid receptors,GPCR;Rhodopsin,established,"alks 33, alks 5461, Buprenorphine+samidorphan",P35372,antagonist,
126,0,Class B1 (Secretin),antibody,amg 334,calrl_human,CALCRL,MMAapril2016_0116,Anti-migraine,Peptide ,3,2017.0,Completed,in trial,Calcitonin receptors,GPCR;Secretin,not established,"amg 334, Erenumab",Q16602,antagonist,
127,0,Class A (Rhodopsin),small molecule,amisulpride,drd2_human,DRD2,MMAmay2016_0704,Antiemetics,Aminergic ,3,2013.0,Completed,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"apd403, apd421",P14416,antagonist,
128,0,Class A (Rhodopsin),small molecule,amisulpride,drd3_human,DRD3,MMAmay2016_0705,Antiemetics,Aminergic ,3,2013.0,Completed,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"apd403, apd421",P35462,antagonist,
129,0,Class B1 (Secretin),peptide,vasoactive intestinal peptide,vipr1_human,VIPR1,288,sexual dysfunction,Peptide ,3,2016.0,Completed,in trial,VIP and PACAP receptors,GPCR;Secretin,not established,"aviptadil,invicorp",P32241,antagonist,Difficult to get info; trials in Europe
130,0,Class B1 (Secretin),peptide,vasoactive intestinal peptide,vipr2_human,VIPR2,288,sexual dysfunction,Peptide ,3,2016.0,Completed,in trial,VIP and PACAP receptors,GPCR;Rhodopsin,not established,"aviptadil,invicorp",P41587,antagonist,Difficult to get info; trials in Europe
131,0,Class A (Rhodopsin),small molecule,"drm04, anticholinergic",acm3_human,CHRM3,MMAfeb2016_0095,hyperhidrosis,Aminergic ,3,2015.0,Completed,in trial,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"drm04, anticholinergic",P20309,antagonist,
132,0,Class A (Rhodopsin),small molecule,istradefylline,aa2ar_human,ADORA2A,1043,Antiparkinson,Nucleotide ,3,2005.0,Completed,in trial,Adenosine receptors,GPCR;Rhodopsin,established,"istradefylline, kw-6002",P29274,antagonist,Not approved by fda -denied in 2008
133,0,Class A (Rhodopsin),small molecule,itopride,drd2_human,DRD2,1049,motilitant,Aminergic ,3,2012.0,Completed,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"itopride,itax",P14416,antagonist,Not approved yet by FDA
134,0,Class A (Rhodopsin),small molecule,lixivaptan,v2r_human,AVPR2,1157,hyponatremia,Peptide ,3,2010.0,Completed,in trial,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,lixivaptan,P30518,antagonist,"Some information from 2012 but does not appear to labeled discontinued, just postponed"
135,0,Class C (Glutamate) ,small molecule,nps-2143,casr_human,CASR,1441,Anti-osteoporotic,Ion ,Preclinical,2015.0,Completed,in trial,Calcium-sensing receptors,GPCR;Glutamate,established,nps-2143,P41180,antagonist,
136,0,Class A (Rhodopsin),small molecule,irdabisant,hrh3_human,HRH3,ASH_Sep2016_246,cognitive impairment,Aminergic ,1,2013.0,Completed,in trial,Histamine receptors,GPCR;Rhodopsin,established,irdabisant,Q9Y5N1,antagonist,
137,0,Class A (Rhodopsin),protein,barusiban,oxyr_human,OXTR,ASH_Sep2016_290,Fertility,Peptide ,2,2012.0,Completed,in trial,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,barusiban,P30559,antagonist,
138,0,Class F (Frizzled),small molecule,glasdegib,smo_human,SMO,ASH_Sep2016_343,Antineoplastic,Protein ,2,2016.0,Completed,in trial,Frizzled,GPCR;Frizzled,established,glasdegib,Q99835,antagonist,
139,0,Class A (Rhodopsin),small molecule,sb-649868,ox1r_human,HCRTR1,ASH_Sep2016_277,insomnia,Peptide ,2,2007.0,Completed,in trial,Orexin receptors,GPCR;Rhodopsin,established,sb-649868,O43613,antagonist,Suspected discontinued
140,0,Class A (Rhodopsin),small molecule,sb-649868,ox2r_human,HCRTR2,ASH_Sep2016_279,insomnia,Peptide ,2,2007.0,Completed,in trial,Orexin receptors,GPCR;Rhodopsin,established,sb-649868,O43614,antagonist,Suspected discontinued
141,0,Class A (Rhodopsin),small molecule,toreforant,hrh4_human,HRH4,ASH_Sep2016_247,Anti-Asthmatic,Aminergic ,2,2014.0,Completed,in trial,Histamine receptors,GPCR;Rhodopsin,established,toreforant,Q9H3N8,antagonist,
142,0,Class A (Rhodopsin),small molecule,ordopidine,drd2_human,DRD2,2422,Antiparkinson,Aminergic ,1,2009.0,Completed,in trial,Dopamine receptors,GPCR;Rhodopsin,established,acr325,P14416,modulator,
143,0,Class A (Rhodopsin),unknown,lu ae04621,drd1_human,DRD1,1175,Antiparkinson,Aminergic ,1,2016.0,Completed,in trial,Dopamine receptors,GPCR;Rhodopsin,established,lu ae04621,P21728,modulator,
144,0,Class A (Rhodopsin),unknown,lu ae04621,drd2_human,DRD2,1175,Antiparkinson,Aminergic ,1,2016.0,Completed,in trial,Dopamine receptors,GPCR;Rhodopsin,established,lu ae04621,P14416,modulator,
145,0,Class A (Rhodopsin),unknown,lu ae04621,drd3_human,DRD3,1175,Antiparkinson,Aminergic ,1,2016.0,Completed,in trial,Dopamine receptors,GPCR;Rhodopsin,established,lu ae04621,P35462,modulator,
146,0,Class A (Rhodopsin),unknown,lu ae04621,drd4_human,DRD4,1175,Antiparkinson,Aminergic ,1,2016.0,Completed,in trial,Dopamine receptors,GPCR;Rhodopsin,established,lu ae04621,P21917,modulator,
147,0,Class A (Rhodopsin),unknown,lu ae04621,drd5_human,DRD5,1175,Antiparkinson,Aminergic ,1,2016.0,Completed,in trial,Dopamine receptors,GPCR;Rhodopsin,established,lu ae04621,P21918,modulator,
148,0,Class A (Rhodopsin),unknown,pti-202,oprd_human,OPRD1,1684,Analgesics,Peptide ,1,2006.0,Completed,in trial,Opioid receptors,GPCR;Rhodopsin,established,pti-202,P41143,modulator,Not good information - may have changed names within Pain Therapeutics
149,0,Class A (Rhodopsin),unknown,pti-202,oprk_human,OPRK1,1684,Analgesics,Peptide ,1,2006.0,Completed,in trial,Opioid receptors,GPCR;Rhodopsin,established,pti-202,P41145,modulator,Not good information - may have changed names within Pain Therapeutics
150,0,Class A (Rhodopsin),unknown,pti-202,oprm_human,OPRM1,1684,Analgesics,Peptide ,1,2006.0,Completed,in trial,Opioid receptors,GPCR;Rhodopsin,established,pti-202,P35372,modulator,Not good information - may have changed names within Pain Therapeutics
151,0,Class C (Glutamate) ,small molecule,pxt002331,grm4_human,GRM4,MMAmay2016_0906,Antiparkinson,Amino acid ,1,2015.0,Completed,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,pxt002331,Q14833,modulator,
152,0,Class C (Glutamate) ,small molecule,adx-48621,grm5_human,GRM5,2472,Antiparkinson,Amino acid ,2,2011.0,Completed,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,established,adx-48621,P41594,modulator,
153,0,Class A (Rhodopsin),small molecule,asm-024,adrb2_human,ADRB2,MMAmay2016_0687,Anti-Asthmatic ; COPD,Aminergic ,2,2015.0,Completed,in trial,Adrenoceptors,GPCR;Rhodopsin,established,asm-024,P07550,modulator,
154,0,Class C (Glutamate) ,small molecule,fasoracetam monohydrate,grm1_human,GRM1,MMAmar2016_0121,attention deficit hyperactivity disorder (ADHD),Amino acid ,3,2016.0,Completed,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,nfc-1,Q13255,modulator,
155,0,Class C (Glutamate) ,small molecule,fasoracetam monohydrate,grm1_human,GRM1,MMAmar2016_0121,attention deficit hyperactivity disorder (ADHD),Amino acid ,3,2016.0,Completed,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,nfc-1,Q13255,modulator,
156,0,Class C (Glutamate) ,small molecule,fasoracetam monohydrate,grm2_human,GRM2,MMAmar2016_0125,attention deficit hyperactivity disorder (ADHD),Amino acid ,3,2016.0,Completed,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,nfc-1,Q14416,modulator,
157,0,Class C (Glutamate) ,small molecule,fasoracetam monohydrate,grm3_human,GRM3,MMAmar2016_0123,attention deficit hyperactivity disorder (ADHD),Amino acid ,3,2016.0,Completed,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,nfc-1,Q14832,modulator,
158,0,Class C (Glutamate) ,small molecule,fasoracetam monohydrate,grm4_human,GRM4,MMAmar2016_0125,attention deficit hyperactivity disorder (ADHD),Amino acid ,3,2016.0,Completed,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,nfc-1,Q14833,modulator,
159,0,Class C (Glutamate) ,small molecule,fasoracetam monohydrate,grm4_human,GRM4,MMAmar2016_0125,attention deficit hyperactivity disorder (ADHD),Amino acid ,3,2016.0,Completed,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,nfc-1,Q14833,modulator,
160,0,Class C (Glutamate) ,small molecule,fasoracetam monohydrate,grm5_human,GRM5,MMAmar2016_0122,attention deficit hyperactivity disorder (ADHD),Amino acid ,3,2016.0,Completed,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,established,nfc-1,P41594,modulator,
161,0,Class C (Glutamate) ,small molecule,fasoracetam monohydrate,grm6_human,GRM6,MMAmar2016_0125,attention deficit hyperactivity disorder (ADHD),Amino acid ,3,2016.0,Completed,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,nfc-1,O15303,modulator,
162,0,Class C (Glutamate) ,small molecule,fasoracetam monohydrate,grm6_human,GRM6,MMAmar2016_0125,attention deficit hyperactivity disorder (ADHD),Amino acid ,3,2016.0,Completed,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,nfc-1,O15303,modulator,
163,0,Class C (Glutamate) ,small molecule,fasoracetam monohydrate,grm7_human,GRM7,MMAmar2016_0124,attention deficit hyperactivity disorder (ADHD),Amino acid ,3,2016.0,Completed,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,nfc-1,Q14831,modulator,
164,0,Class C (Glutamate) ,small molecule,fasoracetam monohydrate,grm7_human,GRM7,MMAmar2016_0124,attention deficit hyperactivity disorder (ADHD),Amino acid ,3,2016.0,Completed,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,nfc-1,Q14831,modulator,
165,0,Class C (Glutamate) ,small molecule,fasoracetam monohydrate,grm8_human,GRM8,MMAmar2016_0125,attention deficit hyperactivity disorder (ADHD),Amino acid ,3,2016.0,Completed,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,nfc-1,O00222,modulator,
166,0,Class C (Glutamate) ,small molecule,fasoracetam monohydrate,grm8_human,GRM8,MMAmar2016_0125,attention deficit hyperactivity disorder (ADHD),Amino acid ,3,2016.0,Completed,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,nfc-1,O00222,modulator,
167,0,Class A (Rhodopsin),small molecule,pridopidine,drd2_human,DRD2,1647,Huntington's disease,Aminergic ,3,2008.0,Completed,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"pridopidine, acr-16,huntexil",P14416,modulator,Needs another Phase 3 trial before FDA considers approval
168,0,Class C (Glutamate) ,small molecule,basimglurant,grm5_human,GRM5,ASH_Sep2016_341,fragile x syndrome,Amino acid ,2,2015.0,Completed,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,established,basimglurant,P41594,modulator,
169,0,Class C (Glutamate) ,small molecule,dipraglurant,grm5_human,GRM5,ASH_Sep2016_339,Antiparkinson,Amino acid ,2,2011.0,Completed,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,established,dipraglurant,P41594,modulator,
170,0,Class A (Rhodopsin),small molecule,fx125l,ccr1_human,CCR1,831,Anti-Asthmatic,Protein ,1,2009.0,Completed,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,fx125l,P32246,na,Great Britain
171,0,Class A (Rhodopsin),small molecule,fx125l,cxcr1_human,CXCR1,831,Anti-Asthmatic,Protein ,1,2009.0,Completed,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,fx125l,P25024,na,Great Britain
172,0,Class A (Rhodopsin),small molecule,fx125l,cxcr2_human,CXCR2,831,Anti-Asthmatic,Protein ,1,2009.0,Completed,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,fx125l,P25025,na,Great Britain
173,0,Class A (Rhodopsin),small molecule,fx125l,cxcr4_human,CXCR4,831,Anti-Asthmatic,Protein ,1,2009.0,Completed,in trial,Chemokine receptors,GPCR;Rhodopsin,established,fx125l,P61073,na,Great Britain
174,0,Class A (Rhodopsin),small molecule,cis-uca eye drops,5ht2a_human,HTR2A,MMAmay2016_0333,for ocular surface inflammation,Aminergic ,2,2014.0,Completed,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,cis-uca eye drops,P28223,na,
175,0,Class A (Rhodopsin),small molecule,ctp-499,aa1r_human,ADORA1,2268,diabetic nephropathy,Nucleotide ,2,2011.0,Completed,in trial,Adenosine receptors,GPCR;Rhodopsin,established,ctp-499,P30542,na,
176,0,Class A (Rhodopsin),small molecule,ctp-499,aa2ar_human,ADORA2A,2268,diabetic nephropathy,Nucleotide ,2,2011.0,Completed,in trial,Adenosine receptors,GPCR;Rhodopsin,established,ctp-499,P29274,na,
177,0,Class A (Rhodopsin),peptide,ep-100,gnrhr_human,GNRHR,715,Antineoplastic,Peptide ,2,2011.0,Completed,in trial,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,ep-100,P30968,na,Seems like still investigating as of 2014 article
178,0,Class A (Rhodopsin),peptide,ep-100,gnrr2_human,GNRHR2,715,Antineoplastic,Peptide ,2,2011.0,Completed,in trial,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,ep-100,Q96P88,na,Seems like still investigating as of 2014 article
179,0,Class A (Rhodopsin),small molecule,min-117,ada1a_human,ADRA1A,MMAapril2016_0206,Anti-depressant,Aminergic ,2,2016.0,Completed,in trial,Adrenoceptors,GPCR;Rhodopsin,established,min-117,P35348,na,
180,0,Class A (Rhodopsin),small molecule,min-117,ada1b_human,ADRA1B,MMAapril2016_0207,Anti-depressant,Aminergic ,2,2016.0,Completed,in trial,Adrenoceptors,GPCR;Rhodopsin,established,min-117,P35368,na,
181,0,Class A (Rhodopsin),small molecule,pa101b,gpr35_human,GPR35,MMAmar2016_0133,autoimmune diseases,Orphan ,2,2016.0,Completed,in trial,Class A orphans,GPCR;Rhodopsin,not established,pa101b,Q9HC97,na,
182,0,Class A (Rhodopsin),small molecule,rx-10045,lt4r1_human,BLT1,2317,dry eye,Lipid ,2,2014.0,Completed,in trial,Leukotriene receptors,GPCR;Rhodopsin,not established,rx-10045,Q15722,na,
183,0,Class A (Rhodopsin),small molecule,rx-10045,cml1_human,CMKLR1,2317,dry eye,Protein ,2,2014.0,Completed,in trial,Chemerin receptor,GPCR;Rhodopsin,not established,rx-10045,Q99788,na,
184,0,Class A (Rhodopsin),small molecule,adx415,ada2a_human,ADRA2A,63,Antihypertensive,Aminergic ,2,2008.0,Completed,in trial,Adrenoceptors,GPCR;Rhodopsin,established,adx415,P08913,nam,
185,0,Class A (Rhodopsin),peptide,felypressin,v1ar_human,AVPR1A,NRDD226,Hemostatic s; Vasoconstricting,Peptide ,1,2010.0,Completed,in trial,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,-,P37288,unknown,"Not approved in US, but used here and elsewhere"
186,0,Class A (Rhodopsin),peptide,apelin,apj_human,APLNR,MMAjun2016_0045,Cardiovascular disorders; Insulin sensitivity,Peptide ,1,2013.0,Completed,in trial,Apelin receptors,GPCR;Rhodopsin,not established,apelin,P35414,unknown,
187,0,Class A (Rhodopsin),small molecule,afamelanotide,mshr_human,MC1R,73,dermatological,Peptide ,3,2009.0,Completed,in trial,Melanocortin receptors,GPCR;Rhodopsin,not established,afamelanotide,Q01726,agonist,Seeking FDA approval
188,0,Class A (Rhodopsin),small molecule,zicronapine,drd4_human,DRD4,1176,schizophrenia,Aminergic ,3,2011.0,Completed,in trial,Dopamine receptors,GPCR;Rhodopsin,established,lu-31130,P21917,modulator,No development reported
189,0,Class C (Glutamate) ,small molecule,strontium ranelate,casr_human,CASR,1905,Anti-osteoporotic,Ion ,3,2015.0,Completed,in trial,Calcium-sensing receptors,GPCR;Glutamate,established,"strontium ranelate, s12911",P41180,inhibitor,European trials and marketed
190,1924,Class B1 (Secretin),peptide,abaloparatide,pth1r_human,PTHR1,ASH_Sep2016_345,Anti-osteoporotic,Peptide,3,2012.0,Completed,in trial,Parathyroid hormone receptors,GPCR;Secretin,established,"Abaloparatide, ITM-058, BA-058",Q03431,unknown,
191,0,Class A (Rhodopsin),small molecule,akp-11,s1pr1_human,S1PR1,MMA2016_0028,psoriasis,Lipid ,1,2016.0,Completed,in trial,Lysophospholipid (S1P) receptors,GPCR;Rhodopsin,established,akp-11,P21453,pam,Australia
192,0,Class A (Rhodopsin),small molecule,ap1030,mc4r_human,MC4R,189,Anti-obesity,Peptide ,1,2010.0,Completed,in trial,Melanocortin receptors,GPCR;Rhodopsin,not established,ap1030,P32245,pam,No development reported
193,0,Class A (Rhodopsin),small molecule,ap1030,mshr_human,MC1R,189,Anti-obesity,Peptide ,1,2010.0,Completed,in trial,Melanocortin receptors,GPCR;Rhodopsin,not established,ap1030,Q01726,pam,
194,0,Class C (Glutamate) ,small molecule,adx-71149,grm2_human,GRM2,64,Antipsychotic ; Anti-depressant; anxiolytic,Amino acid ,2,2011.0,Completed,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,"adx-71149,  JNJ-40411813",Q14416,pam,
195,0,Class A (Rhodopsin),small molecule,cvt-3619,aa1r_human,ADORA1,568,Antihyperlipidemic,Nucleotide ,1,2010.0,Completed,in trial,Adenosine receptors,GPCR;Rhodopsin,established,cvt-3619,P30542,partial agonist,
196,0,Class A (Rhodopsin),small molecule,gepirone,5ht1a_human,HTR1A,848,Anti-depressant,Aminergic ,3,1999.0,Completed,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,gepirone,P08908,partial agonist,"Was rejected 3 times for fda approval, reversed decision in march 2016 - headed for approval and martketing"
197,0,Class A (Rhodopsin),small molecule,apd597,gp119_human,GPR119,2469,Antidiabetic,Lipid ,1,2008.0,discontinued,in trial,"GPR18, GPR55 and GPR119",GPCR;Rhodopsin,not established,"apd597, JNJ-38431055",Q8TDV5,agonist,
198,0,Class A (Rhodopsin),small molecule,apd668,gp119_human,GPR119,194,Antidiabetic,Lipid ,1,2006.0,discontinued,in trial,"GPR18, GPR55 and GPR119",GPCR;Rhodopsin,not established,apd668,Q8TDV5,agonist,
199,0,Class A (Rhodopsin),small molecule,azd2820,mc4r_human,MC4R,MMAmay2016_0297,Anti-obesity,Peptide ,1,2011.0,discontinued,in trial,Melanocortin receptors,GPCR;Rhodopsin,not established,azd2820,P32245,agonist,
200,0,Class A (Rhodopsin),small molecule: combination,cer627,hcar2_human,HCAR2,MMA2015_0072,Dyslipidemia with low HDL,Alicarboxylic acid ,1,2010.0,discontinued,in trial,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,cer627,Q8TDS4,agonist,
201,0,Class A (Rhodopsin),small molecule: combination,cer627,hcar3_human,HCAR3,MMA2015_0071,Dyslipidemia with low HDL,Alicarboxylic acid ,1,2010.0,discontinued,in trial,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,cer627,P49019,agonist,
202,0,Class A (Rhodopsin),small molecule,kos-2187,mtlr_human,MLNR,1078,gastrointestinal motility disorders,Peptide ,1,2006.0,discontinued,in trial,Motilin receptors,GPCR;Rhodopsin,not established,kos-2187,O43193,agonist,
203,0,Class B1 (Secretin),peptide,mar701,gipr_human,GIPR,1217,Antidiabetic,Peptide ,1,2011.0,discontinued,in trial,Glucagon receptor family,GPCR;Secretin,not established,mar701,P48546,agonist,
204,0,Class B1 (Secretin),peptide,mar701,glp1r_human,GLP1R,1217,Antidiabetic,Peptide ,1,2011.0,discontinued,in trial,Glucagon receptor family,GPCR;Secretin,established,mar701,P43220,agonist,
205,0,Class A (Rhodopsin),small molecule,mcd-386,acm1_human,CHRM1,1228,Alzheimer's disease,Aminergic ,1,2005.0,discontinued,in trial,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,mcd-386,P11229,agonist,
206,0,Class B1 (Secretin),protein,mkc-253,glp1r_human,GLP1R,1308,Antidiabetic,Peptide ,1,2008.0,discontinued,in trial,Glucagon receptor family,GPCR;Secretin,established,mkc-253,P43220,agonist,
207,0,Class A (Rhodopsin),small molecule,mn-246,adrb3_human,ADRB3,1318,overactive bladder,Aminergic ,1,2010.0,discontinued,in trial,Adrenoceptors,GPCR;Rhodopsin,established,mn-246,P13945,agonist,
208,0,Class A (Rhodopsin),small molecule,nrp290,oprd_human,OPRD1,1444,Analgesics,Peptide ,1,2006.0,discontinued,in trial,Opioid receptors,GPCR;Rhodopsin,established,nrp290,P41143,agonist,
209,0,Class A (Rhodopsin),small molecule,nrp290,oprk_human,OPRK1,1444,Analgesics,Peptide ,1,2006.0,discontinued,in trial,Opioid receptors,GPCR;Rhodopsin,established,nrp290,P41145,agonist,
210,0,Class A (Rhodopsin),small molecule,nrp290,oprm_human,OPRM1,1444,Analgesics,Peptide ,1,2006.0,discontinued,in trial,Opioid receptors,GPCR;Rhodopsin,established,nrp290,P35372,agonist,
211,0,Class A (Rhodopsin),small molecule,psn602,5ht1a_human,HTR1A,1678,Anti-obesity,Aminergic ,1,2009.0,discontinued,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,psn602,P08908,agonist,
212,0,Class A (Rhodopsin),unknown,td-2749,5ht4r_human,HTR4,1972,motilitant,Aminergic ,1,2005.0,discontinued,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,td-2749,Q13639,agonist,
213,0,Class B1 (Secretin),peptide,th0318,glp1r_human,GLP1R,2008,Antidiabetic,Peptide ,1,2004.0,discontinued,in trial,Glucagon receptor family,GPCR;Secretin,established,th0318,P43220,agonist,
214,0,Class C (Glutamate) ,unknown,"ts-032, pf-4802540",grm2_human,GRM2,2090,schizophrenia,Amino acid ,1,2008.0,discontinued,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,"ts-032, pf-4802540",Q14416,agonist,
215,0,Class C (Glutamate) ,unknown,"ts-032, pf-4802540",grm3_human,GRM3,2090,schizophrenia,Amino acid ,1,2008.0,discontinued,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,"ts-032, pf-4802540",Q14832,agonist,
216,0,Class B1 (Secretin),small molecule,"PTH analog, 768974",pth1r_human,PTH1R,10,Anti-osteoporotic,Peptide ,2,2011.0,discontinued,in trial,Parathyroid hormone receptors,GPCR;Secretin,established,"768974, parathyroid hormone analog",Q03431,agonist,
217,0,Class A (Rhodopsin),small molecule,acp-104,acm1_human,CHRM1,47,schizophrenia,Aminergic ,2,2007.0,discontinued,in trial,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,acp-104,P11229,agonist,
218,0,Class B1 (Secretin),small molecule,akl-0707,ghrhr_human,GHRH,96,hormone replacement,Peptide ,2,2013.0,discontinued,in trial,Glucagon receptor family,GPCR;Secretin,established,"akl-0707, ghrh analog",Q02643,agonist,
219,0,Class A (Rhodopsin),peptide,ap214,mshr_human,MC1R,2538,post-surgical kidney injury,Peptide ,2,2008.0,discontinued,in trial,Melanocortin receptors,GPCR;Rhodopsin,not established,ap214,Q01726,agonist,
220,0,Class A (Rhodopsin),peptide,ap214,mc3r_human,MC3R,2538,post-surgical kidney injury,Peptide ,2,2008.0,discontinued,in trial,Melanocortin receptors,GPCR;Rhodopsin,not established,ap214,P41968,agonist,
221,0,Class A (Rhodopsin),peptide,ap214,mc4r_human,MC4R,2538,post-surgical kidney injury,Peptide ,2,2008.0,discontinued,in trial,Melanocortin receptors,GPCR;Rhodopsin,not established,ap214,P32245,agonist,
222,0,Class A (Rhodopsin),peptide,ap214,mc5r_human,MC5R,2538,post-surgical kidney injury,Peptide ,2,2008.0,discontinued,in trial,Melanocortin receptors,GPCR;Rhodopsin,not established,ap214,P33032,agonist,
223,0,Class A (Rhodopsin),small molecule,apd125,5ht2a_human,HTR2A,192,insomnia,Aminergic ,2,2008.0,discontinued,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,apd125,P28223,agonist,
224,0,Class A (Rhodopsin),small molecule,athx-105,5ht2c_human,HTR2C,263,Anti-obesity,Aminergic ,2,2008.0,discontinued,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,athx-105,P28335,agonist,
225,0,Class A (Rhodopsin),small molecule,bim23a760,drd2_human,DRD2,358,Antineoplastic ; treatment for acromegaly,Aminergic ,2,2009.0,discontinued,in trial,Dopamine receptors,GPCR;Rhodopsin,established,bim23a760,P14416,agonist,
226,0,Class A (Rhodopsin),small molecule,bim23a760,ssr2_human,SSTR2,358,Antineoplastic ; treatment for acromegaly,Peptide ,2,2009.0,discontinued,in trial,Somatostatin receptors,GPCR;Rhodopsin,established,bim23a760,P30874,agonist,
227,0,Class A (Rhodopsin),small molecule,bim23a760,ssr5_human,SSTR5,358,Antineoplastic ; treatment for acromegaly,Peptide ,2,2009.0,discontinued,in trial,Somatostatin receptors,GPCR;Rhodopsin,established,bim23a760,P35346,agonist,
228,0,Class A (Rhodopsin),small molecule,bim23a760,ssr5_human,SSTR5,358,Antineoplastic ; treatment for acromegaly,Peptide ,2,2009.0,discontinued,in trial,Somatostatin receptors,GPCR;Rhodopsin,established,bim23a760,P35346,agonist,
229,0,Class A (Rhodopsin),small molecule,bvt.115959,aa2ar_human,ADORA2A,411,Analgesics,Nucleotide ,2,2007.0,discontinued,in trial,Adenosine receptors,GPCR;Rhodopsin,established,bvt.115959,P29274,agonist,
230,0,Class A (Rhodopsin),small molecule,prs-211375,cnr2_human,CNR2,429,Analgesics,Lipid ,2,2007.0,discontinued,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,cannabinor,P34972,agonist,
231,0,Class B1 (Secretin),peptide,cgrp,calrl_human,CALCRL,477,Anti-Asthmatic,Peptide ,2,2013.0,discontinued,in trial,Calcitonin receptors,GPCR;Secretin,not established,"cgrp, Akela Pharma",Q16602,agonist,EU
232,0,Class A (Rhodopsin),small molecule,cr665,oprk_human,OPRK1,539,Analgesics,Peptide ,2,2004.0,discontinued,in trial,Opioid receptors,GPCR;Rhodopsin,established,"cr665, JNJ 38488502",P41145,agonist,
233,0,Class B1 (Secretin),peptide,dac:glp-1,glp1r_human,GLP1R,590,Antidiabetic,Peptide ,2,2007.0,discontinued,in trial,Glucagon receptor family,GPCR;Secretin,established,"dac:glp-1, cjc-1131",P43220,agonist,
234,0,Class B1 (Secretin),peptide,dac:grf,ghrhr_human,GHRHR,591,hormone replacement,Peptide ,2,2007.0,discontinued,in trial,Glucagon receptor family,GPCR;Secretin,established,dac:grf,Q02643,agonist,
235,0,Class A (Rhodopsin),small molecule,Denufosol,p2ry2_human,P2RY2,990,rhegmatogenous retinal detachment,Nucleotide ,2,2004.0,discontinued,in trial,P2Y receptors,GPCR;Rhodopsin,not established,"Denufosol, ins37217",P41231,agonist,
236,0,Class A (Rhodopsin),peptide,gtp-200,ghsr_human,GHSR,886,Appetite stimulant,Peptide ,2,2006.0,discontinued,in trial,Ghrelin receptors,GPCR;Rhodopsin,not established,gtp-200,Q92847,agonist,
237,0,Class A (Rhodopsin),small molecule,kn38-7271,cnr1_human,CNR1,1076,neuroprotectant,Lipid ,2,2005.0,discontinued,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,"kn38-7271, BAY 7271, BAY-387271",P21554,agonist,No development reported
238,0,Class A (Rhodopsin),small molecule,kn38-7271,cnr2_human,CNR2,1076,neuroprotectant,Lipid ,2,2005.0,discontinued,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,"kn38-7271, BAY 7271, BAY-387271",P34972,agonist,No development reported
239,0,Class A (Rhodopsin),small molecule,mbx-2982,gp119_human,GPR119,1225,Antidiabetic,Lipid ,2,2009.0,discontinued,in trial,"GPR18, GPR55 and GPR119",GPCR;Rhodopsin,not established,mbx-2982,Q8TDV5,agonist,
240,0,Class A (Rhodopsin),small molecule,milveterol,adrb2_human,ADRB2,1290,Bronchodilator,Aminergic ,2,2005.0,discontinued,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"milveterol. td-3327, gsk-159797",P07550,agonist,
241,0,Class A (Rhodopsin),small molecule,mn-305,5ht1a_human,HTR1A,1319,Anti-depressant; hypnotic,Aminergic ,2,2007.0,discontinued,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,mn-305,P08908,agonist,
242,0,Class A (Rhodopsin),small molecule,ngx267,acm1_human,CHRM1,1410,dry mouth,Aminergic ,2,2008.0,discontinued,in trial,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,ngx267,P11229,agonist,
243,0,Class A (Rhodopsin),small molecule,niacin receptor agonist,hcar2_human,HCAR2,1412,Anti-atherosclerotic,Alicarboxylic acid ,2,2009.0,discontinued,in trial,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,niacin receptor agonist,Q8TDS4,agonist,
244,0,Class A (Rhodopsin),small molecule,niacin receptor agonist,hcar3_human,HCAR3,1412,Anti-atherosclerotic,Alicarboxylic acid ,2,2009.0,discontinued,in trial,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,niacin receptor agonist,P49019,agonist,
245,0,Class A (Rhodopsin),small molecule,opc-51803,v2r_human,AVPR2,1503,incontinence,Peptide ,2,2006.0,discontinued,in trial,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,"opc-51803, sou-003",P30518,agonist,
246,0,Class A (Rhodopsin),small molecule,pf-00610355,adrb2_human,ADRB2,1591,Bronchodilator,Aminergic ,2,2009.0,discontinued,in trial,Adrenoceptors,GPCR;Rhodopsin,established,pf-00610355,P07550,agonist,
247,0,Class A (Rhodopsin),small molecule,psn821,gp119_human,GPR119,1679,Antidiabetic,Lipid ,2,2011.0,discontinued,in trial,"GPR18, GPR55 and GPR119",GPCR;Rhodopsin,not established,psn821,Q8TDV5,agonist,
248,0,Class A (Rhodopsin),peptide,spi-1620,ednra_human,EDNRA,1892,adjuvant to chemotherapy,Peptide ,2,2013.0,discontinued,in trial,Endothelin receptors,GPCR;Rhodopsin,established,spi-1620,P25101,agonist,Appears to not meet efficacy end point
249,0,Class A (Rhodopsin),peptide,spi-1620,ednrb_human,EDNRB,1892,adjuvant to chemotherapy,Peptide ,2,2013.0,discontinued,in trial,Endothelin receptors,GPCR;Rhodopsin,established,spi-1620,P24530,agonist,
250,0,Class A (Rhodopsin),small molecule,t-62,aa1r_human,ADORA1,1930,Analgesics,Nucleotide ,2,2008.0,discontinued,in trial,Adenosine receptors,GPCR;Rhodopsin,established,t-62,P30542,agonist,"discontinued because patients experienced asymptomatic, transient elevations in liver transaminases"
251,0,Class A (Rhodopsin),small molecule,tm30339,npy4r_human,PPYR1,2028,Anti-obesity,Peptide ,2,2008.0,discontinued,in trial,Neuropeptide Y receptors,GPCR;Rhodopsin,not established,tm30339,P50391,agonist,
252,0,Class B1 (Secretin),injectible islet neogenesis therapy,tt-223,glp1r_human,GLP1R,2092,Antidiabetic; injectable islet neogenesis therapy for diabetes,Peptide ,2,2008.0,discontinued,in trial,Glucagon receptor family,GPCR;Secretin,established,tt-223,P43220,agonist,
253,0,Class B1 (Secretin),small molecule,ttp054,glp1r_human,GLP1R,MMAmay2016_0113,Antidiabetic,Peptide ,2,2012.0,discontinued,in trial,Glucagon receptor family,GPCR;Secretin,established,ttp054,P43220,agonist,
254,0,Class A (Rhodopsin),peptide,"txa127, angiotensin (1-7)",mas_human,MAS1,MMAmay2016_0617,for stem cell engraftment and thrombocytopenia,Orphan ,2,2012.0,discontinued,in trial,Class A orphans,GPCR;Rhodopsin,not established,"txa127, angiotensin (1-7)",P04201,agonist,
255,0,Class B1 (Secretin),peptide,urocortin 2,crfr2_human,CRHR2,2105,congestive heart failure,Peptide ,2,2012.0,discontinued,in trial,Corticotropin-releasing factor receptors,GPCR;Secretin,not established,"urocortin 2, 358-086-15",Q13324,agonist,
256,0,Class A (Rhodopsin),small molecule,amibegron,adrb3_human,ADRB3,158,Anti-depressant,Aminergic ,3,2008.0,discontinued,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"amibegron, sr 58611",P13945,agonist,
257,0,Class A (Rhodopsin),small molecule,asimadoline,oprk_human,OPRK1,253,Analgesics,Peptide ,3,2015.0,discontinued,in trial,Opioid receptors,GPCR;Rhodopsin,established,asimadoline,P41145,agonist,
258,0,Class A (Rhodopsin),small molecule,denufosol,p2ry2_human,P2RY2,614,cystic fibrosis,Nucleotide ,3,2009.0,discontinued,in trial,P2Y receptors,GPCR;Rhodopsin,not established,"denufosol tetrasodium, ins37217 respiratory",P41231,agonist,
259,0,Class A (Rhodopsin),small molecule,Denufosol,p2ry2_human,P2RY2,991,cystic fibrosis; perennial allergic rhinitis,Nucleotide ,3,2009.0,discontinued,in trial,P2Y receptors,GPCR;Rhodopsin,not established,"Denufosol, ins37217 intranasal",P41231,agonist,
260,0,Class A (Rhodopsin),small molecule,diquafosol,p2ry2_human,P2RY2,644,opthalmological,Nucleotide ,3,2009.0,discontinued,in trial,P2Y receptors,GPCR;Rhodopsin,not established,"diquafosol tetrasodium, ins365 ophthalmic,prolacria",P41231,agonist,
261,0,Class A (Rhodopsin),peptide,dsc127,agtr1_human,AGTR1,2280,diabetic foot ulcers,Peptide ,3,2013.0,discontinued,in trial,Angiotensin receptors,GPCR;Rhodopsin,established,dsc127,P30556,agonist,
262,0,Class A (Rhodopsin),small molecule,etilevodopa,drd1_human,DRD1,749,Antiparkinson,Aminergic ,3,2003.0,discontinued,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"etilevodopa, tv-1203",P21728,agonist,
263,0,Class A (Rhodopsin),small molecule,etilevodopa,drd2_human,DRD2,749,Antiparkinson,Aminergic ,3,2003.0,discontinued,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"etilevodopa, tv-1203",P14416,agonist,
264,0,Class A (Rhodopsin),small molecule,etilevodopa,drd3_human,DRD3,749,Antiparkinson,Aminergic ,3,2003.0,discontinued,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"etilevodopa, tv-1203",P35462,agonist,
265,0,Class A (Rhodopsin),small molecule,etilevodopa,drd4_human,DRD4,749,Antiparkinson,Aminergic ,3,2003.0,discontinued,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"etilevodopa, tv-1203",P21917,agonist,
266,0,Class A (Rhodopsin),small molecule,etilevodopa,drd5_human,DRD5,749,Antiparkinson,Aminergic ,3,2003.0,discontinued,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"etilevodopa, tv-1203",P21918,agonist,
267,0,Class C (Glutamate) ,small molecule,ly2140023,grm2_human,GRM2,1190,schizophrenia,Amino acid ,3,2011.0,discontinued,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,"ly2140023, Pomaglumetad methionil, LY 404039, LY 2140023",Q14416,agonist,Ely Lily discontinued due to lack of efficacy
268,0,Class C (Glutamate) ,small molecule,ly2140023,grm3_human,GRM3,1190,schizophrenia,Amino acid ,3,2011.0,discontinued,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,"ly2140023, Pomaglumetad methionil, LY 404039, LY 2140023",Q14832,agonist,Ely Lily discontinued due to lack of efficacy
269,0,Class A (Rhodopsin),small molecule,pardoprunox,ada1a_human,ADRA1A,1563,Antiparkinson,Aminergic ,3,2009.0,discontinued,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"pardoprunox, slv 308",P35348,agonist,
270,0,Class A (Rhodopsin),small molecule,pardoprunox,ada2a_human,ADRA2A,1563,Antiparkinson,Aminergic ,3,2009.0,discontinued,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"pardoprunox, slv 308",P08913,agonist,
271,0,Class A (Rhodopsin),small molecule,pardoprunox,drd2_human,DRD2,1563,Antiparkinson,Aminergic ,3,2009.0,discontinued,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"pardoprunox, slv 308",P14416,agonist,
272,0,Class A (Rhodopsin),small molecule,pardoprunox,drd3_human,DRD3,1563,Antiparkinson,Aminergic ,3,2009.0,discontinued,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"pardoprunox, slv 308",P35462,agonist,
273,0,Class A (Rhodopsin),small molecule,pardoprunox,drd4_human,DRD4,1563,Antiparkinson,Aminergic ,3,2009.0,discontinued,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"pardoprunox, slv 308",P21917,agonist,
274,0,Class A (Rhodopsin),small molecule,pardoprunox,5ht1a_human,HTR1A,1563,Antiparkinson,Aminergic ,3,2009.0,discontinued,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"pardoprunox, slv 308",P08908,agonist,
275,0,Class A (Rhodopsin),small molecule,pardoprunox,5ht7r_human,HTR7,1563,Antiparkinson,Aminergic ,3,2009.0,discontinued,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"pardoprunox, slv 308",P34969,agonist,
276,0,Class A (Rhodopsin),small molecule,prx-00023,5ht1a_human,HTR1A,1666,Anti-depressant,Aminergic ,3,2011.0,discontinued,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"prx-00023, Naluzotan",P08908,agonist,
277,0,Class A (Rhodopsin),small molecule,renzapride,5ht4r_human,HTR4,1734,irritable bowel syndrome,Aminergic ,3,2008.0,discontinued,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,renzapride,Q13639,agonist,Terminated due to insufficient over placebo in study
278,0,Class A (Rhodopsin),small molecule,"tak-875, fasiglifam",ffar1_human,FFAR1,MMAmay2016_0580,Antidiabetic,Lipid ,3,2013.0,discontinued,in trial,Free fatty acid receptors,GPCR;Rhodopsin,not established,"tak-875, fasiglifam",O14842,agonist,discontinued due to concerns about liver safety
279,0,Class B1 (Secretin),protein,taspoglutide,glp1r_human,GLP1R,1958,Antidiabetic,Peptide ,3,2011.0,discontinued,in trial,Glucagon receptor family,GPCR;Secretin,established,"taspoglutide, itm-077, r1583, bim-51077",P43220,agonist,discontinued due to adverse gastrointestinal reactions
280,0,Class A (Rhodopsin),small molecule,tecadenoson,aa1r_human,ADORA1,1973,Anti-Arrhythmia,Nucleotide ,3,2009.0,discontinued,in trial,Adenosine receptors,GPCR;Rhodopsin,established,tecadenoson,P30542,agonist,
281,0,Class A (Rhodopsin),small molecule,xaliproden,5ht1a_human,HTR1A,2200,neuroprotectant,Aminergic ,3,2006.0,discontinued,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"xaliproden, sr 57746a",P08908,agonist,
282,0,Class A (Rhodopsin),small molecule,adl5747,oprd_human,OPRD1,55,osteoarthritis,Peptide ,2,2010.0,discontinued,in trial,Opioid receptors,GPCR;Rhodopsin,established,adl5747,P41143,agonist,
283,0,Class A (Rhodopsin),small molecule,adl5859,oprd_human,OPRD1,56,osteoarthritis,Peptide ,2,2009.0,discontinued,in trial,Opioid receptors,GPCR;Rhodopsin,established,"adl5859, pf-04856880",P41143,agonist,
284,0,Class A (Rhodopsin),small molecule,azd3199,adrb2_human,ADRB2,ASH_Sep2016_191,chronic obstructive pulmonary disease (COPD),Aminergic ,2,2011.0,discontinued,in trial,Adrenoceptors,GPCR;Rhodopsin,established,azd3199,P07550,agonist,Appears to be discontinued
285,0,Class A (Rhodopsin),small molecule,carmoterol,adrb2_human,ADRB2,ASH_Sep2016_187,chronic obstructive pulmonary disease (COPD),Aminergic ,2,2008.0,discontinued,in trial,Adrenoceptors,GPCR;Rhodopsin,established,carmoterol,P07550,agonist,
286,0,Class B1 (Secretin),protein,davalintide,calcr_human,CALCR,ASH_Sep2016_325,Anti-obesity,Peptide ,2,2008.0,discontinued,in trial,Calcitonin receptors,GPCR;Secretin,established,davalintide,P30988,agonist,
287,0,Class B1 (Secretin),protein,davalintide,calrl_human,CALCRL,ASH_Sep2016_328,Anti-obesity,Peptide ,2,2008.0,discontinued,in trial,Calcitonin receptors,GPCR;Secretin,not established,davalintide,Q16602,agonist,
288,0,Class A (Rhodopsin),protein,modimelanotide,mshr_human,MC1R,ASH_Sep2016_259,acute kidney injury,Peptide ,2,2013.0,discontinued,in trial,Melanocortin receptors,GPCR;Rhodopsin,not established,modimelanotide,Q01726,agonist,
289,0,Class A (Rhodopsin),protein,modimelanotide,mc3r_human,MC3R,ASH_Sep2016_261,acute kidney injury,Peptide ,2,2013.0,discontinued,in trial,Melanocortin receptors,GPCR;Rhodopsin,not established,modimelanotide,P41968,agonist,
290,0,Class A (Rhodopsin),small molecule,piclozotan,5ht1a_human,HTR1A,ASH_Sep2016_3,stroke,Aminergic ,2,2008.0,discontinued,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,piclozotan,P08908,agonist,
291,0,Class A (Rhodopsin),small molecule,vabicaserin,5ht2a_human,HTR2A,ASH_Sep2016_22,schizophrenia,Aminergic ,2,2008.0,discontinued,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,vabicaserin,P28223,agonist,
292,0,Class A (Rhodopsin),small molecule,vabicaserin,5ht2b_human,HTR2B,ASH_Sep2016_27,schizophrenia,Aminergic ,2,2008.0,discontinued,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,vabicaserin,P41595,agonist,
293,0,Class A (Rhodopsin),small molecule,vabicaserin,5ht2c_human,HTR2C,ASH_Sep2016_39,schizophrenia,Aminergic ,2,2008.0,discontinued,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,vabicaserin,P28335,agonist,
294,0,Class A (Rhodopsin),small molecule,apadenoson,aa2ar_human,ADORA2A,ASH_Sep2016_315,atrial fibrillation,Nucleotide ,3,2011.0,discontinued,in trial,Adenosine receptors,GPCR;Rhodopsin,established,apadenoson,P29274,agonist,
295,0,Class A (Rhodopsin),small molecule,cinalukast,cltr1_human,CYSLTR1,NRDD106,Anti-Asthmatic,Lipid ,1,2005.0,discontinued,in trial,Leukotriene receptors,GPCR;Rhodopsin,established,-,Q9Y271,antagonist,
296,0,Class A (Rhodopsin),small molecule,alb-127158(a),mshr_human,MC1R,100,Anti-obesity,Peptide ,1,2011.0,discontinued,in trial,Melanocortin receptors,GPCR;Rhodopsin,not established,alb-127158(a),Q01726,antagonist,UK
297,0,Class A (Rhodopsin),small molecule,alks 33,oprd_human,OPRD1,115,alcohol dependance; Anti-depressant,Peptide ,1,2008.0,discontinued,in trial,Opioid receptors,GPCR;Rhodopsin,established,"alks 29, Baclofen+samidorphan",P41143,antagonist,
298,0,Class A (Rhodopsin),small molecule,alks 33,oprk_human,OPRK1,115,alcohol dependance; Anti-depressant,Peptide ,1,2008.0,discontinued,in trial,Opioid receptors,GPCR;Rhodopsin,established,"alks 29, Baclofen+samidorphan",P41145,antagonist,
299,0,Class A (Rhodopsin),small molecule,alks 33,oprm_human,OPRM1,115,alcohol dependance; Anti-depressant,Peptide ,1,2008.0,discontinued,in trial,Opioid receptors,GPCR;Rhodopsin,established,"alks 29, Baclofen+samidorphan",P35372,antagonist,
300,0,Class A (Rhodopsin),small molecule,am-831,acm1_human,CHRM1,MMAmay2016_0047,Antipsychotic ; schizophrenia,Aminergic ,1,2011.0,discontinued,in trial,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,am-831,P11229,antagonist,
301,0,Class A (Rhodopsin),small molecule,am-831,drd2_human,DRD2,MMAmay2016_0048,Antipsychotic ; schizophrenia,Aminergic ,1,2011.0,discontinued,in trial,Dopamine receptors,GPCR;Rhodopsin,established,am-831,P14416,antagonist,
302,0,Class A (Rhodopsin),small molecule,am-831,5ht2a_human,HTR2A,MMAmay2016_0049,Antipsychotic ; schizophrenia,Aminergic ,1,2011.0,discontinued,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,am-831,P28223,antagonist,
303,0,Class A (Rhodopsin),small molecule,amisulpride,drd2_human,DRD2,161,schizophrenia,Aminergic ,1,1999.0,discontinued,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"amisulpride,solian",P14416,antagonist,Amulsipride is marketed in Europe for schizophrenia but not past Phase 1 trials in US
304,0,Class A (Rhodopsin),small molecule,amisulpride,drd3_human,DRD3,161,schizophrenia,Aminergic ,1,1999.0,discontinued,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"amisulpride,solian",P35462,antagonist,Amulsipride is marketed in Europe for schizophrenia but not past Phase 1 trials in US
305,0,Class A (Rhodopsin),small molecule,avn-322,5ht6r_human,HTR6,292,Alzheimer's disease,Aminergic ,1,2010.0,discontinued,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,avn-322,P50406,antagonist,
306,0,Class B1 (Secretin),antisense oligo,isis 325568,glr_human,GCGR,1030,Antidiabetic,Peptide ,1,2007.0,discontinued,in trial,Glucagon receptor family,GPCR;Secretin,established,isis 325568,P47871,antagonist,
307,0,Class A (Rhodopsin),small molecule,msx-122,cxcr4_human,CXCR4,1354,Antineoplastic,Protein ,1,2007.0,discontinued,in trial,Chemokine receptors,GPCR;Rhodopsin,established,msx-122,P61073,antagonist,
308,0,Class A (Rhodopsin),small molecule,pw2101,adrb2_human,ADRB2,1690,Antihypertensive,Aminergic ,1,2005.0,discontinued,in trial,Adrenoceptors,GPCR;Rhodopsin,established,pw2101,P07550,antagonist,
309,0,Class A (Rhodopsin),small molecule,v24343,cnr1_human,CNR1,2112,Anti-obesity,Lipid ,1,2008.0,discontinued,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,v24343,P21554,antagonist,
310,0,Class A (Rhodopsin),small molecule,acp-104,drd2_human,DRD2,47,schizophrenia,Aminergic ,2,2007.0,discontinued,in trial,Dopamine receptors,GPCR;Rhodopsin,established,acp-104,P14416,antagonist,
311,0,Class A (Rhodopsin),small molecule,acp-104,drd3_human,DRD3,47,schizophrenia,Aminergic ,2,2007.0,discontinued,in trial,Dopamine receptors,GPCR;Rhodopsin,established,acp-104,P35462,antagonist,
312,0,Class A (Rhodopsin),small molecule,alks 37,oprd_human,OPRD1,117,motilitant,Peptide ,2,2011.0,discontinued,in trial,Opioid receptors,GPCR;Rhodopsin,established,alks 37,P41143,antagonist,
313,0,Class A (Rhodopsin),small molecule,alks 37,oprk_human,OPRK1,117,motilitant,Peptide ,2,2011.0,discontinued,in trial,Opioid receptors,GPCR;Rhodopsin,established,alks 37,P41145,antagonist,
314,0,Class A (Rhodopsin),small molecule,alks 37,oprm_human,OPRM1,117,motilitant,Peptide ,2,2011.0,discontinued,in trial,Opioid receptors,GPCR;Rhodopsin,established,alks 37,P35372,antagonist,
315,0,Class A (Rhodopsin),small molecule,amd-070,cxcr4_human,CXCR4,150,antiviral ; HIV,Protein ,2,2004.0,discontinued,in trial,Chemokine receptors,GPCR;Rhodopsin,established,amd-070,P61073,antagonist,
316,0,Class A (Rhodopsin),small molecule,anatibant,bkrb2_human,BDKRB2,177,traumatic brain injury,Peptide ,2,2007.0,discontinued,in trial,Bradykinin receptors,GPCR;Rhodopsin,established,anatibant,P30411,antagonist,
317,0,Class A (Rhodopsin),small molecule,av608,nk1r_human,TACR1,278,Anti-depressant; irritable bowel syndrome; antispasmodic,Peptide ,2,2006.0,discontinued,in trial,Tachykinin receptors,GPCR;Rhodopsin,established,av608,P25103,antagonist,
318,0,Class A (Rhodopsin),small molecule,ave-1625,cnr1_human,CNR1,284,Anti-obesity ; Alzheimer's disease,Lipid ,2,2007.0,discontinued,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,ave-1625,P21554,antagonist,
319,0,Class A (Rhodopsin),small molecule,azd2423,ccr2_human,CCR2,2331,chronic obstructive pulmonary disorder;Analgesics; neuropathic pain,Protein ,2,2010.0,discontinued,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,azd2423,P41597,antagonist,
320,0,Class A (Rhodopsin),small molecule,bgc20-1531 ,pe2r4_human,PTGER4,347,Anti-migraine,Lipid ,2,2009.0,discontinued,in trial,Prostanoid receptors,GPCR;Rhodopsin,established,bgc20-1531,P35408,antagonist,
321,0,Class A (Rhodopsin),protein,ctce-9908,cxcr4_human,CXCR4,2376,Antineoplastic,Protein ,2,2007.0,discontinued,in trial,Chemokine receptors,GPCR;Rhodopsin,established,ctce-9908,P61073,antagonist,
322,0,Class A (Rhodopsin),small molecule,dg041,pe2r3_human,PTGER3,629,Platelet Aggregation Inhibitor,Lipid ,2,2006.0,discontinued,in trial,Prostanoid receptors,GPCR;Rhodopsin,established,dg041,P43115,antagonist,Iceland
323,0,Class A (Rhodopsin),small molecule,elinogrel,p2y12_human,P2RY12,701,antiplatelet,Nucleotide ,2,2008.0,discontinued,in trial,P2Y receptors,GPCR;Rhodopsin,established,"elinogrel, prt060128, adp receptor antagonist",Q9H244,antagonist,
324,0,Class A (Rhodopsin),small molecule,fipamezole,ada2a_human,ADRA2A,795,Antiparkinson,Aminergic ,2,2010.0,discontinued,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"fipamezole , jp-1730",P08913,antagonist,
325,0,Class A (Rhodopsin),small molecule,fipamezole,ada2b_human,ADRA2B,796,Antiparkinson,Aminergic ,2,2010.0,discontinued,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"fipamezole, jp-1730",P18089,antagonist,
326,0,Class A (Rhodopsin),small molecule,fipamezole,ada2c_human,ADRA2C,796,Antiparkinson,Aminergic ,2,2010.0,discontinued,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"fipamezole, jp-1730",P18825,antagonist,
327,0,Class A (Rhodopsin),small molecule,fk352b,aa1r_human,ADORA1,799,Antihypertensive,Nucleotide ,2,2005.0,discontinued,in trial,Adenosine receptors,GPCR;Rhodopsin,established,fk352b,P30542,antagonist,
328,0,Class A (Rhodopsin),small molecule,gsk-1004723,hrh1_human,HRH1,878,Anti-Allergic,Aminergic ,2,2009.0,discontinued,in trial,Histamine receptors,GPCR;Rhodopsin,established,gsk-1004723,P35367,antagonist,
329,0,Class A (Rhodopsin),small molecule,gsk-1004723,hrh3_human,HRH3,878,Anti-Allergic,Aminergic ,2,2009.0,discontinued,in trial,Histamine receptors,GPCR;Rhodopsin,established,gsk-1004723,Q9Y5N1,antagonist,
330,0,Class B1 (Secretin),protein,gtp-010,glp1r_human,GLP1R,885,irritable bowel syndrome,Peptide ,2,2008.0,discontinued,in trial,Glucagon receptor family,GPCR;Secretin,established,gtp-010,P43220,antagonist,
331,0,Class A (Rhodopsin),small molecule,incb3284,ccr2_human,CCR2,966,Anti-inflammatory ; DMARD,Protein ,2,2005.0,discontinued,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,incb3284,P41597,antagonist,
332,0,Class A (Rhodopsin),unknown,ins-50589,p2y12_human,P2RY12,992,antithrombotic,Nucleotide ,2,2006.0,discontinued,in trial,P2Y receptors,GPCR;Rhodopsin,established,ins-50589,Q9H244,antagonist,
333,0,Class A (Rhodopsin),small molecule,tedatioxetine,ada1a_human,ADRA1A,1173,Anti-depressant,Aminergic ,2,2009.0,discontinued,in trial,Adrenoceptors,GPCR;Rhodopsin,established,lu aa24530,P35348,antagonist,discontinued for strategic reasons
334,0,Class A (Rhodopsin),small molecule,tedatioxetine,5ht2c_human,HTR2C,1173,Anti-depressant,Aminergic ,2,2009.0,discontinued,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,lu aa24530,P28335,antagonist,discontinued for strategic reasons
335,0,Class A (Rhodopsin),small molecule,m0002,v2r_human,AVPR2,1204,ascites,Peptide ,2,2010.0,discontinued,in trial,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,m0002,P30518,antagonist,
336,0,Class A (Rhodopsin),small molecule,mc-4232 + mc-1,lpar4_human,LPAR4,1227,cardioprotectant,Lipid ,2,2005.0,discontinued,in trial,Lysophospholipid (LPA) receptors,GPCR;Rhodopsin,not established,mc-4232 + mc-1,Q99677,antagonist,
337,0,Class A (Rhodopsin),small molecule,mc-4232 + mc-1,lpar6_human,LPAR6,1227,cardioprotectant,Lipid ,2,2005.0,discontinued,in trial,Lysophospholipid (LPA) receptors,GPCR;Rhodopsin,not established,mc-4232 + mc-1,P43657,antagonist,
338,0,Class A (Rhodopsin),small molecule,mc-4232 + mc-1,p2ry1_human,P2RY1,1227,cardioprotectant,Nucleotide ,2,2005.0,discontinued,in trial,P2Y receptors,GPCR;Rhodopsin,not established,mc-4232 + mc-1,P47900,antagonist,
339,0,Class A (Rhodopsin),small molecule,mc-4232 + mc-1,p2y10_human,P2RY10,1227,cardioprotectant,Orphan ,2,2005.0,discontinued,in trial,Class A orphans,GPCR;Rhodopsin,not established,mc-4232 + mc-1,O00398,antagonist,
340,0,Class A (Rhodopsin),small molecule,mc-4232 + mc-1,p2y11_human,P2RY11,1227,cardioprotectant,Nucleotide ,2,2005.0,discontinued,in trial,P2Y receptors,GPCR;Rhodopsin,not established,mc-4232 + mc-1,Q96G91,antagonist,
341,0,Class A (Rhodopsin),small molecule,mc-4232 + mc-1,p2y12_human,P2RY12,1227,cardioprotectant,Nucleotide ,2,2005.0,discontinued,in trial,P2Y receptors,GPCR;Rhodopsin,established,mc-4232 + mc-1,Q9H244,antagonist,
342,0,Class A (Rhodopsin),small molecule,mc-4232 + mc-1,p2y13_human,P2RY13,1227,cardioprotectant,Nucleotide ,2,2005.0,discontinued,in trial,P2Y receptors,GPCR;Rhodopsin,not established,mc-4232 + mc-1,Q9BPV8,antagonist,
343,0,Class A (Rhodopsin),small molecule,mc-4232 + mc-1,p2y14_human,P2RY14,1227,cardioprotectant,Nucleotide ,2,2005.0,discontinued,in trial,P2Y receptors,GPCR;Rhodopsin,not established,mc-4232 + mc-1,Q15391,antagonist,
344,0,Class A (Rhodopsin),small molecule,mc-4232 + mc-1,p2ry2_human,P2RY2,1227,cardioprotectant,Nucleotide ,2,2005.0,discontinued,in trial,P2Y receptors,GPCR;Rhodopsin,not established,mc-4232 + mc-1,P41231,antagonist,
345,0,Class A (Rhodopsin),small molecule,mc-4232 + mc-1,p2ry4_human,P2RY4,1227,cardioprotectant,Nucleotide ,2,2005.0,discontinued,in trial,P2Y receptors,GPCR;Rhodopsin,not established,mc-4232 + mc-1,P51582,antagonist,
346,0,Class A (Rhodopsin),small molecule,mc-4232 + mc-1,p2ry6_human,P2RY6,1227,cardioprotectant,Nucleotide ,2,2005.0,discontinued,in trial,P2Y receptors,GPCR;Rhodopsin,not established,mc-4232 + mc-1,Q15077,antagonist,
347,0,Class A (Rhodopsin),small molecule,mc-4232 + mc-1,p2ry8_human,P2RY8,1227,cardioprotectant,Orphan ,2,2005.0,discontinued,in trial,Class A orphans,GPCR;Rhodopsin,not established,mc-4232 + mc-1,Q86VZ1,antagonist,
348,0,Class A (Rhodopsin),antibody,mln-1202,ccr2_human,CCR2,1310,Anti-inflammatory ; DMARD; Diabetic neophropathy,Protein ,2,2009.0,discontinued,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,mln-1202,P41597,antagonist,
349,0,Class A (Rhodopsin),small molecule,ngd-4715,mchr1_human,MCHR1,1408,Appetite suppressant,Peptide ,2,2008.0,discontinued,in trial,Melanin-concentrating hormone,GPCR;Rhodopsin,not established,ngd-4715,Q99705,antagonist,
350,0,Class A (Rhodopsin),small molecule,nxn-188,5ht1b_human,HTR1B,1460,Anti-migraine,Aminergic ,2,2009.0,discontinued,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,nxn-188,P28222,antagonist,
351,0,Class A (Rhodopsin),small molecule,nxn-188,5ht1d_human,HTR1D,1460,Anti-migraine,Aminergic ,2,2009.0,discontinued,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,nxn-188,P28221,antagonist,
352,0,Class A (Rhodopsin),small molecule,opc-28326,ada2b_human,ADRA2B,1501,vasodilator,Aminergic ,2,2006.0,discontinued,in trial,Adrenoceptors,GPCR;Rhodopsin,established,opc-28326,P18089,antagonist,
353,0,Class A (Rhodopsin),small molecule,opc-28326,ada2c_human,ADRA2C,1501,vasodilator,Aminergic ,2,2007.0,discontinued,in trial,Adrenoceptors,GPCR;Rhodopsin,established,opc-28326,P18825,antagonist,
354,0,Class A (Rhodopsin),small molecule,ot-730,adrb1_human,ADRB1,1533,Antiglaucomic,Aminergic ,2,2009.0,discontinued,in trial,Adrenoceptors,GPCR;Rhodopsin,established,ot-730,P08588,antagonist,
355,0,Class A (Rhodopsin),small molecule,ot-730,adrb2_human,ADRB2,1533,Antiglaucomic,Aminergic ,2,2009.0,discontinued,in trial,Adrenoceptors,GPCR;Rhodopsin,established,ot-730,P07550,antagonist,
356,0,Class A (Rhodopsin),small molecule,psd-506,acm2_human,CHRM2,1676,overactive bladder,Aminergic ,2,2009.0,discontinued,in trial,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,psd-506,P08172,antagonist,
357,0,Class A (Rhodopsin),small molecule,psd-506,acm3_human,CHRM3,1676,overactive bladder,Aminergic ,2,2009.0,discontinued,in trial,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,psd-506,P20309,antagonist,
358,0,Class A (Rhodopsin),small molecule,rev131,hrh4_human,HRH4,1745,Anti-Allergic,Aminergic ,2,2006.0,discontinued,in trial,Histamine receptors,GPCR;Rhodopsin,established,rev131,Q9H3N8,antagonist,
359,0,Class C (Glutamate) ,small molecule,ro4917523,grm5_human,GRM5,MMAmay2016_0177,"Major depressive disorder, Fragile X syndrome",Amino acid ,2,2012.0,discontinued,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,established,ro4917523,P41594,antagonist,discontinued due to negative results
360,0,Class C (Glutamate) ,small molecule,ronacaleret,casr_human,CASR,1782,Anti-osteoporotic,Ion ,2,2007.0,discontinued,in trial,Calcium-sensing receptors,GPCR;Glutamate,established,"ronacaleret, 751689",P41180,antagonist,discontinued due to lack of evidence of efficacy
361,0,Class A (Rhodopsin),small molecule,sch-527123,cxcr1_human,CXCR1,1822,chronic obstructive pulmonary disease (COPD),Protein ,2,2009.0,discontinued,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,"sch-527123, ps-291822, ps-938285, navarixin",P25024,antagonist,
362,0,Class A (Rhodopsin),small molecule,sch-527123,cxcr2_human,CXCR2,1822,chronic obstructive pulmonary disease (COPD),Protein ,2,2009.0,discontinued,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,"sch-527123, ps-291822, ps-938285, navarixin",P25025,antagonist,
363,0,Class A (Rhodopsin),peptide,ozarelix,gnrhr_human,GNRHR,1891,Antineoplastic,Peptide ,2,2010.0,discontinued,in trial,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,"spi-153, d-63153,ozarelix",P30968,antagonist,
364,0,Class A (Rhodopsin),peptide,ozarelix,gnrr2_human,GNRHR2,1891,Antineoplastic,Peptide ,2,2010.0,discontinued,in trial,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,"spi-153, d-63153,ozarelix",Q96P88,antagonist,
365,0,Class A (Rhodopsin),small molecule,surinabant,cnr1_human,CNR1,1917,"smoking-cessation, obesity",Lipid ,2,2007.0,discontinued,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,"surinabant, sr 147778",P21554,antagonist,
366,0,Class A (Rhodopsin),small molecule,talnetant,nk3r_human,TACR3,1943,schizophrenia,Peptide ,2,2006.0,discontinued,in trial,Tachykinin receptors,GPCR;Rhodopsin,not established,"talnetant, sb 223412",P29371,antagonist,
367,0,Class A (Rhodopsin),antisense oligo,tpi-asm8,ccr3_human,CCR3,2049,Anti-Asthmatic,Protein ,2,2010.0,discontinued,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,tpi-asm8,P51677,antagonist,
368,0,Class A (Rhodopsin),small molecule,SL 650472,5ht1b_human,HTR1B,2074,intermittent claudication,Aminergic ,2,2006.0,discontinued,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"trelanserin, sl 65.0472",P28222,antagonist,
369,0,Class A (Rhodopsin),small molecule,SL 650472,5ht2a_human,HTR2A,2074,intermittent claudication,Aminergic ,2,2006.0,discontinued,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"trelanserin, sl 65.0472",P28223,antagonist,
370,0,Class A (Rhodopsin),small molecule,velneperit,npy5r_human,NPY5R,2144,Anti-obesity,Peptide ,2,2010.0,discontinued,in trial,Neuropeptide Y receptors,GPCR;Rhodopsin,not established,"velneperit, s-2367",Q15761,antagonist,
371,0,Class A (Rhodopsin),small molecule,vestipitant,nk1r_human,TACR1,2148,tinnitus; hypnotic,Peptide ,2,2012.0,discontinued,in trial,Tachykinin receptors,GPCR;Rhodopsin,established,"vestipitant, gw 597599",P25103,antagonist,
372,0,Class A (Rhodopsin),small molecule,biib014,aa2ar_human,ADORA2A,2164,Antiparkinson,Nucleotide ,2,2006.0,discontinued,in trial,Adenosine receptors,GPCR;Rhodopsin,established,vipadenantis,P29274,antagonist,
373,0,Class A (Rhodopsin),small molecule,vofopitant,nk1r_human,TACR1,2170,post-traumatic stress disorder; hypnotic,Peptide ,2,2008.0,discontinued,in trial,Tachykinin receptors,GPCR;Rhodopsin,established,"vofopitant, gr-205171",P25103,antagonist,
374,0,Class A (Rhodopsin),small molecule,ym-598,ednra_human,EDNRA,2230,Antineoplastic,Peptide ,2,2002.0,discontinued,in trial,Endothelin receptors,GPCR;Rhodopsin,established,ym-598,P25101,antagonist,
375,0,Class A (Rhodopsin),small molecule,tasosartan,agtr1_human,AGTR1,NRDD509,Antihypertensive,Peptide ,3,2000.0,discontinued,in trial,Angiotensin receptors,GPCR;Rhodopsin,established,-,P30556,antagonist,Disontinued due to safety profile
376,0,Class A (Rhodopsin),small molecule,almorexant,ox1r_human,HCRTR1,119,sleep disorder treatment,Peptide ,3,2009.0,discontinued,in trial,Orexin receptors,GPCR;Rhodopsin,established,"almorexant, act-078573",O43613,antagonist,Not marketed-dropped in 2011 because of side effects profile
377,0,Class A (Rhodopsin),small molecule,almorexant,ox2r_human,HCRTR2,119,sleep disorder treatment,Peptide ,3,2009.0,discontinued,in trial,Orexin receptors,GPCR;Rhodopsin,established,"almorexant, act-078573",O43614,antagonist,Not marketed-dropped in 2011 because of side effects profile
378,0,Class A (Rhodopsin),small molecule,atrasentan,ednra_human,EDNRA,270,Antineoplastic,Peptide ,3,2005.0,discontinued,in trial,Endothelin receptors,GPCR;Rhodopsin,established,"atrasentan, abt-627,xinlay",P25101,antagonist,discontinued for this indication
379,0,Class A (Rhodopsin),small molecule,casopitant,nk1r_human,TACR1,436,Antiemetics,Peptide ,3,2009.0,discontinued,in trial,Tachykinin receptors,GPCR;Rhodopsin,established,"casopitant mesilate, 679769,rezonic, zunrisa",P25103,antagonist,discontinued due to safety data
380,0,Class A (Rhodopsin),small molecule,darusentan,ednra_human,EDNRA,599,Antihypertensive,Peptide ,3,2006.0,discontinued,in trial,Endothelin receptors,GPCR;Rhodopsin,established,darusentan,P25101,antagonist,
381,0,Class A (Rhodopsin),small molecule,dexloxiglumide,cckar_human,CCKAR,626,motilitant,Peptide ,3,2005.0,discontinued,in trial,Cholecystokinin receptors,GPCR;Rhodopsin,established,"dexloxiglumide, cr 2017",P32238,antagonist,
382,0,Class A (Rhodopsin),small molecule,esmirtazapine,ada2a_human,ADRA2A,732,insomnia; menopausal symptoms,Aminergic ,3,2009.0,discontinued,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"esmirtazapine, org-4420",P08913,antagonist,discontinued by Organon
383,0,Class A (Rhodopsin),small molecule,esmirtazapine,5ht2a_human,HTR2A,732,insomnia; menopausal symptoms,Aminergic ,3,2009.0,discontinued,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"esmirtazapine, org-4420",P28223,antagonist,discontinued by Organon
384,0,Class A (Rhodopsin),small molecule,iferanserin,5ht2a_human,HTR2A,MMAmay2016_0414,Antihemorrhoidal,Aminergic ,3,2011.0,discontinued,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"iferanserin ointment, ven 309",P28223,antagonist,
385,0,Class A (Rhodopsin),peptide,nemifitide,5ht2a_human,HTR2A,983,Anti-depressant,Aminergic ,3,2010.0,discontinued,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"inn-00835, nemifitide",P28223,antagonist,Dates approximate - difficult to get info
386,0,Class A (Rhodopsin),small molecule,mc-1,lpar4_human,LPAR4,1227,cardioprotectant,Lipid ,3,2006.0,discontinued,in trial,Lysophospholipid (LPA) receptors,GPCR;Rhodopsin,not established,mc-1,Q99677,antagonist,"Had been mislabeled with trial name as mc-4232, but this is mc-1"
387,0,Class A (Rhodopsin),small molecule,mc-1,lpar6_human,LPAR6,1227,cardioprotectant,Lipid ,3,2006.0,discontinued,in trial,Lysophospholipid (LPA) receptors,GPCR;Rhodopsin,not established,mc-1,P43657,antagonist,"Had been mislabeled with trial name as mc-4232, but this is mc-2"
388,0,Class A (Rhodopsin),small molecule,mc-1,p2ry1_human,P2RY1,1227,cardioprotectant,Nucleotide ,3,2006.0,discontinued,in trial,P2Y receptors,GPCR;Rhodopsin,not established,mc-1,P47900,antagonist,"Had been mislabeled with trial name as mc-4232, but this is mc-3"
389,0,Class A (Rhodopsin),small molecule,mc-1,p2ry4_human,P2RY4,1227,cardioprotectant,Nucleotide ,3,2006.0,discontinued,in trial,P2Y receptors,GPCR;Rhodopsin,not established,mc-1,P51582,antagonist,"Had been mislabeled with trial name as mc-4232, but this is mc-4"
390,0,Class A (Rhodopsin),small molecule,mc-1,p2y11_human,P2RY11,1227,cardioprotectant,Nucleotide ,3,2006.0,discontinued,in trial,P2Y receptors,GPCR;Rhodopsin,not established,mc-1,Q96G91,antagonist,"Had been mislabeled with trial name as mc-4232, but this is mc-5"
391,0,Class A (Rhodopsin),small molecule,mc-1,p2y13_human,P2RY13,1227,cardioprotectant,Nucleotide ,3,2006.0,discontinued,in trial,P2Y receptors,GPCR;Rhodopsin,not established,mc-1,Q9BPV8,antagonist,"Had been mislabeled with trial name as mc-4232, but this is mc-6"
392,0,Class A (Rhodopsin),small molecule,mc-1,p2y14_human,P2RY14,1227,cardioprotectant,Nucleotide ,3,2006.0,discontinued,in trial,P2Y receptors,GPCR;Rhodopsin,not established,mc-1,Q15391,antagonist,"Had been mislabeled with trial name as mc-4232, but this is mc-7"
393,0,Class A (Rhodopsin),small molecule,mc-1,p2ry8_human,P2RY8,1227,cardioprotectant,Orphan ,3,2006.0,discontinued,in trial,Class A orphans,GPCR;Rhodopsin,not established,mc-1,Q86VZ1,antagonist,"Had been mislabeled with trial name as mc-4232, but this is mc-8"
394,0,Class A (Rhodopsin),small molecule,mc-1,p2y10_human,P2RY10,1227,cardioprotectant,Orphan ,3,2006.0,discontinued,in trial,Class A orphans,GPCR;Rhodopsin,not established,mc-1,O00398,antagonist,"Had been mislabeled with trial name as mc-4232, but this is mc-9"
395,0,Class A (Rhodopsin),small molecule,laropiprant,pd2r_human,PTGDR,1300,for counteracting niacin-induced flushing,Lipid ,3,2007.0,discontinued,in trial,Prostanoid receptors,GPCR;Rhodopsin,established,"mk-0524a, er niacin/laropiprant,tredaptive, trevaclyn, pelzont",Q13258,antagonist,Side effects
396,0,Class A (Rhodopsin),small molecule,laropiprant,pd2r_human,PTGDR,1301,for counteracting niacin-induced flushing,Lipid ,3,2007.0,discontinued,in trial,Prostanoid receptors,GPCR;Rhodopsin,established,"mk-0542b, extended release niacin + laropiprant +simvastatin",Q13258,antagonist,Side effects
397,0,Class A (Rhodopsin),small molecule,preladenant,aa2ar_human,ADORA2A,1645,Antiparkinson,Nucleotide ,3,2011.0,discontinued,in trial,Adenosine receptors,GPCR;Rhodopsin,established,"preladenant, sch-420814",P29274,antagonist,
398,0,Class A (Rhodopsin),small molecule,renzapride,5ht2a_human,HTR2A,1734,irritable bowel syndrome,Aminergic ,3,2008.0,discontinued,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,renzapride,P28223,antagonist,Terminated due to insufficient over placebo in study
399,0,Class A (Rhodopsin),small molecule,renzapride,5ht2b_human,HTR2B,1734,irritable bowel syndrome,Aminergic ,3,2008.0,discontinued,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,renzapride,P41595,antagonist,Terminated due to insufficient over placebo in study
400,0,Class A (Rhodopsin),small molecule,renzapride,5ht2c_human,HTR2C,1734,irritable bowel syndrome,Aminergic ,3,2008.0,discontinued,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,renzapride,P28335,antagonist,Terminated due to insufficient over placebo in study
401,0,Class A (Rhodopsin),small molecule,rolofylline,aa1r_human,ADORA1,1780,congestive heart failure,Nucleotide ,3,2007.0,discontinued,in trial,Adenosine receptors,GPCR;Rhodopsin,established,"rolofylline, mk-7418, kw-3902",P30542,antagonist,
402,0,Class A (Rhodopsin),small molecule,vicriviroc,ccr5_human,CCR5,2157,antiviral ; HIV,Protein ,3,2007.0,discontinued,in trial,Chemokine receptors,GPCR;Rhodopsin,established,vicriviroc,P51681,antagonist,
403,0,Class A (Rhodopsin),small molecule,volinanserin,5ht2a_human,HTR2A,2172,Hypnotics and Sedatives,Aminergic ,3,2008.0,discontinued,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,volinanserin,P28223,antagonist,discontinued due to absence of demonstration of efficacy of volinanserin in primary insomnia with predominant sleep maintenance problems
404,0,Class A (Rhodopsin),small molecule,zibotentan,ednra_human,EDNRA,2241,Antineoplastic,Peptide ,3,2008.0,discontinued,in trial,Endothelin receptors,GPCR;Rhodopsin,established,"zibotentan, zd-4054, azd-4054",P25101,antagonist,discontinued because early efficacy review by the Independent Data Monitoring Committee indicated it was unlikely to meet its primary efficacy endpoints
405,0,Class A (Rhodopsin),small molecule,yohimbine,ada2a_human,ADRA2A,NRDD564,Mydriatics; Anti-impotence,Aminergic ,Preclinical,2000.0,discontinued,in trial,Adrenoceptors,GPCR;Rhodopsin,established,-,P08913,antagonist,Inferred dates
406,0,Class A (Rhodopsin),small molecule,yohimbine,ada2b_human,ADRA2B,NRDD564,Mydriatics; Anti-impotence,Aminergic ,Preclinical,2000.0,discontinued,in trial,Adrenoceptors,GPCR;Rhodopsin,established,-,P18089,antagonist,Inferred dates
407,0,Class A (Rhodopsin),small molecule,yohimbine,ada2c_human,ADRA2C,NRDD564,Mydriatics; Anti-impotence,Aminergic ,Preclinical,2000.0,discontinued,in trial,Adrenoceptors,GPCR;Rhodopsin,established,-,P18825,antagonist,Inferred dates
408,0,Class F (Frizzled),small molecule,tak-441,smo_human,SMO,ASH_Sep2016_344,basal cell carcinoma,Protein ,1,2010.0,discontinued,in trial,Frizzled,GPCR;Frizzled,established,tak-441,Q99835,antagonist,
409,0,Class A (Rhodopsin),small molecule,amelubant,lt4r1_human,BLT1,ASH_Sep2016_302,chronic obstructive pulmonary disease (COPD),Lipid ,2,2014.0,discontinued,in trial,Leukotriene receptors,GPCR;Rhodopsin,not established,amelubant,Q15722,antagonist,Disontinued due to significant increase in pulmonary related serious adverse events 
410,0,Class A (Rhodopsin),small molecule,atopaxar,par1_human,F2R,ASH_Sep2016_282,acute coronary syndrome,Peptide ,2,2007.0,discontinued,in trial,Proteinase-activated receptors,GPCR;Rhodopsin,established,atopaxar,P25116,antagonist,
411,0,Class A (Rhodopsin),small molecule,azd1981,pd2r2_human,GPR44,ASH_Sep2016_311,Anti-Asthmatic,Lipid ,2,2014.0,discontinued,in trial,Prostanoid receptors,GPCR;Rhodopsin,not established,azd1981,Q9Y5Y4,antagonist,
412,0,Class A (Rhodopsin),small molecule,cerlapirdine,5ht6r_human,HTR6,ASH_Sep2016_43,Alzheimer's disease,Aminergic ,2,2009.0,discontinued,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,cerlapirdine,P50406,antagonist,
413,0,Class A (Rhodopsin),small molecule,drinabant,cnr1_human,CNR1,ASH_Sep2016_306,schizophrenia,Lipid ,2,2007.0,discontinued,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,drinabant,P21554,antagonist,discontinued due to insufficient level of efficacy
414,0,Class A (Rhodopsin),small molecule,elubrixin,cxcr2_human,CXCR2,ASH_Sep2016_300,ulcerative colitis,Protein ,2,2007.0,discontinued,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,elubrixin,P25025,antagonist,
415,0,Class B1 (Secretin),small molecule,emicerfont,crfr1_human,CRHR1,ASH_Sep2016_330,irritable bowel syndrome,Peptide ,2,2007.0,discontinued,in trial,Corticotropin-releasing factor receptors,GPCR;Secretin,not established,emicerfont,P34998,antagonist,
416,0,Class A (Rhodopsin),small molecule,gsk163090,5ht1a_human,HTR1A,ASH_Sep2016_5,unipolar depression,Aminergic ,2,2009.0,discontinued,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,gsk163090,P08908,antagonist,
417,0,Class A (Rhodopsin),small molecule,gsk163090,5ht1b_human,HTR1B,ASH_Sep2016_8,unipolar depression,Aminergic ,2,2009.0,discontinued,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,gsk163090,P28222,antagonist,
418,0,Class A (Rhodopsin),small molecule,gsk163090,5ht1d_human,HTR1D,ASH_Sep2016_9,unipolar depression,Aminergic ,2,2009.0,discontinued,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,gsk163090,P28221,antagonist,
419,0,Class A (Rhodopsin),small molecule,ly2590443,5ht7r_human,HTR7,ASH_Sep2016_46,Anti-migraine,Aminergic ,2,2008.0,discontinued,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,ly2590443,P34969,antagonist,
420,0,Class B1 (Secretin),small molecule,mk-0893,glr_human,GCGR,ASH_Sep2016_333,Antidiabetic,Peptide ,2,2013.0,discontinued,in trial,Glucagon receptor family,GPCR;Secretin,established,mk-0893,P47871,antagonist,
421,0,Class A (Rhodopsin),small molecule,odelepran,oprd_human,OPRD1,ASH_Sep2016_263,alcohol dependence,Peptide ,2,2008.0,discontinued,in trial,Opioid receptors,GPCR;Rhodopsin,established,odelepran,P41143,antagonist,
422,0,Class A (Rhodopsin),small molecule,odelepran,oprk_human,OPRK1,ASH_Sep2016_268,alcohol dependence,Peptide ,2,2008.0,discontinued,in trial,Opioid receptors,GPCR;Rhodopsin,established,odelepran,P41145,antagonist,
423,0,Class A (Rhodopsin),small molecule,odelepran,oprm_human,OPRM1,ASH_Sep2016_275,alcohol dependence,Peptide ,2,2008.0,discontinued,in trial,Opioid receptors,GPCR;Rhodopsin,established,odelepran,P35372,antagonist,
424,0,Class A (Rhodopsin),small molecule,pf-03654746,hrh3_human,HRH3,ASH_Sep2016_245,allergic rhinitis,Aminergic ,2,2011.0,discontinued,in trial,Histamine receptors,GPCR;Rhodopsin,established,pf-03654746,Q9Y5N1,antagonist,
425,0,Class A (Rhodopsin),small molecule,pf-03654764,hrh3_human,HRH3,ASH_Sep2016_244,allergic rhinitis,Aminergic ,2,2009.0,discontinued,in trial,Histamine receptors,GPCR;Rhodopsin,established,pf-03654764,Q9Y5N1,antagonist,
426,0,Class B1 (Secretin),small molecule,rimegepant,calrl_human,CALCRL,ASH_Sep2016_329,Anti-migraine,Peptide ,2,2011.0,discontinued,in trial,Calcitonin receptors,GPCR;Secretin,not established,rimegepant,Q16602,antagonist,
427,0,Class A (Rhodopsin),small molecule,vidupiprant,pd2r2_human,GPR44,ASH_Sep2016_310,Anti-Asthmatic,Lipid ,2,2009.0,discontinued,in trial,Prostanoid receptors,GPCR;Rhodopsin,not established,"vidupiprant, AMG853",Q9Y5Y4,antagonist,
428,0,Class A (Rhodopsin),small molecule,vidupiprant,pd2r_human,PTGDR,ASH_Sep2016_307,Anti-Asthmatic,Lipid ,2,2009.0,discontinued,in trial,Prostanoid receptors,GPCR;Rhodopsin,not established,"vidupiprant, AMG853",Q13258,antagonist,
429,0,Class A (Rhodopsin),small molecule,ibipinabant,cnr1_human,CNR1,ASH_Sep2016_305,Antidiabetic,Lipid ,3,2007.0,discontinued,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,ibipinabant,P21554,antagonist,
430,0,Class A (Rhodopsin),small molecule,darusentan,ednrb_human,EDNRB,ASH_Sep2016_253,Antihypertensive,Peptide ,3,2006.0,discontinued,in trial,Endothelin receptors,GPCR;Rhodopsin,established,darusentan,P24530,antagonist,
431,0,Class A (Rhodopsin),small molecule,esmirtazapine,ada2b_human,ADRA2B,ASH_Sep2016_146,insomnia,Aminergic ,3,2008.0,discontinued,in trial,Adrenoceptors,GPCR;Rhodopsin,established,esmirtazapine,P18089,antagonist,
432,0,Class A (Rhodopsin),small molecule,esmirtazapine,ada2c_human,ADRA2C,ASH_Sep2016_165,insomnia,Aminergic ,3,2008.0,discontinued,in trial,Adrenoceptors,GPCR;Rhodopsin,established,esmirtazapine,P18825,antagonist,
433,0,Class A (Rhodopsin),small molecule,esmirtazapine,hrh1_human,HRH1,ASH_Sep2016_237,insomnia,Aminergic ,3,2008.0,discontinued,in trial,Histamine receptors,GPCR;Rhodopsin,established,esmirtazapine,P35367,antagonist,
434,0,Class A (Rhodopsin),small molecule,esmirtazapine,5ht2c_human,HTR2C,ASH_Sep2016_38,insomnia,Aminergic ,3,2008.0,discontinued,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,esmirtazapine,P28335,antagonist,
435,0,Class A (Rhodopsin),small molecule,lecozotan,5ht1a_human,HTR1A,ASH_Sep2016_2,Alzheimer's disease,Aminergic ,3,2006.0,discontinued,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,lecozotan,P08908,antagonist,
436,0,Class B1 (Secretin),small molecule,pexacerfont,crfr1_human,CRHR1,ASH_Sep2016_331,anxiety,Peptide ,3,2008.0,discontinued,in trial,Corticotropin-releasing factor receptors,GPCR;Secretin,not established,pexacerfont,P34998,antagonist,
437,0,Class B1 (Secretin),small molecule,telcagepant,calrl_human,CALCRL,ASH_Sep2016_326,Anti-migraine,Peptide ,3,2008.0,discontinued,in trial,Calcitonin receptors,GPCR;Secretin,not established,telcagepant,Q16602,antagonist,
438,0,Class A (Rhodopsin),small molecule,tezosentan,ednra_human,EDNRA,ASH_Sep2016_251,heart failure,Peptide ,3,2006.0,discontinued,in trial,Endothelin receptors,GPCR;Rhodopsin,established,tezosentan,P25101,antagonist,
439,0,Class A (Rhodopsin),small molecule,tezosentan,ednrb_human,EDNRB,ASH_Sep2016_252,heart failure,Peptide ,3,2006.0,discontinued,in trial,Endothelin receptors,GPCR;Rhodopsin,established,tezosentan,P24530,antagonist,
440,0,Class A (Rhodopsin),small molecule,vercirnon,ccr9_human,CCR9,ASH_Sep2016_294,crohn's disease,Protein ,3,2011.0,discontinued,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,vercirnon,P51686,antagonist,
441,0,Class A (Rhodopsin),small molecule,tonabersat,5ht1d_human,HTR1D,2038,Anti-migraine,Aminergic ,2,2007.0,discontinued,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,tonabersat,P28221,inhibitor,
442,0,Class A (Rhodopsin),small molecule,acp-104,5ht2a_human,HTR2A,47,schizophrenia,Aminergic ,2,2007.0,discontinued,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,acp-104,P28223,inverse agonist,
443,0,Class A (Rhodopsin),small molecule,eplivanserine,5ht2a_human,HTR2A,721,insomnia,Aminergic ,3,2009.0,discontinued,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"eplivanserine, sr 46349,ciltyri",P28223,inverse agonist,Sanofi withdrew application for fda approval 2009
444,0,Class A (Rhodopsin),small molecule,eplivanserine,5ht2c_human,HTR2C,721,insomnia,Aminergic ,3,2009.0,discontinued,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"eplivanserine, sr 46349,ciltyri",P28335,inverse agonist,Sanofi withdrew application for fda approval 2009
445,0,Class A (Rhodopsin),small molecule,taranabant,cnr1_human,CNR1,1952,Anti-obesity ; smoking-cessation,Lipid ,3,2007.0,discontinued,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,"taranabant, mk-0364",P21554,inverse agonist,discontinued because overall profile does not support development for obesity
446,0,Class A (Rhodopsin),peptide,"ac-100,dentonin",pe2r1_human,PTGER1,29,dental ossificant,Lipid ,1,2010.0,discontinued,in trial,Prostanoid receptors,GPCR;Rhodopsin,established,"ac-100,dentonin",P34995,modulator,
447,0,Class A (Rhodopsin),peptide,"ac-100,dentonin",pe2r1_human,PTGER1,29,dental ossificant,Lipid ,1,2010.0,discontinued,in trial,Prostanoid receptors,GPCR;Rhodopsin,established,"ac-100,dentonin",P34995,modulator,
448,0,Class A (Rhodopsin),peptide,"ac-100,dentonin",pe2r2_human,PTGER2,29,periodontal ossificant,Lipid ,1,2010.0,discontinued,in trial,Prostanoid receptors,GPCR;Rhodopsin,established,"ac-100,dentonin",P43116,modulator,
449,0,Class A (Rhodopsin),peptide,"ac-100,dentonin",pe2r2_human,PTGER2,29,periodontal ossificant,Lipid ,1,2010.0,discontinued,in trial,Prostanoid receptors,GPCR;Rhodopsin,established,"ac-100,dentonin",P43116,modulator,
450,0,Class A (Rhodopsin),peptide,"ac-100,dentonin",pe2r3_human,PTGER3,29,periodontal ossificant,Lipid ,1,2010.0,discontinued,in trial,Prostanoid receptors,GPCR;Rhodopsin,established,"ac-100,dentonin",P43115,modulator,
451,0,Class A (Rhodopsin),peptide,"ac-100,dentonin",pe2r4_human,PTGER4,29,periodontal ossificant,Lipid ,1,2010.0,discontinued,in trial,Prostanoid receptors,GPCR;Rhodopsin,established,"ac-100,dentonin",P35408,modulator,
452,0,Class A (Rhodopsin),peptide,"ac-100,dentonin",pe2r4_human,PTGER4,29,periodontal ossificant,Lipid ,1,2010.0,discontinued,in trial,Prostanoid receptors,GPCR;Rhodopsin,established,"ac-100,dentonin",P35408,modulator,
453,0,Class A (Rhodopsin),unknown,lu 02-750,drd1_human,DRD1,1170,Antiparkinson,Aminergic ,1,2009.0,discontinued,in trial,Dopamine receptors,GPCR;Rhodopsin,established,lu 02-750,P21728,modulator,
454,0,Class A (Rhodopsin),unknown,lu 02-750,drd2_human,DRD2,1170,Antiparkinson,Aminergic ,1,2009.0,discontinued,in trial,Dopamine receptors,GPCR;Rhodopsin,established,lu 02-750,P14416,modulator,
455,0,Class A (Rhodopsin),unknown,lu 02-750,drd3_human,DRD3,1170,Antiparkinson,Aminergic ,1,2009.0,discontinued,in trial,Dopamine receptors,GPCR;Rhodopsin,established,lu 02-750,P35462,modulator,
456,0,Class A (Rhodopsin),unknown,lu 02-750,drd4_human,DRD4,1170,Antiparkinson,Aminergic ,1,2009.0,discontinued,in trial,Dopamine receptors,GPCR;Rhodopsin,established,lu 02-750,P21917,modulator,
457,0,Class A (Rhodopsin),unknown,lu 02-750,drd5_human,DRD5,1170,Antiparkinson,Aminergic ,1,2009.0,discontinued,in trial,Dopamine receptors,GPCR;Rhodopsin,established,lu 02-750,P21918,modulator,
458,0,Class C (Glutamate) ,small molecule,azd2066,grm5_human,GRM5,308,Analgesics; gastroesophageal reflux disease,Amino acid ,2,2010.0,discontinued,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,established,azd2066,P41594,modulator,
459,0,Class A (Rhodopsin),viral gene delivery,np2 enkephalin,oprd_human,DOR,2421,Analgesics,Peptide ,2,2011.0,discontinued,in trial,Opioid receptors,GPCR;Rhodopsin,established,np2 enkephalin,P41143,modulator,
460,0,Class C (Glutamate) ,small molecule,decoglurant,grm2_human,GRM2,ASH_Sep2016_336,unipolar depression,Amino acid ,2,2011.0,discontinued,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,decoglurant,Q14416,modulator,
461,0,Class C (Glutamate) ,small molecule,decoglurant,grm3_human,GRM3,ASH_Sep2016_338,unipolar depression,Amino acid ,2,2011.0,discontinued,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,decoglurant,Q14832,modulator,
462,0,Class A (Rhodopsin),small molecule,ccx832,cml1_human,CMKLR1,451,Anti-inflammatory ; for treatment for autoimmune disease,Protein ,1,2011.0,discontinued,in trial,Chemerin receptor,GPCR;Rhodopsin,not established,ccx832,Q99788,na,
463,0,Class A (Rhodopsin),vaccine,avicine,lshr_human,LHCGR,563,Antineoplastic,Protein ,1,1997.0,discontinued,in trial,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,"ctp-37,avicine",P22888,na,
464,0,Class A (Rhodopsin),protein,nu206,lgr4_human,LGR4,2528,gastrointestinal disease,Orphan ,1,2006.0,discontinued,in trial,Class A orphans,GPCR;Rhodopsin,not established,"nu206, r-spondin1",Q9BXB1,na,
465,0,Class A (Rhodopsin),protein,nu206,lgr5_human,LGR5,2528,gastrointestinal disease,Orphan ,1,2006.0,discontinued,in trial,Class A orphans,GPCR;Rhodopsin,not established,"nu206, r-spondin1",O75473,na,
466,0,Class A (Rhodopsin),protein,pa-401,cxcr1_human,CXCR1,1553,Anti-inflammatory ; immunosuppressant,Protein ,1,2012.0,discontinued,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,"pa-401, pa04-001",P25024,na,
467,0,Class A (Rhodopsin),protein,pa-401,cxcr2_human,CXCR2,1553,Anti-inflammatory ; immunosuppressant,Protein ,1,2012.0,discontinued,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,"pa-401, pa04-001",P25025,na,
468,0,Class A (Rhodopsin),small molecule,vr-147,5ht1b_human,HTR1B,2179,Anti-migraine,Aminergic ,1,2008.0,discontinued,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,vr-147,P28222,na,
469,0,Class A (Rhodopsin),small molecule,vr-147,5ht1d_human,HTR1D,2179,Anti-migraine,Aminergic ,1,2008.0,discontinued,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,vr-147,P28221,na,
470,0,Class A (Rhodopsin),small molecule,avn-397,5ht6r_human,HTR6,2490,Alzheimer's disease,Aminergic ,2,2010.0,discontinued,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,avn-397,P50406,na,Undefined or unknown MoA
471,0,Class A (Rhodopsin),peptide nucleic acid,avr118,aa2ar_human,ADORA2A,2269,"Antineoplastic agent, wound healing accelerant",Nucleotide ,2,2011.0,discontinued,in trial,Adenosine receptors,GPCR;Rhodopsin,established,"avr123, AVR118",P29274,na,
472,0,Class A (Rhodopsin),peptide nucleic acid,avr118,aa2br_human,ADORA2B,2269,"Antineoplastic agent, wound healing accelerant",Nucleotide ,2,2011.0,discontinued,in trial,Adenosine receptors,GPCR;Rhodopsin,established,"avr123, AVR118",P29275,na,
473,0,Class A (Rhodopsin),peptide nucleic acid,avr118,aa3r_human,ADORA3,2269,"Antineoplastic agent, wound healing accelerant",Nucleotide ,2,2011.0,discontinued,in trial,Adenosine receptors,GPCR;Rhodopsin,established,"avr123, AVR118",P0DMS8,na,
474,0,Class B1 (Secretin),peptide,ostabolin-c,pth1r_human,PTH1R,1530,Anti-osteoporotic,Peptide ,2,2008.0,discontinued,in trial,Parathyroid hormone receptors,GPCR;Secretin,established,"ostabolin-c,  zt-031",Q03431,na,Change within company direction
475,0,Class B1 (Secretin),peptide,ostabolin-c,pth2r_human,PTH2R,1530,Anti-osteoporotic,Peptide ,2,2008.0,discontinued,in trial,Parathyroid hormone receptors,GPCR;Secretin,established,"ostabolin-c,  zt-031",P49190,na,Change within company direction
476,0,Class A (Rhodopsin),small molecule,sou-001,ada1a_human,ADRA1A,1881,incontinence,Aminergic ,2,2006.0,discontinued,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"sou-001, drp-001",P35348,na,
477,0,Class A (Rhodopsin),small molecule,sou-001,ada1b_human,ADRA1B,1881,incontinence,Aminergic ,2,2006.0,discontinued,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"sou-001, drp-001",P35368,na,
478,0,Class A (Rhodopsin),small molecule,sou-001,ada1d_human,ADRA1D,1881,incontinence,Aminergic ,2,2006.0,discontinued,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"sou-001, drp-001",P25100,na,
479,0,Class A (Rhodopsin),injectible islet neogenesis therapy,tt-223,gasr_human,CCKBR,2092,Antidiabetic; injectable islet neogenesis therapy for diabetes,Peptide ,2,2008.0,discontinued,in trial,Cholecystokinin receptors,GPCR;Rhodopsin,established,tt-223,P32239,na,
480,0,Class B1 (Secretin),peptide,h-pth 1-34,pth1r_human,PTH1R,2153,Anti-osteoporotic,Peptide ,2,2009.0,discontinued,in trial,Parathyroid hormone receptors,GPCR;Secretin,established,viaderm hpth 1-34,Q03431,na,
481,0,Class B1 (Secretin),peptide,h-pth 1-34,pth2r_human,PTH2R,2153,Anti-osteoporotic,Peptide ,2,2009.0,discontinued,in trial,Parathyroid hormone receptors,GPCR;Secretin,established,viaderm hpth 1-34,P49190,na,
482,0,Class B1 (Secretin),peptide,corticotropin-releasing factor,crfr1_human,CRHR1,528,peritumoral brain edema,Peptide ,3,2005.0,discontinued,in trial,Corticotropin-releasing factor receptors,GPCR;Secretin,not established,"corticotropin-releasing factor,xerecept",P34998,na,
483,0,Class B1 (Secretin),peptide,corticotropin-releasing factor,crfr2_human,CRHR2,528,peritumoral brain edema,Peptide ,3,2005.0,discontinued,in trial,Corticotropin-releasing factor receptors,GPCR;Secretin,not established,"corticotropin-releasing factor,xerecept",Q13324,na,
484,0,Class B1 (Secretin),peptide,rg1068,sctr_human,SCTR,1749,"autism, schizophrenia",Peptide ,3,2004.0,discontinued,in trial,Glucagon receptor family,GPCR;Secretin,established,"rg1068, synthetic secretin,secreflo",P47872,na,
485,0,Class B1 (Secretin),peptide,rg1068,sctr_human,SCTR,1749,"autism, schizophrenia",Peptide ,3,2004.0,discontinued,in trial,Glucagon receptor family,GPCR;Secretin,established,"rg1068, synthetic secretin,secreflo",P47872,na,
486,0,Class C (Glutamate) ,small molecule,adx10059,grm5_human,GRM5,62,Anti-migraine ; gastroesophageal reflux disease,Amino acid ,2,2008.0,discontinued,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,established,adx10059,P41594,nam,
487,0,Class A (Rhodopsin),small molecule,nbi-42902,gnrhr_human,GNRHR,869,postmenopausal symptoms; Antineoplastic,Peptide ,2,2005.0,discontinued,in trial,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,"gnrh receptor antagonist, nbi-42902",P30968,inhibitor,
488,0,Class A (Rhodopsin),small molecule,nbi-42902,gnrr2_human,GNRHR2,869,postmenopausal symptoms; Antineoplastic,Peptide ,2,2005.0,discontinued,in trial,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,"gnrh receptor antagonist, nbi-42902",Q96P88,inhibitor,
489,0,Class A (Rhodopsin),small molecule,mitemcinal,mtlr_human,MLNR,1296,gastroparesis,Peptide ,2,2002.0,discontinued,in trial,Motilin receptors,GPCR;Rhodopsin,not established,"mitemcinal, gm-611",O43193,agonist,
490,0,Class A (Rhodopsin),small molecule,bifeprunox,drd3_human,DRD3,356,Antipsychotic ; Antiparkinson,Aminergic ,3,2009.0,discontinued,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"bifeprunox, du127090",P35462,antagonist,
491,0,Class A (Rhodopsin),small molecule,bifeprunox,5ht2a_human,HTR2A,356,Antipsychotic ; Antiparkinson,Aminergic ,3,2009.0,discontinued,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"bifeprunox, du127090",P28223,agonist,
492,0,Class A (Rhodopsin),small molecule,bifeprunox,5ht2c_human,HTR2C,356,Antipsychotic ; Antiparkinson,Aminergic ,3,2009.0,discontinued,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"bifeprunox, du127090",P28335,agonist,
493,0,Class A (Rhodopsin),small molecule,bifeprunox,5ht7r_human,HTR7,356,Antipsychotic ; Antiparkinson,Aminergic ,3,2009.0,discontinued,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"bifeprunox, du127090",P34969,agonist,
494,0,Class A (Rhodopsin),small molecule,saredutant,nk2r_human,TACR2,1810,Anti-depressant,Peptide ,3,2006.0,discontinued,in trial,Tachykinin receptors,GPCR;Rhodopsin,not established,"saredutant, sr 48968",P21452,antagonist,Sanofi-aventis discontinued due to reprioritization of RD portfolio
495,0,Class A (Rhodopsin),peptide,rusalatide,par1_human,F2R,2048,diabetic foot ulcers,Peptide ,3,2005.0,discontinued,in trial,Proteinase-activated receptors,GPCR;Rhodopsin,established,"tp-508,chrysalin",P25116,modulator,
496,0,Class A (Rhodopsin),peptide,rusalatide,par3_human,F2RL2,2048,diabetic foot ulcers,Peptide ,3,2005.0,discontinued,in trial,Proteinase-activated receptors,GPCR;Rhodopsin,established,"tp-508,chrysalin",O00254,modulator,
497,0,Class A (Rhodopsin),peptide,rusalatide,par4_human,F2RL3,2048,diabetic foot ulcers,Peptide ,3,2005.0,discontinued,in trial,Proteinase-activated receptors,GPCR;Rhodopsin,established,"tp-508,chrysalin",Q96RI0,modulator,
498,0,Class A (Rhodopsin),small molecule,aplindore,drd2_human,DRD2,203,Antiparkinson ; restlegs legs syndrome,Aminergic ,2,2008.0,discontinued,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"aplindore, dab-452",P14416,partial agonist,
499,0,Class A (Rhodopsin),small molecule,bifeprunox,drd2_human,DRD2,356,Antipsychotic ; Antiparkinson,Aminergic ,3,2009.0,discontinued,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"bifeprunox, du127090",P14416,partial agonist,
500,0,Class A (Rhodopsin),small molecule,bifeprunox,5ht1a_human,HTR1A,356,Antipsychotic ; Antiparkinson,Aminergic ,3,2009.0,discontinued,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"bifeprunox, du127090",P08908,partial agonist,
501,0,Class A (Rhodopsin),small molecule,saprisartan,agtr1_human,AGTR1,NRDD489,Antihypertensive,Peptide ,2,1997.0,discontinued,in trial,Angiotensin receptors,GPCR;Rhodopsin,established,-,P30556,antagonist,
502,0,Class A (Rhodopsin),small molecule,bevantolol,adrb1_human,ADRB1,NRDD056,Antihypertensive,Aminergic ,2,1989.0,discontinued,in trial,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588,antagonist,Decided 1989 not to market it in US and elsewhere
503,0,Class A (Rhodopsin),small molecule,cf602,aa3r_human,ADORA3,MMAapril2016_0230,sexual dysfunction,Nucleotide ,1,2017.0,Not open yet,in trial,Adenosine receptors,GPCR;Rhodopsin,established,cf602,P0DMS8,agonist,
504,0,Class A (Rhodopsin),small molecule,ajulemic acid,cnr1_human,CNR1,2361,Analgesics;neuropathic pain,Lipid ,2,2017.0,Not open yet,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,"ip 751, ct-3",P21554,agonist,
505,0,Class A (Rhodopsin),small molecule,ajulemic acid,cnr2_human,CNR2,2361,Analgesics;neuropathic pain,Lipid ,2,2017.0,Not open yet,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,"ip 751, ct-3",P34972,agonist,
506,0,Class A (Rhodopsin),small molecule,cf-101,aa3r_human,ADORA3,473,Anti-inflammatory ; DMARD,Nucleotide ,3,2015.0,Not open yet,in trial,Adenosine receptors,GPCR;Rhodopsin,established,cf-101,P0DMS8,agonist,
507,0,Class A (Rhodopsin),peptide,"txa127, angiotensin (1-7)",mas_human,MAS1,MMAmay2016_0617,"Epidermolysis bulbosa, hypertension, muscular dystrophies",Orphan ,Preclinical,2016.0,Not open yet,in trial,Class A orphans,GPCR;Rhodopsin,not established,"txa127, angiotensin (1-7)",P04201,agonist,
508,0,Class A (Rhodopsin),small molecule,zyn002,cnr1_human,CNR1,MMAapril2016_0296,Anticonvulsants; Antiepileptics,Lipid ,Preclinical,2017.0,Not open yet,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,"zyn002, Topical cannabidiol gel",P21554,agonist,
509,0,Class A (Rhodopsin),small molecule,zyn002,cnr2_human,CNR2,MMAapril2016_0297,Anticonvulsants; Antiepileptics,Lipid ,Preclinical,2017.0,Not open yet,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,"zyn002, Topical cannabidiol gel",P34972,agonist,
510,0,Class A (Rhodopsin),small molecule,cf101,aa3r_human,ADORA3,ASH_Sep2016_320,keratoconjunctivitis sicca,Nucleotide ,3,2015.0,Not open yet,in trial,Adenosine receptors,GPCR;Rhodopsin,established,"cf101, Piclidenoson",P0DMS8,agonist,
511,1973,Class A (Rhodopsin),protein,chorionic gonadotropin,lshr_human,LHCGR,2529,Antineoplastic,Protein ,3,2016.0,Not open yet,in trial,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,"ml-04, LDI-100",P22888,agonist,
512,0,Class A (Rhodopsin),small molecule,"boxaban, hepatoren, vasculan, ifetroban",ta2r_human,TBXA2R,MMAjun2016_0011,Treatment of asystemic scleroderma; hepatorenal syndrome; asthma,Lipid ,2,2017.0,Not open yet,in trial,Prostanoid receptors,GPCR;Rhodopsin,established,"boxaban, hepatoren, vasculan, ifetroban",P21731,antagonist,
513,0,Class A (Rhodopsin),small molecule,ema401,agtr2_human,AGTR2,MMAmay2016_0377,peripheral neuropathic pain; post herpetic neuralgia,Peptide ,2,2017.0,Not open yet,in trial,Angiotensin receptors,GPCR;Rhodopsin,not established,ema401,P50052,antagonist,
514,0,Class A (Rhodopsin),small molecule,cannabidiol,cnr1_human,CNR1,MMAmar2016_0268,epilepsy,Lipid ,3,2016.0,Not open yet,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,cannabidiol,P21554,antagonist,
515,0,Class A (Rhodopsin),small molecule,cannabidiol,cnr2_human,CNR2,MMAmar2016_0269,epilepsy,Lipid ,3,2016.0,Not open yet,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,cannabidiol,P34972,antagonist,
516,0,Class A (Rhodopsin),small molecule,tozadenant,aa2ar_human,ADORA2A,1926,Antiparkinson,Nucleotide ,3,2017.0,Not open yet,in trial,Adenosine receptors,GPCR;Rhodopsin,established,syn-115,P29274,antagonist,
517,0,Class A (Rhodopsin),small molecule,orvepitant,nk1r_human,TACR1,ASH_Sep2016_287,unipolar depression,Peptide ,2,2016.0,Not open yet,in trial,Tachykinin receptors,GPCR;Rhodopsin,established,orvepitant,P25103,antagonist,Trials had been terminated in 2009 due to assessment of isolated events of seizure during program
518,0,Class A (Rhodopsin),small molecule,pitolisant,hrh3_human,HRH3,ASH_Sep2016_242,Antiparkinson,Aminergic ,3,2016.0,Not open yet,in trial,Histamine receptors,GPCR;Rhodopsin,established,pitolisant,Q9Y5N1,inverse agonist,
519,0,Class A (Rhodopsin),antibody,ryi-018,cnr1_human,CNR1,MMAapril2016_0280,liver disease; nonalcoholic steatohepatitis,Lipid ,1,2017.0,Not open yet,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,ryi-018,P21554,modulator,
520,0,Class A (Rhodopsin),peptide,srx-1177,mshr_human,MC1R,MMAapril2016_0099,Antineoplastic,Peptide ,Preclinical,2015.0,Not open yet,in trial,Melanocortin receptors,GPCR;Rhodopsin,not established,srx-1177,Q01726,modulator,
521,0,Class A (Rhodopsin),small molecule,cicletanine ,ada1a_human,ADRA1A,2271,Antihypertensive,Aminergic ,2,2016.0,Not open yet,in trial,Adrenoceptors,GPCR;Rhodopsin,established,cicletanine hydrochloride,P35348,na,Diuretic
522,0,Class A (Rhodopsin),small molecule,cicletanine ,ada1d_human,ADRA1D,2271,Antihypertensive,Aminergic ,2,2016.0,Not open yet,in trial,Adrenoceptors,GPCR;Rhodopsin,established,cicletanine hydrochloride,P25100,na,
523,0,Class A (Rhodopsin),small molecule,cicletanine ,ada2a_human,ADRA2A,2271,Antihypertensive,Aminergic ,2,2016.0,Not open yet,in trial,Adrenoceptors,GPCR;Rhodopsin,established,cicletanine hydrochloride,P08913,na,
524,0,Class A (Rhodopsin),small molecule,cicletanine ,ada2b_human,ADRA2B,2271,Antihypertensive,Aminergic ,2,2016.0,Not open yet,in trial,Adrenoceptors,GPCR;Rhodopsin,established,cicletanine hydrochloride,P18089,na,
525,0,Class A (Rhodopsin),small molecule,cicletanine ,ada2c_human,ADRA2C,2271,Antihypertensive,Aminergic ,2,2016.0,Not open yet,in trial,Adrenoceptors,GPCR;Rhodopsin,established,cicletanine hydrochloride,P18825,na,
526,0,Class A (Rhodopsin),small molecule,cicletanine ,adrb2_human,ADRB2,2271,Antihypertensive,Aminergic ,2,2016.0,Not open yet,in trial,Adrenoceptors,GPCR;Rhodopsin,established,cicletanine hydrochloride,P07550,na,
527,0,Class A (Rhodopsin),peptide,yttrium-90 edotreotide,ssr1_human,SSTR1,2232,Antineoplastic,Peptide ,2,2010.0,Not open yet,in trial,Somatostatin receptors,GPCR;Rhodopsin,established,"yttrium-90 edotreotide,onalta",P30872,na,Issue with drug not being available
528,0,Class A (Rhodopsin),peptide,yttrium-90 edotreotide,ssr2_human,SSTR2,2232,Antineoplastic,Peptide ,2,2010.0,Not open yet,in trial,Somatostatin receptors,GPCR;Rhodopsin,established,"yttrium-90 edotreotide,onalta",P30874,na,Issue with drug not being available
529,0,Class A (Rhodopsin),peptide,yttrium-90 edotreotide,ssr5_human,SSTR5,2232,Antineoplastic,Peptide ,2,2010.0,Not open yet,in trial,Somatostatin receptors,GPCR;Rhodopsin,established,"yttrium-90 edotreotide,onalta",P35346,na,Issue with drug not being available
530,0,Class C (Glutamate) ,small molecule,adx71441,gabr1_human,GABBR1,MMAmay2016_0243,neurologic disorders,Amino acid ,Preclinical,2017.0,Not open yet,in trial,GABAB receptors,GPCR;Glutamate,established,adx71441,Q9UBS5,pam,
531,0,Class C (Glutamate) ,small molecule,adx71441,gabr2_human,GABBR2,MMAmay2016_0244,neurologic disorders,Amino acid ,Preclinical,2017.0,Not open yet,in trial,GABAB receptors,GPCR;Glutamate,established,adx71441,O75899,pam,
532,0,Class A (Rhodopsin),peptide,"azp-531, unacylated ghrelin",ghsr_human,GHSR,MMAapril2016_0315,Antidiabetic,Peptide ,1,2014.0,Ongoing,in trial,Ghrelin receptors,GPCR;Rhodopsin,not established,"azp-531, unacylated ghrelin",Q92847,agonist,
533,0,Class A (Rhodopsin),protein,homspera,nk1r_human,TACR1,1907,idiopathic pulmonary fibrosis,Peptide ,1,2011.0,Ongoing,in trial,Tachykinin receptors,GPCR;Rhodopsin,established,"substance p,homspera, radilex, viprovex",P25103,agonist,
534,0,Class B1 (Secretin),peptide,vrs-859,glp1r_human,GLP1R,2182,Antidiabetic,Peptide ,1,2017.0,Ongoing,in trial,Glucagon receptor family,GPCR;Secretin,established,"vrs-859, Exenatide-XTEN",P43220,agonist,
535,0,Class A (Rhodopsin),small molecule,apd811,pi2r_human,PTGIR,MMAmay2016_0283,Antihypertensive,Lipid ,2,2014.0,Ongoing,in trial,Prostanoid receptors,GPCR;Rhodopsin,established,apd811,P43119,agonist,
536,0,Class A (Rhodopsin),small molecule,dg3173,ssr1_human,SSTR1,632,hormone replacement,Peptide ,2,2014.0,Ongoing,in trial,Somatostatin receptors,GPCR;Rhodopsin,established,dg3173,P30872,agonist,
537,0,Class A (Rhodopsin),small molecule,dg3173,ssr1_human,SSTR1,632,hormone replacement,Peptide ,2,2014.0,Ongoing,in trial,Somatostatin receptors,GPCR;Rhodopsin,established,dg3173,P30872,agonist,
538,0,Class A (Rhodopsin),small molecule,dg3173,ssr2_human,SSTR2,632,hormone replacement,Peptide ,2,2014.0,Ongoing,in trial,Somatostatin receptors,GPCR;Rhodopsin,established,dg3173,P30874,agonist,
539,0,Class A (Rhodopsin),small molecule,dg3173,ssr4_human,SSTR4,632,hormone replacement,Peptide ,2,2014.0,Ongoing,in trial,Somatostatin receptors,GPCR;Rhodopsin,established,dg3173,P31391,agonist,
540,0,Class A (Rhodopsin),small molecule,dg3173,ssr5_human,SSTR5,632,hormone replacement,Peptide ,2,2014.0,Ongoing,in trial,Somatostatin receptors,GPCR;Rhodopsin,established,dg3173,P35346,agonist,
541,0,Class A (Rhodopsin),small molecule,eltoprazine,5ht1a_human,HTR1A,MMAmar2016_0086,dyskinesias,Aminergic ,2,2015.0,Ongoing,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,eltoprazine,P08908,agonist,
542,0,Class A (Rhodopsin),small molecule,eltoprazine,5ht1b_human,HTR1B,MMAmar2016_0087,dyskinesias,Aminergic ,2,2015.0,Ongoing,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,eltoprazine,P28222,agonist,
543,0,Class C (Glutamate) ,small molecule,lesogaberan,gabr1_human,GABBR1,1108,gastrointestinal reflux disease,Amino acid ,2,2016.0,Ongoing,in trial,GABAB receptors,GPCR;Glutamate,established,"lesogaberan, azd-3355",Q9UBS5,agonist,Had been discontinued since 2009 - new trial in 2016
544,0,Class C (Glutamate) ,small molecule,lesogaberan,gabr2_human,GABBR2,1108,gastrointestinal reflux disease,Amino acid ,2,2016.0,Ongoing,in trial,GABAB receptors,GPCR;Glutamate,established,"lesogaberan, azd-3355",O75899,agonist,Had been discontinued since 2009 - new trial in 2016
545,0,Class A (Rhodopsin),small molecule,velusetrag,5ht4r_human,HTR4,2145,motilitant,Aminergic ,2,2014.0,Ongoing,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"velusetrag, td-5108",Q13639,agonist,
546,0,Class A (Rhodopsin),small molecule,ncx116,pf2r_human,PTGFR,378,Antiglaucomic,Lipid ,3,2013.0,Ongoing,in trial,Prostanoid receptors,GPCR;Rhodopsin,established,"bol-303259-x, ncx 116, pf-03187207, Latanoprostene bunod",P43088,agonist,
547,0,Class A (Rhodopsin),peptide,bremelanotide,mshr_human,MC1R,383,sexual dysfunction,Peptide ,3,2015.0,Ongoing,in trial,Melanocortin receptors,GPCR;Rhodopsin,not established,bremelanotide,Q01726,agonist,
548,0,Class A (Rhodopsin),peptide,bremelanotide,mc4r_human,MC4R,383,sexual dysfunction,Peptide ,3,2015.0,Ongoing,in trial,Melanocortin receptors,GPCR;Rhodopsin,not established,bremelanotide,P32245,agonist,
549,0,Class A (Rhodopsin),small molecule,lasmiditan,5ht1f_human,HTR1F,1093,Anti-migraine,Aminergic ,3,2015.0,Ongoing,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"lasmiditan, col-144, ly-573144",P30939,agonist,
550,0,Class A (Rhodopsin),small molecule polymer conjugate,nktr-181,oprm_human,OPRM1,1420,Analgesics,Peptide ,3,2015.0,Ongoing,in trial,Opioid receptors,GPCR;Rhodopsin,established,nktr-181,P35372,agonist,
551,0,Class B1 (Secretin),protein,nn9924,glp1r_human,GLP1R,1429,Antidiabetic,Peptide ,3,2016.0,Ongoing,in trial,Glucagon receptor family,GPCR;Secretin,established,nn9924,P43220,agonist,
552,0,Class A (Rhodopsin),small molecule,t111,aa2ar_human,ADORA2A,MMAmay2016_0579,pruritus,Nucleotide ,3,2014.0,Ongoing,in trial,Adenosine receptors,GPCR;Rhodopsin,established,"t111, Nalbuphine extended release",P29274,agonist,
553,0,Class A (Rhodopsin),protein,bremelanotide,mc3r_human,MC3R,ASH_Sep2016_260,sexual dysfunction,Peptide ,3,2015.0,Ongoing,in trial,Melanocortin receptors,GPCR;Rhodopsin,not established,bremelanotide,P41968,agonist,
554,0,Class A (Rhodopsin),small molecule,siponimod,s1pr1_human,S1PR1,ASH_Sep2016_304,chronic progressive multiple sclerosis,Lipid ,3,2014.0,Ongoing,in trial,Lysophospholipid (S1P) receptors,GPCR;Rhodopsin,established,siponimod,P21453,agonist,
555,0,Class A (Rhodopsin),small molecule,bf-1,5ht2b_human,HTR2B,343,Anti-migraine,Aminergic ,1,2016.0,Ongoing,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,bf-1,P41595,antagonist,
556,0,Class A (Rhodopsin),small molecule,ccx872,ccr2_human,CCR2,MMAapril2016_0147,Antineoplastic ; pancreatic cancer,Protein ,1,2015.0,Ongoing,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,ccx872,P41597,antagonist,
557,0,Class F (Frizzled),antibody,omp-18r5,fzd7_human,FZD7,2457,Antineoplastic,Protein ,1,2013.0,Ongoing,in trial,Frizzled,GPCR;Frizzled,not established,omp-18r5,O75084,antagonist,
558,0,Class A (Rhodopsin),antibody,bms 936564,cxcr4_human,CXCR4,369,Antineoplastic,Protein ,2,2016.0,Ongoing,in trial,Chemokine receptors,GPCR;Rhodopsin,established,"bms 936564, mdx-1338",P61073,antagonist,"discontinued for sole intervention, now in combination trials"
559,0,Class A (Rhodopsin),small molecule,"mle4901,  azd4901",nk3r_human,TACR3,MMAapril2016_0263,for Polycystic Ovarian Syndrome,Peptide ,2,2016.0,Ongoing,in trial,Tachykinin receptors,GPCR;Rhodopsin,not established,"mle4901,  azd4901",P29371,antagonist,
560,0,Class A (Rhodopsin),small molecule,"mle4901,  azd4901",nk3r_human,TACR3,MMAapril2016_0263,for Polycystic Ovarian Syndrome,Peptide ,2,2016.0,Ongoing,in trial,Tachykinin receptors,GPCR;Rhodopsin,not established,"mle4901,  azd4901",P29371,antagonist,
561,0,Class A (Rhodopsin),small molecule,mt-1303,s1pr1_human,S1PR1,MMAmar2016_0211,autoimmune diseases; Multiple Sclerosis; Crohn's disease,Lipid ,2,2015.0,Ongoing,in trial,Lysophospholipid (S1P) receptors,GPCR;Rhodopsin,established,mt-1303,P21453,antagonist,
562,0,Class A (Rhodopsin),small molecule,lu-ae58054,5ht6r_human,HTR6,1177,schizophrenia,Aminergic ,3,2014.0,Ongoing,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"lu-ae58054 , ly-483518, sgs518",P50406,antagonist,
563,0,Class A (Rhodopsin),small molecule,naldemedine,oprm_human,OPRM,ASH_Mar2017_1,opioid-induced constipation,Peptide ,3,2014.0,Ongoing,in trial,Opioid receptors,GPCR;Rhodopsin,established,naldemedine,P35372,antagonist,
564,0,Class A (Rhodopsin),small molecule,"rvt-101, sb-742457, gsk 742457",5ht6r_human,HTR6,MMAmar2016_0106,Alzheimer's disease,Aminergic ,3,2015.0,Ongoing,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"rvt-101, sb-742457, gsk 742457",P50406,antagonist,
565,0,Class A (Rhodopsin),antibody,mogamulizumab,ccr4_human,CCR4,MMAjun2016_0001,Antineoplastic,Protein ,3,2012.0,Ongoing,in trial,Chemokine receptors,GPCR;Rhodopsin,established,mogamulizumab,P51679,antagonist,
566,0,Class A (Rhodopsin),antibody,mogamulizumab,ccr4_human,CCR4,MMAjun2016_0001,Antineoplastic,Protein ,3,2012.0,Ongoing,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,mogamulizumab,P51679,antagonist,
567,0,Class A (Rhodopsin),small molecule,"inv102, nadolol",adrb2_human,ADRB2,MMAmay2016_0225,for inflammatory lung disease,Aminergic ,2,2013.0,Ongoing,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"inv102, nadolol",P07550,inverse agonist,
568,0,Class A (Rhodopsin),small molecule,ati-9242,drd2_human,DRD2,2423,schizophrenia,Aminergic ,1,2016.0,Ongoing,in trial,Dopamine receptors,GPCR;Rhodopsin,established,ati-9242,P14416,modulator,
569,0,Class A (Rhodopsin),small molecule,ati-9242,5ht2a_human,HTR2A,2423,schizophrenia,Aminergic ,1,2016.0,Ongoing,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,ati-9242,P28223,modulator,
570,0,Class A (Rhodopsin),small molecule,reparixin,cxcr1_human,CXCR1,MMAmay2016_0551,Antidiabetic; type I diabetes,Protein ,3,2013.0,Ongoing,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,reparixin,P25024,modulator,
571,0,Class A (Rhodopsin),small molecule,reparixin,cxcr2_human,CXCR2,MMAmay2016_0552,Antidiabetic; type I diabetes,Protein ,3,2013.0,Ongoing,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,reparixin,P25025,modulator,
572,0,Class A (Rhodopsin),small molecule,terguride,5ht2a_human,HTR2A,1981,"Diffuse cutaneous systemic sclerosis, Antihypertensive",Aminergic ,3,2016.0,Ongoing,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,terguride,P28223,modulator,Difficult to get info; 10 year break before investigating again in Europe
573,0,Class A (Rhodopsin),small molecule,terguride,5ht2b_human,HTR2B,1981,"Diffuse cutaneous systemic sclerosis, Antihypertensive",Aminergic ,3,2016.0,Ongoing,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,terguride,P41595,modulator,Difficult to get info; 10 year break before investigating again in Europe
574,0,Class A (Rhodopsin),cell therapy,"cal-1, autologous t cell and blood stem cell therapy",ccr5_human,CCR5,MMAapril2016_0320,antiviral ; HIV,Protein ,2,2012.0,Ongoing,in trial,Chemokine receptors,GPCR;Rhodopsin,established,"cal-1, autologous t cell and blood stem cell therapy",P51681,na,
575,0,Class A (Rhodopsin),small molecule,apd125,5ht2a_human,HTR2A,192,Dementia with Lewy Bodies,Aminergic ,2,2016.0,recruiting,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"apd125, Nelotanserin",P28223,agonist,Added entry because Indication so different
576,0,Class A (Rhodopsin),antibody,mln-1202,ccr2_human,CCR2,1310,Antineoplastic,,1,2016.0,recruiting,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,mln-1202,P41597,antagonist,added entry - new indication
577,0,Class A (Rhodopsin),small molecule,atrasentan,ednra_human,EDNRA,270,Diabetic nephropathy,Peptide ,3,2013.0,recruiting,in trial,Endothelin receptors,GPCR;Rhodopsin,established,Atrasentan,P25101,antagonist,Added entry because Indication so different
578,0,Class A (Rhodopsin),small molecule,procaterol,adrb2_human,ADRB2,NRDD459,Bronchodilator,Aminergic ,3,2015.0,recruiting,in trial,Adrenoceptors,GPCR;Rhodopsin,established,-,P07550,agonist,
579,0,Class A (Rhodopsin),small molecule,guanabenz,ada2b_human,ADRA2B,ASH_Sep2016_147,Multiple Sclerosis,Aminergic ,1,2015.0,recruiting,in trial,Adrenoceptors,GPCR;Rhodopsin,established,guanabenz,P18089,agonist,
580,0,Class B1 (Secretin),peptide,"mod-6031, long-acting oxyntomodulin",glr_human,GCGR,MMAmay2016_0899,Antidiabetic ; Anti-obesity,Peptide ,1,2016.0,recruiting,in trial,Glucagon receptor family,GPCR;Secretin,established,"mod-6031, long-acting oxyntomodulin",P47871,agonist,
581,0,Class B1 (Secretin),peptide,"mod-6031, long-acting oxyntomodulin",glp1r_human,GLP1R,MMAmay2016_0898,Antidiabetic ; Anti-obesity,Peptide ,1,2016.0,recruiting,in trial,Glucagon receptor family,GPCR;Secretin,established,"mod-6031, long-acting oxyntomodulin",P43220,agonist,
582,0,Class A (Rhodopsin),small molecule,solabegron,adrb3_human,ADRB3,1874,Antidiabetic; irritable bowel syndrome; incontinence,Aminergic ,1,2016.0,recruiting,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"solabegron, gw 427353",P13945,agonist,"Had Phase 2 trials for IBS and overactive bladder in 2007, but now after 10 year break clinical trials starting again"
583,0,Class A (Rhodopsin),small molecule,suvn-d4010,5ht4r_human,HTR4,MMAmar2016_0094,Alzheimer's disease,Aminergic ,1,2017.0,recruiting,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,suvn-d4010,Q13639,agonist,
584,0,Class A (Rhodopsin),small molecule,apd334,s1pr1_human,S1PR1,MMAmay2016_0282,for autoimmune disorders,Lipid ,2,2015.0,recruiting,in trial,Lysophospholipid (S1P) receptors,GPCR;Rhodopsin,established,apd334,P21453,agonist,
585,0,Class A (Rhodopsin),small molecule,cf-102,aa3r_human,ADORA3,474,Antineoplastic,Nucleotide ,2,2014.0,recruiting,in trial,Adenosine receptors,GPCR;Rhodopsin,established,cf-102,P0DMS8,agonist,
586,0,Class A (Rhodopsin),small molecule,gtx-758,lshr_human,LHCGR,888,Antineoplastic,Protein ,2,2012.0,recruiting,in trial,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,gtx-758,P22888,agonist,Other studies were terminated from FDA hold
587,0,Class A (Rhodopsin),dna plasmid,jvs-100,cxcr4_human,CXCR4,1056,cardioprotectant,Protein ,2,2015.0,recruiting,in trial,Chemokine receptors,GPCR;Rhodopsin,established,jvs-100,P61073,agonist,
588,0,Class B1 (Secretin),peptide,zp1848,glp2r_human,GLP2R,2251,Crohn's disease,Peptide ,2,2016.0,recruiting,in trial,Glucagon receptor family,GPCR;Secretin,established,zp1848,O95838,agonist,
589,0,Class A (Rhodopsin),small molecule,histamine,hrh2_human,HRH2,463,cytorprotective  during cancer treatment,Aminergic ,3,2015.0,recruiting,in trial,Histamine receptors,GPCR;Rhodopsin,established,ceplene,P25021,agonist,Has orphan designation to be used as adjunct with IL-2 for acute myeloid leukemia
590,0,Class A (Rhodopsin),small molecule,cr845,oprk_human,OPRK1,540,Analgesics,Peptide ,3,2015.0,recruiting,in trial,Opioid receptors,GPCR;Rhodopsin,established,cr845,P41145,agonist,
591,0,Class A (Rhodopsin),small molecule,mosapride,5ht4r_human,HTR4,1337,Gastrointestinal reflux disease (GERD),Aminergic ,3,2016.0,recruiting,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"mosapride citrate, tak-370,gasmotin",Q13639,agonist,"Not approved by the FDA, but in other countries for GERD. Trials for many other indications: diabetes, IBS"
592,0,Class A (Rhodopsin),small molecule,ponesimod,s1pr1_human,S1PR1,1630,Anti-inflammatory ; multiple sclerosis,Lipid ,3,2016.0,recruiting,in trial,Lysophospholipid (S1P) receptors,GPCR;Rhodopsin,established,ponesimod,P21453,agonist,
593,0,Class A (Rhodopsin),peptide,"rm-493, setmelanotide",mc4r_human,MC4R,MMAmay2016_0229,Anti-obesity,Peptide ,3,2017.0,recruiting,in trial,Melanocortin receptors,GPCR;Rhodopsin,not established,"rm-493, setmelanotide",P32245,agonist,
594,0,Class B1 (Secretin),peptide,"semaglutide, nn9535 ",glp1r_human,GLP1R,MMAmay2016_0563,Antidiabetic,Peptide ,3,2017.0,recruiting,in trial,Glucagon receptor family,GPCR;Secretin,established,"semaglutide, nn9535 ",P43220,agonist,
595,0,Class A (Rhodopsin),small molecule,trv130,oprm_human,OPRM1,MMAmay2016_0607,Analgesics; post-operative pain,Peptide ,3,2016.0,recruiting,in trial,Opioid receptors,GPCR;Rhodopsin,established,"trv130, Oliceridine",P35372,agonist,
596,0,Class A (Rhodopsin),small molecule,va106483,v2r_human,AVPR2,2115,BPH-related urinary symptoms,Peptide ,3,2015.0,recruiting,in trial,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,"va106483, Fedovapagon",P30518,agonist,
597,0,Class A (Rhodopsin),small molecule,ym-178,adrb3_human,ADRB3,2229,overactive bladder,Aminergic ,3,2016.0,recruiting,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"ym-178, Mirabegron",P13945,agonist,
598,0,Class A (Rhodopsin),small molecule,fenfluramine,5ht2b_human,HTR2B,MMAmar2016_0273,epilepsy; Dravet's syndrome,Aminergic ,3,2016.0,recruiting,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"zx008, brabafen, low-dose fenfluramine",P41595,agonist,
599,0,Class A (Rhodopsin),small molecule,fenfluramine,5ht2c_human,HTR2C,MMAmar2016_0274,epilepsy; Dravet's syndrome,Aminergic ,3,2016.0,recruiting,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"zx008, brabafen, low-dose fenfluramine",P28335,agonist,
600,0,Class A (Rhodopsin),small molecule,ralinepag,pi2r_human,PTGIR,ASH_Sep2016_314,Antihypertensive,Lipid ,2,2014.0,recruiting,in trial,Prostanoid receptors,GPCR;Rhodopsin,established,"ralinepag, APD-811",P43119,agonist,
601,0,Class A (Rhodopsin),protein,selepressin,v1ar_human,AVPR1A,ASH_Sep2016_288,septic shock,Peptide ,3,2015.0,recruiting,in trial,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,selepressin,P37288,agonist,
602,0,Class A (Rhodopsin),small molecule,cebranopadol,oprd_human,OPRD1,ASH_Sep2016_264,diabetic neuropathy,Peptide ,3,2016.0,recruiting,in trial,Opioid receptors,GPCR;Rhodopsin,established,cebranopadol,P41143,agonist,
603,0,Class A (Rhodopsin),small molecule,cebranopadol,oprk_human,OPRK1,ASH_Sep2016_267,diabetic neuropathy,Peptide ,3,2016.0,recruiting,in trial,Opioid receptors,GPCR;Rhodopsin,established,cebranopadol,P41145,agonist,
604,0,Class A (Rhodopsin),small molecule,cebranopadol,oprx_human,OPRL1,ASH_Sep2016_276,Analgesics,Peptide ,3,2016.0,recruiting,in trial,Opioid receptors,GPCR;Rhodopsin,not established,cebranopadol,P41146,agonist,
605,0,Class A (Rhodopsin),small molecule,cebranopadol,oprm_human,OPRM1,ASH_Sep2016_273,"osteoarthritis, knee",Peptide ,3,2016.0,recruiting,in trial,Opioid receptors,GPCR;Rhodopsin,established,cebranopadol,P35372,agonist,
606,0,Class A (Rhodopsin),small molecule,suvn-g3031,hrh3_human,HRH3,MMAmar2016_0093,Alzheimer's disease,Aminergic ,1,2016.0,recruiting,in trial,Histamine receptors,GPCR;Rhodopsin,established,suvn-g3031,Q9Y5N1,antagonist,
607,0,Class A (Rhodopsin),small molecule,domperidone,drd2_human,DRD2,NRDD184,Antiemetics,Aminergic ,2,2015.0,recruiting,in trial,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,antagonist,
608,0,Class A (Rhodopsin),small molecule,sofpironium bromide,acm3_human,CHRM3,MMAmay2016_0805,Anticholinergics; for thetopical treatment of primary axillary hyperhidrosis,Aminergic ,2,2017.0,recruiting,in trial,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,bbi-4000,P20309,antagonist,
609,0,Class A (Rhodopsin),peptide,bl-8040,cxcr4_human,CXCR4,APR13_0001,Antineoplastic,Protein ,2,2016.0,recruiting,in trial,Chemokine receptors,GPCR;Rhodopsin,established,bl-8040,P61073,antagonist,"discontinued for sole intervention, now in combination trials"
610,0,Class A (Rhodopsin),small molecule,bucindolol,adrb1_human,ADRB1,396,heart failure,Aminergic ,2,2013.0,recruiting,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"bucindolol hydrochloride,gencaro",P08588,antagonist,
611,0,Class A (Rhodopsin),small molecule,bucindolol,adrb2_human,ADRB2,396,heart failure,Aminergic ,2,2013.0,recruiting,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"bucindolol hydrochloride,gencaro",P07550,antagonist,
612,0,Class A (Rhodopsin),small molecule,"cerc-501, ly2456302",oprk_human,OPRK1,MMAfeb2016_0074,Substance use disorders,Peptide ,2,2016.0,recruiting,in trial,Opioid receptors,GPCR;Rhodopsin,established,"cerc-501, ly2456302",P41145,antagonist,
613,0,Class A (Rhodopsin),small molecule,clazosentan,ednra_human,EDNRA,495,vasospasm,Peptide ,2,2015.0,recruiting,in trial,Endothelin receptors,GPCR;Rhodopsin,established,"clazosentan, axv-343434,pivlaz",P25101,antagonist,
614,0,Class A (Rhodopsin),small molecule,cannabidivarin,cnr1_human,CNR1,MMAmay2016_0402,epilepsy,Lipid ,2,2015.0,recruiting,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,"gwp42006, Cannabidivarin",P21554,antagonist,
615,0,Class A (Rhodopsin),small molecule,cannabidivarin,cnr2_human,CNR2,MMAmay2016_0403,epilepsy,Lipid ,2,2015.0,recruiting,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,"gwp42006, Cannabidivarin",P34972,antagonist,
616,0,Class B1 (Secretin),small molecule,lgd-6972,glr_human,GCGR,MMAmay2016_0453,Antidiabetic,Peptide ,2,2016.0,recruiting,in trial,Glucagon receptor family,GPCR;Secretin,established,lgd-6972,P47871,antagonist,
617,0,Class A (Rhodopsin),small molecule,oc000459 ,pd2r2_human,PD2R2,1466,Anti-Allergic,Lipid ,2,2016.0,recruiting,in trial,Prostanoid receptors,GPCR;Rhodopsin,not established,oc000459,Q9Y5Y4,antagonist,
618,0,Class A (Rhodopsin),small molecule,oc459,pd2r2_human,GPR44,MMAmay2016_0684,for allergic rhinitis,Lipid ,2,2016.0,recruiting,in trial,Prostanoid receptors,GPCR;Rhodopsin,not established,oc459,Q9Y5Y4,antagonist,
619,0,Class A (Rhodopsin),small molecule,pbf-509,aa2ar_human,ADORA2A,MMAapril2016_0077,Antineoplastic,Nucleotide ,2,2015.0,recruiting,in trial,Adenosine receptors,GPCR;Rhodopsin,established,pbf-509,P29274,antagonist,
620,0,Class A (Rhodopsin),small molecule,pbf-680,aa1r_human,ADORA1,MMAmar2016_0115,Anti-Asthmatic,Nucleotide ,2,2015.0,recruiting,in trial,Adenosine receptors,GPCR;Rhodopsin,established,pbf-680,P30542,antagonist,
621,0,Class A (Rhodopsin),small molecule,ps433540,agtr1_human,AGTR1,1673,"Focal segmental glomerulosclerosis, Antihypertensive",Peptide ,2,2012.0,recruiting,in trial,Angiotensin receptors,GPCR;Rhodopsin,established,ps433540,P30556,antagonist,
622,0,Class A (Rhodopsin),small molecule,ps433540,agtr2_human,AGTR2,1673,"Focal segmental glomerulosclerosis, Antihypertensive",Peptide ,2,2012.0,recruiting,in trial,Angiotensin receptors,GPCR;Rhodopsin,not established,ps433540,P50052,antagonist,
623,0,Class A (Rhodopsin),small molecule,ps433540,ednra_human,EDNRA,1673,"Focal segmental glomerulosclerosis, Antihypertensive",Peptide ,2,2012.0,recruiting,in trial,Endothelin receptors,GPCR;Rhodopsin,established,ps433540,P25101,antagonist,
624,0,Class B1 (Secretin),antibody,remd-477,glr_human,GCGR,MMAapril2016_0214,Antidiabetic,Peptide ,2,2017.0,recruiting,in trial,Glucagon receptor family,GPCR;Secretin,established,remd-477,P47871,antagonist,
625,0,Class A (Rhodopsin),small molecule,suvn-502,5ht6r_human,HTR6,1920,Alzheimer's disease,Aminergic ,2,2015.0,recruiting,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,suvn-502,P50406,antagonist,
626,0,Class F (Frizzled),small molecule,"taladegib, ly2940680",smo_human,SMO,MMAmar2016_0177,Antineoplastic,Protein ,2,2015.0,recruiting,in trial,Frizzled,GPCR;Frizzled,established,"taladegib, ly2940680",Q99835,antagonist,
627,0,Class A (Rhodopsin),protein,trv120027,agtr1_human,AGTR1,2279,Antihypertensive,Peptide ,2,2013.0,recruiting,in trial,Angiotensin receptors,GPCR;Rhodopsin,established,trv120027,P30556,antagonist,
628,0,Class B1 (Secretin),peptide,"vasomera, pb1046",vipr2_human,VIPR2,MMAmay2016_0630,Antihypertensive,Peptide ,2,2016.0,recruiting,in trial,VIP and PACAP receptors,GPCR;Rhodopsin,not established,"vasomera, pb1046",P41587,antagonist,
629,0,Class A (Rhodopsin),small molecule,"vpd-737, serlopitant",nk1r_human,TACR1,MMAmay2016_0635,pruritus,Peptide ,2,2016.0,recruiting,in trial,Tachykinin receptors,GPCR;Rhodopsin,established,"vpd-737, serlopitant",P25103,antagonist,
630,0,Class A (Rhodopsin),small molecule,flupenthixol,drd2_human,DRD2,NRDD240,schizophrenia,Aminergic ,3,2015.0,recruiting,in trial,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,antagonist,"Never approved by fda, clinical trials in 1989"
631,0,Class A (Rhodopsin),small molecule,flupenthixol,drd1_human,DRD1,NRDD240,schizophrenia,Aminergic ,3,2015.0,recruiting,in trial,Dopamine receptors,GPCR;Rhodopsin,established,-,P21728,antagonist,"Never approved by fda, clinical trials in Europe in 2005"
632,0,Class A (Rhodopsin),small molecule,sulpiride,drd2_human,DRD2,NRDD504,Antidepressive ; Second-Generation; Antipsychotic,Aminergic ,3,2016.0,recruiting,in trial,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,antagonist,Not FDA approved but used in other countries
633,0,Class A (Rhodopsin),small molecule,samidoprhan,oprm_human,MOR,APR13_0013,addiction,Peptide ,3,2016.0,recruiting,in trial,Opioid receptors,GPCR;Rhodopsin,established,alks 3831,P35372,antagonist,
634,0,Class A (Rhodopsin),small molecule,"alks 33, samidorphan",oprd_human,OPRD1,MMAmay2016_0184,Anti-obesity,Peptide ,3,2016.0,recruiting,in trial,Opioid receptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P41143,antagonist,
635,0,Class A (Rhodopsin),small molecule,"alks 33, samidorphan",oprk_human,OPRK1,MMAmay2016_0184,Anti-obesity,Peptide ,3,2016.0,recruiting,in trial,Opioid receptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P41145,antagonist,
636,0,Class A (Rhodopsin),small molecule,"alks 33, samidorphan",oprm_human,OPRM1,MMAmay2016_0184,Anti-obesity,Peptide ,3,2016.0,recruiting,in trial,Opioid receptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P35372,antagonist,
637,0,Class A (Rhodopsin),small molecule,ccx168,c5ar1_human,C5AR1,448,Anti-inflammatory,Peptide ,3,2016.0,recruiting,in trial,Complement peptide receptors,GPCR;Rhodopsin,not established,ccx168,P21730,antagonist,
638,0,Class A (Rhodopsin),small molecule,ecopipam,drd1_human,DRD1,686,Speech and language disorders,Aminergic ,3,2016.0,recruiting,in trial,Dopamine receptors,GPCR;Rhodopsin,established,ecopipam,P21728,antagonist,
639,0,Class A (Rhodopsin),small molecule,cannabidiol,cnr1_human,CNR1,MMAmar2016_0270,epilepsy,Lipid ,3,2016.0,recruiting,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,"epidiolex, oral liquid cannabidiol, gwp42003",P21554,antagonist,
640,0,Class A (Rhodopsin),small molecule,cannabidiol,cnr2_human,CNR2,MMAmar2016_0271,epilepsy,Lipid ,3,2016.0,recruiting,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,"epidiolex, oral liquid cannabidiol, gwp42003",P34972,antagonist,
641,0,Class A (Rhodopsin),small molecule,iti-007,drd2_human,DRD2,1048,schizophrenia,Aminergic ,3,2016.0,recruiting,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"iti-007, iti-722",P14416,antagonist,
642,0,Class A (Rhodopsin),small molecule,iti-007,5ht2a_human,HTR2A,1048,schizophrenia,Aminergic ,3,2016.0,recruiting,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"iti-007, iti-722",P28223,antagonist,
643,0,Class A (Rhodopsin),small molecule,nbi-56418,gnrhr_human,GNRHR,1388,"Endometriosis, Antineoplastic",Peptide ,3,2016.0,recruiting,in trial,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,nbi-56418,P30968,antagonist,
644,0,Class A (Rhodopsin),small molecule,obe001,oxyr_human,OXTR,MMAapril2016_0035,labor and delivery,Peptide ,3,2017.0,recruiting,in trial,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,obe001,P30559,antagonist,
645,0,Class A (Rhodopsin),antibody,pro 140,ccr5_human,CCR5,1649,antiviral ; HIV,Protein ,3,2016.0,recruiting,in trial,Chemokine receptors,GPCR;Rhodopsin,established,pro 140,P51681,antagonist,
646,0,Class A (Rhodopsin),small molecule,tbr-652,ccr5_human,CCR5,1962,antiviral ; HIV; Nonalcoholic Steatohepatitis,Protein ,3,2017.0,recruiting,in trial,Chemokine receptors,GPCR;Rhodopsin,established,"tbr-652, tak-652, Cenicriviroc",P51681,antagonist,
647,0,Class A (Rhodopsin),small molecule,td-4208,acm3_human,CHRM3,MMAmay2016_0081,chronic obstructive pulmonary disease (COPD),Aminergic ,3,2017.0,recruiting,in trial,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"td-4208, Revefenacin",P20309,antagonist,
648,0,Class A (Rhodopsin),small molecule,sens-111,hrh4_human,HRH4,MMAapril2016_0282,for vertigo and tinnitus,Aminergic ,3,2017.0,recruiting,in trial,Histamine receptors,GPCR;Rhodopsin,established,sens-111,Q9H3N8,antagonist,
649,0,Class A (Rhodopsin),small molecule,x4p-001,cxcr4_human,CXCR4,MMAapril2016_0220,Antineoplastic ; renal cell carcinoma,Protein ,3,2016.0,recruiting,in trial,Chemokine receptors,GPCR;Rhodopsin,established,x4p-001,P61073,antagonist,
650,0,Class A (Rhodopsin),small molecule,danirixin,cxcr2_human,CXCR2,ASH_Sep2016_297,chronic obstructive pulmonary disease (COPD),Protein ,2,2017.0,recruiting,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,"danirixin, GSK1325756",P25025,antagonist,
651,0,Class A (Rhodopsin),small molecule,intepirdine,5ht6r_human,HTR6,ASH_Sep2016_44,Alzheimer's disease,Aminergic ,2,2016.0,recruiting,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,intepirdine,P50406,antagonist,
652,0,Class A (Rhodopsin),small molecule,lemborexant,ox1r_human,HCRTR1,ASH_Sep2016_278,insomnia,Peptide ,2,2016.0,recruiting,in trial,Orexin receptors,GPCR;Rhodopsin,established,lemborexant,O43613,antagonist,
653,0,Class A (Rhodopsin),small molecule,lemborexant,ox2r_human,HCRTR2,ASH_Sep2016_280,insomnia,Peptide ,2,2016.0,recruiting,in trial,Orexin receptors,GPCR;Rhodopsin,established,lemborexant,O43614,antagonist,
654,0,Class C (Glutamate) ,small molecule,mavoglurant,grm5_human,GRM5,ASH_Sep2016_340,obsessive-compulsive disorder,Amino acid ,2,2016.0,recruiting,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,established,mavoglurant,P41594,antagonist,
655,0,Class A (Rhodopsin),small molecule,tradipitant,nk1r_human,TACR1,ASH_Sep2016_286,alcohol dependence,Peptide ,2,2016.0,recruiting,in trial,Tachykinin receptors,GPCR;Rhodopsin,established,tradipitant,P25103,antagonist,
656,0,Class A (Rhodopsin),small molecule,cenicriviroc,ccr2_human,CCR2,ASH_Sep2016_292,antiviral ; HIV,Protein ,3,2017.0,recruiting,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,cenicriviroc,P41597,antagonist,
657,0,Class A (Rhodopsin),small molecule,cenicriviroc,ccr5_human,CCR5,ASH_Sep2016_293,antiviral ; HIV,Protein ,3,2017.0,recruiting,in trial,Chemokine receptors,GPCR;Rhodopsin,established,cenicriviroc,P51681,antagonist,
658,0,Class A (Rhodopsin),small molecule,fevipiprant,pd2r2_human,GPR44,ASH_Sep2016_308,Anti-Asthmatic,Lipid ,3,2017.0,recruiting,in trial,Prostanoid receptors,GPCR;Rhodopsin,not established,fevipiprant,Q9Y5Y4,antagonist,
659,0,Class A (Rhodopsin),small molecule,relugolix,gnrhr_human,GNRHR,ASH_Sep2016_258,endometriosis,Peptide ,3,2017.0,recruiting,in trial,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,relugolix,P30968,antagonist,
660,0,Class B1 (Secretin),small molecule,ubrogepant,calrl_human,CALCRL,ASH_Sep2016_327,Anti-migraine,Peptide ,3,2016.0,recruiting,in trial,Calcitonin receptors,GPCR;Secretin,not established,ubrogepant,Q16602,antagonist,
661,0,Class A (Rhodopsin),small molecule,setipiprant,pd2r2_human,GPR44,ASH_Sep2016_309,seasonal allergic rhinitis,Lipid ,3,2016.0,recruiting,in trial,Prostanoid receptors,GPCR;Rhodopsin,not established,setipiprant,Q9Y5Y4,antagonist,
662,0,Class A (Rhodopsin),small molecule,elagolix,gnrhr_human,GNRHR,ASH_Sep2016_257,endometriosis,Peptide ,3,2016.0,recruiting,in trial,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,elagolix,P30968,antagonist,
663,0,Class A (Rhodopsin),small molecule,idalopirdine,5ht6r_human,HTR6,ASH_Sep2016_42,Alzheimer's disease,Aminergic ,3,2014.0,recruiting,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,idalopirdine,P50406,antagonist,
664,0,Class A (Rhodopsin),small molecule,retosiban,oxyr_human,OXTR,ASH_Sep2016_289,premature birth,Peptide ,3,2015.0,recruiting,in trial,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,retosiban,P30559,antagonist,
665,1998,Class A (Rhodopsin),small molecule,sertindole,ada1a_human,ADRA1A,1838,schizophrenia,Aminergic ,3,2015.0,recruiting,withdrawn,Adrenoceptors,GPCR;Rhodopsin,established,serdolect,P35348,antagonist,Not FDA approved but used in other countries; was withdrawn in 1996 but looks to be approved again in Europe and soon to market
666,1998,Class A (Rhodopsin),small molecule,sertindole,ada1b_human,ADRA1B,1838,schizophrenia,Aminergic ,3,2015.0,recruiting,withdrawn,Adrenoceptors,GPCR;Rhodopsin,established,serdolect,P35368,antagonist,Not FDA approved but used in other countries; was withdrawn in 1996 but looks to be approved again in Europe and soon to market
667,1998,Class A (Rhodopsin),small molecule,sertindole,ada1d_human,ADRA1D,1838,schizophrenia,Aminergic ,3,2015.0,recruiting,withdrawn,Adrenoceptors,GPCR;Rhodopsin,established,serdolect,P25100,antagonist,Not FDA approved but used in other countries; was withdrawn in 1996 but looks to be approved again in Europe and soon to market
668,1998,Class A (Rhodopsin),small molecule,sertindole,drd2_human,DRD2,1838,schizophrenia,Aminergic ,3,2015.0,recruiting,withdrawn,Dopamine receptors,GPCR;Rhodopsin,established,serdolect,P14416,antagonist,Not FDA approved but used in other countries; was withdrawn in 1996 but looks to be approved again in Europe and soon to market
669,1998,Class A (Rhodopsin),small molecule,sertindole,5ht2a_human,HTR2A,1838,schizophrenia,Aminergic ,3,2015.0,recruiting,withdrawn,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,serdolect,P28223,antagonist,Not FDA approved but used in other countries; was withdrawn in 1996 but looks to be approved again in Europe and soon to market
670,1998,Class A (Rhodopsin),small molecule,sertindole,5ht6r_human,HTR6,1838,schizophrenia,Aminergic ,3,2015.0,recruiting,withdrawn,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,serdolect,P50406,antagonist,Not FDA approved but used in other countries; was withdrawn in 1996 but looks to be approved again in Europe and soon to market
671,0,Class A (Rhodopsin),small molecule,rigosertib,par1_human,F2R,ASH_Sep2016_281,refractory anemia with excess blasts,Peptide ,3,2015.0,recruiting,in trial,Proteinase-activated receptors,GPCR;Rhodopsin,established,rigosertib,P25116,inhibitor,
672,0,Class A (Rhodopsin),small molecule,"nelotanserin, apd-125",5ht2a_human,HTR2A,MMAmar2016_0233,dementia; Parkinson's disease,Aminergic ,2,2016.0,recruiting,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"nelotanserin, apd-125",P28223,inverse agonist,
673,1998,Class A (Rhodopsin),small molecule,sertindole,5ht2c_human,HTR2C,1838,schizophrenia,Aminergic ,3,2015.0,recruiting,withdrawn,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,serdolect,P28335,inverse agonist,Not FDA approved but used in other countries; was withdrawn in 1996 but looks to be approved again in Europe and soon to market
674,0,Class A (Rhodopsin),small molecule,vsn16r,gpr55_human,GPR55,MMAmay2016_0803,Antispasmodics;  for spatisity related to multiple sclerosis,Lipid ,2,2015.0,recruiting,in trial,"GPR18, GPR55 and GPR119",GPCR;Rhodopsin,not established,vsn16r,Q9Y2T6,modulator,
675,0,Class A (Rhodopsin),small molecule,rpc1063,s1pr1_human,S1PR1,1790,Multiple Sclerosis,Lipid ,3,2015.0,recruiting,in trial,Lysophospholipid (S1P) receptors,GPCR;Rhodopsin,established,rpc1063,P21453,modulator,
676,0,Class A (Rhodopsin),small molecule,ladarixin,cxcr1_human,CXCR1,ASH_Sep2016_296,bullous pemphigoid,Protein ,2,2016.0,recruiting,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,ladarixin,P25024,modulator,
677,0,Class A (Rhodopsin),small molecule,ladarixin,cxcr2_human,CXCR2,ASH_Sep2016_298,bullous pemphigoid,Protein ,2,2016.0,recruiting,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,ladarixin,P25025,modulator,
678,0,Class B1 (Secretin),peptide,exendin (9-39) ,glp1r_human,GLP1R,MMAjun2016_0019,hypoglycemia,Peptide ,2,2016.0,recruiting,in trial,Glucagon receptor family,GPCR;Secretin,established,exendin (9-39) ,P43220,na,Appears pause in research from 2009-2016
679,0,Class A (Rhodopsin),protein,corifollitropin alfa,fshr_human,FSHR,526,Fertility,Protein ,3,2015.0,recruiting,in trial,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,"corifollitropin alfa,elonva",P23945,na,
680,0,Class F (Frizzled),small molecule,ipi-926,smo_human,SMO,2824,Antineoplastic,Protein ,2,2016.0,recruiting,in trial,Frizzled,GPCR;Frizzled,established,"ipi-926, Patidegib",Q99835,inhibitor,
681,0,Class C (Glutamate) ,small molecule,stx107,grm5_human,GRM5,1906,Fragile X syndrome,Amino acid ,2,2011.0,Completed,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,established,stx107,P41594,nam,
682,0,Class A (Rhodopsin),small molecule,adl7445,oprm_human,OPRM1,58,motilitant,Peptide ,1,2011.0,Terminated,in trial,Opioid receptors,GPCR;Rhodopsin,established,adl7445,P35372,agonist,Terminated lack of enrollment
683,0,Class A (Rhodopsin),small molecule,tzp-102,ghsr_human,GHSR,2096,gastroparesis,Peptide ,2,2012.0,Terminated,in trial,Ghrelin receptors,GPCR;Rhodopsin,not established,tzp-102,Q92847,agonist,Clinical trial terminated due to Insufficient efficacy in planned interim futility analysis; no development reported on drug itself
684,0,Class A (Rhodopsin),small molecule,adl5945,oprm_human,OPRM1,57,motilitant,Peptide ,3,2013.0,Terminated,in trial,Opioid receptors,GPCR;Rhodopsin,established,adl5945,P35372,agonist,Terminated lack of enrollment
685,0,Class A (Rhodopsin),small molecule,bl-1020,hrh1_human,HRH1,2424,schizophrenia,Aminergic ,3,2011.0,Terminated,in trial,Histamine receptors,GPCR;Rhodopsin,established,bl-1020,P35367,agonist,
686,0,Class A (Rhodopsin),small molecule,bl-1020,5ht2a_human,HTR2A,2424,schizophrenia,Aminergic ,3,2011.0,Terminated,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,bl-1020,P28223,agonist,
687,0,Class A (Rhodopsin),small molecule,dexpramipexole,drd2_human,DRD2,627,amyotrophic lateral sclerosis (ALS),Aminergic ,3,2012.0,Terminated,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"dexpramipexole, kns-760704",P14416,agonist,Did not meet its primary efficacy endpoint
688,0,Class A (Rhodopsin),small molecule,dexpramipexole,drd3_human,DRD3,627,amyotrophic lateral sclerosis (ALS),Aminergic ,3,2012.0,Terminated,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"dexpramipexole, kns-760704",P35462,agonist,Did not meet its primary efficacy endpoint
689,0,Class A (Rhodopsin),small molecule,dexpramipexole,drd4_human,DRD4,627,amyotrophic lateral sclerosis (ALS),Aminergic ,3,2012.0,Terminated,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"dexpramipexole, kns-760704",P21917,agonist,Did not meet its primary efficacy endpoint
690,0,Class A (Rhodopsin),antibody,"alx- 0651, biparatopic nanobody",cxcr4_human,CXCR4,MMAmay2016_0267,Antineoplastic,Protein ,1,2011.0,Terminated,in trial,Chemokine receptors,GPCR;Rhodopsin,established,"alx- 0651, biparatopic nanobody",P61073,antagonist,
691,0,Class A (Rhodopsin),protein,ccl2-lpm,ccr2_human,CCR2,445,Anti-inflammatory,Protein ,1,2009.0,Terminated,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,ccl2-lpm,P41597,antagonist,Terminated due to resources and slow enrollment not safety
692,0,Class A (Rhodopsin),small molecule,pbf-999,aa1r_human,ADORA1,MMAapril2016_0022,Huntington's disease,Nucleotide ,1,2016.0,Terminated,in trial,Adenosine receptors,GPCR;Rhodopsin,established,pbf-999,P30542,antagonist,Terminated due to change in therapeutic indication
693,0,Class A (Rhodopsin),small molecule,agn-214868,ada1a_human,ADRA1A,85,Analgesics; neuralgia,Aminergic ,2,2012.0,Terminated,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"agn-214868, Senrebotase",P35348,antagonist,
694,0,Class A (Rhodopsin),small molecule,agn-214868,ada1b_human,ADRA1B,85,Analgesics; neuralgia,Aminergic ,2,2012.0,Terminated,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"agn-214868, Senrebotase",P35368,antagonist,
695,0,Class A (Rhodopsin),small molecule,agn-214868,ada1d_human,ADRA1D,85,Analgesics; neuralgia,Aminergic ,2,2012.0,Terminated,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"agn-214868, Senrebotase",P25100,antagonist,
696,0,Class A (Rhodopsin),small molecule,agn-214868,ada2a_human,ADRA2A,85,Analgesics; neuralgia,Aminergic ,2,2012.0,Terminated,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"agn-214868, Senrebotase",P08913,antagonist,
697,0,Class A (Rhodopsin),small molecule,agn-214868,ada2b_human,ADRA2B,85,Analgesics; neuralgia,Aminergic ,2,2012.0,Terminated,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"agn-214868, Senrebotase",P18089,antagonist,
698,0,Class A (Rhodopsin),small molecule,agn-214868,ada2c_human,ADRA2C,85,Analgesics; neuralgia,Aminergic ,2,2012.0,Terminated,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"agn-214868, Senrebotase",P18825,antagonist,
699,0,Class A (Rhodopsin),small molecule,bg-9928,aa1r_human,ADORA1,345,congestive heart failure,Nucleotide ,2,2008.0,Terminated,in trial,Adenosine receptors,GPCR;Rhodopsin,established,bg-9928,P30542,antagonist,
700,0,Class A (Rhodopsin),small molecule,avosentan,ednra_human,EDNRA,295,Diabetic nephropathy,Peptide ,3,2005.0,Terminated,in trial,Endothelin receptors,GPCR;Rhodopsin,established,"avosentan, spp 301",P25101,antagonist,
701,0,Class A (Rhodopsin),small molecule,bl-1020,drd2_human,DRD2,2424,schizophrenia,Aminergic ,3,2011.0,Terminated,in trial,Dopamine receptors,GPCR;Rhodopsin,established,bl-1020,P14416,antagonist,
702,0,Class A (Rhodopsin),small molecule,ccx282,ccr9_human,CCR9,449,Anti-inflammatory ; Crohn's disease; ulceraite colitis,Protein ,3,2012.0,Terminated,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,"ccx282, traficet-en",P51686,antagonist,Terminated due to lack of efficacy
703,0,Class A (Rhodopsin),small molecule,"mg01ci, extended-release metadoxine,",5ht2b_human,HTR2B,MMAmay2016_0480,neurologic disorders; ADHD,Aminergic ,3,2015.0,Terminated,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"mg01ci, extended-release metadoxine,",P41595,antagonist,FDA clinical hold
704,0,Class A (Rhodopsin),small molecule,pf-05212377,5ht6r_human,HTR6,ASH_Sep2016_45,Alzheimer's disease,Aminergic ,2,2012.0,Terminated,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,pf-05212377,P50406,antagonist,Terminated not due to safety concerns - may still be viable drug to investigate
705,0,Class A (Rhodopsin),small molecule,am-211,pd2r2_human,GPR44,145,Anti-inflammatory ; antiallergy,Lipid ,1,2011.0,Unknown,in trial,Prostanoid receptors,GPCR;Rhodopsin,not established,am-211,Q9Y5Y4,antagonist,
706,0,Class A (Rhodopsin),small molecule,am-461,pd2r_human,PTGDR,146,Anti-inflammatory,Lipid ,1,2011.0,Unknown,in trial,Prostanoid receptors,GPCR;Rhodopsin,established,am-461,Q13258,antagonist,
707,0,Class A (Rhodopsin),small molecule,ccx025,ccr9_human,CCR9,446,Anti-inflammatory,Protein ,1,2009.0,Unknown,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,ccx025,P51686,antagonist,
708,0,Class A (Rhodopsin),small molecule,avn-211,5ht6r_human,HTR6,291,schizophrenia,Aminergic ,2,2010.0,Unknown,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,avn-211,P50406,antagonist,
709,0,Class A (Rhodopsin),small molecule,bvt.28949,5ht2a_human,HTR2A,412,Antiglaucomic,Aminergic ,2,2010.0,Unknown,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,bvt.28949,P28223,antagonist,Sweden
710,0,Class A (Rhodopsin),small molecule,temanogrel,5ht2a_human,HTR2A,ASH_Sep2016_24,acute coronary syndrome,Aminergic ,1,2015.0,Unknown,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,temanogrel,P28223,inverse agonist,
711,0,Class A (Rhodopsin),small molecule,fenoterol,adrb2_human,ADRB2,NRDD229,Bronchodilator ; Tocolytic,Aminergic ,4,,withdrawn,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P07550,agonist,
712,1984,Class A (Rhodopsin),small molecule,minaprine,drd1_human,DRD1,NRDD368,Anti-depressant,Aminergic ,4,,withdrawn,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21728,antagonist,Not approved by fda - but used
713,1984,Class A (Rhodopsin),small molecule,minaprine,drd2_human,DRD2,NRDD368,Anti-depressant,Aminergic ,4,,withdrawn,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,antagonist,Not approved by fda - but used
714,1984,Class A (Rhodopsin),small molecule,minaprine,5ht2a_human,HTR2A,NRDD368,Anti-depressant,Aminergic ,4,,withdrawn,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28223,antagonist,Not approved by fda - but used
715,1984,Class A (Rhodopsin),small molecule,minaprine,5ht2b_human,HTR2B,NRDD368,Anti-depressant,Aminergic ,4,,withdrawn,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P41595,antagonist,Not approved by fda - but used
716,1984,Class A (Rhodopsin),small molecule,minaprine,5ht2c_human,HTR2C,NRDD368,Anti-depressant,Aminergic ,4,,withdrawn,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28335,antagonist,Not approved by fda - but used
717,0,Class A (Rhodopsin),small molecule,bavisant,hrh3_human,HRH3,ASH_Sep2016_243,attention deficit hyperactivity disorder,Aminergic ,2,2011.0,withdrawn,in trial,Histamine receptors,GPCR;Rhodopsin,established,bavisant,Q9Y5N1,antagonist,No development reported
718,0,Class A (Rhodopsin),small molecule,epelsiban,oxyr_human,OXTR,ASH_Sep2016_291,premature ejaculation,Peptide ,2,2016.0,withdrawn,in trial,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,epelsiban,P30559,antagonist,"Had no activity since 2009, then shows 2016 a phase 2 trial, but withdrawn due to change in portfolio prioritization"
719,0,Class A (Rhodopsin),peptide,"p2045, 188re-p2045",ssr2_human,SSTR2,MMAmay2016_0746,Antineoplastic,Peptide ,1,2014.0,withdrawn,in trial,Somatostatin receptors,GPCR;Rhodopsin,established,"p2045, 188re-p2045",P30874,na,Withdrawn due to PI left study institution; had 10 year break in research
720,0,Class A (Rhodopsin),small molecule,beraprost,pi2r_human,PTGIR,337,Antihypertensive,Lipid ,3,2011.0,withdrawn,in trial,Prostanoid receptors,GPCR;Rhodopsin,established,beraprost,P43119,agonist,"No longer marketed, but may still be available"
721,2017,Class C (Glutamate) ,peptide,"etelcalcetide, amg 416, velcalcetide, kai-4169, ono-5163",casr_human,CASR,MMAapril2016_0047,parathyroid disorders,Ion ,4,,-,approved,Calcium-sensing receptors,GPCR;Glutamate,established,"etelcalcetide, amg 416, velcalcetide, kai-4169, ono-5163",P41180,agonist,new fda approval in Feb 2017
722,2007,Class A (Rhodopsin),small molecule,levocetirizine,hrh1_human,HRH1,1118,Anti-Allergic,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,"levocetirizine dihydrochloride,xusal, xyzal",P35367,antagonist,Actually approved in 2007 but not considered a NME because enantiomer of cetirizine  I think
723,2007,Class A (Rhodopsin),small molecule,nrp104,ada1b_human,ADRA1B,2199,ADHD,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,vyvanse,P35368,releasing agent,FDA approval 2007 for ADHD; pro-drug of dextroamphetamine so not NME
724,1968,Class A (Rhodopsin),small molecule,flunarizine,hrh1_human,HRH1,NRDD236,Anticonvulsants; Vasodilator,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,antagonist,
725,0,Class C (Glutamate) ,small molecule,progabide,gabr1_human,GABBR1,NRDD461,Anticonvulsants,Amino acid ,4,,-,approved,GABAB receptors,GPCR;Glutamate,established,-,Q9UBS5,agonist,Not FDA approved but used in other countries
726,0,Class A (Rhodopsin),small molecule,forasartan,agtr1_human,AGTR1,NRDD248,Antihypertensive,Peptide ,4,,-,approved,Angiotensin receptors,GPCR;Rhodopsin,established,-,P30556,antagonist,"Never approved by fda, used from long time ago"
727,1982,Class A (Rhodopsin),small molecule,levomepromazine,ada1a_human,ADRA1A,NRDD342,schizophrenia,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,antagonist,Approved prior to 1982 and then discontinued
728,1982,Class A (Rhodopsin),small molecule,levomepromazine,ada1b_human,ADRA1B,NRDD342,schizophrenia,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35368,antagonist,Approved prior to 1982 and then discontinued
729,1982,Class A (Rhodopsin),small molecule,levomepromazine,ada1d_human,ADRA1D,NRDD342,schizophrenia,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P25100,antagonist,Approved prior to 1982 and then discontinued
730,1982,Class A (Rhodopsin),small molecule,levomepromazine,acm1_human,CHRM1,NRDD342,schizophrenia,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,antagonist,Approved prior to 1982 and then discontinued
731,1982,Class A (Rhodopsin),small molecule,levomepromazine,acm2_human,CHRM2,NRDD342,schizophrenia,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172,antagonist,Approved prior to 1982 and then discontinued
732,1982,Class A (Rhodopsin),small molecule,levomepromazine,acm3_human,CHRM3,NRDD342,schizophrenia,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P20309,antagonist,Approved prior to 1982 and then discontinued
733,1982,Class A (Rhodopsin),small molecule,levomepromazine,acm4_human,CHRM4,NRDD342,schizophrenia,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08173,antagonist,Approved prior to 1982 and then discontinued
734,1982,Class A (Rhodopsin),small molecule,levomepromazine,acm5_human,CHRM5,NRDD342,schizophrenia,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08912,antagonist,Approved prior to 1982 and then discontinued
735,1982,Class A (Rhodopsin),small molecule,levomepromazine,drd3_human,DRD3,NRDD342,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P35462,antagonist,Approved prior to 1982 and then discontinued
736,1982,Class A (Rhodopsin),small molecule,levomepromazine,hrh1_human,HRH1,NRDD342,schizophrenia,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,antagonist,Approved prior to 1982 and then discontinued
737,1982,Class A (Rhodopsin),small molecule,levomepromazine,5ht2b_human,HTR2B,NRDD342,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P41595,antagonist,Approved prior to 1982 and then discontinued
738,0,Class A (Rhodopsin),small molecule,nicergoline,ada1a_human,ADRA1A,NRDD384,Nootropic ; Vasodilator,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,antagonist,"Marketed but I don't think fda approved, if so then long ago"
739,0,Class A (Rhodopsin),small molecule,pirenzepine,acm1_human,CHRM1,NRDD446,GI Anti-Ulcer ; anticholinergic; Antispasmodics,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,antagonist,
740,0,Class A (Rhodopsin),small molecule,practolol,adrb1_human,ADRB1,NRDD449,Anti-Arrhythmia,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588,antagonist,
741,0,Class A (Rhodopsin),small molecule,pranlukast,cltr1_human,CYSLTR1,NRDD451,Anti-Asthmatic,Lipid ,4,,-,approved,Leukotriene receptors,GPCR;Rhodopsin,established,-,Q9Y271,antagonist,
742,1966,Class A (Rhodopsin),small molecule,alprenolol,adrb1_human,ADRB1,NRDD019,Anti-Arrhythmia ; Antihypertensive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588,antagonist,"No longer marketed, but may still be available"
743,1966,Class A (Rhodopsin),small molecule,alprenolol,adrb2_human,ADRB2,NRDD019,Anti-Arrhythmia ; Antihypertensive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P07550,antagonist,"No longer marketed, but may still be available"
744,1990,Class A (Rhodopsin),small molecule,remoxipride,drd2_human,DRD2,NRDD479,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,antagonist,Withdrawn 
745,0,Class A (Rhodopsin),small molecule,aceprometazine,hrh1_human,HRH1,NRDD003,Hypnotics and Sedatives,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,antagonist,Withdrawn in EU - not sure if ever in trials in US
746,0,Class A (Rhodopsin),small molecule,clenbuterol,adrb2_human,ADRB2,NRDD113,Bronchodilator,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P07550,agonist,Not approved in US
747,1987,Class A (Rhodopsin),small molecule,chlophedianol,hrh1_human,HRH1,NRDD087,Antitussive,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,antagonist,Not available in US- discontinued
748,1970,Class A (Rhodopsin),small molecule,debrisoquin,ada1a_human,ADRA1A,NRDD143,Antihypertensive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,unknown,Approved from before 1970
749,1970,Class A (Rhodopsin),small molecule,debrisoquin,ada1b_human,ADRA1B,NRDD143,Antihypertensive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35368,unknown,Approved from before 1970
750,1970,Class A (Rhodopsin),small molecule,debrisoquin,ada1d_human,ADRA1D,NRDD143,Antihypertensive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P25100,unknown,Approved from before 1970
751,1970,Class A (Rhodopsin),small molecule,debrisoquin,ada2a_human,ADRA2A,NRDD143,Antihypertensive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08913,unknown,Approved from before 1970
752,1970,Class A (Rhodopsin),small molecule,debrisoquin,ada2b_human,ADRA2B,NRDD143,Antihypertensive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P18089,unknown,Approved from before 1970
753,1970,Class A (Rhodopsin),small molecule,debrisoquin,ada2c_human,ADRA2C,NRDD143,Antihypertensive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P18825,unknown,Approved from before 1970
754,0,Class A (Rhodopsin),small molecule,mequitazine,hrh1_human,HRH1,NRDD329,Anti-Allergic,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,antagonist,"Marketed but I don't think fda approved, if so then long ago"
755,1996,Class A (Rhodopsin),small molecule,mianserin,ada2a_human,ADRA2A,NRDD363,Anti-depressant,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08913,unknown,"Doesn't appear to be FDA approved, but analogue mirtazapine is "
756,1996,Class A (Rhodopsin),small molecule,mianserin,hrh1_human,HRH1,NRDD363,Anti-depressant,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,unknown,"Doesn't appear to be FDA approved, but analogue mirtazapine is "
757,1996,Class A (Rhodopsin),small molecule,mianserin,5ht2a_human,HTR2A,NRDD363,Anti-depressant,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28223,unknown,"Doesn't appear to be FDA approved, but analogue mirtazapine is "
758,1996,Class A (Rhodopsin),small molecule,mianserin,5ht2c_human,HTR2C,NRDD363,Anti-depressant,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28335,unknown,"Doesn't appear to be FDA approved, but analogue mirtazapine is "
759,0,Class A (Rhodopsin),small molecule,propericiazine,ada1a_human,ADRA1A,NRDD466,schizophrenia,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,unknown,Not FDA approved but used in other countries
760,0,Class A (Rhodopsin),small molecule,propericiazine,ada1b_human,ADRA1B,NRDD466,schizophrenia,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35368,unknown,Not FDA approved but used in other countries
761,0,Class A (Rhodopsin),small molecule,propericiazine,ada1d_human,ADRA1D,NRDD466,schizophrenia,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P25100,unknown,Not FDA approved but used in other countries
762,1986,Class A (Rhodopsin),small molecule,alfentanil,oprm_human,OPRM1,NRDD015,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P35372,agonist,
763,1982,Class A (Rhodopsin),small molecule,anileridine,oprm_human,OPRM1,NRDD027,Analgesics; Narcotics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P35372,agonist,
764,1987,Class A (Rhodopsin),small molecule,apraclonidine,ada2a_human,ADRA2A,NRDD032,Antiglaucomic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08913,agonist,
765,2006,Class A (Rhodopsin),small molecule,arformoterol,adrb2_human,ADRB2,NRDD036,Bronchodilator,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P07550,agonist,
766,1982,Class A (Rhodopsin),small molecule,betazole,hrh2_human,HRH2,NRDD053,Diagnostic,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P25021,agonist,
767,1948,Class A (Rhodopsin),small molecule,bethanechol,acm1_human,CHRM1,NRDD054,Parasympathomimetics,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,agonist,
768,1996,Class A (Rhodopsin),small molecule,cabergoline,drd2_human,DRD2,NRDD071,Antiparkinson,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,agonist,
769,1972,Class A (Rhodopsin),small molecule,carbachol,acm1_human,CHRM1,NRDD077,Antiglaucomic,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,agonist,
770,1972,Class A (Rhodopsin),small molecule,carbachol,acm2_human,CHRM2,NRDD077,Antiglaucomic,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172,agonist,
771,1965,Class A (Rhodopsin),small molecule,carboprost tromethamine,pe2r1_human,PTGER1,NRDD081,Abortifacient,Lipid ,4,,-,approved,Prostanoid receptors,GPCR;Rhodopsin,established,-,P34995,agonist,
772,1982,Class A (Rhodopsin),small molecule,ceruletide,cckar_human,CCKAR,NRDD085,Diagnostic,Peptide ,4,,-,approved,Cholecystokinin receptors,GPCR;Rhodopsin,established,-,P32238,agonist,
773,1982,Class A (Rhodopsin),small molecule,ceruletide,cckar_human,CCKAR,NRDD085,Diagnostic,Peptide ,4,,-,approved,Cholecystokinin receptors,GPCR;Rhodopsin,established,-,P32238,agonist,
774,2000,Class A (Rhodopsin),small molecule,cevimeline,acm1_human,CHRM1,NRDD086,Parasympathomimetics,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,agonist,
775,2000,Class A (Rhodopsin),small molecule,cevimeline,acm3_human,CHRM3,NRDD086,Parasympathomimetics,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P20309,agonist,
776,1973,Class A (Rhodopsin),protein,chorionic gonadotropin,fshr_human,FSHR,NRDD099,Fertility,Protein ,4,,-,approved,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,-,P23945,agonist,
777,1973,Class A (Rhodopsin),protein,chorionic gonadotropin,lshr_human,LHCGR,NRDD099,Fertility,Protein ,4,,-,approved,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,-,P22888,agonist,
778,1973,Class A (Rhodopsin),protein,chorionic gonadotropin,fshr_human,FSHR,NRDD099,Fertility,Protein ,4,,-,approved,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,-,P23945,agonist,
779,1993,Class A (Rhodopsin),small molecule,cisapride,5ht4r_human,HTR4,NRDD109,Parasympathomimetics,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,Q13639,agonist,
780,2009,Class A (Rhodopsin),small molecule,codeine,oprd_human,OPRD1,NRDD124,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P41143,agonist,
781,2009,Class A (Rhodopsin),small molecule,codeine,oprk_human,OPRK1,NRDD124,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P41145,agonist,
782,2009,Class A (Rhodopsin),small molecule,codeine,oprm_human,OPRM1,NRDD124,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P35372,agonist,
783,1955,Class A (Rhodopsin),protein,corticotropin,acthr_human,MC2R,NRDD127,Diagnostic,Peptide ,4,,-,approved,Melanocortin receptors,GPCR;Rhodopsin,established,-,Q01718,agonist,
784,1955,Class A (Rhodopsin),protein,corticotropin,acthr_human,MC2R,NRDD127,Diagnostic,Peptide ,4,,-,approved,Melanocortin receptors,GPCR;Rhodopsin,established,-,Q01718,agonist,
785,1970,Class A (Rhodopsin),peptide,cosyntropin,acthr_human,MC2R,NRDD128,Diagnostic,Peptide ,4,,-,approved,Melanocortin receptors,GPCR;Rhodopsin,established,-,Q01718,agonist,
786,1976,Class A (Rhodopsin),small molecule,danazol,gnrhr_human,GNRHR,NRDD139,Antiendometriosis ; Antineoplastic,Peptide ,4,,-,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,-,P30968,agonist,
787,1976,Class A (Rhodopsin),small molecule,danazol,gnrr2_human,GNRHR2,NRDD139,Antiendometriosis ; Antineoplastic,Peptide ,4,,-,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,-,Q96P88,agonist,
788,1976,Class A (Rhodopsin),small molecule,danazol,gnrr2_human,GNRHR2,NRDD139,Antiendometriosis; Antineoplastic,Peptide ,4,,-,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,-,Q96P88,agonist,
789,1999,Class A (Rhodopsin),small molecule,dexmedetomidine,ada2a_human,ADRA2A,NRDD155,Analgesics; Hypnotics and Sedatives,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08913,agonist,
790,1981,Class A (Rhodopsin),small molecule,dinoprost tromethamine,pi2r_human,PTGIR,NRDD171,Abortifacient,Lipid ,4,,-,approved,Prostanoid receptors,GPCR;Rhodopsin,established,-,P43119,agonist,
791,1977,Class A (Rhodopsin),small molecule,dinoprostone,pe2r1_human,PTGER1,NRDD172,Abortifacient,Lipid ,4,,-,approved,Prostanoid receptors,GPCR;Rhodopsin,established,-,P34995,agonist,
792,1977,Class A (Rhodopsin),small molecule,dinoprostone,pe2r2_human,PTGER2,NRDD172,Abortifacient,Lipid ,4,,-,approved,Prostanoid receptors,GPCR;Rhodopsin,established,-,P43116,agonist,
793,1977,Class A (Rhodopsin),small molecule,dinoprostone,pe2r3_human,PTGER3,NRDD172,Abortifacient,Lipid ,4,,-,approved,Prostanoid receptors,GPCR;Rhodopsin,established,-,P43115,agonist,
794,1977,Class A (Rhodopsin),small molecule,dinoprostone,pe2r4_human,PTGER4,NRDD172,Abortifacient,Lipid ,4,,-,approved,Prostanoid receptors,GPCR;Rhodopsin,established,-,P35408,agonist,
795,1960,Class A (Rhodopsin),small molecule,diphenoxylate,oprm_human,OPRM1,NRDD176,Antidiuretic,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P35372,agonist,
796,1980,Class A (Rhodopsin),small molecule,dipivefrin,ada2a_human,ADRA2A,NRDD178,opthalmological,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08913,agonist,
797,1978,Class A (Rhodopsin),small molecule,dobutamine,adrb1_human,ADRB1,NRDD182,Cardiotonic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588,agonist,
798,1995,Class A (Rhodopsin),small molecule,epoprostenol,pi2r_human,PTGIR,NRDD206,Antihypertensive ; Platelet Aggregation Inhibitors,Lipid ,4,,-,approved,Prostanoid receptors,GPCR;Rhodopsin,established,-,P43119,agonist,
799,1953,Class A (Rhodopsin),small molecule,ergoloid,ada1a_human,ADRA1A,NRDD209,Nootropic ; Vasodilator,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,agonist,
800,1953,Class A (Rhodopsin),small molecule,ergoloid,ada2a_human,ADRA2A,NRDD209,Nootropic ; Vasodilator,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08913,agonist,
801,1960,Class A (Rhodopsin),small molecule,ergotamine,5ht1b_human,HTR1B,NRDD210,Anti-migraine,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28222,agonist,
802,1960,Class A (Rhodopsin),small molecule,ergotamine,5ht1d_human,HTR1D,NRDD210,Anti-migraine,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28221,agonist,
803,1997,Class A (Rhodopsin),protein,follitropin,fshr_human,FSHR,NRDD246,Fertility,Protein ,4,,-,approved,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,-,P23945,agonist,
804,1960,Class B1 (Secretin),peptide,glucagon,glr_human,GCGR,NRDD256,Antihypoglycemic,Peptide ,4,,-,approved,Glucagon receptor family,GPCR;Secretin,established,-,P47871,agonist,
805,1982,Class A (Rhodopsin),small molecule,gonadorelin,gnrhr_human,GNRHR,NRDD259,Fertility,Peptide ,4,,-,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,-,P30968,agonist,
806,1982,Class A (Rhodopsin),small molecule,gonadorelin,gnrr2_human,GNRHR2,NRDD259,Fertility,Peptide ,4,,-,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,-,Q96P88,agonist,
807,1989,Class A (Rhodopsin),peptide,goserelin,lshr_human,LHCGR,NRDD260,Antineoplastic s; Hormonal,Protein ,4,,-,approved,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,-,P22888,agonist,
808,1982,Class A (Rhodopsin),small molecule,guanabenz,ada2a_human,ADRA2A,NRDD261,Antihypertensive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08913,agonist,
809,1979,Class A (Rhodopsin),small molecule,isoetharine,adrb1_human,ADRB1,NRDD290,Bronchodilator,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588,agonist,
810,1956,Class A (Rhodopsin),small molecule,isoproterenol,adrb1_human,ADRB1,NRDD293,Bronchodilator ; Cardiotonic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588,agonist,
811,1956,Class A (Rhodopsin),small molecule,isoproterenol,adrb2_human,ADRB2,NRDD293,Bronchodilator ; Cardiotonic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P07550,agonist,
812,1993,Class A (Rhodopsin),small molecule,levomethadyl acetate,oprm_human,OPRM1,NRDD302,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P35372,agonist,
813,1953,Class A (Rhodopsin),small molecule,levorphanol,oprm_human,OPRM1,NRDD303,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P35372,agonist,
814,2010,Class B1 (Secretin),peptide,liraglutide,glp1r_human,GLP1R,NRDD305,Antidiabetic,Peptide ,4,,-,approved,Glucagon receptor family,GPCR;Secretin,established,-,P43220,agonist,
815,1976,Class A (Rhodopsin),small molecule,loperamide,oprm_human,OPRM1,NRDD308,Antidiuretic,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P35372,agonist,
816,2004,Class A (Rhodopsin),peptide,lutropin alfa,lshr_human,LHCGR,NRDD311,Fertility,Protein ,4,,-,approved,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,-,P22888,agonist,
817,1985,Class A (Rhodopsin),small molecule,marinol,cnr1_human,CNR1,NRDD314,Antiemetics,Lipid ,4,,-,approved,Cannabinoid receptors,GPCR;Rhodopsin,established,-,P21554,agonist,
818,1975,Class A (Rhodopsin),protein,menotropins,fshr_human,FSHR,NRDD322,Fertility,Protein ,4,,-,approved,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,-,P23945,agonist,
819,1975,Class A (Rhodopsin),protein,menotropins,lshr_human,LHCGR,NRDD322,Fertility,Protein ,4,,-,approved,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,-,P22888,agonist,
820,1942,Class A (Rhodopsin),small molecule,meperidine,oprk_human,OPRK1,NRDD325,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P41145,agonist,
821,1951,Class A (Rhodopsin),small molecule,mephentermine,ada1a_human,ADRA1A,NRDD326,Antihypotensive ; Vasoconstrictor,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,agonist,
822,1954,Class A (Rhodopsin),small molecule,metaraminol,ada1a_human,ADRA1A,NRDD333,Antihypotensive ; Vasoconstrictor,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,agonist,
823,1947,Class A (Rhodopsin),small molecule,methadone,oprm_human,OPRM1,NRDD334,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P35372,agonist,
824,1982,Class A (Rhodopsin),small molecule,methoxamine,ada1a_human,ADRA1A,NRDD343,Antihypotensive ; Vasoconstrictor,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,agonist,
825,1982,Class A (Rhodopsin),small molecule,methoxamine,ada1b_human,ADRA1B,NRDD343,Antihypotensive ; Vasoconstrictor,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35368,agonist,
826,1962,Class A (Rhodopsin),small molecule,methyldopa,ada2a_human,ADRA2A,NRDD346,Antihypertensive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08913,agonist,
827,1996,Class A (Rhodopsin),small molecule,midodrine,ada1a_human,ADRA1A,NRDD365,Antihypotensive ; Vasoconstrictor,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,agonist,
828,1996,Class A (Rhodopsin),small molecule,midodrine,ada1b_human,ADRA1B,NRDD365,Antihypotensive ; Vasoconstrictor,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35368,agonist,
829,1990,Class A (Rhodopsin),small molecule,nafarelin,gnrhr_human,GNRHR,NRDD377,Antiendometriosis,Peptide ,4,,-,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,-,P30968,agonist,
830,1990,Class A (Rhodopsin),small molecule,nafarelin,gnrr2_human,GNRHR2,NRDD377,Antiendometriosis,Peptide ,4,,-,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,-,Q96P88,agonist,
831,1950,Class A (Rhodopsin),small molecule,norepinephrine,ada1a_human,ADRA1A,NRDD395,Antihypotensive ; Vasoconstrictor,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,agonist,
832,1950,Class A (Rhodopsin),small molecule,norepinephrine,ada1b_human,ADRA1B,NRDD395,Antihypotensive ; Vasoconstrictor,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35368,agonist,
833,1950,Class A (Rhodopsin),small molecule,norepinephrine,ada1d_human,ADRA1D,NRDD395,Antihypotensive ; Vasoconstrictor,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P25100,agonist,
834,1950,Class A (Rhodopsin),small molecule,norepinephrine,ada2a_human,ADRA2A,NRDD395,Antihypotensive ; Vasoconstrictor,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08913,agonist,
835,1950,Class A (Rhodopsin),small molecule,norepinephrine,ada2b_human,ADRA2B,NRDD395,Antihypotensive ; Vasoconstrictor,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P18089,agonist,
836,1950,Class A (Rhodopsin),small molecule,norepinephrine,ada2c_human,ADRA2C,NRDD395,Antihypotensive ; Vasoconstrictor,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P18825,agonist,
837,1950,Class A (Rhodopsin),small molecule,norepinephrine,adrb1_human,ADRB1,NRDD395,Antihypotensive ; Vasoconstrictor,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588,agonist,
838,1950,Class A (Rhodopsin),small molecule,norepinephrine,adrb2_human,ADRB2,NRDD395,Antihypotensive ; Vasoconstrictor,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P07550,agonist,
839,1950,Class A (Rhodopsin),small molecule,norepinephrine,adrb3_human,ADRB3,NRDD395,Antihypotensive ; Vasoconstrictor,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P13945,agonist,
840,1973,Class A (Rhodopsin),small molecule,orciprenaline,adrb2_human,ADRB2,NRDD399,Bronchodilator,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P07550,agonist,
841,1988,Class A (Rhodopsin),small molecule,pergolide,drd1_human,DRD1,NRDD422,Antiparkinson,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21728,agonist,
842,1988,Class A (Rhodopsin),small molecule,pergolide,drd2_human,DRD2,NRDD422,Antiparkinson,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,agonist,
843,1958,Class A (Rhodopsin),small molecule,phenylpropanolamine,ada1a_human,ADRA1A,NRDD439,Appetite Depressants; Nasal Decongestants,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,agonist,
844,1958,Class A (Rhodopsin),small molecule,phenylpropanolamine,ada2a_human,ADRA2A,NRDD439,Appetite Depressants; Nasal Decongestants,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08913,agonist,
845,1957,Class A (Rhodopsin),small molecule,propoxyphene,oprd_human,OPRD1,NRDD468,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P41143,agonist,
846,1957,Class A (Rhodopsin),small molecule,propoxyphene,oprk_human,OPRK1,NRDD468,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P41145,agonist,
847,1957,Class A (Rhodopsin),small molecule,propoxyphene,oprm_human,OPRM1,NRDD468,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P35372,agonist,
848,1987,Class A (Rhodopsin),small molecule,ritodrine,adrb2_human,ADRB2,NRDD485,Tocolytic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P07550,agonist,
849,1998,Class A (Rhodopsin),small molecule,rizatriptan,5ht1b_human,HTR1B,NRDD486,Anti-migraine,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28222,agonist,
850,1998,Class A (Rhodopsin),small molecule,rizatriptan,5ht1d_human,HTR1D,NRDD486,Anti-migraine,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28221,agonist,
851,2002,Class B1 (Secretin),peptide,secretin,sctr_human,SCTR,NRDD493,Diagnostic,Peptide ,4,,-,approved,Glucagon receptor family,GPCR;Secretin,established,-,P47872,agonist,
852,1990,Class B1 (Secretin),peptide,sermorelin,ghrhr_human,GHRHR,NRDD494,Hormone Replacement,Peptide ,4,,-,approved,Glucagon receptor family,GPCR;Secretin,established,-,Q02643,agonist,
853,1952,Class A (Rhodopsin),small molecule,succinylcholine,acm1_human,CHRM1,NRDD501,Muscle Relaxants; Skeletal,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,agonist,
854,1974,Class A (Rhodopsin),small molecule,terbutaline,adrb2_human,ADRB2,NRDD515,Bronchodilator ; Tocolytic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P07550,agonist,
855,1998,Class A (Rhodopsin),protein,thyrotropin alfa,tshr_human,TSHR,NRDD522,Diagnostic,Protein ,4,,-,approved,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,-,P16473,agonist,
856,1998,Class A (Rhodopsin),protein,thyrotropin alfa,tshr_human,TSHR,NRDD522,Diagnostic,Protein ,4,,-,approved,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,-,P16473,agonist,
857,1948,Class A (Rhodopsin),small molecule,tolazoline,ada1a_human,ADRA1A,NRDD530,Antihypertensive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,agonist,
858,2002,Class A (Rhodopsin),small molecule,treprostinil,p2y12_human,P2RY12,NRDD537,Antihypertensive ; Antithrombotic,Nucleotide ,4,,-,approved,P2Y receptors,GPCR;Rhodopsin,established,-,Q9H244,agonist,
859,1986,Class A (Rhodopsin),protein,urofollitropin,fshr_human,FSHR,NRDD554,Fertility,Protein ,4,,-,approved,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,-,P23945,agonist,
860,1982,Class A (Rhodopsin),peptide,vasopressin,v1ar_human,AVPR1A,NRDD560,Antidiuretic,Peptide ,4,,-,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,-,P37288,agonist,
861,1982,Class A (Rhodopsin),peptide,vasopressin,v1br_human,AVPR1B,NRDD560,Antidiuretic,Peptide ,4,,-,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,-,P47901,agonist,
862,1982,Class A (Rhodopsin),peptide,vasopressin,v2r_human,AVPR2,NRDD560,Antidiuretic,Peptide ,4,,-,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,-,P30518,agonist,
863,1973,Class A (Rhodopsin),small molecule,acetylcholine,acm3_human,CHRM3,ASH_Sep2016_68,Antiglaucomic,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,acetylcholine,P20309,agonist,
864,2001,Class A (Rhodopsin),small molecule,formoterol,adrb2_human,ADRB2,MMAmay2016_0044,Anti-Asthmatic ; COPD,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,aclidinium,P07550,agonist,
865,1968,Class A (Rhodopsin),small molecule,fentanyl,oprd_human,OPRD1,51,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,ad 923,P41143,agonist,
866,1968,Class A (Rhodopsin),small molecule,fentanyl,oprm_human,OPRM1,51,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,ad 923,P35372,agonist,
867,1989,Class A (Rhodopsin),small molecule,adenosine,aa1r_human,ADORA1,2267,Analgesics,Nucleotide ,4,,-,approved,Adenosine receptors,GPCR;Rhodopsin,established,"adenogesic, adenosine (intravenous)",P30542,agonist,
868,1989,Class A (Rhodopsin),small molecule,adenosine,aa2ar_human,ADORA2A,2267,Analgesics,Nucleotide ,4,,-,approved,Adenosine receptors,GPCR;Rhodopsin,established,"adenogesic, adenosine (intravenous)",P29274,agonist,
869,1989,Class A (Rhodopsin),small molecule,adenosine,aa2br_human,ADORA2B,2267,Analgesics,Nucleotide ,4,,-,approved,Adenosine receptors,GPCR;Rhodopsin,established,"adenogesic, adenosine (intravenous)",P29275,agonist,
870,1989,Class A (Rhodopsin),small molecule,adenosine,aa3r_human,ADORA3,2267,Analgesics,Nucleotide ,4,,-,approved,Adenosine receptors,GPCR;Rhodopsin,established,"adenogesic, adenosine (intravenous)",P0DMS8,agonist,
871,1989,Class A (Rhodopsin),small molecule,adenosine,aa1r_human,ADORA1,2267,Analgesics,Nucleotide ,4,,-,approved,Adenosine receptors,GPCR;Rhodopsin,established,"adenogesic, adenosine (intravenous)",P30542,agonist,
872,1994,Class A (Rhodopsin),small molecule,salmeterol,adrb2_human,ADRB2,61,Bronchodilator,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,advair/seretide/adoair,P07550,agonist,
873,1968,Class A (Rhodopsin),small molecule,fentanyl,oprd_human,OPRD1,69,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,aerolef,P41143,agonist,
874,1968,Class A (Rhodopsin),small molecule,fentanyl,oprm_human,OPRM1,69,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,aerolef,P35372,agonist,
875,2015,Class B1 (Secretin),protein,parathyroid hormone,pth1r_human,PTH1R,2799,hypoparathyroidism,Peptide ,4,,-,approved,Parathyroid hormone receptors,GPCR;Secretin,established,"air parathyroid hormone, air pth",Q03431,agonist,
876,2014,Class B1 (Secretin),protein,albiglutide,glp1r_human,GLP1R,101,Antidiabetic,Peptide ,4,,-,approved,Glucagon receptor family,GPCR;Secretin,established,"albiglutide, gsk716155,syncria",P43220,agonist,
877,1981,Class A (Rhodopsin),small molecule,albuterol,adrb2_human,ADRB2,ASH_Sep2016_173,chronic obstructive pulmonary disease (COPD),Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,albuterol,P07550,agonist,
878,1981,Class A (Rhodopsin),small molecule,salbutamol,adrb2_human,ADRB2,102,Bronchodilator,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"albuterol,ventolin",P07550,agonist,
879,2003,Class A (Rhodopsin),small molecule,alfuzosin,ada1a_human,ADRA1A,107,benign prostatic hyperplasia,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"alfuzosin,uroxatral",P35348,agonist,
880,2003,Class A (Rhodopsin),small molecule,alfuzosin,ada1b_human,ADRA1B,107,benign prostatic hyperplasia,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"alfuzosin,uroxatral",P35368,agonist,
881,2003,Class A (Rhodopsin),small molecule,alfuzosin,ada1d_human,ADRA1D,107,benign prostatic hyperplasia,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"alfuzosin,uroxatral",P25100,agonist,
882,2007,Class C (Glutamate) ,small molecule,baclofen,gabr1_human,GABBR1,115,alcohol dependance,Amino acid ,4,,-,approved,GABAB receptors,GPCR;Glutamate,established,alks 29,Q9UBS5,agonist,
883,2007,Class C (Glutamate) ,small molecule,baclofen,gabr2_human,GABBR2,115,alcohol dependance,Amino acid ,4,,-,approved,GABAB receptors,GPCR;Glutamate,established,alks 29,O75899,agonist,
884,1981,Class A (Rhodopsin),small molecule,buprenorphine,oprd_human,OPRD1,118,Anti-depressant; Analgesics; opioid addiction,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,alks 5461,P41143,agonist,
885,1981,Class A (Rhodopsin),small molecule,buprenorphine,oprk_human,OPRK1,118,Anti-depressant; Analgesics; opioid addiction,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,alks 5461,P41145,agonist,
886,2001,Class A (Rhodopsin),small molecule,almotriptan,5ht1f_human,HTR1F,ASH_Sep2016_11,Anti-migraine,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,almotriptan,P30939,agonist,
887,2001,Class A (Rhodopsin),small molecule,almotriptan,5ht1b_human,HTR1B,120,Anti-migraine,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"almotriptan,axert, almogran, amignul",P28222,agonist,
888,2001,Class A (Rhodopsin),small molecule,almotriptan,5ht1d_human,HTR1D,120,Anti-migraine,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"almotriptan,axert, almogran, amignul",P28221,agonist,
889,1984,Class A (Rhodopsin),small molecule,morphine,oprd_human,OPRD1,122,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"alo-01, morphine sulfate and naltrexone hydrochloride,embeda, kadian nt",P41143,agonist,
890,1984,Class A (Rhodopsin),small molecule,morphine,oprk_human,OPRK1,122,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"alo-01, morphine sulfate and naltrexone hydrochloride,embeda, kadian nt",P41145,agonist,
891,1984,Class A (Rhodopsin),small molecule,morphine,oprm_human,OPRM1,122,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"alo-01, morphine sulfate and naltrexone hydrochloride,embeda, kadian nt",P35372,agonist,
892,1960,Class A (Rhodopsin),small molecule,levonordefrin,ada1a_human,ADRA1A,ASH_Oct2016_429,nasal decongestant,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,alpha-methylnoradrenaline,P35348,agonist,
893,2001,Class A (Rhodopsin),small molecule,formoterol,adrb2_human,ADRB2,2275,Appetite stimulant,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,apd209,P07550,agonist,
894,1988,Class A (Rhodopsin),small molecule,misoprostol,pi2r_human,PTGIR,202,Labor Inducing,Lipid ,4,,-,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"apl-202,isprelor",P43119,agonist,
895,2001,Class A (Rhodopsin),small molecule,apomorphine,drd2_human,DRD2,206,sexual dysfunction in women; erectile dysfunction; Antiparkinson,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"apomorphine hcl,uprima, ixense",P14416,agonist,
896,2001,Class A (Rhodopsin),small molecule,apomorphine,drd3_human,DRD3,206,sexual dysfunction in women; erectile dysfunction; Antiparkinson,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"apomorphine hcl,uprima, ixense",P35462,agonist,
897,2001,Class A (Rhodopsin),small molecule,apomorphine,drd4_human,DRD4,206,sexual dysfunction in women; erectile dysfunction; Antiparkinson,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"apomorphine hcl,uprima, ixense",P21917,agonist,
898,2001,Class A (Rhodopsin),small molecule,apomorphine,drd2_human,DRD2,207,sexual dysfunction in women; erectile dysfunction; Antiparkinson,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"apomorphine hydrochloride,apokyn, apo-go",P14416,agonist,
899,2001,Class A (Rhodopsin),small molecule,apomorphine,drd3_human,DRD3,207,sexual dysfunction in women; erectile dysfunction; Antiparkinson,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"apomorphine hydrochloride,apokyn, apo-go",P35462,agonist,
900,2001,Class A (Rhodopsin),small molecule,apomorphine,drd4_human,DRD4,207,sexual dysfunction in women; erectile dysfunction; Antiparkinson,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"apomorphine hydrochloride,apokyn, apo-go",P21917,agonist,
901,1987,Class A (Rhodopsin),small molecule,apraclonidine,ada2b_human,ADRA2B,ASH_Sep2016_135,Antiglaucomic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,apraclonidine,P18089,agonist,
902,1987,Class A (Rhodopsin),small molecule,apraclonidine,ada2c_human,ADRA2C,ASH_Sep2016_162,Antiglaucomic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,apraclonidine,P18825,agonist,
903,1974,Class A (Rhodopsin),small molecule,clonidine,ada2a_human,ADRA2A,220,diabetic neuropathy; ADHD; antimucositic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"arc-4558, 0.1% clonidine hycrochloride gel",P08913,agonist,
904,1974,Class A (Rhodopsin),small molecule,clonidine,ada2b_human,ADRA2B,220,diabetic neuropathy; ADHD; antimucositic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"arc-4558, 0.1% clonidine hycrochloride gel",P18089,agonist,
905,1974,Class A (Rhodopsin),small molecule,clonidine,ada2c_human,ADRA2C,220,diabetic neuropathy; ADHD; antimucositic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"arc-4558, 0.1% clonidine hycrochloride gel",P18825,agonist,
906,1984,Class A (Rhodopsin),small molecule,sufentanil,oprd_human,OPRD1,242,Analgesics; adjuvant to anesthesia,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"arx-01, sufentanil nanotab",P41143,agonist,
907,1984,Class A (Rhodopsin),small molecule,sufentanil,oprk_human,OPRK1,242,Analgesics; adjuvant to anesthesia,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"arx-01, sufentanil nanotab",P41145,agonist,
908,1984,Class A (Rhodopsin),small molecule,sufentanil,oprm_human,OPRM1,242,Analgesics; adjuvant to anesthesia,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"arx-01, sufentanil nanotab",P35372,agonist,
909,1984,Class A (Rhodopsin),small molecule,sufentanil,oprd_human,OPRD1,243,Analgesics; adjuvant to anesthesia,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"arx-03, sufentanil + triazolam nanotab",P41143,agonist,
910,1984,Class A (Rhodopsin),small molecule,sufentanil,oprk_human,OPRK1,243,Analgesics; adjuvant to anesthesia,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"arx-03, sufentanil + triazolam nanotab",P41145,agonist,
911,1984,Class A (Rhodopsin),small molecule,sufentanil,oprm_human,OPRM1,243,Analgesics; adjuvant to anesthesia,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"arx-03, sufentanil + triazolam nanotab",P35372,agonist,
912,1968,Class A (Rhodopsin),small molecule,fentanyl,oprd_human,OPRD1,259,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,at3022,P41143,agonist,
913,1968,Class A (Rhodopsin),small molecule,fentanyl,oprm_human,OPRM1,259,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,at3022,P35372,agonist,
914,1968,Class A (Rhodopsin),small molecule,fentanyl,oprd_human,OPRD1,303,adjuvant to anesthesia,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"az-003, staccato fentanyl",P41143,agonist,
915,1968,Class A (Rhodopsin),small molecule,fentanyl,oprm_human,OPRM1,303,adjuvant to anesthesia,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"az-003, staccato fentanyl",P35372,agonist,
916,1981,Class A (Rhodopsin),small molecule,buprenorphine,oprk_human,OPRK1,333,Anti-depressant; Analgesics; opioid addiction,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"bema buprenorphine, buccal mucosa adhesive",P41145,agonist,
917,1981,Class A (Rhodopsin),small molecule,buprenorphine,oprm_human,OPRM1,333,Anti-depressant; Analgesics; opioid addiction,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"bema buprenorphine, buccal mucosa adhesive",P35372,agonist,
918,1968,Class A (Rhodopsin),small molecule,fentanyl,oprd_human,OPRD1,334,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"bema fentanyl,onsolis, breakyl",P41143,agonist,
919,1968,Class A (Rhodopsin),small molecule,fentanyl,oprm_human,OPRM1,334,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"bema fentanyl,onsolis, breakyl",P35372,agonist,
920,1997,Class A (Rhodopsin),protein,follitropin,fshr_human,FSHR,MMAmay2016_0738,Fertility,Protein ,4,,-,approved,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,"bemfola, afolia recombinant follicle stimulating hormone",P23945,agonist,
921,1948,Class A (Rhodopsin),small molecule,bethanechol,acm2_human,CHRM2,ASH_Sep2016_57,eosinophilic esophagitis,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,bethanechol,P08172,agonist,
922,1948,Class A (Rhodopsin),small molecule,bethanechol,acm3_human,CHRM3,ASH_Sep2016_83,eosinophilic esophagitis,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,bethanechol,P20309,agonist,
923,2001,Class A (Rhodopsin),small molecule,bimatoprost,pe2r1_human,PTGER1,359,Antiglaucomic,Lipid ,4,,-,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"bimatoprost,  agn 192024,lumigan",P34995,agonist,
924,2001,Class A (Rhodopsin),small molecule,bimatoprost,pe2r3_human,PTGER3,359,Antiglaucomic,Lipid ,4,,-,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"bimatoprost,  agn 192024,lumigan",P43115,agonist,
925,2001,Class A (Rhodopsin),small molecule,bimatoprost,pf2r_human,PTGFR,359,Antiglaucomic,Lipid ,4,,-,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"bimatoprost,  agn 192024,lumigan",P43088,agonist,
926,1984,Class A (Rhodopsin),small molecule,bitolterol,adrb2_human,ADRB2,ASH_Sep2016_183,obstructive lung disease,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,bitolterol,P07550,agonist,
927,1986,Class B1 (Secretin),small molecule,calcitonin human,calcr_human,CALCR,376,Anti-osteoporotic,Peptide ,4,,-,approved,Calcitonin receptors,GPCR;Secretin,established,"bn-002,capsitonin",P30988,agonist,
928,2015,Class B1 (Secretin),protein,parathyroid hormone,pth1r_human,PTH1R,2012,Anti-osteoporotic,Peptide ,4,,-,approved,Parathyroid hormone receptors,GPCR;Secretin,established,"bn-003,capthymone,thpth",Q03431,agonist,
929,1996,Class A (Rhodopsin),small molecule,brimonidine,ada2a_human,ADRA2A,385,Antiglaucomic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"brimonidine tartrate,alphagan",P08913,agonist,
930,1996,Class A (Rhodopsin),small molecule,brimonidine,ada2b_human,ADRA2B,385,Antiglaucomic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"brimonidine tartrate,alphagan",P18089,agonist,
931,1996,Class A (Rhodopsin),small molecule,brimonidine,ada2c_human,ADRA2C,385,Antiglaucomic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"brimonidine tartrate,alphagan",P18825,agonist,
932,1996,Class A (Rhodopsin),small molecule,brimonidine,ada2a_human,ADRA2A,386,Antiglaucomic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"brimonidine tartrate/timolol maleate,combigan",P08913,agonist,
933,1996,Class A (Rhodopsin),small molecule,brimonidine,ada2b_human,ADRA2B,386,Antiglaucomic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"brimonidine tartrate/timolol maleate,combigan",P18089,agonist,
934,1996,Class A (Rhodopsin),small molecule,brimonidine,ada2c_human,ADRA2C,386,Antiglaucomic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"brimonidine tartrate/timolol maleate,combigan",P18825,agonist,
935,1978,Class A (Rhodopsin),small molecule,bromocriptine,drd4_human,DRD4,ASH_Sep2016_216,growth hormone excess,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,bromocriptine,P21917,agonist,
936,1978,Class A (Rhodopsin),small molecule,bromocriptine,drd2_human,DRD2,389,Antidiabetic,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"bromocriptine mesylate,cycloset, ergoset",P14416,agonist,
937,1978,Class A (Rhodopsin),small molecule,bromocriptine,drd3_human,DRD3,389,Antidiabetic,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"bromocriptine mesylate,cycloset, ergoset",P35462,agonist,
938,2006,Class A (Rhodopsin),small molecule,arformoterol,adrb2_human,ADRB2,2276,Bronchodilator,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,brovana,P07550,agonist,
939,1968,Class A (Rhodopsin),small molecule,fentanyl,oprd_human,OPRD1,394,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,buccal fentanyl,P41143,agonist,
940,1968,Class A (Rhodopsin),small molecule,fentanyl,oprm_human,OPRM1,394,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,buccal fentanyl,P35372,agonist,
941,2001,Class A (Rhodopsin),small molecule,formoterol,adrb2_human,ADRB2,397,Bronchodilator,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"budesonide + formoterol,symbicort",P07550,agonist,
942,1981,Class A (Rhodopsin),small molecule,buprenorphine,oprk_human,OPRK1,405,Anti-depressant; Analgesics; opioid addiction,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"buprenorphine + naloxone capsule,nanobup",P41145,agonist,
943,1981,Class A (Rhodopsin),small molecule,buprenorphine,oprm_human,OPRM1,405,Anti-depressant; Analgesics; opioid addiction,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"buprenorphine + naloxone capsule,nanobup",P35372,agonist,
944,1981,Class A (Rhodopsin),small molecule,buprenorphine,oprk_human,OPRK1,406,Anti-depressant; Analgesics; opioid addiction,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"buprenorphine + naloxone,suboxone",P41145,agonist,
945,1981,Class A (Rhodopsin),small molecule,buprenorphine,oprm_human,OPRM1,406,Anti-depressant; Analgesics; opioid addiction,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"buprenorphine + naloxone,suboxone",P35372,agonist,
946,1981,Class A (Rhodopsin),small molecule,buprenorphine,oprk_human,OPRK1,407,Anti-depressant; Analgesics; opioid addiction,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"buprenorphine subcutaneous implant,probuphine",P41145,agonist,
947,1981,Class A (Rhodopsin),small molecule,buprenorphine,oprm_human,OPRM1,407,Anti-depressant; Analgesics; opioid addiction,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"buprenorphine subcutaneous implant,probuphine",P35372,agonist,
948,1981,Class A (Rhodopsin),small molecule,buprenorphine,oprk_human,OPRK1,408,Anti-depressant; Analgesics; opioid addiction,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"buprenorphine sublingual tablet,subutex",P41145,agonist,
949,1981,Class A (Rhodopsin),small molecule,buprenorphine,oprm_human,OPRM1,408,Anti-depressant; Analgesics; opioid addiction,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"buprenorphine sublingual tablet,subutex",P35372,agonist,
950,1981,Class A (Rhodopsin),small molecule,buprenorphine,oprm_human,OPRM1,MMAmar2016_0045,Anti-depressant; Analgesics; opioid addiction,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"butab, rel-1028, oral, enteric-coated buprenorphine",P35372,agonist,
951,1981,Class A (Rhodopsin),small molecule,buprenorphine,oprk_human,OPRK1,MMAmar2016_0047,Anti-depressant; Analgesics; opioid addiction,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"butab, rel-1028, oral, enteric-coated buprenorphine",P41145,agonist,
952,1981,Class A (Rhodopsin),small molecule,buprenorphine,oprk_human,OPRK1,409,Anti-depressant; Analgesics; opioid addiction,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"butrans is a transdermal patch formulation of  buprenorphine, a partial agonist at mu opioid receptors and an antagonist at kappa opioid receptors. it is indicated as an analgesics to deliver continuous pain relief for seven days.  the efficacy of butrans",P41145,agonist,
953,1981,Class A (Rhodopsin),small molecule,buprenorphine,oprm_human,OPRM1,409,Anti-depressant; Analgesics; opioid addiction,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"butrans is a transdermal patch formulation of  buprenorphine, a partial agonist at mu opioid receptors and an antagonist at kappa opioid receptors. it is indicated as an analgesics to deliver continuous pain relief for seven days.  the efficacy of butrans",P35372,agonist,
954,2005,Class A (Rhodopsin),peptide,calcitonin salmon recombinant,calcr_human,CALCR,ASH_Oct2016_418,Paget's disease,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Secretin,established,calcitonin (salmon),P30988,agonist,
955,1986,Class B1 (Secretin),protein,calcitonin human,calcr_human,CALCR,ASH_Sep2016_324,parathyroid disease,Peptide ,4,,-,approved,Calcitonin receptors,GPCR;Secretin,established,calcitonin human,P30988,agonist,
956,1978,Class B1 (Secretin),protein,calcitonin salmon recombinant,calcr_human,CALCR,ASH_Sep2016_323,postmenopausal osteoporosis,Peptide ,4,,-,approved,Calcitonin receptors,GPCR;Secretin,established,calcitonin salmon,P30988,agonist,
957,2005,Class B1 (Secretin),protein,calcitonin salmon recombinant,calcr_human,CALCR,ASH_Sep2016_321,osteitis deformans,Peptide ,4,,-,approved,Calcitonin receptors,GPCR;Secretin,established,calcitonin salmon recombinant,P30988,agonist,
958,1988,Class A (Rhodopsin),peptide,octreotide,ssr1_human,SSTR1,421,Antineoplastic,Peptide ,4,,-,approved,Somatostatin receptors,GPCR;Rhodopsin,established,cam-2029,P30872,agonist,
959,1988,Class A (Rhodopsin),peptide,octreotide,ssr2_human,SSTR2,421,Antineoplastic,Peptide ,4,,-,approved,Somatostatin receptors,GPCR;Rhodopsin,established,cam-2029,P30874,agonist,
960,1988,Class A (Rhodopsin),peptide,octreotide,ssr5_human,SSTR5,421,Antineoplastic,Peptide ,4,,-,approved,Somatostatin receptors,GPCR;Rhodopsin,established,cam-2029,P35346,agonist,
961,1981,Class A (Rhodopsin),small molecule,buprenorphine,oprk_human,OPRK1,422,Anti-depressant; Analgesics; opioid addiction,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,cam2038,P41145,agonist,
962,1981,Class A (Rhodopsin),small molecule,buprenorphine,oprm_human,OPRM1,422,Anti-depressant; Analgesics; opioid addiction,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,cam2038,P35372,agonist,
963,1972,Class A (Rhodopsin),small molecule,carbachol,acm3_human,CHRM3,ASH_Sep2016_80,Antiglaucomic,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,carbachol,P20309,agonist,
964,1985,Class A (Rhodopsin),small molecule,dronabinol,cnr1_human,CNR1,437,Analgesics,Lipid ,4,,-,approved,Cannabinoid receptors,GPCR;Rhodopsin,established,"cat-310 , relivar",P21554,agonist,
965,1985,Class A (Rhodopsin),small molecule,dronabinol,cnr2_human,CNR2,438,Analgesics,Lipid ,4,,-,approved,Cannabinoid receptors,GPCR;Rhodopsin,established,"cat-310,relivar",P34972,agonist,
966,1996,Class A (Rhodopsin),small molecule,brimonidine,ada2a_human,ADRA2A,2274,erythema,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"cd07805/47, sansrosa, col-118",P08913,agonist,
967,1996,Class A (Rhodopsin),small molecule,brimonidine,ada2b_human,ADRA2B,2274,erythema,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"cd07805/47, sansrosa, col-118",P18089,agonist,
968,1996,Class A (Rhodopsin),small molecule,brimonidine,ada2c_human,ADRA2C,2274,erythema,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"cd07805/47, sansrosa, col-118",P18825,agonist,
969,1983,Class A (Rhodopsin),small molecule,chenodeoxycholic acid,nr1h4_human,NR1H4,ASH_Oct2016_413,gall stones,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),Nuclear receptor,established,chenodeoxycholic acid,Q96RI1,agonist,
970,2001,Class A (Rhodopsin),small molecule,formoterol,adrb2_human,ADRB2,481,Anti-Asthmatic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"chf-1535, beclomethasone dipropionate + formoterol fumarate",P07550,agonist,
971,1973,Class A (Rhodopsin),protein,chorionic gonadotropin,lshr_human,LHCGR,ASH_Sep2016_301,Fertility,Protein ,4,,-,approved,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,chorionic gonadotropin,P22888,agonist,
972,1992,Class A (Rhodopsin),small molecule,sumatriptan,5ht1a_human,HTR1A,MMAapril2016_0106,Anti-migraine,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"cl-h1t, promethazine + sumatriptan",P08908,agonist,
973,1992,Class A (Rhodopsin),small molecule,sumatriptan,5ht1d_human,HTR1D,MMAapril2016_0107,Anti-migraine,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"cl-h1t, promethazine + sumatriptan",P28221,agonist,
974,1992,Class A (Rhodopsin),small molecule,sumatriptan,5ht1b_human,HTR1B,MMAapril2016_0108,Anti-migraine,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"cl-h1t, promethazine + sumatriptan",P28222,agonist,
975,1992,Class A (Rhodopsin),small molecule,sumatriptan,5ht1f_human,HTR1F,MMAapril2016_0109,Anti-migraine,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"cl-h1t, promethazine + sumatriptan",P30939,agonist,
976,1974,Class A (Rhodopsin),small molecule,clonidine,ada2a_human,ADRA2A,501,diabetic neuropathy; ADHD; antimucositic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"clonidine hydrochloride extended release,kapvay, jenloga xr (clonibid)",P08913,agonist,
977,1974,Class A (Rhodopsin),small molecule,clonidine,ada2b_human,ADRA2B,501,diabetic neuropathy; ADHD; antimucositic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"clonidine hydrochloride extended release,kapvay, jenloga xr (clonibid)",P18089,agonist,
978,1974,Class A (Rhodopsin),small molecule,clonidine,ada2c_human,ADRA2C,501,diabetic neuropathy; ADHD; antimucositic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"clonidine hydrochloride extended release,kapvay, jenloga xr (clonibid)",P18825,agonist,
979,1974,Class A (Rhodopsin),small molecule,clonidine,ada2a_human,ADRA2A,502,diabetic neuropathy; ADHD; antimucositic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"clonidine lauriad, ba-028",P08913,agonist,
980,1974,Class A (Rhodopsin),small molecule,clonidine,ada2b_human,ADRA2B,502,diabetic neuropathy; ADHD; antimucositic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"clonidine lauriad, ba-028",P18089,agonist,
981,1974,Class A (Rhodopsin),small molecule,clonidine,ada2c_human,ADRA2C,502,diabetic neuropathy; ADHD; antimucositic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"clonidine lauriad, ba-028",P18825,agonist,
982,1998,Class A (Rhodopsin),small molecule,oxycodone,oprd_human,OPRD1,514,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"col-003, sustained release oxycodone",P41143,agonist,
983,1998,Class A (Rhodopsin),small molecule,oxycodone,oprk_human,OPRK1,514,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"col-003, sustained release oxycodone",P41145,agonist,
984,1998,Class A (Rhodopsin),small molecule,oxycodone,oprm_human,OPRM1,514,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"col-003, sustained release oxycodone",P35372,agonist,
985,1998,Class A (Rhodopsin),small molecule,oxycodone,oprd_human,OPRD1,515,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"col-172, extended-release oxycodone",P41143,agonist,
986,1998,Class A (Rhodopsin),small molecule,oxycodone,oprk_human,OPRK1,515,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"col-172, extended-release oxycodone",P41145,agonist,
987,1998,Class A (Rhodopsin),small molecule,oxycodone,oprm_human,OPRM1,515,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"col-172, extended-release oxycodone",P35372,agonist,
988,1987,Class B1 (Secretin),peptide,teriparatide,pth1r_human,PTHR1,MMAmay2016_0763,Anti-osteoporotic,Peptide ,4,,-,approved,Parathyroid hormone receptors,GPCR;Secretin,established,"cp046, intranasal teriparatide",Q03431,agonist,
989,1950,Class A (Rhodopsin),small molecule,norepinephrine,ada1a_human,ADRA1A,2273,for prevention of dermatitis during radiotherapy,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,dermx,P35348,agonist,
990,1950,Class A (Rhodopsin),small molecule,norepinephrine,ada1b_human,ADRA1B,2273,for prevention of dermatitis during radiotherapy,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,dermx,P35368,agonist,
991,1950,Class A (Rhodopsin),small molecule,norepinephrine,ada1d_human,ADRA1D,2273,for prevention of dermatitis during radiotherapy,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,dermx,P25100,agonist,
992,1950,Class A (Rhodopsin),small molecule,norepinephrine,ada2a_human,ADRA2A,2273,for prevention of dermatitis during radiotherapy,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,dermx,P08913,agonist,
993,1950,Class A (Rhodopsin),small molecule,norepinephrine,ada2b_human,ADRA2B,2273,for prevention of dermatitis during radiotherapy,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,dermx,P18089,agonist,
994,1950,Class A (Rhodopsin),small molecule,norepinephrine,ada2c_human,ADRA2C,2273,for prevention of dermatitis during radiotherapy,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,dermx,P18825,agonist,
995,1950,Class A (Rhodopsin),small molecule,norepinephrine,adrb1_human,ADRB1,2273,for prevention of dermatitis during radiotherapy,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,dermx,P08588,agonist,
996,1950,Class A (Rhodopsin),small molecule,norepinephrine,adrb2_human,ADRB2,2273,for prevention of dermatitis during radiotherapy,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,dermx,P07550,agonist,
997,1950,Class A (Rhodopsin),small molecule,norepinephrine,adrb3_human,ADRB3,2273,for prevention of dermatitis during radiotherapy,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,dermx,P13945,agonist,
998,1999,Class A (Rhodopsin),small molecule,dexmedetomidin,ada2a_human,ADRA2A,MMAapril2016_0144,Analgesics,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"dex-in, intranasal dexmedetomidin",P08913,agonist,
999,1999,Class A (Rhodopsin),small molecule,dexmedetomidine,ada2b_human,ADRA2B,ASH_Sep2016_130,Analgesics,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,dexmedetomidine,P18089,agonist,
1000,1999,Class A (Rhodopsin),small molecule,dexmedetomidine,ada2c_human,ADRA2C,ASH_Sep2016_149,Antineoplastic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,dexmedetomidine,P18825,agonist,
1001,1978,Class A (Rhodopsin),small molecule,difenoxin,oprm_human,OPRM1,ASH_Sep2016_271,recurrent infection of the gastrointestinal tract,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,difenoxin,P35372,agonist,
1002,1958,Class A (Rhodopsin),small molecule,dihydrocodeine,oprm_human,OPRM1,ASH_Sep2016_269,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,dihydrocodeine,P35372,agonist,
1003,1960,Class B1 (Secretin),peptide,glucagon,glr_human,GCGR,2458,for prevention of hypoglycemia,Peptide ,4,,-,approved,Glucagon receptor family,GPCR;Secretin,established,dio-901,P47871,agonist,
1004,1980,Class A (Rhodopsin),small molecule,dipivefrin,ada1a_human,ADRA1A,ASH_Sep2016_88,Antiglaucomic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,dipivefrin,P35348,agonist,
1005,1980,Class A (Rhodopsin),small molecule,dipivefrin,ada1b_human,ADRA1B,ASH_Sep2016_103,Antiglaucomic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,dipivefrin,P35368,agonist,
1006,1980,Class A (Rhodopsin),small molecule,dipivefrin,ada1d_human,ADRA1D,ASH_Sep2016_106,Antiglaucomic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,dipivefrin,P25100,agonist,
1007,1980,Class A (Rhodopsin),small molecule,dipivefrin,ada2b_human,ADRA2B,ASH_Sep2016_143,Antiglaucomic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,dipivefrin,P18089,agonist,
1008,1980,Class A (Rhodopsin),small molecule,dipivefrin,ada2c_human,ADRA2C,ASH_Sep2016_164,Antiglaucomic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,dipivefrin,P18825,agonist,
1009,1980,Class A (Rhodopsin),small molecule,dipivefrin,adrb1_human,ADRB1,ASH_Sep2016_167,Antiglaucomic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,dipivefrin,P08588,agonist,
1010,1980,Class A (Rhodopsin),small molecule,dipivefrin,adrb2_human,ADRB2,ASH_Sep2016_185,Antiglaucomic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,dipivefrin,P07550,agonist,
1011,1980,Class A (Rhodopsin),small molecule,dipivefrin,adrb3_human,ADRB3,ASH_Sep2016_197,Antiglaucomic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,dipivefrin,P13945,agonist,
1012,1993,Class A (Rhodopsin),small molecule,levodopa,drd1_human,DRD1,646,Antiparkinson,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,dm-1992,P21728,agonist,
1013,1993,Class A (Rhodopsin),small molecule,levodopa,drd2_human,DRD2,646,Antiparkinson,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,dm-1992,P14416,agonist,
1014,1993,Class A (Rhodopsin),small molecule,levodopa,drd3_human,DRD3,646,Antiparkinson,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,dm-1992,P35462,agonist,
1015,1993,Class A (Rhodopsin),small molecule,levodopa,drd4_human,DRD4,646,Antiparkinson,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,dm-1992,P21917,agonist,
1016,1993,Class A (Rhodopsin),small molecule,levodopa,drd5_human,DRD5,646,Antiparkinson,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,dm-1992,P21918,agonist,
1017,1978,Class A (Rhodopsin),small molecule,dobutamine,adrb2_human,ADRB2,ASH_Sep2016_179,heart failure,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,dobutamine,P07550,agonist,
1018,1974,Class A (Rhodopsin),small molecule,dopamine,adrb1_human,ADRB1,ASH_Sep2016_169,hypotension,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,dopamine,P08588,agonist,
1019,1985,Class A (Rhodopsin),small molecule,dronabinol,cnr1_human,CNR1,667,Appetite stimulant,Lipid ,4,,-,approved,Cannabinoid receptors,GPCR;Rhodopsin,established,"dronabinol ,marinol",P21554,agonist,
1020,1985,Class A (Rhodopsin),small molecule,dronabinol,cnr2_human,CNR2,667,Appetite stimulant,Lipid ,4,,-,approved,Cannabinoid receptors,GPCR;Rhodopsin,established,"dronabinol ,marinol",P34972,agonist,
1021,2014,Class A (Rhodopsin),small molecule,droxidopa,ada1a_human,ADRA1A,2272,orthostatic hypotension,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,droxidopa,P35348,agonist,
1022,2014,Class A (Rhodopsin),small molecule,droxidopa,ada1b_human,ADRA1B,2272,orthostatic hypotension,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,droxidopa,P35368,agonist,
1023,2014,Class A (Rhodopsin),small molecule,droxidopa,ada1d_human,ADRA1D,2272,orthostatic hypotension,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,droxidopa,P25100,agonist,
1024,2014,Class A (Rhodopsin),small molecule,droxidopa,ada2a_human,ADRA2A,2272,orthostatic hypotension,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,droxidopa,P08913,agonist,
1025,2014,Class A (Rhodopsin),small molecule,droxidopa,ada2b_human,ADRA2B,2272,orthostatic hypotension,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,droxidopa,P18089,agonist,
1026,2014,Class A (Rhodopsin),small molecule,droxidopa,ada2c_human,ADRA2C,2272,orthostatic hypotension,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,droxidopa,P18825,agonist,
1027,2014,Class A (Rhodopsin),small molecule,droxidopa,adrb1_human,ADRB1,2272,orthostatic hypotension,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,droxidopa,P08588,agonist,
1028,2014,Class A (Rhodopsin),small molecule,droxidopa,adrb2_human,ADRB2,2272,orthostatic hypotension,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,droxidopa,P07550,agonist,
1029,2014,Class A (Rhodopsin),small molecule,droxidopa,adrb3_human,ADRB3,2272,orthostatic hypotension,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,droxidopa,P13945,agonist,
1030,2014,Class B1 (Secretin),protein,dulaglutide,glp1r_human,GLP1R,ASH_Sep2016_332,Antidiabetic,Peptide ,4,,-,approved,Glucagon receptor family,GPCR;Secretin,established,dulaglutide,P43220,agonist,
1031,1995,Class A (Rhodopsin),small molecule,tramadol,5ht2c_human,HTR2C,MMAmay2016_0676,Analgesics,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,e-58425,P28335,agonist,
1032,1995,Class A (Rhodopsin),small molecule,tramadol,oprm_human,OPRM1,MMAmay2016_0678,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,e-58425,P35372,agonist,
1033,1995,Class A (Rhodopsin),small molecule,tramadol,oprk_human,OPRK1,MMAmay2016_0679,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,e-58425,P41145,agonist,
1034,1984,Class A (Rhodopsin),small molecule,morphine,oprk_human,OPRK1,MMAmar2016_0055,Analgesics; opioid addiction,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"egalet-001, reformulated morphine",P41145,agonist,
1035,1984,Class A (Rhodopsin),small molecule,morphine,oprm_human,OPRM1,MMAmar2016_0056,Analgesics; opioid addiction,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"egalet-001, reformulated morphine",P35372,agonist,
1036,1984,Class A (Rhodopsin),small molecule,morphine,oprd_human,OPRD1,MMAmar2016_0057,Analgesics; opioid addiction,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"egalet-001, reformulated morphine",P41143,agonist,
1037,2002,Class A (Rhodopsin),small molecule,eletriptan,5ht1b_human,HTR1B,ASH_Sep2016_6,Anti-migraine,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,eletriptan,P28222,agonist,
1038,2002,Class A (Rhodopsin),small molecule,eletriptan,5ht1f_human,HTR1F,ASH_Sep2016_10,Anti-migraine,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,eletriptan,P30939,agonist,
1039,1998,Class A (Rhodopsin),small molecule,oxycodone,oprd_human,OPRD1,696,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"eli-154, oxycodone (once daily)",P41143,agonist,
1040,1998,Class A (Rhodopsin),small molecule,oxycodone,oprk_human,OPRK1,696,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"eli-154, oxycodone (once daily)",P41145,agonist,
1041,1998,Class A (Rhodopsin),small molecule,oxycodone,oprm_human,OPRM1,696,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"eli-154, oxycodone (once daily)",P35372,agonist,
1042,1998,Class A (Rhodopsin),small molecule,oxycodone,oprm_human,OPRM1,MMAfeb2016_0087,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,eli-200,P35372,agonist,
1043,1998,Class A (Rhodopsin),small molecule,oxycodone,oprd_human,OPRD1,MMAfeb2016_0088,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,eli-200,P41143,agonist,
1044,1998,Class A (Rhodopsin),small molecule,oxycodone,oprk_human,OPRK1,MMAfeb2016_0089,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,eli-200,P41145,agonist,
1045,1985,Class A (Rhodopsin),peptide,leuprolide,gnrhr_human,GNRHR,697,Antineoplastic,Peptide ,4,,-,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,eligard,P30968,agonist,
1046,1993,Class A (Rhodopsin),small molecule,levodopa,drd1_human,DRD1,712,Antiparkinson,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"entacapone/levodopa/carbidopa,stalevo",P21728,agonist,
1047,1993,Class A (Rhodopsin),small molecule,levodopa,drd2_human,DRD2,712,Antiparkinson,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"entacapone/levodopa/carbidopa,stalevo",P14416,agonist,
1048,1993,Class A (Rhodopsin),small molecule,levodopa,drd3_human,DRD3,712,Antiparkinson,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"entacapone/levodopa/carbidopa,stalevo",P35462,agonist,
1049,1993,Class A (Rhodopsin),small molecule,levodopa,drd4_human,DRD4,712,Antiparkinson,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"entacapone/levodopa/carbidopa,stalevo",P21917,agonist,
1050,1993,Class A (Rhodopsin),small molecule,levodopa,drd5_human,DRD5,712,Antiparkinson,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"entacapone/levodopa/carbidopa,stalevo",P21918,agonist,
1051,1953,Class A (Rhodopsin),small molecule,ergoloid,5ht1a_human,HTR1A,ASH_Sep2016_0,cardiovascular disease,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,ergoloid,P08908,agonist,
1052,1953,Class A (Rhodopsin),small molecule,ergoloid,5ht1b_human,HTR1B,ASH_Sep2016_7,cardiovascular disease,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,ergoloid,P28222,agonist,
1053,1953,Class A (Rhodopsin),small molecule,ergoloid,drd2_human,DRD2,ASH_Sep2016_60,cardiovascular disease,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,ergoloid,P14416,agonist,
1054,1953,Class A (Rhodopsin),small molecule,ergoloid,ada1b_human,ADRA1B,ASH_Sep2016_100,cardiovascular disease,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,ergoloid,P35368,agonist,
1055,1953,Class A (Rhodopsin),small molecule,ergoloid,ada1d_human,ADRA1D,ASH_Sep2016_109,cardiovascular disease,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,ergoloid,P25100,agonist,
1056,1953,Class A (Rhodopsin),small molecule,ergoloid,ada2b_human,ADRA2B,ASH_Sep2016_141,cardiovascular disease,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,ergoloid,P18089,agonist,
1057,1953,Class A (Rhodopsin),small molecule,ergoloid,ada2c_human,ADRA2C,ASH_Sep2016_155,cardiovascular disease,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,ergoloid,P18825,agonist,
1058,1953,Class A (Rhodopsin),small molecule,ergoloid,drd1_human,DRD1,ASH_Sep2016_198,cardiovascular disease,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,ergoloid,P21728,agonist,
1059,1953,Class A (Rhodopsin),small molecule,ergoloid,drd3_human,DRD3,ASH_Sep2016_206,cardiovascular disease,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,ergoloid,P35462,agonist,
1060,1953,Class A (Rhodopsin),small molecule,ergoloid,drd4_human,DRD4,ASH_Sep2016_215,cardiovascular disease,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,ergoloid,P21917,agonist,
1061,1953,Class A (Rhodopsin),small molecule,ergoloid,drd5_human,DRD5,ASH_Sep2016_229,cardiovascular disease,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,ergoloid,P21918,agonist,
1062,1960,Class A (Rhodopsin),small molecule,ergotamine,ada1a_human,ADRA1A,ASH_Sep2016_87,Anti-migraine,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,ergotamine,P35348,agonist,
1063,1960,Class A (Rhodopsin),small molecule,ergotamine,ada1b_human,ADRA1B,ASH_Sep2016_99,Anti-migraine,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,ergotamine,P35368,agonist,
1064,1960,Class A (Rhodopsin),small molecule,ergotamine,ada1d_human,ADRA1D,ASH_Sep2016_112,Anti-migraine,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,ergotamine,P25100,agonist,
1065,1960,Class A (Rhodopsin),small molecule,ergotamine,ada2a_human,ADRA2A,ASH_Sep2016_124,Anti-migraine,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,ergotamine,P08913,agonist,
1066,1960,Class A (Rhodopsin),small molecule,ergotamine,ada2b_human,ADRA2B,ASH_Sep2016_140,Anti-migraine,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,ergotamine,P18089,agonist,
1067,1960,Class A (Rhodopsin),small molecule,ergotamine,ada2c_human,ADRA2C,ASH_Sep2016_158,Anti-migraine,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,ergotamine,P18825,agonist,
1068,2005,Class B1 (Secretin),peptide,exenatide,glp1r_human,GLP1R,769,Antidiabetic,Peptide ,4,,-,approved,Glucagon receptor family,GPCR;Secretin,established,exenatide,P43220,agonist,
1069,1996,Class A (Rhodopsin),small molecule,latanoprost,pf2r_human,PTGFR,MMAmay2016_0719,Antiglaucomic,Lipid ,4,,-,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"eye-d, controlled-release latanoprost insert",P43088,agonist,
1070,1968,Class A (Rhodopsin),small molecule,fentanyl,oprd_human,OPRD1,775,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"febt,fentora, effentora",P41143,agonist,
1071,1968,Class A (Rhodopsin),small molecule,fentanyl,oprm_human,OPRM1,775,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"febt,fentora, effentora",P35372,agonist,
1072,1997,Class A (Rhodopsin),small molecule,fenoldopam,drd1_human,DRD1,778,Antihypertensive,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"fenoldopam mesylate, skf-82526,corlopam",P21728,agonist,
1073,1997,Class A (Rhodopsin),small molecule,fenoldopam,drd5_human,DRD5,778,Antihypertensive,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"fenoldopam mesylate, skf-82526,corlopam",P21918,agonist,
1074,1968,Class A (Rhodopsin),small molecule,fentanyl,oprd_human,OPRD1,780,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"fentanyl (sublingual), kw-2246,abstral, rapinyl",P41143,agonist,
1075,1968,Class A (Rhodopsin),small molecule,fentanyl,oprm_human,OPRM1,780,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"fentanyl (sublingual), kw-2246,abstral, rapinyl",P35372,agonist,
1076,1968,Class A (Rhodopsin),small molecule,fentanyl,oprd_human,OPRD1,781,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"fentanyl citrate,pecfent, nasalfent",P41143,agonist,
1077,1968,Class A (Rhodopsin),small molecule,fentanyl,oprm_human,OPRM1,781,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"fentanyl citrate,pecfent, nasalfent",P35372,agonist,
1078,1968,Class A (Rhodopsin),small molecule,fentanyl,oprd_human,OPRD1,782,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"fentanyl lauriad, ba-041",P41143,agonist,
1079,1968,Class A (Rhodopsin),small molecule,fentanyl,oprm_human,OPRM1,782,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"fentanyl lauriad, ba-041",P35372,agonist,
1080,1968,Class A (Rhodopsin),small molecule,fentanyl,oprd_human,OPRD1,783,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,fentanyl mdts,P41143,agonist,
1081,1968,Class A (Rhodopsin),small molecule,fentanyl,oprm_human,OPRM1,783,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,fentanyl mdts,P35372,agonist,
1082,1968,Class A (Rhodopsin),small molecule,fentanyl,oprd_human,OPRD1,784,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"fentanyl spray, intranasal,instanyl",P41143,agonist,
1083,1968,Class A (Rhodopsin),small molecule,fentanyl,oprm_human,OPRM1,784,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"fentanyl spray, intranasal,instanyl",P35372,agonist,
1084,1968,Class A (Rhodopsin),small molecule,fentanyl,oprd_human,OPRD1,785,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,fentanyl sublingual spray,P41143,agonist,
1085,1968,Class A (Rhodopsin),small molecule,fentanyl,oprm_human,OPRM1,785,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,fentanyl sublingual spray,P35372,agonist,
1086,1968,Class A (Rhodopsin),small molecule,fentanyl,oprd_human,OPRD1,786,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,fentanyl taifun,P41143,agonist,
1087,1968,Class A (Rhodopsin),small molecule,fentanyl,oprm_human,OPRM1,786,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,fentanyl taifun,P35372,agonist,
1088,1968,Class A (Rhodopsin),small molecule,fentanyl,oprd_human,OPRD1,787,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"fentanyl transdermal system,duragesic, ionsys",P41143,agonist,
1089,1968,Class A (Rhodopsin),small molecule,fentanyl,oprm_human,OPRM1,787,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"fentanyl transdermal system,duragesic, ionsys",P35372,agonist,
1090,2013,Class A (Rhodopsin),small molecule,vilanterol,adrb2_human,ADRB2,MMAmar2016_0195,chronic obstructive pulmonary disease (COPD),Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"ff/umec/vi, fluticasone furoate + umeclidinium + vilanterol",P07550,agonist,
1091,2010,Class A (Rhodopsin),small molecule,fingolimod,s1pr1_human,S1PR1,794,Multiple Sclerosis,Lipid ,4,,-,approved,Lysophospholipid (S1P) receptors,GPCR;Rhodopsin,established,"fingolimod, fty 720,gilenia, gilenya",P21453,agonist,
1092,2013,Class A (Rhodopsin),small molecule,vilanterol,adrb2_human,ADRB2,MMAmay2016_0779,chronic obstructive pulmonary disease (COPD),Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,fluticasone furoate and vilanterol inhalation powder,P07550,agonist,
1093,1997,Class A (Rhodopsin),protein,follitropin,fshr_human,FSHR,814,Fertility,Protein ,4,,-,approved,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,"follitropin alpha ,gonal-f",P23945,agonist,
1094,2001,Class A (Rhodopsin),small molecule,formoterol,adrb2_human,ADRB2,815,Bronchodilator,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"formoterol ,foradil",P07550,agonist,
1095,2001,Class A (Rhodopsin),small molecule,formoterol,adrb2_human,ADRB2,816,chronic obstructive pulmonary disease (COPD),Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"formoterol fumarate,perforomist",P07550,agonist,
1096,2005,Class B1 (Secretin),peptide,calcitonin salmon recombinant,calcr_human,CALCR,817,Anti-osteoporotic,Peptide ,4,,-,approved,Calcitonin receptors,GPCR;Secretin,established,fortical,P30988,agonist,
1097,2001,Class A (Rhodopsin),small molecule,frovatriptan,5ht1b_human,HTR1B,823,Anti-migraine,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"frovatriptan,frovelan, frova",P28222,agonist,
1098,2001,Class A (Rhodopsin),small molecule,frovatriptan,5ht1d_human,HTR1D,823,Anti-migraine,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"frovatriptan,frovelan, frova",P28221,agonist,
1099,1998,Class B1 (Secretin),protein,glucagon,glr_human,GCGR,ASH_Sep2016_334,hypoglycemia,Peptide ,4,,-,approved,Glucagon receptor family,GPCR;Secretin,established,glucagon hydrochloride recombinant,P47871,agonist,
1100,1989,Class A (Rhodopsin),protein,goserelin,gnrhr_human,GNRHR,ASH_Sep2016_255,Antineoplastic,Peptide ,4,,-,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,goserelin,P30968,agonist,
1101,1982,Class A (Rhodopsin),small molecule,guanabenz,ada2c_human,ADRA2C,ASH_Sep2016_166,Antineoplastic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,guanabenz,P18825,agonist,
1102,1986,Class A (Rhodopsin),small molecule,guanfacine,ada2b_human,ADRA2B,ASH_Sep2016_133,attention deficit hyperactivity disorder,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,guanfacine,P18089,agonist,
1103,1986,Class A (Rhodopsin),small molecule,guanfacine,ada2c_human,ADRA2C,ASH_Sep2016_152,obstructive sleep apnea,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,guanfacine,P18825,agonist,
1104,1986,Class A (Rhodopsin),small molecule,guanfacine,ada2a_human,ADRA2A,889,ADHD,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"guanfacine, spd 503,intuniv",P08913,agonist,
1105,2001,Class A (Rhodopsin),small molecule,bimatoprost,pe2r1_human,PTGER1,MMAmar2016_0296,Antiglaucomic,Lipid ,4,,-,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"helios insert, bimatoprost ocular insert",P34995,agonist,
1106,2001,Class A (Rhodopsin),small molecule,bimatoprost,pf2r_human,PTGFR,MMAmar2016_0297,Antiglaucomic,Lipid ,4,,-,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"helios insert, bimatoprost ocular insert",P43088,agonist,
1107,2001,Class A (Rhodopsin),small molecule,bimatoprost,pe2r3_human,PTGER3,MMAmar2016_0298,Antiglaucomic,Lipid ,4,,-,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"helios insert, bimatoprost ocular insert",P43115,agonist,
1108,1939,Class A (Rhodopsin),small molecule,histamine,hrh1_human,HRH1,ASH_Sep2016_239,Anti-migraine,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,histamine,P35367,agonist,
1109,1939,Class A (Rhodopsin),small molecule,histamine,hrh2_human,HRH2,ASH_Oct2016_410,for diagnosis of gastric acid secretory function,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,histamine ,P25021,agonist,
1110,1943,Class A (Rhodopsin),small molecule,hydrocodone,oprm_human,OPRM1,MMAapril2016_0192,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,hydrocodone,P35372,agonist,
1111,1943,Class A (Rhodopsin),small molecule,hydrocodone,oprd_human,OPRD1,MMAapril2016_0193,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,hydrocodone,P41143,agonist,
1112,2013,Class A (Rhodopsin),small molecule,hydrocodone,oprk_human,OPRK1,ASH_Sep2016_265,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,hydrocodone,P41145,agonist,
1113,1943,Class A (Rhodopsin),small molecule,hydrocodone,oprm_human,OPRM1,MMAmay2016_0753,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,hydrocodone bitartrate with acetaminophen,P35372,agonist,
1114,1943,Class A (Rhodopsin),small molecule,hydrocodone,oprd_human,OPRD1,MMAmay2016_0754,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,hydrocodone bitartrate with acetaminophen,P41143,agonist,
1115,1943,Class A (Rhodopsin),small molecule,hydrocodone,oprm_human,OPRM1,MMAmar2016_0009,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"hysingla er, hydrocodone bitartrate extended release",P35372,agonist,
1116,1943,Class A (Rhodopsin),small molecule,hydrocodone,oprd_human,OPRD1,MMAmar2016_0010,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"hysingla er, hydrocodone bitartrate extended release",P41143,agonist,
1117,2009,Class B1 (Secretin),protein,liraglutide,glp1r_human,GLP1R,MMAmay2016_0808,Antidiabetic,Peptide ,4,,-,approved,Glucagon receptor family,GPCR;Secretin,established,"ideglira,  insulin degludec + liraglutide,  nn-9068",P43220,agonist,
1118,2004,Class A (Rhodopsin),small molecule,iloprost,pe2r1_human,PTGER1,952,Antihypertensive,Lipid ,4,,-,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"iloprost,ventavis",P34995,agonist,
1119,2004,Class A (Rhodopsin),small molecule,iloprost,pi2r_human,PTGIR,952,Antihypertensive,Lipid ,4,,-,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"iloprost,ventavis",P43119,agonist,
1120,2004,Class A (Rhodopsin),small molecule,iloprost,pd2r_human,PTGDR,ASH_Oct2016_435,Antihypertensive,Lipid ,4,,-,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"iloprost,ventavis",Q13258,agonist,
1121,2009,Class A (Rhodopsin),small molecule,indacaterol,adrb2_human,ADRB2,969,Bronchodilator,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,indacaterol,P07550,agonist,
1122,2001,Class A (Rhodopsin),small molecule,apomorphine,drd2_human,DRD2,976,sexual dysfunction in women; erectile dysfunction; Antiparkinson,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"inhaled apomorphine hydrochloride, vr004, vr-040, vr-400",P14416,agonist,
1123,2001,Class A (Rhodopsin),small molecule,apomorphine,drd3_human,DRD3,976,sexual dysfunction in women; erectile dysfunction; Antiparkinson,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"inhaled apomorphine hydrochloride, vr004, vr-040, vr-400",P35462,agonist,
1124,2001,Class A (Rhodopsin),small molecule,apomorphine,drd4_human,DRD4,976,sexual dysfunction in women; erectile dysfunction; Antiparkinson,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"inhaled apomorphine hydrochloride, vr004, vr-040, vr-400",P21917,agonist,
1125,1988,Class A (Rhodopsin),peptide,octreotide,ssr1_human,SSTR1,981,Antineoplastic,Peptide ,4,,-,approved,Somatostatin receptors,GPCR;Rhodopsin,established,"injectable octreotide acetate,sandostatin lar",P30872,agonist,
1126,1988,Class A (Rhodopsin),peptide,octreotide,ssr2_human,SSTR2,981,Antineoplastic,Peptide ,4,,-,approved,Somatostatin receptors,GPCR;Rhodopsin,established,"injectable octreotide acetate,sandostatin lar",P30874,agonist,
1127,1988,Class A (Rhodopsin),peptide,octreotide,ssr5_human,SSTR5,981,Antineoplastic,Peptide ,4,,-,approved,Somatostatin receptors,GPCR;Rhodopsin,established,"injectable octreotide acetate,sandostatin lar",P35346,agonist,
1128,2001,Class A (Rhodopsin),small molecule,apomorphine,drd2_human,DRD2,1009,sexual dysfunction in women; erectile dysfunction; Antiparkinson,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,intranasal apomorphine,P14416,agonist,
1129,2001,Class A (Rhodopsin),small molecule,apomorphine,drd3_human,DRD3,1009,sexual dysfunction in women; erectile dysfunction; Antiparkinson,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,intranasal apomorphine,P35462,agonist,
1130,2001,Class A (Rhodopsin),small molecule,apomorphine,drd4_human,DRD4,1009,sexual dysfunction in women; erectile dysfunction; Antiparkinson,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,intranasal apomorphine,P21917,agonist,
1131,1984,Class A (Rhodopsin),small molecule,morphine,oprd_human,OPRD1,1013,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"intranasal morphine,rylomine",P41143,agonist,
1132,1984,Class A (Rhodopsin),small molecule,morphine,oprk_human,OPRK1,1013,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"intranasal morphine,rylomine",P41145,agonist,
1133,1984,Class A (Rhodopsin),small molecule,morphine,oprm_human,OPRM1,1013,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"intranasal morphine,rylomine",P35372,agonist,
1134,1981,Class A (Rhodopsin),small molecule,salbutamol,adrb2_human,ADRB2,1021,chronic obstructive pulmonary disease (COPD),Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"ipratropium bromide + albuterol sulfate,duoneb",P07550,agonist,
1135,1979,Class A (Rhodopsin),small molecule,isoetharine,adrb2_human,ADRB2,ASH_Sep2016_182,obstructive lung disease,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,isoetharine,P07550,agonist,
1136,1979,Class A (Rhodopsin),small molecule,isoetharine,adrb1_human,ADRB1,ASH_Oct2016_361,Anti-Asthmatic,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,isoetharine,P08588,agonist,
1137,1956,Class A (Rhodopsin),small molecule,isoproterenol,adrb3_human,ADRB3,ASH_Oct2016_401,cardiovascular ; Anti-Asthmatic ,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,isoprenaline,P13945,agonist,
1138,1956,Class A (Rhodopsin),small molecule,isoproterenol,adrb1_human,ADRB1,ASH_Oct2016_402,cardiovascular ; Anti-Asthmatic ,Peptide ,4,,-,approved,Thyrotropin-releasing hormone receptors,GPCR;Rhodopsin,established,isoprenaline,p08588,agonist,
1139,1956,Class B1 (Secretin),small molecule,isoproterenol,adrb2_human,ADRB2,ASH_Oct2016_403,cardiovascular ; Anti-Asthmatic ,Peptide ,4,,-,approved,Corticotropin-releasing factor receptors,GPCR;Rhodopsin,established,isoprenaline,P07550,agonist,
1140,1956,Class A (Rhodopsin),small molecule,isoproterenol,adrb3_human,ADRB3,ASH_Sep2016_193,Anti-Asthmatic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,isoproterenol,P13945,agonist,
1141,2005,Class B1 (Secretin),peptide,exenatide,glp1r_human,GLP1R,1046,Antidiabetic,Peptide ,4,,-,approved,Glucagon receptor family,GPCR;Secretin,established,itca 650,P43220,agonist,
1142,1997,Class A (Rhodopsin),small molecule,ropinirole,drd2_human,DRD2,1057,restless legs syndrome,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,jzp-7,P14416,agonist,
1143,1997,Class A (Rhodopsin),small molecule,ropinirole,drd3_human,DRD3,1057,restless legs syndrome,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,jzp-7,P35462,agonist,
1144,2001,Class A (Rhodopsin),protein,lanreotide,ssr2_human,SSTR2,ASH_Sep2016_283,Antineoplastic,Peptide ,4,,-,approved,Somatostatin receptors,GPCR;Rhodopsin,established,lanreotide,P30874,agonist,
1145,2001,Class A (Rhodopsin),small molecule,lanreotide,ssr1_human,SSTR1,1088,acromegaly,Peptide ,4,,-,approved,Somatostatin receptors,GPCR;Rhodopsin,established,"lanreotide ,somatuline autogel, somatuline depot",P30872,agonist,
1146,2001,Class A (Rhodopsin),small molecule,lanreotide,ssr5_human,SSTR5,1089,acromegaly,Peptide ,4,,-,approved,Somatostatin receptors,GPCR;Rhodopsin,established,"lanreotide,somatuline autogel, somatuline depot",P35346,agonist,
1147,1996,Class A (Rhodopsin),small molecule,latanoprost,pf2r_human,PTGFR,1095,Antiglaucomic,Lipid ,4,,-,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"latanoprost + timolol,xalcom, xalacom",P43088,agonist,
1148,1996,Class A (Rhodopsin),small molecule,latanoprost,pf2r_human,PTGFR,1096,Antiglaucomic,Lipid ,4,,-,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"latanoprost, (sustained release, punctal plug delivery system)",P43088,agonist,
1149,1996,Class A (Rhodopsin),small molecule,latanoprost,pf2r_human,PTGFR,1097,Antiglaucomic,Lipid ,4,,-,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"latanoprost,xalatan fixed flow device",P43088,agonist,
1150,1985,Class A (Rhodopsin),peptide,leuprolide,gnrhr_human,GNRHR,1113,Antineoplastic ; endometriosis,Peptide ,4,,-,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,leuprolide,P30968,agonist,
1151,1985,Class A (Rhodopsin),peptide,leuprolide,gnrhr_human,GNRHR,1114,Antineoplastic ; endometriosis,Peptide ,4,,-,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,"leuprolide acetate, tap-144 sr",P30968,agonist,
1152,1985,Class A (Rhodopsin),peptide,leuprolide,gnrhr_human,GNRHR,1115,Antineoplastic ; endometriosis,Peptide ,4,,-,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,leupromaxx,P30968,agonist,
1153,1981,Class A (Rhodopsin),small molecule,salbutamol,adrb2_human,ADRB2,1116,Bronchodilator,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,levalbuterol,P07550,agonist,
1154,1993,Class A (Rhodopsin),small molecule,levodopa,drd1_human,DRD1,1119,Antiparkinson,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"levodopa + carbidopa,duodopa",P21728,agonist,
1155,1993,Class A (Rhodopsin),small molecule,levodopa,drd2_human,DRD2,1119,Antiparkinson,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"levodopa + carbidopa,duodopa",P14416,agonist,
1156,1993,Class A (Rhodopsin),small molecule,levodopa,drd3_human,DRD3,1119,Antiparkinson,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"levodopa + carbidopa,duodopa",P35462,agonist,
1157,1993,Class A (Rhodopsin),small molecule,levodopa,drd4_human,DRD4,1119,Antiparkinson,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"levodopa + carbidopa,duodopa",P21917,agonist,
1158,1993,Class A (Rhodopsin),small molecule,levodopa,drd5_human,DRD5,1119,Antiparkinson,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"levodopa + carbidopa,duodopa",P21918,agonist,
1159,1960,Class A (Rhodopsin),small molecule,levonordefrin,ada1a_human,ADRA1A,ASH_Oct2016_405,decongestant,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,levonordefrin,P35348,agonist,
1160,1999,Class A (Rhodopsin),small molecule,levosalbutamol,adrb2_human,ADRB2,ASH_Sep2016_174,Anti-Asthmatic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,levosalbutamol,P07550,agonist,
1161,1981,Class A (Rhodopsin),small molecule,salbutamol,adrb2_human,ADRB2,1146,symptomatic exophthalmos associated with thyroid-related eye disease,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"lipo-102, salmeterol xinafoate + fluticasone propionate",P07550,agonist,
1162,2009,Class B1 (Secretin),protein,liraglutide,glp1r_human,GLP1R,1154,Antidiabetic,Peptide ,4,,-,approved,Glucagon receptor family,GPCR;Secretin,established,liraglutide,P43220,agonist,
1163,2012,Class A (Rhodopsin),small molecule,lorcaserin,5ht2c_human,HTR2C,1164,Anti-obesity,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,lorcaserin,P28335,agonist,
1164,1984,Class A (Rhodopsin),small molecule,hydromorphone,oprm_human,OPRM1,MMAapril2016_0260,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"ltx-04,  hydromorphone hcl",P35372,agonist,
1165,1984,Class A (Rhodopsin),small molecule,hydromorphone,oprd_human,OPRD1,MMAapril2016_0261,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"ltx-04,  hydromorphone hcl",P41143,agonist,
1166,1984,Class A (Rhodopsin),small molecule,hydromorphone,oprk_human,OPRK1,MMAapril2016_0262,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"ltx-04,  hydromorphone hcl",P41145,agonist,
1167,2013,Class A (Rhodopsin),small molecule,vortioxetine,5ht1a_human,HTR1A,1171,Anti-depressant,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,lu aa21004,P08908,agonist,
1168,2013,Class A (Rhodopsin),small molecule,vortioxetine,5ht1b_human,HTR1B,1171,Anti-depressant,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,lu aa21004,P28222,agonist,
1169,2013,Class A (Rhodopsin),small molecule,vortioxetine,5ht7r_human,HTR7,1171,Anti-depressant,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,lu aa21004,P34969,agonist,
1170,1984,Class A (Rhodopsin),small molecule,morphine,oprd_human,OPRD1,1207,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"m6g, cee 04-410",P41143,agonist,
1171,1984,Class A (Rhodopsin),small molecule,morphine,oprk_human,OPRK1,1207,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"m6g, cee 04-410",P41145,agonist,
1172,1984,Class A (Rhodopsin),small molecule,morphine,oprm_human,OPRM1,1207,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"m6g, cee 04-410",P35372,agonist,
1173,1997,Class A (Rhodopsin),small molecule,dihydroergotamine,5ht1b_human,HTR1B,1214,Anti-migraine,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"map-0004, tempo migraine,levadex",P28222,agonist,
1174,1997,Class A (Rhodopsin),small molecule,dihydroergotamine,5ht1d_human,HTR1D,1214,Anti-migraine,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"map-0004, tempo migraine,levadex",P28221,agonist,
1175,2001,Class A (Rhodopsin),small molecule,formoterol,adrb2_human,ADRB2,1215,Bronchodilator,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,map-0005,P07550,agonist,
1176,1985,Class A (Rhodopsin),peptide,leuprolide,gnrhr_human,GNRHR,1250,Alzheimer's disease,Peptide ,4,,-,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,memryte,P30968,agonist,
1177,1942,Class A (Rhodopsin),small molecule,meperidine,oprm_human,OPRM1,ASH_Sep2016_270,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,meperidine,P35372,agonist,
1178,1951,Class A (Rhodopsin),small molecule,mephentermine,ada1b_human,ADRA1B,ASH_Sep2016_90,cardiovascular disease,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,mephentermine,P35368,agonist,
1179,1951,Class A (Rhodopsin),small molecule,mephentermine,ada1d_human,ADRA1D,ASH_Sep2016_105,cardiovascular disease,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,mephentermine,P25100,agonist,
1180,1951,Class A (Rhodopsin),small molecule,mephentermine,ada2a_human,ADRA2A,ASH_Sep2016_123,cardiovascular disease,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,mephentermine,P08913,agonist,
1181,1951,Class A (Rhodopsin),small molecule,mephentermine,ada2b_human,ADRA2B,ASH_Sep2016_145,cardiovascular disease,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,mephentermine,P18089,agonist,
1182,1951,Class A (Rhodopsin),small molecule,mephentermine,ada2c_human,ADRA2C,ASH_Sep2016_161,cardiovascular disease,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,mephentermine,P18825,agonist,
1183,1951,Class A (Rhodopsin),small molecule,mephentermine,adrb1_human,ADRB1,ASH_Sep2016_171,cardiovascular disease,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,mephentermine,P08588,agonist,
1184,1951,Class A (Rhodopsin),small molecule,mephentermine,adrb2_human,ADRB2,ASH_Sep2016_186,cardiovascular disease,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,mephentermine,P07550,agonist,
1185,1951,Class A (Rhodopsin),small molecule,mephentermine,adrb3_human,ADRB3,ASH_Sep2016_196,cardiovascular disease,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,mephentermine,P13945,agonist,
1186,1973,Class A (Rhodopsin),small molecule,metaproterenol,adrb2_human,ADRB2,ASH_Sep2016_175,Anti-Asthmatic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,metaproterenol,P07550,agonist,
1187,1954,Class A (Rhodopsin),small molecule,metaraminol,ada1b_human,ADRA1B,ASH_Sep2016_92,cardiovascular disease,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,metaraminol,P35368,agonist,
1188,1954,Class A (Rhodopsin),small molecule,metaraminol,ada1d_human,ADRA1D,ASH_Sep2016_110,cardiovascular disease,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,metaraminol,P25100,agonist,
1189,1986,Class A (Rhodopsin),small molecule,methacholine,acm3_human,CHRM3,ASH_Sep2016_81,Anti-Asthmatic,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,methacholine,P20309,agonist,
1190,1982,Class A (Rhodopsin),small molecule,methoxamine,ada1d_human,ADRA1D,ASH_Sep2016_119,cardiovascular disease,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,methoxamine,P25100,agonist,
1191,1962,Class A (Rhodopsin),small molecule,methyldopa,ada2b_human,ADRA2B,ASH_Sep2016_142,Antihypertensive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,methyldopa,P18089,agonist,
1192,1962,Class A (Rhodopsin),small molecule,methyldopa,ada2c_human,ADRA2C,ASH_Sep2016_157,Antihypertensive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,methyldopa,P18825,agonist,
1193,1984,Class A (Rhodopsin),small molecule,morphine,oprd_human,OPRD1,1279,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"mh-200, tak-453 sr, morphine hcl,anpec",P41143,agonist,
1194,1984,Class A (Rhodopsin),small molecule,morphine,oprk_human,OPRK1,1279,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"mh-200, tak-453 sr, morphine hcl,anpec",P41145,agonist,
1195,1984,Class A (Rhodopsin),small molecule,morphine,oprm_human,OPRM1,1279,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"mh-200, tak-453 sr, morphine hcl,anpec",P35372,agonist,
1196,1996,Class A (Rhodopsin),small molecule,midodrine,ada1d_human,ADRA1D,ASH_Sep2016_104,cardiovascular disease,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,midodrine,P25100,agonist,
1197,1997,Class A (Rhodopsin),small molecule,pramipexole,drd2_human,DRD2,1293,Antiparkinson,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,mirapex,P14416,agonist,
1198,1997,Class A (Rhodopsin),small molecule,pramipexole,drd3_human,DRD3,1293,Antiparkinson,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,mirapex,P35462,agonist,
1199,1997,Class A (Rhodopsin),small molecule,pramipexole,drd4_human,DRD4,1293,Antiparkinson,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,mirapex,P21917,agonist,
1200,1988,Class A (Rhodopsin),small molecule,misoprostol,pe2r3_human,PTGER3,ASH_Sep2016_312,hemorrhage,Lipid ,4,,-,approved,Prostanoid receptors,GPCR;Rhodopsin,established,misoprostol,P43115,agonist,
1201,2001,Class A (Rhodopsin),small molecule,formoterol,adrb2_human,ADRB2,1325,Anti-Asthmatic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"mometasone furoate + formoterol fumarate dihydrate,dulera",P07550,agonist,
1202,1984,Class A (Rhodopsin),small molecule,morphine,oprd_human,OPRD1,1333,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"morphine sulfate,avinza",P41143,agonist,
1203,1984,Class A (Rhodopsin),small molecule,morphine,oprk_human,OPRK1,1333,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"morphine sulfate,avinza",P41145,agonist,
1204,1984,Class A (Rhodopsin),small molecule,morphine,oprm_human,OPRM1,1333,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"morphine sulfate,avinza",P35372,agonist,
1205,1984,Class A (Rhodopsin),small molecule,morphine,oprd_human,OPRD1,1334,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"morphine sulfate,depodur, depomorphine",P41143,agonist,
1206,1984,Class A (Rhodopsin),small molecule,morphine,oprk_human,OPRK1,1334,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"morphine sulfate,depodur, depomorphine",P41145,agonist,
1207,1984,Class A (Rhodopsin),small molecule,morphine,oprm_human,OPRM1,1334,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"morphine sulfate,depodur, depomorphine",P35372,agonist,
1208,1984,Class A (Rhodopsin),small molecule,morphine,oprd_human,OPRD1,1335,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"morphine/dextromethorphan,morphidex",P41143,agonist,
1209,1984,Class A (Rhodopsin),small molecule,morphine,oprk_human,OPRK1,1335,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"morphine/dextromethorphan,morphidex",P41145,agonist,
1210,1984,Class A (Rhodopsin),small molecule,morphine,oprm_human,OPRM1,1335,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"morphine/dextromethorphan,morphidex",P35372,agonist,
1211,1984,Class A (Rhodopsin),small molecule,morphine,oprd_human,OPRD1,1336,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,morviva,P41143,agonist,
1212,1984,Class A (Rhodopsin),small molecule,morphine,oprk_human,OPRK1,1336,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,morviva,P41145,agonist,
1213,1984,Class A (Rhodopsin),small molecule,morphine,oprm_human,OPRM1,1336,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,morviva,P35372,agonist,
1214,1984,Class A (Rhodopsin),small molecule,morphine,oprd_human,OPRD1,1341,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,moxduo,P41143,agonist,
1215,1984,Class A (Rhodopsin),small molecule,morphine,oprk_human,OPRK1,1341,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,moxduo,P41145,agonist,
1216,1984,Class A (Rhodopsin),small molecule,morphine,oprm_human,OPRM1,1341,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,moxduo,P35372,agonist,
1217,1998,Class A (Rhodopsin),small molecule,oxycodone,oprd_human,OPRD1,1341,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,moxduo,P41143,agonist,
1218,1998,Class A (Rhodopsin),small molecule,oxycodone,oprk_human,OPRK1,1341,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,moxduo,P41145,agonist,
1219,1998,Class A (Rhodopsin),small molecule,oxycodone,oprm_human,OPRM1,1341,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,moxduo,P35372,agonist,
1220,1997,Class A (Rhodopsin),small molecule,dihydroergotamine,5ht1b_human,HTR1B,1356,Anti-migraine,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,mt 300,P28222,agonist,
1221,1997,Class A (Rhodopsin),small molecule,dihydroergotamine,5ht1d_human,HTR1D,1356,Anti-migraine,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,mt 300,P28221,agonist,
1222,1992,Class A (Rhodopsin),small molecule,sumatriptan,5ht1a_human,HTR1A,1357,Anti-migraine,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"mt 400,treximet",P08908,agonist,
1223,1992,Class A (Rhodopsin),small molecule,sumatriptan,5ht1b_human,HTR1B,1357,Anti-migraine,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"mt 400,treximet",P28222,agonist,
1224,1992,Class A (Rhodopsin),small molecule,sumatriptan,5ht1d_human,HTR1D,1357,Anti-migraine,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"mt 400,treximet",P28221,agonist,
1225,1992,Class A (Rhodopsin),small molecule,sumatriptan,5ht1f_human,HTR1F,1357,Anti-migraine,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"mt 400,treximet",P30939,agonist,
1226,2015,Class A (Rhodopsin),small molecule,eluxadoline,oprd_human,OPRD1,1363,irritable bowel syndrome,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"mu delta, eluxadoline",P41143,agonist,
1227,2015,Class A (Rhodopsin),small molecule,eluxadoline,oprm_human,OPRM1,1363,irritable bowel syndrome,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"mu delta, eluxadoline",P35372,agonist,
1228,1985,Class A (Rhodopsin),small molecule,nabilone,cnr1_human,CNR1,1373,Antiemetics,Lipid ,4,,-,approved,Cannabinoid receptors,GPCR;Rhodopsin,established,"nabilone,cesamet",P21554,agonist,
1229,1985,Class A (Rhodopsin),small molecule,nabilone,cnr2_human,CNR2,1373,Antiemetics,Lipid ,4,,-,approved,Cannabinoid receptors,GPCR;Rhodopsin,established,"nabilone,cesamet",P34972,agonist,
1230,1979,Class A (Rhodopsin),small molecule,nalbuphine,oprd_human,OPRD1,1374,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"nalbuphine hydrochloride,  pw-4142",P41143,agonist,
1231,1979,Class A (Rhodopsin),small molecule,nalbuphine,oprk_human,OPRK1,1374,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"nalbuphine hydrochloride,  pw-4142",P41145,agonist,
1232,1979,Class A (Rhodopsin),small molecule,nalbuphine,oprm_human,OPRM1,1374,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"nalbuphine hydrochloride,  pw-4142",P35372,agonist,
1233,1971,Class A (Rhodopsin),small molecule,naphazoline,ada1a_human,ADRA1A,ASH_Sep2016_86,nasal obstruction,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,naphazoline,P35348,agonist,
1234,1971,Class A (Rhodopsin),small molecule,naphazoline,ada1b_human,ADRA1B,ASH_Sep2016_96,nasal obstruction,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,naphazoline,P35368,agonist,
1235,1971,Class A (Rhodopsin),small molecule,naphazoline,ada1d_human,ADRA1D,ASH_Sep2016_111,eye allergy,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,naphazoline,P25100,agonist,
1236,1971,Class A (Rhodopsin),small molecule,naphazoline,ada2a_human,ADRA2A,ASH_Sep2016_126,eye allergy,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,naphazoline,P08913,agonist,
1237,1971,Class A (Rhodopsin),small molecule,naphazoline,ada2b_human,ADRA2B,ASH_Sep2016_129,nasal obstruction,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,naphazoline,P18089,agonist,
1238,1971,Class A (Rhodopsin),small molecule,naphazoline,ada2c_human,ADRA2C,ASH_Sep2016_150,nasal obstruction,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,naphazoline,P18825,agonist,
1239,1998,Class A (Rhodopsin),small molecule,naratriptan,5ht1a_human,HTR1A,1381,Anti-migraine,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"naratriptan,naramig, amerge",P08908,agonist,
1240,1998,Class A (Rhodopsin),small molecule,naratriptan,5ht1b_human,HTR1B,1381,Anti-migraine,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"naratriptan,naramig, amerge",P28222,agonist,
1241,1998,Class A (Rhodopsin),small molecule,naratriptan,5ht1d_human,HTR1D,1381,Anti-migraine,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"naratriptan,naramig, amerge",P28221,agonist,
1242,1998,Class A (Rhodopsin),small molecule,naratriptan,5ht1f_human,HTR1F,1381,Anti-migraine,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"naratriptan,naramig, amerge",P30939,agonist,
1243,1993,Class A (Rhodopsin),small molecule,levodopa,drd2_human,DRD2,MMAmay2016_0101,Antiparkinson,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"nd0612,  levodopa/carbidopa subcutaneous patch",P14416,agonist,
1244,1993,Class A (Rhodopsin),small molecule,levodopa,drd1_human,DRD1,MMAmay2016_0102,Antiparkinson,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"nd0612,  levodopa/carbidopa subcutaneous patch",P21728,agonist,
1245,1993,Class A (Rhodopsin),small molecule,levodopa,drd4_human,DRD4,MMAmay2016_0103,Antiparkinson,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"nd0612,  levodopa/carbidopa subcutaneous patch",P21917,agonist,
1246,1993,Class A (Rhodopsin),small molecule,levodopa,drd5_human,DRD5,MMAmay2016_0104,Antiparkinson,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"nd0612,  levodopa/carbidopa subcutaneous patch",P21918,agonist,
1247,1993,Class A (Rhodopsin),small molecule,levodopa,drd3_human,DRD3,MMAmay2016_0105,Antiparkinson,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"nd0612,  levodopa/carbidopa subcutaneous patch",P35462,agonist,
1248,2006,Class A (Rhodopsin),small molecule,rotigotine,drd2_human,DRD2,1404,Antiparkinson,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,neupro,P14416,agonist,
1249,2006,Class A (Rhodopsin),small molecule,rotigotine,drd3_human,DRD3,1404,Antiparkinson,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,neupro,P35462,agonist,
1250,2006,Class A (Rhodopsin),small molecule,rotigotine,drd4_human,DRD4,1404,Antiparkinson,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,neupro,P21917,agonist,
1251,1984,Class A (Rhodopsin),small molecule,hydromorphone,oprd_human,OPRD1,1422,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"nmed-1077,exalgo, jurnista, dilaudid",P41143,agonist,
1252,1984,Class A (Rhodopsin),small molecule,hydromorphone,oprk_human,OPRK1,1422,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"nmed-1077,exalgo, jurnista, dilaudid",P41145,agonist,
1253,1984,Class A (Rhodopsin),small molecule,hydromorphone,oprm_human,OPRM1,1422,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"nmed-1077,exalgo, jurnista, dilaudid",P35372,agonist,
1254,1996,Class A (Rhodopsin),small molecule,latanoprost,pf2r_human,PTGFR,1436,Antiglaucomic,Lipid ,4,,-,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"nova21027,catioprost",P43088,agonist,
1255,1992,Class A (Rhodopsin),small molecule,sumatriptan,5ht1a_human,HTR1A,1438,Anti-migraine,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"np101,zelrix",P08908,agonist,
1256,1992,Class A (Rhodopsin),small molecule,sumatriptan,5ht1b_human,HTR1B,1438,Anti-migraine,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"np101,zelrix",P28222,agonist,
1257,1992,Class A (Rhodopsin),small molecule,sumatriptan,5ht1d_human,HTR1D,1438,Anti-migraine,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"np101,zelrix",P28221,agonist,
1258,1992,Class A (Rhodopsin),small molecule,sumatriptan,5ht1f_human,HTR1F,1438,Anti-migraine,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"np101,zelrix",P30939,agonist,
1259,1996,Class A (Rhodopsin),small molecule,tizanidine,ada2a_human,ADRA2A,1458,skeletal muscular spasticity,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"nvd-422, tizanidine oral spray",P08913,agonist,
1260,1996,Class A (Rhodopsin),small molecule,tizanidine,ada2b_human,ADRA2B,1458,skeletal muscular spasticity,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"nvd-422, tizanidine oral spray",P18089,agonist,
1261,1996,Class A (Rhodopsin),small molecule,tizanidine,ada2c_human,ADRA2C,1458,skeletal muscular spasticity,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"nvd-422, tizanidine oral spray",P18825,agonist,
1262,1988,Class A (Rhodopsin),protein,octreotide,ssr3_human,SSTR3,ASH_Sep2016_284,growth hormone excess,Peptide ,4,,-,approved,Somatostatin receptors,GPCR;Rhodopsin,established,octreotide,P32745,agonist,
1263,1988,Class A (Rhodopsin),protein,octreotide,ssr4_human,SSTR4,ASH_Sep2016_285,growth hormone excess,Peptide ,4,,-,approved,Somatostatin receptors,GPCR;Rhodopsin,established,octreotide,P31391,agonist,
1264,1988,Class A (Rhodopsin),peptide,octreotide,ssr1_human,SSTR1,1470,Antineoplastic,Peptide ,4,,-,approved,Somatostatin receptors,GPCR;Rhodopsin,established,"octrotide,atrigel",P30872,agonist,
1265,1988,Class A (Rhodopsin),peptide,octreotide,ssr2_human,SSTR2,1470,Antineoplastic,Peptide ,4,,-,approved,Somatostatin receptors,GPCR;Rhodopsin,established,"octrotide,atrigel",P30874,agonist,
1266,1988,Class A (Rhodopsin),peptide,octreotide,ssr5_human,SSTR5,1470,Antineoplastic,Peptide ,4,,-,approved,Somatostatin receptors,GPCR;Rhodopsin,established,"octrotide,atrigel",P35346,agonist,
1267,1986,Class A (Rhodopsin),small molecule,oxymetazoline,ada1a_human,ADRA1A,1491,Analgesics,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,oms-103hp,P35348,agonist,
1268,1986,Class A (Rhodopsin),small molecule,oxymetazoline,ada2a_human,ADRA2A,1491,Analgesics,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,oms-103hp,P08913,agonist,
1269,1980,Class A (Rhodopsin),peptide,oxytocin,oxyr_human,OXTR,MMA2016_0022,autism,Peptide ,4,,-,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,"opn-300, intranasal oxytocin",P30559,agonist,
1270,1976,Class A (Rhodopsin),small molecule,danazol,gnrhr_human,GNRHR,2297,diabetic macular edema,Peptide ,4,,-,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,optina,P30968,agonist,
1271,1976,Class A (Rhodopsin),small molecule,danazol,gnrr2_human,GNRHR2,2297,diabetic macular edema,Peptide ,4,,-,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,optina,Q96P88,agonist,
1272,1988,Class A (Rhodopsin),peptide,octreotide,ssr1_human,SSTR1,1508,Antihypertensive,Peptide ,4,,-,approved,Somatostatin receptors,GPCR;Rhodopsin,established,"oral octreotide actetate ,octreolin",P30872,agonist,
1273,1988,Class A (Rhodopsin),peptide,octreotide,ssr2_human,SSTR2,1509,Antihypertensive,Peptide ,4,,-,approved,Somatostatin receptors,GPCR;Rhodopsin,established,"oral octreotide actetate,octreolin",P30874,agonist,
1274,1988,Class A (Rhodopsin),peptide,octreotide,ssr5_human,SSTR5,1509,Antihypertensive,Peptide ,4,,-,approved,Somatostatin receptors,GPCR;Rhodopsin,established,"oral octreotide actetate,octreolin",P35346,agonist,
1275,1981,Class A (Rhodopsin),small molecule,buprenorphine,oprm_human,OPRM1,MMAmay2016_0514,Anti-depressant; Analgesics; opioid addiction,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"ox219, buprenorphine + naloxone sublingual tablet",P35372,agonist,
1276,1981,Class A (Rhodopsin),small molecule,buprenorphine,oprk_human,OPRK1,MMAmay2016_0516,Anti-depressant; Analgesics; opioid addiction,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"ox219, buprenorphine + naloxone sublingual tablet",P41145,agonist,
1277,1986,Class A (Rhodopsin),small molecule,alfentanil,oprm_human,OPRM1,MMAmay2016_0108,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"ox51,  sublingual alfentanil",P35372,agonist,
1278,1998,Class A (Rhodopsin),small molecule,oxycodone,oprd_human,OPRD1,1545,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"oxycodone art, eli216,oxynal",P41143,agonist,
1279,1998,Class A (Rhodopsin),small molecule,oxycodone,oprk_human,OPRK1,1545,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"oxycodone art, eli216,oxynal",P41145,agonist,
1280,1998,Class A (Rhodopsin),small molecule,oxycodone,oprm_human,OPRM1,1545,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"oxycodone art, eli216,oxynal",P35372,agonist,
1281,1998,Class A (Rhodopsin),small molecule,oxycodone,oprd_human,OPRD1,1546,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"oxycodone hcl + niacin,acurox, oxyadf",P41143,agonist,
1282,1998,Class A (Rhodopsin),small molecule,oxycodone,oprk_human,OPRK1,1546,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"oxycodone hcl + niacin,acurox, oxyadf",P41145,agonist,
1283,1998,Class A (Rhodopsin),small molecule,oxycodone,oprm_human,OPRM1,1546,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"oxycodone hcl + niacin,acurox, oxyadf",P35372,agonist,
1284,1998,Class A (Rhodopsin),small molecule,oxycodone,oprd_human,OPRD1,1547,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"oxycodone, pti-821,remoxy",P41143,agonist,
1285,1998,Class A (Rhodopsin),small molecule,oxycodone,oprk_human,OPRK1,1547,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"oxycodone, pti-821,remoxy",P41145,agonist,
1286,1998,Class A (Rhodopsin),small molecule,oxycodone,oprm_human,OPRM1,1547,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"oxycodone, pti-821,remoxy",P35372,agonist,
1287,1986,Class A (Rhodopsin),small molecule,oxymetazoline,ada1b_human,ADRA1B,ASH_Sep2016_98,Antiglaucomic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,oxymetazoline,P35368,agonist,
1288,1986,Class A (Rhodopsin),small molecule,oxymetazoline,ada1d_human,ADRA1D,ASH_Sep2016_115,allergic conjunctivitis,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,oxymetazoline,P25100,agonist,
1289,1986,Class A (Rhodopsin),small molecule,oxymetazoline,ada2b_human,ADRA2B,ASH_Sep2016_132,dry eye,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,oxymetazoline,P18089,agonist,
1290,1986,Class A (Rhodopsin),small molecule,oxymetazoline,ada2c_human,ADRA2C,ASH_Sep2016_151,dry eye,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,oxymetazoline,P18825,agonist,
1291,1959,Class A (Rhodopsin),small molecule,oxymorphone,oprk_human,OPRK1,ASH_Sep2016_266,opiate dependence,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,oxymorphone,P41145,agonist,
1292,1959,Class A (Rhodopsin),small molecule,oxymorphone,oprd_human,OPRD1,1548,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"oxymorphone hydrochloride, en3202,opana, opana er",P41143,agonist,
1293,1959,Class A (Rhodopsin),small molecule,oxymorphone,oprm_human,OPRM1,1548,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"oxymorphone hydrochloride, en3202,opana, opana er",P35372,agonist,
1294,1997,Class A (Rhodopsin),small molecule,pramipexole,drd2_human,DRD2,MMAmar2016_0004,Antiparkinson,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,p2b001,P14416,agonist,
1295,1997,Class A (Rhodopsin),small molecule,pramipexole,drd4_human,DRD4,MMAmar2016_0005,Antiparkinson,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,p2b001,P21917,agonist,
1296,1997,Class A (Rhodopsin),small molecule,pramipexole,drd3_human,DRD3,MMAmar2016_0006,Antiparkinson,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,p2b001,P35462,agonist,
1297,2012,Class A (Rhodopsin),peptide,pasireotide,ssr1_human,SSTR1,1567,Antineoplastic ; acromegaly,Peptide ,4,,-,approved,Somatostatin receptors,GPCR;Rhodopsin,established,"pasireotide, som230",P30872,agonist,
1298,2012,Class A (Rhodopsin),peptide,pasireotide,ssr2_human,SSTR2,1567,Antineoplastic ; acromegaly,Peptide ,4,,-,approved,Somatostatin receptors,GPCR;Rhodopsin,established,"pasireotide, som230",P30874,agonist,
1299,2012,Class A (Rhodopsin),peptide,pasireotide,ssr3_human,SSTR3,1567,Antineoplastic ; acromegaly,Peptide ,4,,-,approved,Somatostatin receptors,GPCR;Rhodopsin,established,"pasireotide, som230",P32745,agonist,
1300,2012,Class A (Rhodopsin),peptide,pasireotide,ssr5_human,SSTR5,1567,Antineoplastic ; acromegaly,Peptide ,4,,-,approved,Somatostatin receptors,GPCR;Rhodopsin,established,"pasireotide, som230",P35346,agonist,
1301,1988,Class A (Rhodopsin),small molecule,pergolide,drd3_human,DRD3,ASH_Sep2016_209,Antiparkinson,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,pergolide,P35462,agonist,
1302,1988,Class A (Rhodopsin),small molecule,pergolide,drd4_human,DRD4,ASH_Sep2016_226,Antiparkinson,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,pergolide,P21917,agonist,
1303,1988,Class A (Rhodopsin),small molecule,pergolide,drd5_human,DRD5,ASH_Sep2016_231,Antiparkinson,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,pergolide,P21918,agonist,
1304,1942,Class A (Rhodopsin),small molecule,pethidine,oprk_human,OPRK1,ASH_Oct2016_350,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,pethidine,P41145,agonist,
1305,1986,Class A (Rhodopsin),small molecule,pirbuterol,adrb2_human,ADRB2,ASH_Sep2016_181,obstructive lung disease,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,pirbuterol,P07550,agonist,
1306,2005,Class B1 (Secretin),protein,pramlintide acetate,calcr_human,CALCR,ASH_Sep2016_322,Antidiabetic,Peptide ,4,,-,approved,Calcitonin receptors,GPCR;Secretin,established,pramlintide acetate,P30988,agonist,
1307,1976,Class A (Rhodopsin),small molecule,protirelin,trfr_human,TRHR,ASH_Oct2016_408,Diagnostic,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,protirelin,P34981,agonist,
1308,1952,Class A (Rhodopsin),small molecule,phenylephrine,ada1a_human,ADRA1A,1675,incontinence,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"psd-503, phenylephrine",P35348,agonist,
1309,1952,Class A (Rhodopsin),small molecule,phenylephrine,ada1b_human,ADRA1B,1675,incontinence,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"psd-503, phenylephrine",P35368,agonist,
1310,1952,Class A (Rhodopsin),small molecule,phenylephrine,ada1d_human,ADRA1D,1675,incontinence,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"psd-503, phenylephrine",P25100,agonist,
1311,2001,Class A (Rhodopsin),small molecule,formoterol,adrb2_human,ADRB2,1681,chronic obstructive pulmonary disease (COPD),Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"pt003, glycopyrrolate + formoterol inhalation aerosol",P07550,agonist,
1312,2001,Class A (Rhodopsin),small molecule,formoterol,adrb2_human,ADRB2,1682,chronic obstructive pulmonary disease (COPD),Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"pt005, formoterol fumarate hydrofluoroalkane metered dose inhaler",P07550,agonist,
1313,1995,Class A (Rhodopsin),small molecule,tramadol,5ht2c_human,HTR2C,1685,Analgesics,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,pti-601,P28335,agonist,
1314,1995,Class A (Rhodopsin),small molecule,tramadol,oprk_human,OPRK1,1685,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,pti-601,P41145,agonist,
1315,1995,Class A (Rhodopsin),small molecule,tramadol,oprm_human,OPRM1,1685,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,pti-601,P35372,agonist,
1316,1943,Class A (Rhodopsin),small molecule,hydrocodone,oprd_human,OPRD1,1686,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,pti-701,P41143,agonist,
1317,1943,Class A (Rhodopsin),small molecule,hydrocodone,oprm_human,OPRM1,1686,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,pti-701,P35372,agonist,
1318,1998,Class A (Rhodopsin),small molecule,oxycodone,oprd_human,OPRD1,1687,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"pti-801,oxytrex",P41143,agonist,
1319,1998,Class A (Rhodopsin),small molecule,oxycodone,oprk_human,OPRK1,1687,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"pti-801,oxytrex",P41145,agonist,
1320,1998,Class A (Rhodopsin),small molecule,oxycodone,oprm_human,OPRM1,1687,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"pti-801,oxytrex",P35372,agonist,
1321,2007,Class C (Glutamate) ,small molecule,baclofen,gabr2_human,GABBR2,MMAmay2016_0071,for type 1A Charcot-Marie-Tooth disease,Amino acid ,4,,-,approved,GABAB receptors,GPCR;Glutamate,established,"pxt3003, baclofen + naltrexone + sorbitol",O75899,agonist,
1322,2007,Class C (Glutamate) ,small molecule,baclofen,gabr1_human,GABBR1,MMAmay2016_0072,for type 1A Charcot-Marie-Tooth disease,Amino acid ,4,,-,approved,GABAB receptors,GPCR;Glutamate,established,"pxt3003, baclofen + naltrexone + sorbitol",Q9UBS5,agonist,
1323,2009,Class A (Rhodopsin),small molecule,indacaterol,acm1_human,CHRM1,1702,chronic obstructive pulmonary disease (COPD),Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"qva149, glycopyrronium + indacaterol",P11229,agonist,
1324,2005,Class A (Rhodopsin),small molecule,ramelteon,mtr1a_human,MTNR1A,1713,insomnia,Melatonin ,4,,-,approved,Melatonin,GPCR;Rhodopsin,established,"ramelteon, tak-375,rozerem",P48039,agonist,
1325,2005,Class A (Rhodopsin),small molecule,ramelteon,mtr1b_human,MTNR1B,1713,insomnia,Melatonin ,4,,-,approved,Melatonin,GPCR;Rhodopsin,established,"ramelteon, tak-375,rozerem",P49286,agonist,
1326,1970,Class A (Rhodopsin),small molecule,cosyntropin,acthr_human,MC2R,MMAmar2016_0275,epilepsy,Peptide ,4,,-,approved,Melanocortin receptors,GPCR;Rhodopsin,established,"re-034, cosyntropin, tetracosactid",Q01718,agonist,
1327,2008,Class A (Rhodopsin),small molecule,regadenoson,aa2ar_human,ADORA2A,1726,Diagnostic,Nucleotide ,4,,-,approved,Adenosine receptors,GPCR;Rhodopsin,established,"regadenoson,lexiscan",P29274,agonist,
1328,2002,Class A (Rhodopsin),small molecule,eletriptan,5ht1d_human,HTR1D,1731,Anti-migraine,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,relpax,P28221,agonist,
1329,1996,Class A (Rhodopsin),small molecule,remifentanil,oprm_human,OPRM1,1732,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"remifentanil,ultiva",P35372,agonist,
1330,1979,Class A (Rhodopsin),small molecule,nalbuphine,oprd_human,OPRD1,1733,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,ren-213,P41143,agonist,
1331,1979,Class A (Rhodopsin),small molecule,nalbuphine,oprk_human,OPRK1,1733,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,ren-213,P41145,agonist,
1332,1979,Class A (Rhodopsin),small molecule,nalbuphine,oprm_human,OPRM1,1733,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,ren-213,P35372,agonist,
1333,1997,Class A (Rhodopsin),small molecule,ropinirole,drd2_human,DRD2,1737,Antiparkinson,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,requip,P14416,agonist,
1334,1997,Class A (Rhodopsin),small molecule,ropinirole,drd3_human,DRD3,1737,Antiparkinson,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,requip,P35462,agonist,
1335,1998,Class A (Rhodopsin),small molecule,oxycodone,oprm_human,OPRM1,MMAmar2016_0078,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"rexista, oxycodone xr",P35372,agonist,
1336,1998,Class A (Rhodopsin),small molecule,oxycodone,oprd_human,OPRD1,MMAmar2016_0079,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"rexista, oxycodone xr",P41143,agonist,
1337,1998,Class A (Rhodopsin),small molecule,oxycodone,oprk_human,OPRK1,MMAmar2016_0080,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"rexista, oxycodone xr",P41145,agonist,
1338,1973,Class A (Rhodopsin),protein,chorionic gonadotropin,lshr_human,LHCGR,1756,Antineoplastic,Protein ,4,,-,approved,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,"r-hcg,ovidrel",P22888,agonist,
1339,1996,Class A (Rhodopsin),small molecule,latanoprost,pf2r_human,PTGFR,MMAfeb2016_0059,Antiglaucomic,Lipid ,4,,-,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"roclatan, rhopressa + latanoprost",P43088,agonist,
1340,1997,Class A (Rhodopsin),small molecule,ropinirole,drd4_human,DRD4,ASH_Sep2016_218,Antiparkinson,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,ropinirole,P21917,agonist,
1341,1943,Class A (Rhodopsin),small molecule,hydrocodone,oprm_human,OPRM1,MMAmar2016_0081,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"s-718632, extended release hydrocodone",P35372,agonist,
1342,1943,Class A (Rhodopsin),small molecule,hydrocodone,oprd_human,OPRD1,MMAmar2016_0082,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"s-718632, extended release hydrocodone",P41143,agonist,
1343,1985,Class A (Rhodopsin),small molecule,nabilone,cnr1_human,CNR1,1812,Analgesics; neuropathic pain; restlegs legs syndrome,Lipid ,4,,-,approved,Cannabinoid receptors,GPCR;Rhodopsin,established,sativex,P21554,agonist,
1344,1985,Class A (Rhodopsin),small molecule,nabilone,cnr2_human,CNR2,1812,Analgesics; neuropathic pain; restlegs legs syndrome,Lipid ,4,,-,approved,Cannabinoid receptors,GPCR;Rhodopsin,established,sativex,P34972,agonist,
1345,2015,Class A (Rhodopsin),small molecule,selexipag,pi2r_human,PTGIR,1831,Antihypertensive,Lipid ,4,,-,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"selexipag, act-293987",P43119,agonist,
1346,2015,Class A (Rhodopsin),small molecule,selexipag,pi2r_human,PTGIR,MMAmay2016_0747,Antihypertensive,Lipid ,4,,-,approved,Prostanoid receptors,GPCR;Rhodopsin,established,selixipag,P43119,agonist,
1347,1994,Class A (Rhodopsin),small molecule,salmeterol,adrb2_human,ADRB2,1839,Bronchodilator,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,serevent,P07550,agonist,
1348,2001,Class A (Rhodopsin),small molecule,formoterol,adrb2_human,ADRB2,1861,Bronchodilator,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"skyepharma,flutiform",P07550,agonist,
1349,1984,Class A (Rhodopsin),small molecule,morphine,oprk_human,OPRK1,1903,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,statex,P41145,agonist,
1350,1973,Class A (Rhodopsin),protein,chorionic gonadotropin,lshr_human,LHCGR,1904,stroke,Protein ,4,,-,approved,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,"stem,ntx-265",P22888,agonist,
1351,1984,Class A (Rhodopsin),small molecule,sufentanil,oprd_human,OPRD1,1909,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"sufentanil transdermal patch,transdur-sufentanil",P41143,agonist,
1352,1984,Class A (Rhodopsin),small molecule,sufentanil,oprk_human,OPRK1,1909,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"sufentanil transdermal patch,transdur-sufentanil",P41145,agonist,
1353,1984,Class A (Rhodopsin),small molecule,sufentanil,oprm_human,OPRM1,1909,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"sufentanil transdermal patch,transdur-sufentanil",P35372,agonist,
1354,1984,Class A (Rhodopsin),small molecule,sufentanil,oprd_human,OPRD1,1910,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"sufentanil,chronogesic",P41143,agonist,
1355,1984,Class A (Rhodopsin),small molecule,sufentanil,oprk_human,OPRK1,1910,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"sufentanil,chronogesic",P41145,agonist,
1356,1984,Class A (Rhodopsin),small molecule,sufentanil,oprm_human,OPRM1,1910,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"sufentanil,chronogesic",P35372,agonist,
1357,1992,Class A (Rhodopsin),small molecule,sumatriptan,5ht1a_human,HTR1A,1914,Anti-migraine,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,sumatriptan,P08908,agonist,
1358,1992,Class A (Rhodopsin),small molecule,sumatriptan,5ht1b_human,HTR1B,1914,Anti-migraine,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,sumatriptan,P28222,agonist,
1359,1992,Class A (Rhodopsin),small molecule,sumatriptan,5ht1d_human,HTR1D,1914,Anti-migraine,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,sumatriptan,P28221,agonist,
1360,1992,Class A (Rhodopsin),small molecule,sumatriptan,5ht1f_human,HTR1F,1914,Anti-migraine,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,sumatriptan,P30939,agonist,
1361,1992,Class A (Rhodopsin),small molecule,sumatriptan,5ht1a_human,HTR1A,1915,Anti-migraine,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"sumatriptan, triptan",P08908,agonist,
1362,1992,Class A (Rhodopsin),small molecule,sumatriptan,5ht1b_human,HTR1B,1915,Anti-migraine,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"sumatriptan, triptan",P28222,agonist,
1363,1992,Class A (Rhodopsin),small molecule,sumatriptan,5ht1d_human,HTR1D,1915,Anti-migraine,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"sumatriptan, triptan",P28221,agonist,
1364,1992,Class A (Rhodopsin),small molecule,sumatriptan,5ht1f_human,HTR1F,1915,Anti-migraine,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"sumatriptan, triptan",P30939,agonist,
1365,1992,Class A (Rhodopsin),small molecule,sumatriptan,5ht1a_human,HTR1A,1916,Anti-migraine,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"sumatriptan,imitrex",P08908,agonist,
1366,1992,Class A (Rhodopsin),small molecule,sumatriptan,5ht1b_human,HTR1B,1916,Anti-migraine,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"sumatriptan,imitrex",P28222,agonist,
1367,1992,Class A (Rhodopsin),small molecule,sumatriptan,5ht1d_human,HTR1D,1916,Anti-migraine,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"sumatriptan,imitrex",P28221,agonist,
1368,1992,Class A (Rhodopsin),small molecule,sumatriptan,5ht1f_human,HTR1F,1916,Anti-migraine,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"sumatriptan,imitrex",P30939,agonist,
1369,1996,Class A (Rhodopsin),small molecule,latanoprost,pf2r_human,PTGFR,1918,Antiglaucomic,Lipid ,4,,-,approved,Prostanoid receptors,GPCR;Rhodopsin,established,sustained release latanoprost,P43088,agonist,
1370,2005,Class B1 (Secretin),peptide,pramlintide acetate,calcr_human,CALCR,1924,Antidiabetic,Peptide ,4,,-,approved,Calcitonin receptors,GPCR;Secretin,established,symlin,P30988,agonist,
1371,2012,Class A (Rhodopsin),small molecule,tafluprost,pf2r_human,PTGFR,MMAmay2016_0794,Reduce intraocular pressure,Lipid ,4,,-,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"taflotan, tapros, zioptan, tafluprost, saflutan, de-085, mk-2452",P43088,agonist,
1372,2008,Class A (Rhodopsin),small molecule,tapentadol,oprm_human,OPRM1,1950,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,tapentadol,P35372,agonist,
1373,2008,Class A (Rhodopsin),small molecule,tapentadol,oprm_human,MOR,1951,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"tapentadol hydrochloride, cg-5503, r331333",P35372,agonist,
1374,1998,Class A (Rhodopsin),small molecule,oxycodone,oprm_human,OPRM1,MMAmay2016_0706,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"targin,  targinac, targiniq er,  oxycodone hydrochloride + naloxone hydrochloride extended-release tablets",P35372,agonist,
1375,1998,Class A (Rhodopsin),small molecule,oxycodone,oprd_human,OPRD1,MMAmay2016_0707,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"targin,  targinac, targiniq er,  oxycodone hydrochloride + naloxone hydrochloride extended-release tablets",P41143,agonist,
1376,1998,Class A (Rhodopsin),small molecule,oxycodone,oprk_human,OPRK1,MMAmay2016_0708,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"targin,  targinac, targiniq er,  oxycodone hydrochloride + naloxone hydrochloride extended-release tablets",P41145,agonist,
1377,2014,Class A (Rhodopsin),small molecule,tasimelteon,mtr1a_human,MTNR1A,1956,Hypnotics and Sedatives,Melatonin ,4,,-,approved,Melatonin,GPCR;Rhodopsin,established,"tasimelteon, vec-162",P48039,agonist,
1378,2014,Class A (Rhodopsin),small molecule,tasimelteon,mtr1b_human,MTNR1B,1956,Hypnotics and Sedatives,Melatonin ,4,,-,approved,Melatonin,GPCR;Rhodopsin,established,"tasimelteon, vec-162",P49286,agonist,
1379,2012,Class B1 (Secretin),peptide,teduglutide,glp2r_human,GLP2R,2463,short bowel syndrome,Peptide ,4,,-,approved,Glucagon receptor family,GPCR;Secretin,established,teduglutide,O95838,agonist,
1380,1987,Class B1 (Secretin),peptide,teriparatide,pth1r_human,PTHR1,1983,Anti-osteoporotic,Peptide ,4,,-,approved,Parathyroid hormone receptors,GPCR;Secretin,established,"teriparatide, inhaled air",Q03431,agonist,
1381,1987,Class B1 (Secretin),peptide,teriparatide,pth1r_human,PTHR1,1984,Anti-osteoporotic,Peptide ,4,,-,approved,Parathyroid hormone receptors,GPCR;Secretin,established,"teriparatide, pth1-34 nasal spray",Q03431,agonist,
1382,1987,Class B1 (Secretin),peptide,teriparatide,pth1r_human,PTHR1,1985,Anti-osteoporotic,Peptide ,4,,-,approved,Parathyroid hormone receptors,GPCR;Secretin,established,"teriparatide,forteo, forsteo",Q03431,agonist,
1383,2010,Class B1 (Secretin),peptide,tesamorelin,ghrhr_human,GHRHR,1987,HIV-associated lipodystrophy,Peptide ,4,,-,approved,Glucagon receptor family,GPCR;Secretin,established,tesamorelin,Q02643,agonist,
1384,1979,Class A (Rhodopsin),small molecule,tetrahydrozoline,ada1a_human,ADRA1A,ASH_Sep2016_85,eye allergy,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,tetrahydrozoline,P35348,agonist,
1385,1979,Class A (Rhodopsin),small molecule,tetrahydrozoline,ada1b_human,ADRA1B,ASH_Sep2016_94,nasal obstruction,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,tetrahydrozoline,P35368,agonist,
1386,1979,Class A (Rhodopsin),small molecule,tetrahydrozoline,ada1d_human,ADRA1D,ASH_Sep2016_120,nasal obstruction,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,tetrahydrozoline,P25100,agonist,
1387,1979,Class A (Rhodopsin),small molecule,tetrahydrozoline,ada2a_human,ADRA2A,ASH_Sep2016_122,eye allergy,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,tetrahydrozoline,P08913,agonist,
1388,1979,Class A (Rhodopsin),small molecule,tetrahydrozoline,ada2b_human,ADRA2B,ASH_Sep2016_139,nasal obstruction,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,tetrahydrozoline,P18089,agonist,
1389,1979,Class A (Rhodopsin),small molecule,tetrahydrozoline,ada2c_human,ADRA2C,ASH_Sep2016_159,nasal obstruction,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,tetrahydrozoline,P18825,agonist,
1390,1982,Class B1 (Secretin),small molecule,tetryzoline,ada1a_human,ADRA1A,ASH_Oct2016_411,"for eye irritation, decongestant",Peptide ,4,,-,approved,Calcitonin receptors,GPCR;Rhodopsin,established,tetryzoline,P35348,agonist,
1391,2015,Class B1 (Secretin),protein,parathyroid hormone,pth2r_human,PTH2R,2012,Anti-osteoporotic,Peptide ,4,,-,approved,Parathyroid hormone receptors,GPCR;Secretin,established,thpth,P49190,agonist,
1392,1974,Class A (Rhodopsin),small molecule,pilocarpine,acm1_human,CHRM1,2013,incontinence,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,thvd-201,P11229,agonist,
1393,1974,Class A (Rhodopsin),small molecule,pilocarpine,acm2_human,CHRM2,2013,incontinence,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,thvd-201,P08172,agonist,
1394,1974,Class A (Rhodopsin),small molecule,pilocarpine,acm3_human,CHRM3,2013,incontinence,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,thvd-201,P20309,agonist,
1395,1980,Class A (Rhodopsin),peptide,oxytocin,oxyr_human,OXTR,2014,Analgesics,Peptide ,4,,-,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,"ti-001, intranasal oxytocin",P30559,agonist,
1396,2014,Class A (Rhodopsin),small molecule,olodaterol,adrb2_human,ADRB2,MMAmay2016_0592,chronic obstructive pulmonary disease (COPD),Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,tiotropium + olodaterol,P07550,agonist,
1397,1996,Class A (Rhodopsin),small molecule,tizanidine,ada2a_human,ADRA2A,2021,Muscle Relaxants,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"tizanidine hydrochloride,zanaflex",P08913,agonist,
1398,1996,Class A (Rhodopsin),small molecule,tizanidine,ada2b_human,ADRA2B,2021,Muscle Relaxants,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"tizanidine hydrochloride,zanaflex",P18089,agonist,
1399,1996,Class A (Rhodopsin),small molecule,tizanidine,ada2c_human,ADRA2C,2021,Muscle Relaxants,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"tizanidine hydrochloride,zanaflex",P18825,agonist,
1400,1948,Class A (Rhodopsin),small molecule,tolazoline,ada1b_human,ADRA1B,ASH_Sep2016_97,cardiovascular disease,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,tolazoline,P35368,agonist,
1401,1948,Class A (Rhodopsin),small molecule,tolazoline,ada1d_human,ADRA1D,ASH_Sep2016_113,cardiovascular disease,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,tolazoline,P25100,agonist,
1402,1948,Class A (Rhodopsin),small molecule,tolazoline,ada2a_human,ADRA2A,ASH_Sep2016_125,cardiovascular disease,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,tolazoline,P08913,agonist,
1403,1948,Class A (Rhodopsin),small molecule,tolazoline,ada2b_human,ADRA2B,ASH_Sep2016_134,arthralgia,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,tolazoline,P18089,agonist,
1404,1948,Class A (Rhodopsin),small molecule,tolazoline,ada2c_human,ADRA2C,ASH_Sep2016_154,arthralgia,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,tolazoline,P18825,agonist,
1405,1948,Class A (Rhodopsin),small molecule,tolazoline,hrh1_human,HRH1,ASH_Sep2016_233,cardiovascular disease,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,tolazoline,P35367,agonist,
1406,1948,Class A (Rhodopsin),small molecule,tolazoline,hrh2_human,HRH2,ASH_Sep2016_241,arthralgia,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,tolazoline,P25021,agonist,
1407,1984,Class A (Rhodopsin),small molecule,morphine,oprd_human,OPRD1,2051,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,tpm-1/morphine,P41143,agonist,
1408,1984,Class A (Rhodopsin),small molecule,morphine,oprk_human,OPRK1,2051,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,tpm-1/morphine,P41145,agonist,
1409,1984,Class A (Rhodopsin),small molecule,morphine,oprm_human,OPRM1,2051,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,tpm-1/morphine,P35372,agonist,
1410,1995,Class A (Rhodopsin),small molecule,tramadol,5ht2c_human,HTR2C,2055,Analgesics,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"tramadol extended-release,raliva er",P28335,agonist,
1411,1995,Class A (Rhodopsin),small molecule,tramadol,oprk_human,OPRK1,2055,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"tramadol extended-release,raliva er",P41145,agonist,
1412,1995,Class A (Rhodopsin),small molecule,tramadol,oprm_human,OPRM1,2055,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"tramadol extended-release,raliva er",P35372,agonist,
1413,1995,Class A (Rhodopsin),small molecule,tramadol,5ht2c_human,HTR2C,2056,Analgesics,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"tramadol hydrochloride,ultram",P28335,agonist,
1414,1995,Class A (Rhodopsin),small molecule,tramadol,oprk_human,OPRK1,2056,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"tramadol hydrochloride,ultram",P41145,agonist,
1415,1995,Class A (Rhodopsin),small molecule,tramadol,oprm_human,OPRM1,2056,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"tramadol hydrochloride,ultram",P35372,agonist,
1416,1995,Class A (Rhodopsin),small molecule,tramadol,5ht2c_human,HTR2C,2057,Analgesics,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"tramadol,tridural, ryzolt",P28335,agonist,
1417,1995,Class A (Rhodopsin),small molecule,tramadol,oprk_human,OPRK1,2057,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"tramadol,tridural, ryzolt",P41145,agonist,
1418,1995,Class A (Rhodopsin),small molecule,tramadol,oprm_human,OPRM1,2057,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"tramadol,tridural, ryzolt",P35372,agonist,
1419,2002,Class A (Rhodopsin),small molecule,treprostinil,pi2r_human,PTGIR,MMA2016_0038,Antihypertensive,Lipid ,4,,-,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"transcon treprostinil, subcutaneous injection",P43119,agonist,
1420,2002,Class A (Rhodopsin),small molecule,treprostinil,p2y12_human,P2RY12,MMA2016_0040,Antihypertensive,Nucleotide ,4,,-,approved,P2Y receptors,GPCR;Rhodopsin,established,"transcon treprostinil, subcutaneous injection",Q9H244,agonist,
1421,1976,Class A (Rhodopsin),small molecule,epinephrine,ada1a_human,ADRA1A,2066,Anesthetics,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"transdermal lidocaine/epinephrine patch,lidosite",P35348,agonist,
1422,1976,Class A (Rhodopsin),small molecule,epinephrine,ada1b_human,ADRA1B,2066,Anesthetics,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"transdermal lidocaine/epinephrine patch,lidosite",P35368,agonist,
1423,1976,Class A (Rhodopsin),small molecule,epinephrine,ada1d_human,ADRA1D,2066,Anesthetics,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"transdermal lidocaine/epinephrine patch,lidosite",P25100,agonist,
1424,1976,Class A (Rhodopsin),small molecule,epinephrine,ada2a_human,ADRA2A,2066,Anesthetics,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"transdermal lidocaine/epinephrine patch,lidosite",P08913,agonist,
1425,1976,Class A (Rhodopsin),small molecule,epinephrine,ada2b_human,ADRA2B,2066,Anesthetics,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"transdermal lidocaine/epinephrine patch,lidosite",P18089,agonist,
1426,1976,Class A (Rhodopsin),small molecule,epinephrine,adrb1_human,ADRB1,2066,Anesthetics,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"transdermal lidocaine/epinephrine patch,lidosite",P08588,agonist,
1427,1976,Class A (Rhodopsin),small molecule,epinephrine,adrb2_human,ADRB2,2066,Anesthetics,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"transdermal lidocaine/epinephrine patch,lidosite",P07550,agonist,
1428,1998,Class A (Rhodopsin),small molecule,oxycodone,oprd_human,OPRD1,2068,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,transdermal oxycodone,P41143,agonist,
1429,1998,Class A (Rhodopsin),small molecule,oxycodone,oprk_human,OPRK1,2068,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,transdermal oxycodone,P41145,agonist,
1430,1998,Class A (Rhodopsin),small molecule,oxycodone,oprm_human,OPRM1,2068,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,transdermal oxycodone,P35372,agonist,
1431,1968,Class A (Rhodopsin),small molecule,fentanyl,oprd_human,OPRD1,2069,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"transmucosal fentanyl,actiq",P41143,agonist,
1432,1968,Class A (Rhodopsin),small molecule,fentanyl,oprm_human,OPRM1,2069,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"transmucosal fentanyl,actiq",P35372,agonist,
1433,2001,Class A (Rhodopsin),small molecule,travoprost,pf2r_human,PTGFR,2071,Antiglaucomic,Lipid ,4,,-,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"travoprost + timolol,extravan, duotrav",P43088,agonist,
1434,2002,Class A (Rhodopsin),small molecule,treprostinil,p2y12_human,P2RY12,2767,Antihypertensive,Nucleotide ,4,,-,approved,P2Y receptors,GPCR;Rhodopsin,established,"treprostinil inhaled/oral,tyvaso, viveta",Q9H244,agonist,
1435,2002,Class A (Rhodopsin),small molecule,treprostinil,pi2r_human,PTGIR,2767,Antihypertensive,Lipid ,4,,-,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"treprostinil inhaled/oral,tyvaso, viveta",P43119,agonist,
1436,2002,Class A (Rhodopsin),small molecule,treprostinil,p2y12_human,P2RY12,2768,Antihypertensive,Nucleotide ,4,,-,approved,P2Y receptors,GPCR;Rhodopsin,established,"treprostinil subcutaneous/intravenous,remodulin",Q9H244,agonist,
1437,2002,Class A (Rhodopsin),small molecule,treprostinil,pi2r_human,PTGIR,2768,Antihypertensive,Lipid ,4,,-,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"treprostinil subcutaneous/intravenous,remodulin",P43119,agonist,
1438,2001,Class A (Rhodopsin),small molecule,triptorelin,gnrhr_human,GNRHR,ASH_Oct2016_430,palliiative treatment of advanced prostate cancer,Peptide ,4,,-,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,triptorelin,P30968,agonist,
1439,2001,Class A (Rhodopsin),peptide,triptorelin,gnrhr_human,GNRHR,2084,Antineoplastic,Peptide ,4,,-,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,"triptorelin pamoate,trelstar, decapeptyl, salvacyl, moapar, pamorelin",P30968,agonist,
1440,2001,Class A (Rhodopsin),peptide,triptorelin,gnrr2_human,GNRHR2,2084,Antineoplastic,Peptide ,4,,-,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,"triptorelin pamoate,trelstar, decapeptyl, salvacyl, moapar, pamorelin",Q96P88,agonist,
1441,2013,Class A (Rhodopsin),small molecule,vilanterol,adrb2_human,ADRB2,MMAmay2016_0619,chronic obstructive pulmonary disease (COPD),Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,umeclidinium bromide (gsk573719) + vilanterol,P07550,agonist,
1442,1981,Class A (Rhodopsin),small molecule,buprenorphine,oprd_human,OPRD1,2109,Anti-depressant; Analgesics; opioid addiction,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,v1003,P41143,agonist,
1443,1981,Class A (Rhodopsin),small molecule,buprenorphine,oprk_human,OPRK1,2109,Anti-depressant; Analgesics; opioid addiction,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,v1003,P41145,agonist,
1444,1981,Class A (Rhodopsin),small molecule,buprenorphine,oprm_human,OPRM1,2109,Anti-depressant; Analgesics; opioid addiction,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,v1003,P35372,agonist,
1445,0,Class A (Rhodopsin),small molecule,vapreotide,ssr2_human,SSTR2,2124,liver cirrhosis-related variceal bleeding,Peptide ,4,,-,approved,Somatostatin receptors,GPCR;Rhodopsin,established,"vapreotide, debio 8609,sanvar, docrised",P30874,agonist,
1446,0,Class A (Rhodopsin),small molecule,vapreotide,ssr5_human,SSTR5,2124,liver cirrhosis-related variceal bleeding,Peptide ,4,,-,approved,Somatostatin receptors,GPCR;Rhodopsin,established,"vapreotide, debio 8609,sanvar, docrised",P35346,agonist,
1447,1986,Class B1 (Secretin),small molecule,calcitonin human,calcr_human,CALCR,2154,Anti-osteoporotic,Peptide ,4,,-,approved,Calcitonin receptors,GPCR;Secretin,established,viaderm-calcitonin,P30988,agonist,
1448,1991,Class A (Rhodopsin),small molecule,histrelin,gnrhr_human,GNRHR,2177,Antineoplastic,Peptide ,4,,-,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,"vp 002, histrelin implant,vantas, supprelin",P30968,agonist,
1449,1991,Class A (Rhodopsin),small molecule,histrelin,gnrr2_human,GNRHR2,2177,Antineoplastic,Peptide ,4,,-,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,"vp 002, histrelin implant,vantas, supprelin",Q96P88,agonist,
1450,1977,Class C (Glutamate) ,small molecule,baclofen,gabr1_human,GABBR1,2222,gastrointestinal reflux disease,Amino acid ,4,,-,approved,GABAB receptors,GPCR;Glutamate,established,xp19986,Q9UBS5,agonist,
1451,1977,Class C (Glutamate) ,small molecule,baclofen,gabr2_human,GABBR2,2222,gastrointestinal reflux disease,Amino acid ,4,,-,approved,GABAB receptors,GPCR;Glutamate,established,xp19986,O75899,agonist,
1452,2012,Class A (Rhodopsin),small molecule,mirabegron,adrb3_human,ADRB3,MMAmay2016_0790,incontinence,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"ym178, mirabegron",P13945,agonist,
1453,1997,Class A (Rhodopsin),small molecule,zolmitriptan,5ht1a_human,HTR1A,2246,Anti-migraine,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"zolmitriptan,zomig",P08908,agonist,
1454,1997,Class A (Rhodopsin),small molecule,zolmitriptan,5ht1b_human,HTR1B,2246,Anti-migraine,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"zolmitriptan,zomig",P28222,agonist,
1455,1997,Class A (Rhodopsin),small molecule,zolmitriptan,5ht1d_human,HTR1D,2246,Anti-migraine,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"zolmitriptan,zomig",P28221,agonist,
1456,1997,Class A (Rhodopsin),small molecule,zolmitriptan,5ht1f_human,HTR1F,2246,Anti-migraine,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"zolmitriptan,zomig",P30939,agonist,
1457,1960,Class B1 (Secretin),peptide,glucagon,glr_human,GCGR,MMAmar2016_0239,Antidiabetic,Peptide ,4,,-,approved,Glucagon receptor family,GPCR;Secretin,established,zp-glucagon,P47871,agonist,
1458,1997,Class A (Rhodopsin),small molecule,zolmitriptan,5ht1a_human,HTR1A,MMAapril2016_0110,Anti-migraine,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,zp-triptan,P08908,agonist,
1459,1997,Class A (Rhodopsin),small molecule,zolmitriptan,5ht1d_human,HTR1D,MMAapril2016_0111,Anti-migraine,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,zp-triptan,P28221,agonist,
1460,1997,Class A (Rhodopsin),small molecule,zolmitriptan,5ht1b_human,HTR1B,MMAapril2016_0112,Anti-migraine,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,zp-triptan,P28222,agonist,
1461,1997,Class A (Rhodopsin),small molecule,zolmitriptan,5ht1f_human,HTR1F,MMAapril2016_0113,Anti-migraine,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,zp-triptan,P30939,agonist,
1462,1987,Class B1 (Secretin),peptide,teriparatide,pth1r_human,PTH1R,2252,Anti-osteoporotic,Peptide ,4,,-,approved,Parathyroid hormone receptors,GPCR;Secretin,established,"zt-034, teriparatide nasal spray",Q03431,agonist,
1463,1987,Class B1 (Secretin),peptide,teriparatide,pth1r_human,PTHR1,2252,Anti-osteoporotic,Peptide ,4,,-,approved,Parathyroid hormone receptors,GPCR;Secretin,established,"zt-034, teriparatide nasal spray",Q03431,agonist,
1464,1943,Class A (Rhodopsin),small molecule,hydrocodone,oprd_human,OPRD1,2254,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"zx002, hydrocodone bitartrate",P41143,agonist,
1465,1943,Class A (Rhodopsin),small molecule,hydrocodone,oprm_human,OPRM1,2254,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"zx002, hydrocodone bitartrate",P35372,agonist,
1466,1984,Class A (Rhodopsin),small molecule,acebutolol,adrb1_human,ADRB1,NRDD001,Antihypertensive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588,antagonist,
1467,1961,Class A (Rhodopsin),small molecule,acetophenazine,drd1_human,DRD1,NRDD006,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21728,antagonist,
1468,1961,Class A (Rhodopsin),small molecule,acetophenazine,drd2_human,DRD2,NRDD006,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,antagonist,
1469,2010,Class A (Rhodopsin),small molecule,alcaftadine,hrh1_human,HRH1,NRDD011,Anti-Allergic,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,antagonist,
1470,2008,Class A (Rhodopsin),small molecule,alvimopan,oprm_human,OPRM1,NRDD021,Opiate Antagonists,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P35372,antagonist,
1471,1982,Class A (Rhodopsin),small molecule,anisotropine methylbromide,acm1_human,CHRM1,NRDD029,Antispasmodics; Anti-ulcer,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,antagonist,
1472,1982,Class A (Rhodopsin),small molecule,anisotropine methylbromide,acm2_human,CHRM2,NRDD029,Antispasmodics; Anti-ulcer,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172,antagonist,
1473,1982,Class A (Rhodopsin),small molecule,anisotropine methylbromide,acm3_human,CHRM3,NRDD029,Antispasmodics; Anti-ulcer,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P20309,antagonist,
1474,1988,Class A (Rhodopsin),small molecule,astemizole,hrh1_human,HRH1,NRDD037,Anti-Allergic,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,antagonist,
1475,1981,Class A (Rhodopsin),small molecule,atenolol,adrb1_human,ADRB1,NRDD038,Anti-Arrhythmia ; Antihypertensive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588,antagonist,
1476,1977,Class A (Rhodopsin),small molecule,azatadine,hrh1_human,HRH1,NRDD041,Anti-Allergic,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,antagonist,
1477,1954,Class A (Rhodopsin),small molecule,benztropine,acm1_human,CHRM1,NRDD049,Antiparkinson,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,antagonist,
1478,1985,Class A (Rhodopsin),small molecule,betaxolol,adrb1_human,ADRB1,NRDD052,Antihypertensive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588,antagonist,
1479,1959,Class A (Rhodopsin),small molecule,biperiden,acm1_human,CHRM1,NRDD057,Antidyskinetics,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,antagonist,
1480,1992,Class A (Rhodopsin),small molecule,bisoprolol,adrb1_human,ADRB1,NRDD058,Antihypertensive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588,antagonist,
1481,1954,Class A (Rhodopsin),small molecule,bromodiphenhydramine,hrh1_human,HRH1,NRDD062,Anti-Allergic,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,antagonist,
1482,1957,Class A (Rhodopsin),small molecule,brompheniramine,hrh1_human,HRH1,NRDD063,Anti-Allergic,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,antagonist,
1483,1982,Class A (Rhodopsin),small molecule,buclizine,acm1_human,CHRM1,NRDD064,Antiemetics,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,antagonist,
1484,1982,Class A (Rhodopsin),small molecule,buclizine,hrh1_human,HRH1,NRDD064,Antiemetics,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,antagonist,
1485,1999,Class A (Rhodopsin),small molecule,caffeine,aa1r_human,ADORA1,NRDD072,Central Nervous System Stimulants,Nucleotide ,4,,-,approved,Adenosine receptors,GPCR;Rhodopsin,established,-,P30542,antagonist,
1486,1999,Class A (Rhodopsin),small molecule,caffeine,aa2ar_human,ADORA2A,NRDD072,Central Nervous System Stimulants,Nucleotide ,4,,-,approved,Adenosine receptors,GPCR;Rhodopsin,established,-,P29274,antagonist,
1487,2003,Class A (Rhodopsin),small molecule,carbinoxamine,acm1_human,CHRM1,NRDD080,Anti-Allergic,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,antagonist,
1488,2003,Class A (Rhodopsin),small molecule,carbinoxamine,hrh1_human,HRH1,NRDD080,Anti-Allergic,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,antagonist,
1489,1982,Class A (Rhodopsin),small molecule,carphenazine,drd1_human,DRD1,NRDD082,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21728,antagonist,
1490,1982,Class A (Rhodopsin),small molecule,carphenazine,drd2_human,DRD2,NRDD082,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,antagonist,
1491,1982,Class A (Rhodopsin),small molecule,carphenazine,drd5_human,DRD5,NRDD082,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21918,antagonist,
1492,1988,Class A (Rhodopsin),small molecule,carteolol,adrb1_human,ADRB1,NRDD084,Antiglaucomic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588,antagonist,
1493,1950,Class A (Rhodopsin),small molecule,chlorpheniramine,hrh1_human,HRH1,NRDD094,Anti-Allergic,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,antagonist,
1494,1967,Class A (Rhodopsin),small molecule,chlorprothixene,drd1_human,DRD1,NRDD096,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21728,antagonist,
1495,1967,Class A (Rhodopsin),small molecule,chlorprothixene,drd2_human,DRD2,NRDD096,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,antagonist,
1496,1967,Class A (Rhodopsin),small molecule,chlorprothixene,drd3_human,DRD3,NRDD096,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P35462,antagonist,
1497,1967,Class A (Rhodopsin),small molecule,chlorprothixene,hrh1_human,HRH1,NRDD096,schizophrenia,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,antagonist,
1498,1967,Class A (Rhodopsin),small molecule,chlorprothixene,5ht2a_human,HTR2A,NRDD096,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28223,antagonist,
1499,1967,Class A (Rhodopsin),small molecule,chlorprothixene,5ht2b_human,HTR2B,NRDD096,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P41595,antagonist,
1500,1967,Class A (Rhodopsin),small molecule,chlorprothixene,5ht2c_human,HTR2C,NRDD096,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28335,antagonist,
1501,1977,Class A (Rhodopsin),small molecule,cimetidine,hrh2_human,HRH2,NRDD104,GI Anti-Ulcer ; antihistamines,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P25021,antagonist,
1502,1977,Class A (Rhodopsin),small molecule,clemastine,hrh1_human,HRH1,NRDD112,Anti-Allergic,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,antagonist,
1503,2013,Class A (Rhodopsin),small molecule,clidinium,acm1_human,CHRM1,NRDD114,GI Anti-Ulcer ; anticholinergic; Antispasmodics,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,antagonist,
1504,1989,Class A (Rhodopsin),small molecule,clozapine,drd1_human,DRD1,NRDD120,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21728,antagonist,
1505,1989,Class A (Rhodopsin),small molecule,clozapine,drd2_human,DRD2,NRDD120,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,antagonist,
1506,1989,Class A (Rhodopsin),small molecule,clozapine,drd4_human,DRD4,NRDD120,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21917,antagonist,
1507,1989,Class A (Rhodopsin),small molecule,clozapine,hrh1_human,HRH1,NRDD120,schizophrenia,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,antagonist,
1508,1989,Class A (Rhodopsin),small molecule,clozapine,hrh4_human,HRH4,NRDD120,schizophrenia,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,-,Q9H3N8,antagonist,
1509,1989,Class A (Rhodopsin),small molecule,clozapine,5ht1a_human,HTR1A,NRDD120,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P08908,antagonist,
1510,1989,Class A (Rhodopsin),small molecule,clozapine,5ht2a_human,HTR2A,NRDD120,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28223,antagonist,
1511,1989,Class A (Rhodopsin),small molecule,clozapine,5ht2c_human,HTR2C,NRDD120,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28335,antagonist,
1512,1982,Class A (Rhodopsin),small molecule,cyclizine,hrh1_human,HRH1,NRDD130,Antiemetics,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,antagonist,
1513,1977,Class A (Rhodopsin),small molecule,cyclobenzaprine,5ht2a_human,HTR2A,NRDD131,Anti-depressant,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28223,antagonist,
1514,1974,Class A (Rhodopsin),small molecule,cyclopentolate,acm1_human,CHRM1,NRDD132,Mydriatics,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,antagonist,
1515,1982,Class A (Rhodopsin),small molecule,cycrimine,acm1_human,CHRM1,NRDD134,Antiparkinson,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,antagonist,
1516,1961,Class A (Rhodopsin),small molecule,cyproheptadine,hrh1_human,HRH1,NRDD135,Anti-Allergic ; Appetite Stimulant,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,antagonist,
1517,1961,Class A (Rhodopsin),small molecule,cyproheptadine,5ht2a_human,HTR2A,NRDD135,Anti-Allergic ; Appetite Stimulant,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28223,antagonist,
1518,1990,Class A (Rhodopsin),small molecule,dapiprazole,ada1a_human,ADRA1A,NRDD141,opthalmological,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,antagonist,
1519,1990,Class A (Rhodopsin),small molecule,dapiprazole,ada1b_human,ADRA1B,NRDD141,opthalmological,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35368,antagonist,
1520,1990,Class A (Rhodopsin),small molecule,dapiprazole,ada1d_human,ADRA1D,NRDD141,opthalmological,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P25100,antagonist,
1521,1963,Class A (Rhodopsin),small molecule,dexbrompheniramine,hrh1_human,HRH1,NRDD153,Anti-Allergic,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,antagonist,
1522,1950,Class A (Rhodopsin),small molecule,dicyclomine,acm1_human,CHRM1,NRDD162,Antispasmodics,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,antagonist,
1523,1972,Class A (Rhodopsin),small molecule,dimenhydrinate,hrh1_human,HRH1,NRDD170,Antiemetics,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,antagonist,
1524,1976,Class A (Rhodopsin),small molecule,diphemanil,acm3_human,CHRM3,NRDD173,Bronchodilator,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P20309,antagonist,
1525,1946,Class A (Rhodopsin),small molecule,diphenhydramine,hrh1_human,HRH1,NRDD174,Anti-Allergic ; Hypnotics and sedatives; Antiemetics; Antipruritics; Antitussives,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,antagonist,
1526,1967,Class A (Rhodopsin),small molecule,diphenidol,acm1_human,CHRM1,NRDD175,Antiemetics,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,antagonist,
1527,1967,Class A (Rhodopsin),small molecule,diphenidol,acm2_human,CHRM2,NRDD175,Antiemetics,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172,antagonist,
1528,1967,Class A (Rhodopsin),small molecule,diphenidol,acm3_human,CHRM3,NRDD175,Antiemetics,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P20309,antagonist,
1529,1982,Class A (Rhodopsin),small molecule,diphenylpyraline,hrh1_human,HRH1,NRDD177,Anti-Allergic,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,antagonist,
1530,1991,Class A (Rhodopsin),small molecule,doxacurium,acm2_human,CHRM2,NRDD185,Muscle Relaxants,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172,antagonist,
1531,1991,Class A (Rhodopsin),small molecule,doxacurium,acm2_human,CHRM2,NRDD186,Muscle Relaxants,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172,antagonist,
1532,1990,Class A (Rhodopsin),small molecule,doxazosin,ada1a_human,ADRA1A,NRDD187,Anticholesteremic ; Antihypertensive ; Vasodilator,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,antagonist,
1533,1990,Class A (Rhodopsin),small molecule,doxazosin,ada1b_human,ADRA1B,NRDD187,Anticholesteremic ; Antihypertensive ; Vasodilator,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35368,antagonist,
1534,1990,Class A (Rhodopsin),small molecule,doxazosin,ada1d_human,ADRA1D,NRDD187,Anticholesteremic ; Antihypertensive ; Vasodilator,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P25100,antagonist,
1535,1948,Class A (Rhodopsin),small molecule,doxylamine,hrh1_human,HRH1,NRDD188,Anti-Allergic ; Antiemetics; Antitussive ; Hypnotics and Sedatives,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,antagonist,
1536,1970,Class A (Rhodopsin),small molecule,droperidol,drd2_human,DRD2,NRDD191,Adjuvants; Anesthesia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,antagonist,
1537,1997,Class A (Rhodopsin),small molecule,emedastine,hrh1_human,HRH1,NRDD199,Anti-Allergic,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,antagonist,
1538,1997,Class A (Rhodopsin),small molecule,eprosartan,agtr1_human,AGTR1,NRDD207,Antihypertensive,Peptide ,4,,-,approved,Angiotensin receptors,GPCR;Rhodopsin,established,-,P30556,antagonist,
1539,1986,Class A (Rhodopsin),small molecule,esmolol,adrb1_human,ADRB1,NRDD212,Anti-Arrhythmia,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588,antagonist,
1540,1982,Class A (Rhodopsin),small molecule,ethopropazine,acm1_human,CHRM1,NRDD217,Antidyskinetics,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,antagonist,
1541,1959,Class A (Rhodopsin),small molecule,fluphenazine,drd1_human,DRD1,NRDD241,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21728,antagonist,
1542,1959,Class A (Rhodopsin),small molecule,fluphenazine,drd2_human,DRD2,NRDD241,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,antagonist,
1543,1967,Class A (Rhodopsin),small molecule,haloperidol,drd2_human,DRD2,NRDD266,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,antagonist,
1544,1956,Class A (Rhodopsin),small molecule,hydroxyzine,hrh1_human,HRH1,NRDD275,Antipruritics; Anxiolytics sedatives and hypnotics,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,antagonist,
1545,1984,Class A (Rhodopsin),small molecule,labetalol,ada1a_human,ADRA1A,NRDD296,Antihypertensive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,antagonist,
1546,1984,Class A (Rhodopsin),small molecule,labetalol,ada1b_human,ADRA1B,NRDD296,Antihypertensive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35368,antagonist,
1547,1984,Class A (Rhodopsin),small molecule,labetalol,adrb1_human,ADRB1,NRDD296,Antihypertensive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588,antagonist,
1548,1984,Class A (Rhodopsin),small molecule,labetalol,adrb2_human,ADRB2,NRDD296,Antihypertensive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P07550,antagonist,
1549,1982,Class A (Rhodopsin),small molecule,levallorphan,oprm_human,OPRM1,NRDD298,Opiate Antagonists,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P35372,antagonist,
1550,1985,Class A (Rhodopsin),small molecule,levobunolol,adrb1_human,ADRB1,NRDD299,Antiglaucomic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588,antagonist,
1551,1985,Class A (Rhodopsin),small molecule,levobunolol,adrb2_human,ADRB2,NRDD299,Antiglaucomic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P07550,antagonist,
1552,1993,Class A (Rhodopsin),small molecule,levocabastine,hrh1_human,HRH1,NRDD301,Anti-Allergic,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,antagonist,
1553,1995,Class A (Rhodopsin),small molecule,losartan,agtr1_human,AGTR1,NRDD310,Antihypertensive,Peptide ,4,,-,approved,Angiotensin receptors,GPCR;Rhodopsin,established,-,P30556,antagonist,
1554,1957,Class A (Rhodopsin),small molecule,meclizine,hrh1_human,HRH1,NRDD315,Antiemetics,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,antagonist,
1555,1956,Class A (Rhodopsin),small molecule,mepenzolate,hcar2_human,HCAR2,NRDD324,Antispasmodics,Alicarboxylic acid ,4,,-,approved,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,-,Q8TDS4,antagonist,
1556,1956,Class A (Rhodopsin),small molecule,mepenzolate,hcar3_human,HCAR3,NRDD324,Antispasmodics,Alicarboxylic acid ,4,,-,approved,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,-,P49019,antagonist,
1557,1970,Class A (Rhodopsin),small molecule,mesoridazine,drd2_human,DRD2,NRDD331,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,antagonist,
1558,1970,Class A (Rhodopsin),small molecule,mesoridazine,5ht2a_human,HTR2A,NRDD331,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28223,antagonist,
1559,1951,Class A (Rhodopsin),small molecule,methantheline,acm1_human,CHRM1,NRDD336,GI Anti-Ulcer ; anticholinergic; Antispasmodics,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,antagonist,
1560,1982,Class A (Rhodopsin),small molecule,methdilazine,hrh1_human,HRH1,NRDD339,Anti-Allergic,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,antagonist,
1561,2008,Class A (Rhodopsin),small molecule,methylnaltrexone,oprm_human,OPRM1,NRDD348,OIC treatment,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P35372,antagonist,
1562,1962,Class A (Rhodopsin),small molecule,methysergide,5ht1a_human,HTR1A,NRDD353,Anti-migraine s; Vasoconstrictor,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P08908,antagonist,
1563,1962,Class A (Rhodopsin),small molecule,methysergide,5ht2a_human,HTR2A,NRDD353,Anti-migraine s; Vasoconstrictor,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28223,antagonist,
1564,1962,Class A (Rhodopsin),small molecule,methysergide,5ht2c_human,HTR2C,NRDD353,Anti-migraine s; Vasoconstrictor,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28335,antagonist,
1565,1962,Class A (Rhodopsin),small molecule,methysergide,5ht7r_human,HTR7,NRDD353,Anti-migraine s; Vasoconstrictor,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P34969,antagonist,
1566,1989,Class A (Rhodopsin),small molecule,metipranolol,adrb1_human,ADRB1,NRDD354,Anti-Arrhythmia ; Antihypertensive ; Anti-glaucoma,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588,antagonist,
1567,1989,Class A (Rhodopsin),small molecule,metipranolol,adrb2_human,ADRB2,NRDD354,Anti-Arrhythmia ; Antihypertensive ; Anti-glaucoma,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P07550,antagonist,
1568,1982,Class A (Rhodopsin),small molecule,metixene,acm1_human,CHRM1,NRDD355,Antiparkinson,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,antagonist,
1569,1982,Class A (Rhodopsin),small molecule,metixene,acm2_human,CHRM2,NRDD355,Antiparkinson,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172,antagonist,
1570,1982,Class A (Rhodopsin),small molecule,metixene,acm3_human,CHRM3,NRDD355,Antiparkinson,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P20309,antagonist,
1571,1982,Class A (Rhodopsin),small molecule,metixene,acm4_human,CHRM4,NRDD355,Antiparkinson,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08173,antagonist,
1572,1982,Class A (Rhodopsin),small molecule,metixene,acm5_human,CHRM5,NRDD355,Antiparkinson,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08912,antagonist,
1573,1978,Class A (Rhodopsin),small molecule,metoprolol,adrb1_human,ADRB1,NRDD359,Anti-Arrhythmia ; Antihypertensive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588,antagonist,
1574,1992,Class A (Rhodopsin),small molecule,mivacurium,acm2_human,CHRM2,NRDD370,Muscle Relaxants,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172,antagonist,
1575,1974,Class A (Rhodopsin),small molecule,molindone,drd2_human,DRD2,NRDD372,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,antagonist,
1576,1979,Class A (Rhodopsin),small molecule,nadolol,adrb1_human,ADRB1,NRDD376,Anti-Arrhythmia ; Antihypertensive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588,antagonist,
1577,1979,Class A (Rhodopsin),small molecule,nadolol,adrb2_human,ADRB2,NRDD376,Anti-Arrhythmia ; Antihypertensive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P07550,antagonist,
1578,1988,Class A (Rhodopsin),small molecule,nizatidine,hrh2_human,HRH2,NRDD394,GI Anti-Ulcer ; antihistamines,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P25021,antagonist,
1579,1957,Class A (Rhodopsin),small molecule,orphenadrine,hrh1_human,HRH1,NRDD400,Antiparkinson s; Muscle Relaxants; Central,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,antagonist,
1580,1983,Class A (Rhodopsin),small molecule,oxprenolol,adrb1_human,ADRB1,NRDD405,Antihypertensive ; Anti-Arrhythmia,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588,antagonist,
1581,1983,Class A (Rhodopsin),small molecule,oxprenolol,adrb2_human,ADRB2,NRDD405,Antihypertensive ; Anti-Arrhythmia,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P07550,antagonist,
1582,1982,Class A (Rhodopsin),small molecule,oxyphencyclimine,acm1_human,CHRM1,NRDD407,GI Anti-Ulcer ; anticholinergic; Antispasmodics,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,antagonist,
1583,1982,Class A (Rhodopsin),small molecule,oxyphencyclimine,acm2_human,CHRM2,NRDD407,GI Anti-Ulcer ; anticholinergic; Antispasmodics,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172,antagonist,
1584,1982,Class A (Rhodopsin),small molecule,oxyphencyclimine,acm3_human,CHRM3,NRDD407,GI Anti-Ulcer ; anticholinergic; Antispasmodics,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P20309,antagonist,
1585,1982,Class A (Rhodopsin),small molecule,oxyphenonium,acm1_human,CHRM1,NRDD408,Mydriatics,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,antagonist,
1586,1987,Class A (Rhodopsin),small molecule,penbutolol,adrb1_human,ADRB1,NRDD417,Antihypertensive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588,antagonist,
1587,1987,Class A (Rhodopsin),small molecule,penbutolol,adrb2_human,ADRB2,NRDD417,Antihypertensive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P07550,antagonist,
1588,1957,Class A (Rhodopsin),small molecule,perphenazine,drd1_human,DRD1,NRDD425,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21728,antagonist,
1589,1957,Class A (Rhodopsin),small molecule,perphenazine,drd2_human,DRD2,NRDD425,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,antagonist,
1590,1994,Class A (Rhodopsin),small molecule,pheniramine,hrh1_human,HRH1,NRDD431,Anti-Allergic,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,antagonist,
1591,1953,Class A (Rhodopsin),small molecule,phenoxybenzamine,ada1a_human,ADRA1A,NRDD434,Anticonvulsants; Hypnotics and Sedatives,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,antagonist,
1592,1952,Class A (Rhodopsin),small molecule,phentolamine,ada2a_human,ADRA2A,NRDD437,Antihypertensive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08913,antagonist,
1593,1984,Class A (Rhodopsin),small molecule,pimozide,drd2_human,DRD2,NRDD443,Antidyskinetics; Antipsychotic,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,antagonist,
1594,1976,Class A (Rhodopsin),small molecule,prazosin,ada1a_human,ADRA1A,NRDD453,Antihypertensive ; antispasmodics,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,antagonist,
1595,1976,Class A (Rhodopsin),small molecule,prazosin,ada1b_human,ADRA1B,NRDD453,Antihypertensive ; antispasmodics,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35368,antagonist,
1596,1976,Class A (Rhodopsin),small molecule,prazosin,ada1d_human,ADRA1D,NRDD453,Antihypertensive ; antispasmodics,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P25100,antagonist,
1597,1955,Class A (Rhodopsin),small molecule,procyclidine,acm1_human,CHRM1,NRDD460,Antidyskinetics; Antiparkinson s,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,antagonist,
1598,1955,Class A (Rhodopsin),small molecule,procyclidine,acm2_human,CHRM2,NRDD460,Antidyskinetics; Antiparkinson s,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172,antagonist,
1599,1955,Class A (Rhodopsin),small molecule,procyclidine,acm4_human,CHRM4,NRDD460,Antidyskinetics; Antiparkinson s,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08173,antagonist,
1600,1956,Class A (Rhodopsin),small molecule,promazine,ada1a_human,ADRA1A,NRDD462,Antiemetics; Antipsychotic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,antagonist,
1601,1956,Class A (Rhodopsin),small molecule,promazine,ada1b_human,ADRA1B,NRDD462,Antiemetics; Antipsychotic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35368,antagonist,
1602,1956,Class A (Rhodopsin),small molecule,promazine,ada1d_human,ADRA1D,NRDD462,Antiemetics; Antipsychotic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P25100,antagonist,
1603,1956,Class A (Rhodopsin),small molecule,promazine,acm1_human,CHRM1,NRDD462,Antiemetics; Antipsychotic,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,antagonist,
1604,1956,Class A (Rhodopsin),small molecule,promazine,acm2_human,CHRM2,NRDD462,Antiemetics; Antipsychotic,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172,antagonist,
1605,1956,Class A (Rhodopsin),small molecule,promazine,acm3_human,CHRM3,NRDD462,Antiemetics; Antipsychotic,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P20309,antagonist,
1606,1956,Class A (Rhodopsin),small molecule,promazine,acm4_human,CHRM4,NRDD462,Antiemetics; Antipsychotic,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08173,antagonist,
1607,1956,Class A (Rhodopsin),small molecule,promazine,acm5_human,CHRM5,NRDD462,Antiemetics; Antipsychotic,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08912,antagonist,
1608,1956,Class A (Rhodopsin),small molecule,promazine,drd1_human,DRD1,NRDD462,Antiemetics; Antipsychotic,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21728,antagonist,
1609,1956,Class A (Rhodopsin),small molecule,promazine,drd2_human,DRD2,NRDD462,Antiemetics; Antipsychotic,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,antagonist,
1610,1956,Class A (Rhodopsin),small molecule,promazine,drd4_human,DRD4,NRDD462,Antiemetics; Antipsychotic,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21917,antagonist,
1611,1956,Class A (Rhodopsin),small molecule,promazine,hrh1_human,HRH1,NRDD462,Antiemetics; Antipsychotic,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,antagonist,
1612,1956,Class A (Rhodopsin),small molecule,promazine,5ht2a_human,HTR2A,NRDD462,Antiemetics; Antipsychotic,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28223,antagonist,
1613,1956,Class A (Rhodopsin),small molecule,promazine,5ht2c_human,HTR2C,NRDD462,Antiemetics; Antipsychotic,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28335,antagonist,
1614,1951,Class A (Rhodopsin),small molecule,promethazine,acm1_human,CHRM1,NRDD463,Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,antagonist,
1615,1951,Class A (Rhodopsin),small molecule,promethazine,acm2_human,CHRM2,NRDD463,Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172,antagonist,
1616,1951,Class A (Rhodopsin),small molecule,promethazine,acm3_human,CHRM3,NRDD463,Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P20309,antagonist,
1617,1951,Class A (Rhodopsin),small molecule,promethazine,acm4_human,CHRM4,NRDD463,Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08173,antagonist,
1618,1951,Class A (Rhodopsin),small molecule,promethazine,acm5_human,CHRM5,NRDD463,Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08912,antagonist,
1619,1951,Class A (Rhodopsin),small molecule,promethazine,hrh1_human,HRH1,NRDD463,Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,antagonist,
1620,1953,Class A (Rhodopsin),small molecule,propantheline,acm1_human,CHRM1,NRDD464,GI Anti-Ulcer ; anticholinergic; Antispasmodics,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,antagonist,
1621,1960,Class A (Rhodopsin),small molecule,propiomazine,ada1a_human,ADRA1A,NRDD467,Hypnotics and Sedatives,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,antagonist,
1622,1960,Class A (Rhodopsin),small molecule,propiomazine,ada1b_human,ADRA1B,NRDD467,Hypnotics and Sedatives,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35368,antagonist,
1623,1960,Class A (Rhodopsin),small molecule,propiomazine,ada1d_human,ADRA1D,NRDD467,Hypnotics and Sedatives,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P25100,antagonist,
1624,1960,Class A (Rhodopsin),small molecule,propiomazine,acm1_human,CHRM1,NRDD467,Hypnotics and Sedatives,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,antagonist,
1625,1960,Class A (Rhodopsin),small molecule,propiomazine,acm2_human,CHRM2,NRDD467,Hypnotics and Sedatives,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172,antagonist,
1626,1960,Class A (Rhodopsin),small molecule,propiomazine,acm3_human,CHRM3,NRDD467,Hypnotics and Sedatives,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P20309,antagonist,
1627,1960,Class A (Rhodopsin),small molecule,propiomazine,acm4_human,CHRM4,NRDD467,Hypnotics and Sedatives,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08173,antagonist,
1628,1960,Class A (Rhodopsin),small molecule,propiomazine,acm5_human,CHRM5,NRDD467,Hypnotics and Sedatives,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08912,antagonist,
1629,1960,Class A (Rhodopsin),small molecule,propiomazine,drd1_human,DRD1,NRDD467,Hypnotics and Sedatives,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21728,antagonist,
1630,1960,Class A (Rhodopsin),small molecule,propiomazine,drd2_human,DRD2,NRDD467,Hypnotics and Sedatives,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,antagonist,
1631,1960,Class A (Rhodopsin),small molecule,propiomazine,drd4_human,DRD4,NRDD467,Hypnotics and Sedatives,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21917,antagonist,
1632,1960,Class A (Rhodopsin),small molecule,propiomazine,hrh1_human,HRH1,NRDD467,Hypnotics and Sedatives,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,antagonist,
1633,1960,Class A (Rhodopsin),small molecule,propiomazine,5ht2a_human,HTR2A,NRDD467,Hypnotics and Sedatives,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28223,antagonist,
1634,1960,Class A (Rhodopsin),small molecule,propiomazine,5ht2c_human,HTR2C,NRDD467,Hypnotics and Sedatives,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28335,antagonist,
1635,1993,Class A (Rhodopsin),small molecule,risperidone,drd2_human,DRD2,NRDD484,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,antagonist,
1636,1993,Class A (Rhodopsin),small molecule,risperidone,5ht2a_human,HTR2A,NRDD484,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28223,antagonist,
1637,1953,Class A (Rhodopsin),small molecule,scopolamine,acm1_human,CHRM1,NRDD491,Adjuvants; Anesthesia; Antispasmodics; Mydriatics,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,antagonist,
1638,1987,Class A (Rhodopsin),small molecule,terazosin,ada1a_human,ADRA1A,NRDD514,Antineoplastic s; Antihypertensive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,antagonist,
1639,1987,Class A (Rhodopsin),small molecule,terazosin,ada1b_human,ADRA1B,NRDD514,Antineoplastic s; Antihypertensive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35368,antagonist,
1640,1987,Class A (Rhodopsin),small molecule,terazosin,ada1d_human,ADRA1D,NRDD514,Antineoplastic s; Antihypertensive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P25100,antagonist,
1641,1961,Class A (Rhodopsin),small molecule,thiethylperazine,acm1_human,CHRM1,NRDD519,Antiemetics,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,antagonist,
1642,1961,Class A (Rhodopsin),small molecule,thiethylperazine,acm2_human,CHRM2,NRDD519,Antiemetics,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172,antagonist,
1643,1961,Class A (Rhodopsin),small molecule,thiethylperazine,acm3_human,CHRM3,NRDD519,Antiemetics,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P20309,antagonist,
1644,1961,Class A (Rhodopsin),small molecule,thiethylperazine,acm4_human,CHRM4,NRDD519,Antiemetics,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08173,antagonist,
1645,1961,Class A (Rhodopsin),small molecule,thiethylperazine,acm5_human,CHRM5,NRDD519,Antiemetics,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08912,antagonist,
1646,1961,Class A (Rhodopsin),small molecule,thiethylperazine,drd1_human,DRD1,NRDD519,Antiemetics,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21728,antagonist,
1647,1961,Class A (Rhodopsin),small molecule,thiethylperazine,drd2_human,DRD2,NRDD519,Antiemetics,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,antagonist,
1648,1961,Class A (Rhodopsin),small molecule,thiethylperazine,drd4_human,DRD4,NRDD519,Antiemetics,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21917,antagonist,
1649,1961,Class A (Rhodopsin),small molecule,thiethylperazine,hrh1_human,HRH1,NRDD519,Antiemetics,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,antagonist,
1650,1961,Class A (Rhodopsin),small molecule,thiethylperazine,5ht2a_human,HTR2A,NRDD519,Antiemetics,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28223,antagonist,
1651,1961,Class A (Rhodopsin),small molecule,thiethylperazine,5ht2c_human,HTR2C,NRDD519,Antiemetics,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28335,antagonist,
1652,1962,Class A (Rhodopsin),small molecule,thioridazine,ada1a_human,ADRA1A,NRDD521,schizophrenia,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,antagonist,
1653,1962,Class A (Rhodopsin),small molecule,thioridazine,drd1_human,DRD1,NRDD521,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21728,antagonist,
1654,1962,Class A (Rhodopsin),small molecule,thioridazine,drd2_human,DRD2,NRDD521,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,antagonist,
1655,1962,Class A (Rhodopsin),small molecule,thioridazine,5ht2a_human,HTR2A,NRDD521,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28223,antagonist,
1656,1991,Class A (Rhodopsin),small molecule,ticlopidine,p2y12_human,P2RY12,NRDD525,Platelet Aggregation Inhibitors,Nucleotide ,4,,-,approved,P2Y receptors,GPCR;Rhodopsin,established,-,Q9H244,antagonist,
1657,1954,Class A (Rhodopsin),small molecule,tridihexethyl,acm1_human,CHRM1,NRDD540,GI Anti-Ulcer ; anticholinergic; Antispasmodics,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,antagonist,
1658,1954,Class A (Rhodopsin),small molecule,tridihexethyl,acm2_human,CHRM2,NRDD540,GI Anti-Ulcer ; anticholinergic; Antispasmodics,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172,antagonist,
1659,1954,Class A (Rhodopsin),small molecule,tridihexethyl,acm3_human,CHRM3,NRDD540,GI Anti-Ulcer ; anticholinergic; Antispasmodics,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P20309,antagonist,
1660,1959,Class A (Rhodopsin),small molecule,trifluoperazine,ada1a_human,ADRA1A,NRDD541,Antiemetics; Antipsychotic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,antagonist,
1661,1959,Class A (Rhodopsin),small molecule,trifluoperazine,drd2_human,DRD2,NRDD541,Antiemetics; Antipsychotic,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,antagonist,
1662,1957,Class A (Rhodopsin),small molecule,triflupromazine,acm1_human,CHRM1,NRDD542,Antiemetics; Antipsychotic,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,antagonist,
1663,1957,Class A (Rhodopsin),small molecule,triflupromazine,acm2_human,CHRM2,NRDD542,Antiemetics; Antipsychotic,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172,antagonist,
1664,1957,Class A (Rhodopsin),small molecule,triflupromazine,drd1_human,DRD1,NRDD542,Antiemetics; Antipsychotic,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21728,antagonist,
1665,1957,Class A (Rhodopsin),small molecule,triflupromazine,drd2_human,DRD2,NRDD542,Antiemetics; Antipsychotic,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,antagonist,
1666,1957,Class A (Rhodopsin),small molecule,triflupromazine,5ht2b_human,HTR2B,NRDD542,Antiemetics; Antipsychotic,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P41595,antagonist,
1667,1949,Class A (Rhodopsin),small molecule,trihexyphenidyl,acm1_human,CHRM1,NRDD543,Antiparkinson,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,antagonist,
1668,1982,Class A (Rhodopsin),small molecule,trimeprazine,hrh1_human,HRH1,NRDD545,Antipruritics,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,antagonist,
1669,1948,Class A (Rhodopsin),small molecule,tripelennamine,hrh1_human,HRH1,NRDD550,Anti-Allergic,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,antagonist,
1670,1982,Class A (Rhodopsin),small molecule,triprolidine,hrh1_human,HRH1,NRDD551,Anti-Allergic,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,antagonist,
1671,1960,Class A (Rhodopsin),small molecule,tropicamide,acm4_human,CHRM4,NRDD552,Diagnostic,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08173,antagonist,
1672,1975,Class A (Rhodopsin),small molecule,oxybutynin,acm1_human,CHRM1,14,incontinence,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,aa-2010,P11229,antagonist,
1673,1975,Class A (Rhodopsin),small molecule,oxybutynin,acm2_human,CHRM2,14,incontinence,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,aa-2010,P08172,antagonist,
1674,1975,Class A (Rhodopsin),small molecule,oxybutynin,acm3_human,CHRM3,14,incontinence,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,aa-2010,P20309,antagonist,
1675,2003,Class A (Rhodopsin),peptide,abarelix,gnrhr_human,GNRHR,19,Antineoplastic,Peptide ,4,,-,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,"abarelix, plenaxis",P30968,antagonist,
1676,2004,Class C (Glutamate) ,small molecule,acamprosate,grm5_human,GRM5,34,Antineoplastic,Amino acid ,4,,-,approved,Metabotropic glutamate receptors,GPCR;Glutamate,established,"acamprosate,campral",P41594,antagonist,
1677,2012,Class A (Rhodopsin),small molecule,aclidinium,acm1_human,CHRM1,44,Bronchodilator,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,aclidinium,P11229,antagonist,
1678,2012,Class A (Rhodopsin),small molecule,aclidinium,acm2_human,CHRM2,44,Bronchodilator,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,aclidinium,P08172,antagonist,
1679,2012,Class A (Rhodopsin),small molecule,aclidinium,acm3_human,CHRM3,44,Bronchodilator,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,aclidinium,P20309,antagonist,
1680,2012,Class A (Rhodopsin),small molecule,aclidinium,acm4_human,CHRM4,44,Bronchodilator,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,aclidinium,P08173,antagonist,
1681,2012,Class A (Rhodopsin),small molecule,aclidinium,acm5_human,CHRM5,44,Bronchodilator,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,aclidinium,P08912,antagonist,
1682,2012,Class A (Rhodopsin),small molecule,aclidinium,acm4_human,CHRM4,44,Bronchodilator,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,aclidinium,P08173,antagonist,
1683,2012,Class A (Rhodopsin),small molecule,aclidinium,acm5_human,CHRM5,44,Bronchodilator,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,aclidinium,P08912,antagonist,
1684,2012,Class A (Rhodopsin),small molecule,aclidinium,acm2_human,CHRM2,MMAmay2016_0039,chronic obstructive pulmonary disease (COPD),Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,aclidinium bromide + formoterol fumarate,P08172,antagonist,
1685,2012,Class A (Rhodopsin),small molecule,aclidinium,acm4_human,CHRM4,MMAmay2016_0040,chronic obstructive pulmonary disease (COPD),Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,aclidinium bromide + formoterol fumarate,P08173,antagonist,
1686,2012,Class A (Rhodopsin),small molecule,aclidinium,acm5_human,CHRM5,MMAmay2016_0041,chronic obstructive pulmonary disease (COPD),Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,aclidinium bromide + formoterol fumarate,P08912,antagonist,
1687,2012,Class A (Rhodopsin),small molecule,aclidinium,acm1_human,CHRM1,MMAmay2016_0042,chronic obstructive pulmonary disease (COPD),Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,aclidinium bromide + formoterol fumarate,P11229,antagonist,
1688,2012,Class A (Rhodopsin),small molecule,aclidinium,acm3_human,CHRM3,MMAmay2016_0043,chronic obstructive pulmonary disease (COPD),Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,aclidinium bromide + formoterol fumarate,P20309,antagonist,
1689,1994,Class A (Rhodopsin),small molecule,acrivastine,hrh1_human,HRH1,ASH_Sep2016_235,Anti-Allergic,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,acrivastine,P35367,antagonist,
1690,1968,Class A (Rhodopsin),small molecule,amantadine hcl,drd2_human,DRD2,MMAmay2016_0242,dyskinesias,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"ads-5102, amantadine hcl extended release",P14416,antagonist,
1691,2004,Class A (Rhodopsin),small molecule,trospium,acm1_human,CHRM1,2350,chronic pulmonary obstructive disorder,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,alks,P11229,antagonist,
1692,1996,Class A (Rhodopsin),small molecule,olanzapine,ada1a_human,ADRA1A,APR13_0013,schizophrenia,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,alks 3831,P35348,antagonist,
1693,1996,Class A (Rhodopsin),small molecule,olanzapine,ada1b_human,ADRA1B,APR13_0013,schizophrenia,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,alks 3831,P35368,antagonist,
1694,1996,Class A (Rhodopsin),small molecule,olanzapine,ada2a_human,ADRA2A,APR13_0013,schizophrenia,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,alks 3831,P08913,antagonist,
1695,1996,Class A (Rhodopsin),small molecule,olanzapine,ada2b_human,ADRA2B,APR13_0013,schizophrenia,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,alks 3831,P18089,antagonist,
1696,1996,Class A (Rhodopsin),small molecule,olanzapine,ada2c_human,ADRA2C,APR13_0013,schizophrenia,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,alks 3831,P18825,antagonist,
1697,1996,Class A (Rhodopsin),small molecule,olanzapine,acm1_human,CHRM1,APR13_0013,schizophrenia,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,alks 3831,P11229,antagonist,
1698,1996,Class A (Rhodopsin),small molecule,olanzapine,acm2_human,CHRM2,APR13_0013,schizophrenia,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,alks 3831,P08172,antagonist,
1699,1996,Class A (Rhodopsin),small molecule,olanzapine,acm3_human,CHRM3,APR13_0013,schizophrenia,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,alks 3831,P20309,antagonist,
1700,1996,Class A (Rhodopsin),small molecule,olanzapine,acm4_human,CHRM4,APR13_0013,schizophrenia,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,alks 3831,P08173,antagonist,
1701,1996,Class A (Rhodopsin),small molecule,olanzapine,acm5_human,CHRM5,APR13_0013,schizophrenia,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,alks 3831,P08912,antagonist,
1702,1996,Class A (Rhodopsin),small molecule,olanzapine,drd1_human,DRD1,APR13_0013,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,alks 3831,P21728,antagonist,
1703,1996,Class A (Rhodopsin),small molecule,olanzapine,drd2_human,DRD2,APR13_0013,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,alks 3831,P14416,antagonist,
1704,1996,Class A (Rhodopsin),small molecule,olanzapine,drd3_human,DRD3,APR13_0013,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,alks 3831,P35462,antagonist,
1705,1996,Class A (Rhodopsin),small molecule,olanzapine,drd4_human,DRD4,APR13_0013,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,alks 3831,P21917,antagonist,
1706,1996,Class A (Rhodopsin),small molecule,olanzapine,drd5_human,DRD5,APR13_0013,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,alks 3831,P21918,antagonist,
1707,1996,Class A (Rhodopsin),small molecule,olanzapine,hrh1_human,HRH1,APR13_0013,schizophrenia,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,alks 3831,P35367,antagonist,
1708,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht1a_human,HTR1A,APR13_0013,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,alks 3831,P08908,antagonist,
1709,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht1b_human,HTR1B,APR13_0013,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,alks 3831,P28222,antagonist,
1710,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht1d_human,HTR1D,APR13_0013,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,alks 3831,P28221,antagonist,
1711,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht1e_human,HTR1E,APR13_0013,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,alks 3831,P28566,antagonist,
1712,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht2a_human,HTR2A,APR13_0013,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,alks 3831,P28223,antagonist,
1713,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht2c_human,HTR2C,APR13_0013,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,alks 3831,P28335,antagonist,
1714,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht6r_human,HTR6,APR13_0013,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,alks 3831,P50406,antagonist,
1715,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht7r_human,HTR7,APR13_0013,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,alks 3831,P34969,antagonist,
1716,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht1e_human,HTR1E,APR13_0013,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,alks 3831,P28566,antagonist,
1717,1996,Class A (Rhodopsin),small molecule,olanzapine,acm2_human,CHRM2,MMAmay2016_0185,Antipsychotic ; antipsychotic-related metabolic weight gain,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P08172,antagonist,
1718,1996,Class A (Rhodopsin),small molecule,olanzapine,acm4_human,CHRM4,MMAmay2016_0186,schizophrenia,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P08173,antagonist,
1719,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht1a_human,HTR1A,MMAmay2016_0187,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P08908,antagonist,
1720,1996,Class A (Rhodopsin),small molecule,olanzapine,acm5_human,CHRM5,MMAmay2016_0188,schizophrenia,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P08912,antagonist,
1721,1996,Class A (Rhodopsin),small molecule,olanzapine,ada2a_human,ADRA2A,MMAmay2016_0189,schizophrenia,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P08913,antagonist,
1722,1996,Class A (Rhodopsin),small molecule,olanzapine,acm1_human,CHRM1,MMAmay2016_0190,schizophrenia,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P11229,antagonist,
1723,1996,Class A (Rhodopsin),small molecule,olanzapine,drd2_human,DRD2,MMAmay2016_0191,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P14416,antagonist,
1724,1996,Class A (Rhodopsin),small molecule,olanzapine,ada2b_human,ADRA2B,MMAmay2016_0192,schizophrenia,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P18089,antagonist,
1725,1996,Class A (Rhodopsin),small molecule,olanzapine,ada2c_human,ADRA2C,MMAmay2016_0193,schizophrenia,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P18825,antagonist,
1726,1996,Class A (Rhodopsin),small molecule,olanzapine,acm3_human,CHRM3,MMAmay2016_0194,schizophrenia,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P20309,antagonist,
1727,1996,Class A (Rhodopsin),small molecule,olanzapine,drd1_human,DRD1,MMAmay2016_0195,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P21728,antagonist,
1728,1996,Class A (Rhodopsin),small molecule,olanzapine,drd4_human,DRD4,MMAmay2016_0196,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P21917,antagonist,
1729,1996,Class A (Rhodopsin),small molecule,olanzapine,drd5_human,DRD5,MMAmay2016_0197,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P21918,antagonist,
1730,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht1d_human,HTR1D,MMAmay2016_0198,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P28221,antagonist,
1731,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht1b_human,HTR1B,MMAmay2016_0199,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P28222,antagonist,
1732,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht2a_human,HTR2A,MMAmay2016_0200,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P28223,antagonist,
1733,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht2c_human,HTR2C,MMAmay2016_0201,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P28335,antagonist,
1734,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht1e_human,HTR1E,MMAmay2016_0202,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P28566,antagonist,
1735,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht7r_human,HTR7,MMAmay2016_0203,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P34969,antagonist,
1736,1996,Class A (Rhodopsin),small molecule,olanzapine,ada1a_human,ADRA1A,MMAmay2016_0204,schizophrenia,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P35348,antagonist,
1737,1996,Class A (Rhodopsin),small molecule,olanzapine,hrh1_human,HRH1,MMAmay2016_0205,schizophrenia,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P35367,antagonist,
1738,1996,Class A (Rhodopsin),small molecule,olanzapine,ada1b_human,ADRA1B,MMAmay2016_0206,schizophrenia,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P35368,antagonist,
1739,1996,Class A (Rhodopsin),small molecule,olanzapine,drd3_human,DRD3,MMAmay2016_0207,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P35462,antagonist,
1740,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht6r_human,HTR6,MMAmay2016_0209,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P50406,antagonist,
1741,1998,Class A (Rhodopsin),small molecule,naltrexone,oprd_human,OPRD1,122,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"alo-01, morphine sulfate and naltrexone hydrochloride,embeda, kadian nt",P41143,antagonist,
1742,1998,Class A (Rhodopsin),small molecule,naltrexone,oprk_human,OPRK1,122,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"alo-01, morphine sulfate and naltrexone hydrochloride,embeda, kadian nt",P41145,antagonist,
1743,1998,Class A (Rhodopsin),small molecule,naltrexone,oprm_human,OPRM1,122,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"alo-01, morphine sulfate and naltrexone hydrochloride,embeda, kadian nt",P35372,antagonist,
1744,1994,Class A (Rhodopsin),small molecule,antazoline,hrh1_human,HRH1,ASH_Sep2016_232,atrial fibrillation,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,antazoline,P35367,antagonist,
1745,1975,Class A (Rhodopsin),small molecule,oxybutynin,acm1_human,CHRM1,190,overactive bladder,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"ap-1034,anturol",P11229,antagonist,
1746,1975,Class A (Rhodopsin),small molecule,oxybutynin,acm2_human,CHRM2,190,overactive bladder,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"ap-1034,anturol",P08172,antagonist,
1747,1975,Class A (Rhodopsin),small molecule,oxybutynin,acm3_human,CHRM3,190,overactive bladder,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"ap-1034,anturol",P20309,antagonist,
1748,2003,Class A (Rhodopsin),small molecule,aprepitant,nk1r_human,TACR1,209,Antiemetics,Peptide ,4,,-,approved,Tachykinin receptors,GPCR;Rhodopsin,established,"aprepitant, mk-869, fosaprepitant dimeglumine, mk-0517,emend",P25103,antagonist,
1749,2009,Class A (Rhodopsin),small molecule,asenapine,ada1a_human,ADRA1A,250,schizophrenia,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,asenapine,P35348,antagonist,
1750,2009,Class A (Rhodopsin),small molecule,asenapine,ada2a_human,ADRA2A,250,schizophrenia,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,asenapine,P08913,antagonist,
1751,2009,Class A (Rhodopsin),small molecule,asenapine,ada2b_human,ADRA2B,250,schizophrenia,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,asenapine,P18089,antagonist,
1752,2009,Class A (Rhodopsin),small molecule,asenapine,ada2c_human,ADRA2C,250,schizophrenia,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,asenapine,P18825,antagonist,
1753,2009,Class A (Rhodopsin),small molecule,asenapine,drd1_human,DRD1,250,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,asenapine,P21728,antagonist,
1754,2009,Class A (Rhodopsin),small molecule,asenapine,drd2_human,DRD2,250,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,asenapine,P14416,antagonist,
1755,2009,Class A (Rhodopsin),small molecule,asenapine,drd3_human,DRD3,250,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,asenapine,P35462,antagonist,
1756,2009,Class A (Rhodopsin),small molecule,asenapine,drd4_human,DRD4,250,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,asenapine,P21917,antagonist,
1757,2009,Class A (Rhodopsin),small molecule,asenapine,hrh1_human,HRH1,250,schizophrenia,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,asenapine,P35367,antagonist,
1758,2009,Class A (Rhodopsin),small molecule,asenapine,hrh2_human,HRH2,250,schizophrenia,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,asenapine,P25021,antagonist,
1759,2009,Class A (Rhodopsin),small molecule,asenapine,5ht1a_human,HTR1A,250,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,asenapine,P08908,antagonist,
1760,2009,Class A (Rhodopsin),small molecule,asenapine,5ht1b_human,HTR1B,250,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,asenapine,P28222,antagonist,
1761,2009,Class A (Rhodopsin),small molecule,asenapine,5ht2a_human,HTR2A,250,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,asenapine,P28223,antagonist,
1762,2009,Class A (Rhodopsin),small molecule,asenapine,5ht2b_human,HTR2B,250,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,asenapine,P41595,antagonist,
1763,2009,Class A (Rhodopsin),small molecule,asenapine,5ht2c_human,HTR2C,250,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,asenapine,P28335,antagonist,
1764,2009,Class A (Rhodopsin),small molecule,asenapine,5ht5a_human,HTR5A,250,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,asenapine,P47898,antagonist,
1765,2009,Class A (Rhodopsin),small molecule,asenapine,5ht6r_human,HTR6,250,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,asenapine,P50406,antagonist,
1766,2009,Class A (Rhodopsin),small molecule,asenapine,5ht7r_human,HTR7,250,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,asenapine,P34969,antagonist,
1767,2009,Class A (Rhodopsin),small molecule,asenapine,5ht5a_human,HTR5A,250,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,asenapine,P47898,antagonist,
1768,1952,Class A (Rhodopsin),small molecule,phentolamine,ada1a_human,ADRA1A,288,sexual dysfunction,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"aviptadil,invicorp",P35348,antagonist,
1769,1952,Class A (Rhodopsin),small molecule,phentolamine,ada2a_human,ADRA2A,288,sexual dysfunction,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"aviptadil,invicorp",P08913,antagonist,
1770,1956,Class A (Rhodopsin),small molecule,prochlorperazine,drd2_human,DRD2,301,Anti-migraine,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"az-001, staccato prochlorperazine",P14416,antagonist,
1771,1975,Class A (Rhodopsin),small molecule,loxapine,drd2_human,DRD2,304,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,az-004,P14416,antagonist,
1772,1975,Class A (Rhodopsin),small molecule,loxapine,5ht2a_human,HTR2A,304,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,az-004,P28223,antagonist,
1773,1996,Class A (Rhodopsin),small molecule,azelastine,hrh1_human,HRH1,313,Anti-Allergic,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,azelastine,P35367,antagonist,
1774,1996,Class A (Rhodopsin),small molecule,azelastine,hrh1_human,HRH1,314,Anti-Allergic,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,"azelastine hydrochloride nasal spray,astepro",P35367,antagonist,
1775,2011,Class A (Rhodopsin),small molecule,azilsartan medoxomil,agtr1_human,AGTR1,ASH_Sep2016_248,Antihypertensive,Peptide ,4,,-,approved,Angiotensin receptors,GPCR;Rhodopsin,established,azilsartan medoxomil,P30556,antagonist,
1776,2011,Class A (Rhodopsin),small molecule,azilsartan medoxomil,agtr1_human,AGTR1,315,Antihypertensive,Peptide ,4,,-,approved,Angiotensin receptors,GPCR;Rhodopsin,established,"azilsartan medoxomil, tak-491",P30556,antagonist,
1777,2009,Class A (Rhodopsin),small molecule,bepotastine,hrh1_human,HRH1,336,Anti-Allergic,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,"bepotastine besilate,bepreve, talion",P35367,antagonist,
1778,1981,Class A (Rhodopsin),small molecule,timolol,adrb1_human,ADRB1,386,Antiglaucomic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"brimonidine tartrate/timolol maleate,combigan",P08588,antagonist,
1779,1981,Class A (Rhodopsin),small molecule,timolol,adrb2_human,ADRB2,386,Antiglaucomic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"brimonidine tartrate/timolol maleate,combigan",P07550,antagonist,
1780,1956,Class A (Rhodopsin),small molecule,prochlorperazine,drd2_human,DRD2,395,Antiemetics,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"buccal prochlorperazine maleate,emezine",P14416,antagonist,
1781,1971,Class A (Rhodopsin),small molecule,naloxone,oprd_human,OPRD1,405,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"buprenorphine + naloxone capsule,nanobup",P41143,antagonist,
1782,1971,Class A (Rhodopsin),small molecule,naloxone,oprk_human,OPRK1,405,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"buprenorphine + naloxone capsule,nanobup",P41145,antagonist,
1783,1971,Class A (Rhodopsin),small molecule,naloxone,oprm_human,OPRM1,405,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"buprenorphine + naloxone capsule,nanobup",P35372,antagonist,
1784,1971,Class A (Rhodopsin),small molecule,naloxone,oprd_human,OPRD1,406,Analgesics; opioid addiction,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"buprenorphine + naloxone,suboxone",P41143,antagonist,
1785,1971,Class A (Rhodopsin),small molecule,naloxone,oprk_human,OPRK1,406,Analgesics; opioid addiction,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"buprenorphine + naloxone,suboxone",P41145,antagonist,
1786,1971,Class A (Rhodopsin),small molecule,naloxone,oprm_human,OPRM1,406,Analgesics; opioid addiction,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"buprenorphine + naloxone,suboxone",P35372,antagonist,
1787,1999,Class A (Rhodopsin),small molecule,caffeine,aa2br_human,ADORA2B,ASH_Sep2016_317,coronary artery disease,Nucleotide ,4,,-,approved,Adenosine receptors,GPCR;Rhodopsin,established,caffeine,P29275,antagonist,
1788,1999,Class A (Rhodopsin),small molecule,caffeine,aa3r_human,ADORA3,ASH_Sep2016_319,atherosclerosis,Nucleotide ,4,,-,approved,Adenosine receptors,GPCR;Rhodopsin,established,caffeine,P0DMS8,antagonist,
1789,1998,Class A (Rhodopsin),small molecule,candesartan cilexetil,agtr1_human,AGTR1,ASH_Sep2016_249,Antihypertensive,Peptide ,4,,-,approved,Angiotensin receptors,GPCR;Rhodopsin,established,candesartan cilexetil,P30556,antagonist,
1790,1998,Class A (Rhodopsin),small molecule,candesartan cilexetil,agtr1_human,AGTR1,427,Antihypertensive,Peptide ,4,,-,approved,Angiotensin receptors,GPCR;Rhodopsin,established,"candesartan cilexetil,atacand",P30556,antagonist,
1791,2015,Class A (Rhodopsin),small molecule,cangrelor,p2y12_human,P2RY12,428,antithrombotic,Nucleotide ,4,,-,approved,P2Y receptors,GPCR;Rhodopsin,established,"cangrelor, ar69931",Q9H244,antagonist,
1792,2015,Class A (Rhodopsin),small molecule,cangrelor,p2y12_human,P2RY12,428,antithrombotic,Nucleotide ,4,,-,approved,P2Y receptors,GPCR;Rhodopsin,established,"cangrelor, ar69931",Q9H244,antagonist,
1793,1988,Class A (Rhodopsin),small molecule,carteolol,adrb2_human,ADRB2,ASH_Sep2016_176,cardiovascular disease,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,carteolol,P07550,antagonist,
1794,1988,Class A (Rhodopsin),small molecule,carteolol,adrb3_human,ADRB3,ASH_Sep2016_194,Antiglaucomic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,carteolol,P13945,antagonist,
1795,1995,Class A (Rhodopsin),small molecule,carvedilol,ada1b_human,ADRA1B,ASH_Sep2016_91,Antihypertensive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,carvedilol,P35368,antagonist,
1796,1995,Class A (Rhodopsin),small molecule,carvedilol,ada1d_human,ADRA1D,ASH_Sep2016_107,Antihypertensive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,carvedilol,P25100,antagonist,
1797,1995,Class A (Rhodopsin),small molecule,carvedilol,adrb3_human,ADRB3,ASH_Sep2016_192,Antihypertensive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,carvedilol,P13945,antagonist,
1798,1995,Class A (Rhodopsin),small molecule,carvedilol,ada1a_human,ADRA1A,434,congestive heart failure,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"carvedilol, coreg",P35348,antagonist,
1799,1995,Class A (Rhodopsin),small molecule,carvedilol,adrb1_human,ADRB1,435,cardiovascular disease,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"carvedilol,coreg",P08588,antagonist,
1800,1995,Class A (Rhodopsin),small molecule,carvedilol,adrb2_human,ADRB2,435,cardiovascular disease,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"carvedilol,coreg",P07550,antagonist,
1801,1996,Class A (Rhodopsin),small molecule,azelastine,hrh1_human,HRH1,456,Anti-Allergic,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,"cdx-313, budesonide + azelastine nasal spray",P35367,antagonist,
1802,2007,Class A (Rhodopsin),small molecule,cetirizine,hrh1_human,HRH1,471,Anti-Allergic,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,"cetirizine hcl,zyrtec",P35367,antagonist,
1803,2000,Class A (Rhodopsin),peptide,cetrorelix,gnrhr_human,GNRHR,472,Antineoplastic,Peptide ,4,,-,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,"cetrorelix,cetrotide",P30968,antagonist,
1804,1997,Class A (Rhodopsin),small molecule,clopidogrel,p2y12_human,P2RY12,478,antiplatelet,Nucleotide ,4,,-,approved,P2Y receptors,GPCR;Rhodopsin,established,cgt-2168,Q9H244,antagonist,
1805,1957,Class A (Rhodopsin),small molecule,chlorpromazine,5ht2a_human,HTR2A,ASH_Sep2016_16,psychosis,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,chlorpromazine,P28223,antagonist,
1806,1957,Class A (Rhodopsin),small molecule,chlorpromazine,drd2_human,DRD2,ASH_Sep2016_59,psychosis,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,chlorpromazine,P14416,antagonist,
1807,1957,Class A (Rhodopsin),small molecule,chlorpromazine,drd3_human,DRD3,ASH_Sep2016_204,psychosis,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,chlorpromazine,P35462,antagonist,
1808,1957,Class A (Rhodopsin),small molecule,chlorpromazine,drd4_human,DRD4,ASH_Sep2016_220,psychosis,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,chlorpromazine,P21917,antagonist,
1809,1951,Class A (Rhodopsin),small molecule,promethazine,acm2_human,CHRM2,MMAapril2016_0100,Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic ; Treat migraines and cluster headaches,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"cl-h1t, promethazine + sumatriptan",P08172,antagonist,
1810,1951,Class A (Rhodopsin),small molecule,promethazine,acm4_human,CHRM4,MMAapril2016_0101,Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic ; Treat migraines and cluster headaches,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"cl-h1t, promethazine + sumatriptan",P08173,antagonist,
1811,1951,Class A (Rhodopsin),small molecule,promethazine,acm5_human,CHRM5,MMAapril2016_0102,Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic ; Treat migraines and cluster headaches,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"cl-h1t, promethazine + sumatriptan",P08912,antagonist,
1812,1951,Class A (Rhodopsin),small molecule,promethazine,acm1_human,CHRM1,MMAapril2016_0103,Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic ; Treat migraines and cluster headaches,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"cl-h1t, promethazine + sumatriptan",P11229,antagonist,
1813,1951,Class A (Rhodopsin),small molecule,promethazine,acm3_human,CHRM3,MMAapril2016_0104,Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic ; Treat migraines and cluster headaches,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"cl-h1t, promethazine + sumatriptan",P20309,antagonist,
1814,1951,Class A (Rhodopsin),small molecule,promethazine,hrh1_human,HRH1,MMAapril2016_0105,Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic ; Treat migraines and cluster headaches,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,"cl-h1t, promethazine + sumatriptan",P35367,antagonist,
1815,2005,Class A (Rhodopsin),small molecule,conivaptan,v1ar_human,AVPR1A,519,hyponatremia,Peptide ,4,,-,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,"conivaptan, ym-087,vaprisol",P37288,antagonist,
1816,2005,Class A (Rhodopsin),small molecule,conivaptan,v2r_human,AVPR2,519,hyponatremia,Peptide ,4,,-,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,"conivaptan, ym-087,vaprisol",P30518,antagonist,
1817,2005,Class A (Rhodopsin),small molecule,conivaptan,v2r_human,AVPR2,519,hyponatremia,Peptide ,4,,-,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,"conivaptan, ym-087,vaprisol",P30518,antagonist,
1818,1998,Class A (Rhodopsin),small molecule,naltrexone,oprd_human,OPRD1,522,Appetite suppressant,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,contrave,P41143,antagonist,
1819,1998,Class A (Rhodopsin),small molecule,naltrexone,oprk_human,OPRK1,522,Appetite suppressant,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,contrave,P41145,antagonist,
1820,1998,Class A (Rhodopsin),small molecule,naltrexone,oprm_human,OPRM1,522,Appetite suppressant,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,contrave,P35372,antagonist,
1821,2002,Class A (Rhodopsin),small molecule,olmesartan medoxomil,agtr1_human,AGTR1,557,Antihypertensive,Peptide ,4,,-,approved,Angiotensin receptors,GPCR;Rhodopsin,established,"cs-8663, amlodipine + olmesartan,azor, sevikar",P30556,antagonist,
1822,1977,Class A (Rhodopsin),small molecule,cyclobenzaprine,5ht2c_human,HTR2C,ASH_Sep2016_32,spasticity,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,cyclobenzaprine,P28335,antagonist,
1823,1977,Class A (Rhodopsin),small molecule,cyclobenzaprine,5ht2a_human,HTR2A,2489,Muscle Relaxants,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"cyclobenzaprine hydrochloride extended-release capsules,amrix",P28223,antagonist,
1824,1974,Class A (Rhodopsin),small molecule,cyclopentolate,acm3_human,CHRM3,ASH_Sep2016_73,cycloplegia,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,cyclopentolate,P20309,antagonist,
1825,2010,Class A (Rhodopsin),small molecule,lurasidone,5ht1a_human,HTR1A,MMAapril2016_0233,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"cyclurad, d-cycloserine + lurasidone",P08908,antagonist,
1826,2010,Class A (Rhodopsin),small molecule,lurasidone,drd2_human,DRD2,MMAapril2016_0234,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"cyclurad, d-cycloserine + lurasidone",P14416,antagonist,
1827,2010,Class A (Rhodopsin),small molecule,lurasidone,ada2c_human,ADRA2C,MMAapril2016_0235,schizophrenia,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"cyclurad, d-cycloserine + lurasidone",P18825,antagonist,
1828,2010,Class A (Rhodopsin),small molecule,lurasidone,5ht2a_human,HTR2A,MMAapril2016_0236,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"cyclurad, d-cycloserine + lurasidone",P28223,antagonist,
1829,2010,Class A (Rhodopsin),small molecule,lurasidone,5ht7r_human,HTR7,MMAapril2016_0237,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"cyclurad, d-cycloserine + lurasidone",P34969,antagonist,
1830,2004,Class A (Rhodopsin),small molecule,darifenacin,acm2_human,CHRM2,ASH_Sep2016_54,overactive bladder,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,darifenacin,P08172,antagonist,
1831,2004,Class A (Rhodopsin),small molecule,darifenacin,acm3_human,CHRM3,598,overactive bladder,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"darifenacin,enablex, emselex",P20309,antagonist,
1832,2008,Class A (Rhodopsin),small molecule,degarelix,gnrhr_human,GNRHR,610,Antineoplastic,Peptide ,4,,-,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,degarelix,P30968,antagonist,
1833,2008,Class A (Rhodopsin),small molecule,degarelix,gnrr2_human,GNRHR2,610,Antineoplastic,Peptide ,4,,-,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,degarelix,Q96P88,antagonist,
1834,2001,Class A (Rhodopsin),small molecule,desloratadine,hrh1_human,HRH1,620,Anti-Allergic,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,"desloratadine , clarinex",P35367,antagonist,
1835,1981,Class A (Rhodopsin),small molecule,dexchlorpheniramine,hrh1_human,HRH1,ASH_Sep2016_238,sunburn,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,dexchlorpheniramine,P35367,antagonist,
1836,1948,Class A (Rhodopsin),small molecule,doxylamine,hrh1_human,HRH1,MMAmay2016_0669,Antihistamine; for nausea and vomiting of pregnancy,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,diclectin + diclegis; doxylamine succinate + pyridoxine hydrochloride dr tablets,P35367,antagonist,
1837,1950,Class A (Rhodopsin),small molecule,dicyclomine,acm3_human,CHRM3,ASH_Sep2016_77,digestive system disease,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,dicyclomine,P20309,antagonist,
1838,1982,Class A (Rhodopsin),small molecule,diphemanil,acm1_human,CHRM1,ASH_Sep2016_48,digestive system disease,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,diphemanil,P11229,antagonist,
1839,1975,Class A (Rhodopsin),small molecule,oxybutynin,acm1_human,CHRM1,2351,incontinence,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,dr-3001,P11229,antagonist,
1840,1975,Class A (Rhodopsin),small molecule,oxybutynin,acm2_human,CHRM2,2351,incontinence,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,dr-3001,P08172,antagonist,
1841,1975,Class A (Rhodopsin),small molecule,oxybutynin,acm3_human,CHRM3,2351,incontinence,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,dr-3001,P20309,antagonist,
1842,1970,Class A (Rhodopsin),small molecule,droperidol,5ht2a_human,HTR2A,ASH_Sep2016_17,psychosis,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,droperidol,P28223,antagonist,
1843,1970,Class A (Rhodopsin),small molecule,droperidol,drd3_human,DRD3,ASH_Sep2016_201,vomiting,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,droperidol,P35462,antagonist,
1844,1970,Class A (Rhodopsin),small molecule,droperidol,drd4_human,DRD4,ASH_Sep2016_224,psychosis,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,droperidol,P21917,antagonist,
1845,1997,Class A (Rhodopsin),small molecule,tamsulosin,ada1a_human,ADRA1A,675,benign prostatic hyperplasia,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"dutasteride + tamsulosin,jalyn",P35348,antagonist,
1846,1996,Class A (Rhodopsin),small molecule,azelastine,hrh1_human,HRH1,MMAmay2016_0366,Anti-Allergic,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,"dymista, azelastine hydrochloride + fluticasone propionate",P35367,antagonist,
1847,1996,Class A (Rhodopsin),small molecule,azelastine,hrh1_human,HRH1,679,Anti-Allergic,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,"dymista, azelastine hydrochloride + fluticasone propionate, mp29-02",P35367,antagonist,
1848,2011,Class A (Rhodopsin),small molecule,azilsartan medoxomil,agtr1_human,AGTR1,MMAmay2016_0371,Antihypertensive,Peptide ,4,,-,approved,Angiotensin receptors,GPCR;Rhodopsin,established,"edarbyclor, azilsartan medoxomil + chlorthalidone",P30556,antagonist,
1849,1998,Class A (Rhodopsin),small molecule,naltrexone,oprm_human,OPRM1,MMAfeb2016_0084,addiction,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,eli-200,P35372,antagonist,
1850,1998,Class A (Rhodopsin),small molecule,naltrexone,oprd_human,OPRD1,MMAfeb2016_0085,addiction,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,eli-200,P41143,antagonist,
1851,1998,Class A (Rhodopsin),small molecule,naltrexone,oprk_human,OPRK1,MMAfeb2016_0086,addiction,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,eli-200,P41145,antagonist,
1852,2008,Class A (Rhodopsin),small molecule,alvimopan,oprm_human,MOR,2549,opioid-induced bowel dysfunction,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,entereg,P35372,antagonist,
1853,1961,Class A (Rhodopsin),small molecule,glycopyrrolate,acm1_human,CHRM1,MMAmay2016_0378,chronic obstructive pulmonary disease (COPD),Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,ep-101,P11229,antagonist,
1854,2003,Class A (Rhodopsin),small molecule,epinastine,hrh1_human,HRH1,719,Anti-Allergic,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,epinastine,P35367,antagonist,
1855,2003,Class A (Rhodopsin),small molecule,epinastine,hrh2_human,HRH2,719,Anti-Allergic,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,epinastine,P25021,antagonist,
1856,1986,Class A (Rhodopsin),small molecule,esmolol,adrb2_human,ADRB2,ASH_Sep2016_184,tinnitus,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,esmolol,P07550,antagonist,
1857,1979,Class A (Rhodopsin),small molecule,metoclopramide,acm1_human,CHRM1,758,diabetic gastroparesis,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,evk-001,P11229,antagonist,
1858,1979,Class A (Rhodopsin),small molecule,metoclopramide,drd2_human,DRD2,758,diabetic gastroparesis,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,evk-001,P14416,antagonist,
1859,1979,Class A (Rhodopsin),small molecule,metoclopramide,acm1_human,CHRM1,MMAmay2016_0859,Antiemetics,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"evk-001, metoclopramide nasal spray",P11229,antagonist,
1860,1979,Class A (Rhodopsin),small molecule,metoclopramide,drd2_human,DRD2,MMAmay2016_0860,Antiemetics,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"evk-001, metoclopramide nasal spray",P14416,antagonist,
1861,2007,Class A (Rhodopsin),small molecule,fesoterodine,acm2_human,CHRM2,ASH_Sep2016_53,prostate adenocarcinoma,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,fesoterodine,P08172,antagonist,
1862,2007,Class A (Rhodopsin),small molecule,fesoterodine,acm3_human,CHRM3,788,overactive bladder syndrome,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"fesoterodine fumarate, spm 907,toviaz",P20309,antagonist,
1863,1996,Class A (Rhodopsin),small molecule,fexofenadine,hrh1_human,HRH1,789,Anti-Allergic,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,fexofenadine + ps/,P35367,antagonist,
1864,2013,Class A (Rhodopsin),small molecule,umeclidinium,acm2_human,CHRM2,MMAmar2016_0193,chronic obstructive pulmonary disease (COPD),Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"ff/umec/vi, fluticasone furoate + umeclidinium + vilanterol",P08172,antagonist,
1865,2013,Class A (Rhodopsin),small molecule,umeclidinium,acm3_human,CHRM3,MMAmar2016_0194,chronic obstructive pulmonary disease (COPD),Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"ff/umec/vi, fluticasone furoate + umeclidinium + vilanterol",P20309,antagonist,
1866,2008,Class A (Rhodopsin),small molecule,icatibant,bkrb2_human,BDKRB2,797,hereditary angioedema,Peptide ,4,,-,approved,Bradykinin receptors,GPCR;Rhodopsin,established,"firazyr, icatibant, je049",P30411,antagonist,
1867,2008,Class A (Rhodopsin),small molecule,icatibant,bkrb1_human,BDKRB1,ASH_Oct2016_434,hereditary angioedema,Peptide ,4,,-,approved,Bradykinin receptors,GPCR;Rhodopsin,established,"firazyr, icatibant, je049",P46663,antagonist,
1868,1972,Class A (Rhodopsin),small molecule,fluphenazine decanoate,drd2_human,DRD2,ASH_Sep2016_61,psychosis,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,fluphenazine decanoate,P14416,antagonist,
1869,1967,Class A (Rhodopsin),small molecule,fluphenazine enanthate,drd2_human,DRD2,ASH_Sep2016_66,psychosis,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,fluphenazine enanthate,P14416,antagonist,
1870,1999,Class A (Rhodopsin),small molecule,ganirelix acetate,gnrhr_human,GNRHR,ASH_Oct2016_412,for prevention of premature ovulation in fertility treatment,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,ganirelix,P30968,antagonist,
1871,1999,Class A (Rhodopsin),protein,ganirelix acetate,gnrhr_human,GNRHR,ASH_Sep2016_256,Fertility,Peptide ,4,,-,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,ganirelix acetate,P30968,antagonist,
1872,1961,Class A (Rhodopsin),small molecule,glycopyrrolate,acm3_human,CHRM3,ASH_Sep2016_71,obstructive lung disease,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,glycopyrrolate,P20309,antagonist,
1873,1961,Class A (Rhodopsin),small molecule,glycopyrrolate,acm1_human,CHRM1,864,Antineoplastic,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"glycopyrrolate, fhpc-02,cuvposa",P11229,antagonist,
1874,1967,Class A (Rhodopsin),small molecule,haloperidol,5ht2a_human,HTR2A,ASH_Sep2016_13,conduct disorder,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,haloperidol,P28223,antagonist,
1875,1967,Class A (Rhodopsin),small molecule,haloperidol,drd3_human,DRD3,ASH_Sep2016_202,gastroparesis,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,haloperidol,P35462,antagonist,
1876,1967,Class A (Rhodopsin),small molecule,haloperidol,drd4_human,DRD4,ASH_Sep2016_214,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,haloperidol,P21917,antagonist,
1877,1986,Class A (Rhodopsin),small molecule,haloperidol decanoate,5ht2a_human,HTR2A,ASH_Sep2016_21,psychosis,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,haloperidol decanoate,P28223,antagonist,
1878,1986,Class A (Rhodopsin),small molecule,haloperidol decanoate,drd2_human,DRD2,ASH_Sep2016_65,psychosis,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,haloperidol decanoate,P14416,antagonist,
1879,1986,Class A (Rhodopsin),small molecule,haloperidol decanoate,drd3_human,DRD3,ASH_Sep2016_212,psychosis,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,haloperidol decanoate,P35462,antagonist,
1880,1986,Class A (Rhodopsin),small molecule,haloperidol decanoate,drd4_human,DRD4,ASH_Sep2016_227,psychosis,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,haloperidol decanoate,P21917,antagonist,
1881,1982,Class A (Rhodopsin),small molecule,hexocyclium,acm1_human,CHRM1,ASH_Sep2016_52,digestive system disease,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,hexocyclium,P11229,antagonist,
1882,1982,Class A (Rhodopsin),small molecule,hexocyclium,acm3_human,CHRM3,ASH_Sep2016_78,digestive system disease,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,hexocyclium,P20309,antagonist,
1883,1986,Class A (Rhodopsin),small molecule,famotidine,hrh2_human,HRH2,929,acid reducer,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,"hzt-501,  ibuprofen + famotidine,duexa",P25021,antagonist,
1884,1986,Class A (Rhodopsin),small molecule,famotidine,hrh2_human,HRH2,929,gastric ulcer and gastroesophageal reflux,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,"hzt-501,  ibuprofen + famotidine,duexa",P25021,antagonist,
1885,2009,Class A (Rhodopsin),small molecule,iloperidone,ada1a_human,ADRA1A,951,Antipsychotic ; atypical,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"iloperidone,fanapt, fiapta, zomaril",P35348,antagonist,
1886,2009,Class A (Rhodopsin),small molecule,iloperidone,ada2c_human,ADRA2C,951,Antipsychotic ; atypical,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"iloperidone,fanapt, fiapta, zomaril",P18825,antagonist,
1887,2009,Class A (Rhodopsin),small molecule,iloperidone,drd1_human,DRD1,951,Antipsychotic ; atypical,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"iloperidone,fanapt, fiapta, zomaril",P21728,antagonist,
1888,2009,Class A (Rhodopsin),small molecule,iloperidone,drd2_human,DRD2,951,Antipsychotic ; atypical,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"iloperidone,fanapt, fiapta, zomaril",P14416,antagonist,
1889,2009,Class A (Rhodopsin),small molecule,iloperidone,drd3_human,DRD3,951,Antipsychotic ; atypical,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"iloperidone,fanapt, fiapta, zomaril",P35462,antagonist,
1890,2009,Class A (Rhodopsin),small molecule,iloperidone,hrh1_human,HRH1,951,Antipsychotic ; atypical,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,"iloperidone,fanapt, fiapta, zomaril",P35367,antagonist,
1891,2009,Class A (Rhodopsin),small molecule,iloperidone,5ht1a_human,HTR1A,951,Antipsychotic ; atypical,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"iloperidone,fanapt, fiapta, zomaril",P08908,antagonist,
1892,2009,Class A (Rhodopsin),small molecule,iloperidone,5ht2a_human,HTR2A,951,Antipsychotic ; atypical,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"iloperidone,fanapt, fiapta, zomaril",P28223,antagonist,
1893,2009,Class A (Rhodopsin),small molecule,iloperidone,5ht6r_human,HTR6,951,Antipsychotic ; atypical,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"iloperidone,fanapt, fiapta, zomaril",P50406,antagonist,
1894,2009,Class A (Rhodopsin),small molecule,iloperidone,5ht7r_human,HTR7,951,Antipsychotic ; atypical,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"iloperidone,fanapt, fiapta, zomaril",P34969,antagonist,
1895,2013,Class A (Rhodopsin),small molecule,umeclidinium,acm2_human,CHRM2,MMAmay2016_0713,chronic obstructive pulmonary disease (COPD),Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"incruse ellipta,  umeclidinium bromide",P08172,antagonist,
1896,2013,Class A (Rhodopsin),small molecule,umeclidinium,acm3_human,CHRM3,MMAmay2016_0714,chronic obstructive pulmonary disease (COPD),Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"incruse ellipta,  umeclidinium bromide",P20309,antagonist,
1897,1973,Class A (Rhodopsin),small molecule,atropine,acm1_human,CHRM1,977,nerve  antidote,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,inhaled atropine,P11229,antagonist,
1898,1973,Class A (Rhodopsin),small molecule,atropine,acm2_human,CHRM2,977,nerve  antidote,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,inhaled atropine,P08172,antagonist,
1899,1973,Class A (Rhodopsin),small molecule,atropine,acm3_human,CHRM3,977,nerve  antidote,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,inhaled atropine,P20309,antagonist,
1900,1973,Class A (Rhodopsin),small molecule,atropine,acm4_human,CHRM4,977,nerve  antidote,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,inhaled atropine,P08173,antagonist,
1901,1973,Class A (Rhodopsin),small molecule,atropine,acm5_human,CHRM5,977,nerve  antidote,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,inhaled atropine,P08912,antagonist,
1902,1995,Class A (Rhodopsin),small molecule,losartan,agtr1_human,AGTR1,MMAmay2016_0431,Antihypertensive ; for Diabetic neuropathy,Peptide ,4,,-,approved,Angiotensin receptors,GPCR;Rhodopsin,established,inv-144,P30556,antagonist,
1903,1986,Class A (Rhodopsin),small molecule,ipratropium,acm3_human,CHRM3,ASH_Sep2016_72,chronic obstructive pulmonary disease (COPD),Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,ipratropium,P20309,antagonist,
1904,1986,Class A (Rhodopsin),small molecule,ipratropium,acm1_human,CHRM1,1021,chronic obstructive pulmonary disease (COPD),Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"ipratropium bromide + albuterol sulfate,duoneb",P11229,antagonist,
1905,1986,Class A (Rhodopsin),small molecule,ipratropium,acm2_human,CHRM2,1021,chronic obstructive pulmonary disease (COPD),Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"ipratropium bromide + albuterol sulfate,duoneb",P08172,antagonist,
1906,1997,Class A (Rhodopsin),small molecule,irbesartan,agtr1_human,AGTR1,1023,Antihypertensive,Peptide ,4,,-,approved,Angiotensin receptors,GPCR;Rhodopsin,established,"irbesartan,avapro, irbetan",P30556,antagonist,
1907,1957,Class A (Rhodopsin),small molecule,isopropamide,acm1_human,CHRM1,ASH_Sep2016_51,digestive system disease,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,isopropamide,P11229,antagonist,
1908,1957,Class A (Rhodopsin),small molecule,isopropamide,acm3_human,CHRM3,ASH_Sep2016_74,digestive system disease,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,isopropamide,P20309,antagonist,
1909,1975,Class A (Rhodopsin),small molecule,oxybutynin,acm1_human,CHRM1,MMAapril2016_0197,overactive bladder,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,jnp-010,P11229,antagonist,
1910,1975,Class A (Rhodopsin),small molecule,oxybutynin,acm2_human,CHRM2,MMAapril2016_0198,overactive bladder,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,jnp-010,P08172,antagonist,
1911,1975,Class A (Rhodopsin),small molecule,oxybutynin,acm3_human,CHRM3,MMAapril2016_0199,overactive bladder,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,jnp-010,P20309,antagonist,
1912,1999,Class A (Rhodopsin),small molecule,ketotifen,hrh1_human,HRH1,1074,Anti-Allergic,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,"ketotifen fumarate,zaditen, zaditor",P35367,antagonist,
1913,1984,Class A (Rhodopsin),small molecule,labetalol,ada1d_human,ADRA1D,ASH_Sep2016_116,cardiovascular disease,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,labetalol,P25100,antagonist,
1914,1984,Class A (Rhodopsin),small molecule,labetalol,ada2a_human,ADRA2A,ASH_Sep2016_128,cardiovascular disease,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,labetalol,P08913,antagonist,
1915,1984,Class A (Rhodopsin),small molecule,labetalol,ada2b_human,ADRA2B,ASH_Sep2016_138,cardiovascular disease,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,labetalol,P18089,antagonist,
1916,1984,Class A (Rhodopsin),small molecule,labetalol,ada2c_human,ADRA2C,ASH_Sep2016_156,cardiovascular disease,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,labetalol,P18825,antagonist,
1917,1984,Class A (Rhodopsin),small molecule,labetalol,adrb3_human,ADRB3,ASH_Sep2016_195,cardiovascular disease,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,labetalol,P13945,antagonist,
1918,1981,Class A (Rhodopsin),small molecule,timolol,adrb1_human,ADRB1,1095,Antiglaucomic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"latanoprost + timolol,xalcom, xalacom",P08588,antagonist,
1919,1981,Class A (Rhodopsin),small molecule,timolol,adrb2_human,ADRB2,1095,Antiglaucomic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"latanoprost + timolol,xalcom, xalacom",P07550,antagonist,
1920,2007,Class A (Rhodopsin),small molecule,ambrisentan,ednra_human,EDNRA,1111,Antihypertensive,Peptide ,4,,-,approved,Endothelin receptors,GPCR;Rhodopsin,established,letairis,P25101,antagonist,
1921,2007,Class A (Rhodopsin),small molecule,ambrisentan,ednrb_human,EDNRB,1111,Antihypertensive,Peptide ,4,,-,approved,Endothelin receptors,GPCR;Rhodopsin,established,letairis,P24530,antagonist,
1922,1982,Class A (Rhodopsin),small molecule,levomepromazine,drd2_human,DRD2,ASH_Sep2016_63,psychosis,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,levomepromazine,P14416,antagonist,Approved prior to 1982 and then discontinued
1923,1982,Class A (Rhodopsin),small molecule,levomepromazine,drd3_human,DRD3,ASH_Sep2016_213,psychosis,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,levomepromazine,P35462,antagonist,Approved prior to 1982 and then discontinued
1924,1982,Class A (Rhodopsin),small molecule,levomepromazine,drd4_human,DRD4,ASH_Sep2016_225,psychosis,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,levomepromazine,P21917,antagonist,Approved prior to 1982 and then discontinued
1925,1993,Class A (Rhodopsin),small molecule,loratadine,hrh1_human,HRH1,1163,Anti-Asthmatic,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,"loratadine + montelukast sodium,claritin + singulair",P35367,antagonist,
1926,1998,Class A (Rhodopsin),small molecule,montelukast,cltr1_human,CYSLTR1,1163,Anti-Asthmatic,Lipid ,4,,-,approved,Leukotriene receptors,GPCR;Rhodopsin,established,"loratadine + montelukast sodium,claritin + singulair",Q9Y271,antagonist,
1927,1975,Class A (Rhodopsin),small molecule,loxapine,5ht2c_human,HTR2C,ASH_Sep2016_31,psychosis,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,loxapine,P28335,antagonist,
1928,1975,Class A (Rhodopsin),small molecule,loxapine,drd3_human,DRD3,ASH_Sep2016_207,psychosis,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,loxapine,P35462,antagonist,
1929,1975,Class A (Rhodopsin),small molecule,loxapine,drd4_human,DRD4,ASH_Sep2016_223,psychosis,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,loxapine,P21917,antagonist,
1930,2010,Class A (Rhodopsin),small molecule,lurasidone,ada2c_human,ADRA2C,1184,schizophrenia,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"lurasidone, sm-13496,latuda",P18825,antagonist,
1931,2010,Class A (Rhodopsin),small molecule,lurasidone,drd2_human,DRD2,1184,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"lurasidone, sm-13496,latuda",P14416,antagonist,
1932,2010,Class A (Rhodopsin),small molecule,lurasidone,5ht1a_human,HTR1A,1184,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"lurasidone, sm-13496,latuda",P08908,antagonist,
1933,2010,Class A (Rhodopsin),small molecule,lurasidone,5ht2a_human,HTR2A,1184,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"lurasidone, sm-13496,latuda",P28223,antagonist,
1934,2010,Class A (Rhodopsin),small molecule,lurasidone,5ht7r_human,HTR7,1184,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"lurasidone, sm-13496,latuda",P34969,antagonist,
1935,2013,Class A (Rhodopsin),small molecule,macitentan,ednra_human,EDNRA,1209,cardiovascular disease,Peptide ,4,,-,approved,Endothelin receptors,GPCR;Rhodopsin,established,"macitentan , act-064992",P25101,antagonist,
1936,2013,Class A (Rhodopsin),small molecule,macitentan,ednrb_human,EDNRB,1210,cardiovascular disease,Peptide ,4,,-,approved,Endothelin receptors,GPCR;Rhodopsin,established,"macitentan, act-064992",P24530,antagonist,
1937,1956,Class A (Rhodopsin),small molecule,mepenzolate,acm1_human,CHRM1,ASH_Sep2016_47,digestive system disease,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,mepenzolate,P11229,antagonist,
1938,1956,Class A (Rhodopsin),small molecule,mepenzolate,acm3_human,CHRM3,ASH_Sep2016_79,digestive system disease,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,mepenzolate,P20309,antagonist,
1939,1951,Class A (Rhodopsin),small molecule,methantheline,hrh2_human,HRH2,ASH_Sep2016_240,digestive system disease,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,methantheline,P25021,antagonist,
1940,1982,Class A (Rhodopsin),small molecule,methixene,5ht2c_human,HTR2C,ASH_Sep2016_35,Antiparkinson,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,methixene,P28335,antagonist,
1941,1982,Class A (Rhodopsin),small molecule,methixene,acm1_human,CHRM1,ASH_Sep2016_49,Antiparkinson,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,methixene,P11229,antagonist,
1942,1953,Class A (Rhodopsin),small molecule,methscopolamine,acm1_human,CHRM1,ASH_Sep2016_50,cycloplegia,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,methscopolamine,P11229,antagonist,
1943,1953,Class A (Rhodopsin),small molecule,methscopolamine,acm3_human,CHRM3,ASH_Sep2016_75,digestive system disease,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,methscopolamine,P20309,antagonist,
1944,2008,Class A (Rhodopsin),small molecule,methylnaltrexone,oprm_human,OPRM1,1262,opioid-induced constipation,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,methylnaltrexone,P35372,antagonist,
1945,1962,Class A (Rhodopsin),small molecule,methysergide,5ht2b_human,HTR2B,ASH_Sep2016_25,Anti-migraine,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,methysergide,P41595,antagonist,
1946,1979,Class A (Rhodopsin),small molecule,metoclopramide,5ht4r_human,HTR4,ASH_Sep2016_40,pregnancy,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,metoclopramide,Q13639,antagonist,
1947,1979,Class A (Rhodopsin),small molecule,metoclopramide,acm1_human,CHRM1,1268,motilitant; gastroesophageal reflux disease,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"metoclopramide hcl,metzoliv odt",P11229,antagonist,
1948,1979,Class A (Rhodopsin),small molecule,metoclopramide,drd2_human,DRD2,1268,motilitant; gastroesophageal reflux disease,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"metoclopramide hcl,metzoliv odt",P14416,antagonist,
1949,1979,Class A (Rhodopsin),small molecule,metoclopramide,acm1_human,CHRM1,1269,Antiemetics,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"metoclopramide,emitasol, pramidin",P11229,antagonist,
1950,1979,Class A (Rhodopsin),small molecule,metoclopramide,drd2_human,DRD2,1269,Antiemetics,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"metoclopramide,emitasol, pramidin",P14416,antagonist,
1951,1978,Class A (Rhodopsin),small molecule,metoprolol,adrb1_human,ADRB1,1270,Antihypertensive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"metoprolol succinate,toprol-xl",P08588,antagonist,
1952,1996,Class A (Rhodopsin),small molecule,mirtazapine,5ht2c_human,HTR2C,ASH_Sep2016_29,unipolar depression,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,mirtazapine,P28335,antagonist,
1953,1996,Class A (Rhodopsin),small molecule,mirtazapine,ada2b_human,ADRA2B,ASH_Sep2016_131,unipolar depression,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,mirtazapine,P18089,antagonist,
1954,1996,Class A (Rhodopsin),small molecule,mirtazapine,ada2c_human,ADRA2C,ASH_Sep2016_148,unipolar depression,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,mirtazapine,P18825,antagonist,
1955,1996,Class A (Rhodopsin),small molecule,mirtazapine,ada2a_human,ADRA2A,1295,Anti-depressant,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"mirtazapine,remeron, remeron soltab, reflex",P08913,antagonist,
1956,1996,Class A (Rhodopsin),small molecule,mirtazapine,5ht2a_human,HTR2A,1295,Anti-depressant,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"mirtazapine,remeron, remeron soltab, reflex",P28223,antagonist,
1957,2014,Class A (Rhodopsin),small molecule,suvorexant,ox1r_human,HCRTR1,1304,Hypnotics and Sedatives,Peptide ,4,,-,approved,Orexin receptors,GPCR;Rhodopsin,established,mk-4305,O43613,antagonist,
1958,2014,Class A (Rhodopsin),small molecule,suvorexant,ox2r_human,HCRTR2,1304,Hypnotics and Sedatives,Peptide ,4,,-,approved,Orexin receptors,GPCR;Rhodopsin,established,mk-4305,O43614,antagonist,
1959,1974,Class A (Rhodopsin),small molecule,molindone,5ht2a_human,HTR2A,ASH_Sep2016_12,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,molindone,P28223,antagonist,
1960,1998,Class A (Rhodopsin),small molecule,montelukast,cltr1_human,CYSLTR1,1327,Anti-Asthmatic,Lipid ,4,,-,approved,Leukotriene receptors,GPCR;Rhodopsin,established,"montelukast sodium,singulair",Q9Y271,antagonist,
1961,1998,Class A (Rhodopsin),small molecule,naltrexone,oprd_human,OPRD1,1336,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,morviva,P41143,antagonist,
1962,1998,Class A (Rhodopsin),small molecule,naltrexone,oprk_human,OPRK1,1336,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,morviva,P41145,antagonist,
1963,1998,Class A (Rhodopsin),small molecule,naltrexone,oprm_human,OPRM1,1336,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,morviva,P35372,antagonist,
1964,1979,Class A (Rhodopsin),small molecule,metoclopramide,acm1_human,CHRM1,1355,Anti-migraine,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,mt 100,P11229,antagonist,
1965,1979,Class A (Rhodopsin),small molecule,metoclopramide,drd2_human,DRD2,1355,Anti-migraine,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,mt 100,P14416,antagonist,
1966,2013,Class A (Rhodopsin),small molecule,nalmefene,oprd_human,OPRD1,1375,smoking-cessation ; addiction,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"nalmefene, cph-101",P41143,antagonist,
1967,2013,Class A (Rhodopsin),small molecule,nalmefene,oprk_human,OPRK1,1375,smoking-cessation ; addiction,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"nalmefene, cph-101",P41145,antagonist,
1968,2013,Class A (Rhodopsin),small molecule,nalmefene,oprm_human,OPRM1,1375,smoking-cessation ; addiction,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"nalmefene, cph-101",P35372,antagonist,
1969,1971,Class A (Rhodopsin),small molecule,naloxone,oprm_human,OPRM1,MMAmay2016_0645,Analgesics; overdose/drug toxicity,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"naloxone nasal spray, indivior",P35372,antagonist,
1970,1971,Class A (Rhodopsin),small molecule,naloxone,oprd_human,OPRD1,MMAmay2016_0646,Analgesics; overdose/drug toxicity,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"naloxone nasal spray, indivior",P41143,antagonist,
1971,1971,Class A (Rhodopsin),small molecule,naloxone,oprk_human,OPRK1,MMAmay2016_0647,Analgesics; overdose/drug toxicity,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"naloxone nasal spray, indivior",P41145,antagonist,
1972,1971,Class A (Rhodopsin),small molecule,naloxone,oprm_human,OPRM1,MMAmar2016_0088,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"naloxone nasal spray, lightlake therapeutics for binge eating disorder",P35372,antagonist,
1973,1971,Class A (Rhodopsin),small molecule,naloxone,oprd_human,OPRD1,MMAmar2016_0089,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"naloxone nasal spray, lightlake therapeutics for binge eating disorder",P41143,antagonist,
1974,1971,Class A (Rhodopsin),small molecule,naloxone,oprk_human,OPRK1,MMAmar2016_0090,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"naloxone nasal spray, lightlake therapeutics for binge eating disorder",P41145,antagonist,
1975,2007,Class A (Rhodopsin),small molecule,nebivolol,adrb2_human,ADRB2,ASH_Sep2016_172,Antihypertensive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,nebivolol,P07550,antagonist,
1976,2007,Class A (Rhodopsin),small molecule,nebivolol,adrb1_human,ADRB1,1394,Antihypertensive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"nebivolol ,bystolic",P08588,antagonist,
1977,2014,Class A (Rhodopsin),small molecule,netupitant,nk1r_human,TACR1,MMAmay2016_0499,Antiemetics,Peptide ,4,,-,approved,Tachykinin receptors,GPCR;Rhodopsin,established,netupitant + palonosetron,P25103,antagonist,
1978,2014,Class A (Rhodopsin),small molecule,naloxegol,oprm_human,OPRM1,1419,opioid-induced constipation,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,nktr-118,P35372,antagonist,
1979,1961,Class A (Rhodopsin),small molecule,glycopyrronium,acm1_human,CHRM1,1457,chronic obstructive pulmonary disease (COPD),Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"nva237, inhaled glycopyrronium bromide",P11229,antagonist,
1980,1996,Class A (Rhodopsin),small molecule,olanzapine,ada1a_human,ADRA1A,1475,schizophrenia,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P35348,antagonist,
1981,1996,Class A (Rhodopsin),small molecule,olanzapine,ada1b_human,ADRA1B,1475,schizophrenia,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P35368,antagonist,
1982,1996,Class A (Rhodopsin),small molecule,olanzapine,ada2a_human,ADRA2A,1475,schizophrenia,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P08913,antagonist,
1983,1996,Class A (Rhodopsin),small molecule,olanzapine,ada2b_human,ADRA2B,1475,schizophrenia,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P18089,antagonist,
1984,1996,Class A (Rhodopsin),small molecule,olanzapine,ada2c_human,ADRA2C,1475,schizophrenia,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P18825,antagonist,
1985,1996,Class A (Rhodopsin),small molecule,olanzapine,acm1_human,CHRM1,1475,schizophrenia,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P11229,antagonist,
1986,1996,Class A (Rhodopsin),small molecule,olanzapine,acm2_human,CHRM2,1475,schizophrenia,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P08172,antagonist,
1987,1996,Class A (Rhodopsin),small molecule,olanzapine,acm3_human,CHRM3,1475,schizophrenia,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P20309,antagonist,
1988,1996,Class A (Rhodopsin),small molecule,olanzapine,acm4_human,CHRM4,1475,schizophrenia,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P08173,antagonist,
1989,1996,Class A (Rhodopsin),small molecule,olanzapine,acm5_human,CHRM5,1475,schizophrenia,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P08912,antagonist,
1990,1996,Class A (Rhodopsin),small molecule,olanzapine,drd1_human,DRD1,1475,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P21728,antagonist,
1991,1996,Class A (Rhodopsin),small molecule,olanzapine,drd2_human,DRD2,1475,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P14416,antagonist,
1992,1996,Class A (Rhodopsin),small molecule,olanzapine,drd3_human,DRD3,1475,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P35462,antagonist,
1993,1996,Class A (Rhodopsin),small molecule,olanzapine,drd4_human,DRD4,1475,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P21917,antagonist,
1994,1996,Class A (Rhodopsin),small molecule,olanzapine,drd5_human,DRD5,1475,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P21918,antagonist,
1995,1996,Class A (Rhodopsin),small molecule,olanzapine,hrh1_human,HRH1,1475,schizophrenia,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P35367,antagonist,
1996,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht1a_human,HTR1A,1475,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P08908,antagonist,
1997,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht1b_human,HTR1B,1475,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P28222,antagonist,
1998,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht1d_human,HTR1D,1475,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P28221,antagonist,
1999,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht1e_human,HTR1E,1475,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P28566,antagonist,
2000,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht2a_human,HTR2A,1475,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P28223,antagonist,
2001,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht2c_human,HTR2C,1475,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P28335,antagonist,
2002,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht6r_human,HTR6,1475,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P50406,antagonist,
2003,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht7r_human,HTR7,1475,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P34969,antagonist,
2004,1996,Class A (Rhodopsin),small molecule,olanzapine,ada1a_human,ADRA1A,1476,Anti-depressant,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P35348,antagonist,
2005,1996,Class A (Rhodopsin),small molecule,olanzapine,ada1b_human,ADRA1B,1476,Anti-depressant,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P35368,antagonist,
2006,1996,Class A (Rhodopsin),small molecule,olanzapine,ada2a_human,ADRA2A,1476,Anti-depressant,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P08913,antagonist,
2007,1996,Class A (Rhodopsin),small molecule,olanzapine,ada2b_human,ADRA2B,1476,Anti-depressant,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P18089,antagonist,
2008,1996,Class A (Rhodopsin),small molecule,olanzapine,ada2c_human,ADRA2C,1476,Anti-depressant,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P18825,antagonist,
2009,1996,Class A (Rhodopsin),small molecule,olanzapine,acm1_human,CHRM1,1476,Anti-depressant,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P11229,antagonist,
2010,1996,Class A (Rhodopsin),small molecule,olanzapine,acm2_human,CHRM2,1476,Anti-depressant,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P08172,antagonist,
2011,1996,Class A (Rhodopsin),small molecule,olanzapine,acm3_human,CHRM3,1476,Anti-depressant,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P20309,antagonist,
2012,1996,Class A (Rhodopsin),small molecule,olanzapine,acm4_human,CHRM4,1476,Anti-depressant,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P08173,antagonist,
2013,1996,Class A (Rhodopsin),small molecule,olanzapine,acm5_human,CHRM5,1476,Anti-depressant,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P08912,antagonist,
2014,1996,Class A (Rhodopsin),small molecule,olanzapine,drd1_human,DRD1,1476,Anti-depressant,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P21728,antagonist,
2015,1996,Class A (Rhodopsin),small molecule,olanzapine,drd2_human,DRD2,1476,Anti-depressant,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P14416,antagonist,
2016,1996,Class A (Rhodopsin),small molecule,olanzapine,drd3_human,DRD3,1476,Anti-depressant,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P35462,antagonist,
2017,1996,Class A (Rhodopsin),small molecule,olanzapine,drd4_human,DRD4,1476,Anti-depressant,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P21917,antagonist,
2018,1996,Class A (Rhodopsin),small molecule,olanzapine,drd5_human,DRD5,1476,Anti-depressant,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P21918,antagonist,
2019,1996,Class A (Rhodopsin),small molecule,olanzapine,hrh1_human,HRH1,1476,Anti-depressant,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P35367,antagonist,
2020,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht1a_human,HTR1A,1476,Anti-depressant,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P08908,antagonist,
2021,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht1b_human,HTR1B,1476,Anti-depressant,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P28222,antagonist,
2022,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht1d_human,HTR1D,1476,Anti-depressant,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P28221,antagonist,
2023,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht1e_human,HTR1E,1476,Anti-depressant,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P28566,antagonist,
2024,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht2a_human,HTR2A,1476,Anti-depressant,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P28223,antagonist,
2025,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht2c_human,HTR2C,1476,Anti-depressant,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P28335,antagonist,
2026,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht6r_human,HTR6,1476,Anti-depressant,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P50406,antagonist,
2027,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht7r_human,HTR7,1476,Anti-depressant,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P34969,antagonist,
2028,2002,Class A (Rhodopsin),small molecule,olmesartan medoxomil,agtr1_human,AGTR1,ASH_Sep2016_250,cardiovascular disease,Peptide ,4,,-,approved,Angiotensin receptors,GPCR;Rhodopsin,established,olmesartan medoxomil,P30556,antagonist,
2029,2002,Class A (Rhodopsin),small molecule,olmesartan medoxomil,agtr1_human,AGTR1,1478,Antihypertensive,Peptide ,4,,-,approved,Angiotensin receptors,GPCR;Rhodopsin,established,"olmesartan medoxomil (cs-866),benicar",P30556,antagonist,
2030,2002,Class A (Rhodopsin),small molecule,olmesartan medoxomil,agtr1_human,AGTR1,1479,Antiglaucomic,Peptide ,4,,-,approved,Angiotensin receptors,GPCR;Rhodopsin,established,"olmesartan, de-092",P30556,antagonist,
2031,1996,Class A (Rhodopsin),small molecule,olopatadine,hrh1_human,HRH1,1480,Anti-Allergic,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,"olopatadine hydrochloride,patanase",P35367,antagonist,
2032,1996,Class A (Rhodopsin),small molecule,olanzapine,ada1a_human,ADRA1A,1515,schizophrenia,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P35348,antagonist,
2033,1996,Class A (Rhodopsin),small molecule,olanzapine,ada1b_human,ADRA1B,1515,schizophrenia,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P35368,antagonist,
2034,1996,Class A (Rhodopsin),small molecule,olanzapine,ada2a_human,ADRA2A,1515,schizophrenia,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P08913,antagonist,
2035,1996,Class A (Rhodopsin),small molecule,olanzapine,ada2b_human,ADRA2B,1515,schizophrenia,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P18089,antagonist,
2036,1996,Class A (Rhodopsin),small molecule,olanzapine,ada2c_human,ADRA2C,1515,schizophrenia,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P18825,antagonist,
2037,1996,Class A (Rhodopsin),small molecule,olanzapine,acm1_human,CHRM1,1515,schizophrenia,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P11229,antagonist,
2038,1996,Class A (Rhodopsin),small molecule,olanzapine,acm2_human,CHRM2,1515,schizophrenia,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P08172,antagonist,
2039,1996,Class A (Rhodopsin),small molecule,olanzapine,acm3_human,CHRM3,1515,schizophrenia,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P20309,antagonist,
2040,1996,Class A (Rhodopsin),small molecule,olanzapine,acm4_human,CHRM4,1515,schizophrenia,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P08173,antagonist,
2041,1996,Class A (Rhodopsin),small molecule,olanzapine,acm5_human,CHRM5,1515,schizophrenia,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P08912,antagonist,
2042,1996,Class A (Rhodopsin),small molecule,olanzapine,drd1_human,DRD1,1515,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P21728,antagonist,
2043,1996,Class A (Rhodopsin),small molecule,olanzapine,drd2_human,DRD2,1515,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P14416,antagonist,
2044,1996,Class A (Rhodopsin),small molecule,olanzapine,drd3_human,DRD3,1515,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P35462,antagonist,
2045,1996,Class A (Rhodopsin),small molecule,olanzapine,drd4_human,DRD4,1515,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P21917,antagonist,
2046,1996,Class A (Rhodopsin),small molecule,olanzapine,drd5_human,DRD5,1515,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P21918,antagonist,
2047,1996,Class A (Rhodopsin),small molecule,olanzapine,hrh1_human,HRH1,1515,schizophrenia,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P35367,antagonist,
2048,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht1a_human,HTR1A,1515,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P08908,antagonist,
2049,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht1b_human,HTR1B,1515,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P28222,antagonist,
2050,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht1d_human,HTR1D,1515,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P28221,antagonist,
2051,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht1e_human,HTR1E,1515,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P28566,antagonist,
2052,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht2a_human,HTR2A,1515,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P28223,antagonist,
2053,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht2c_human,HTR2C,1515,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P28335,antagonist,
2054,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht6r_human,HTR6,1515,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P50406,antagonist,
2055,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht7r_human,HTR7,1515,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P34969,antagonist,
2056,1986,Class A (Rhodopsin),small molecule,famotidine,hrh2_human,HRH2,1539,acid reducer,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,ox17,P25021,antagonist,
2057,1971,Class A (Rhodopsin),small molecule,naloxone,oprm_human,OPRM1,MMAmay2016_0517,Analgesics; opioid addiction,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"ox219, buprenorphine + naloxone sublingual tablet",P35372,antagonist,
2058,1971,Class A (Rhodopsin),small molecule,naloxone,oprk_human,OPRK1,MMAmay2016_0518,Analgesics; opioid addiction,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"ox219, buprenorphine + naloxone sublingual tablet",P41145,antagonist,
2059,1971,Class A (Rhodopsin),small molecule,naloxone,oprd_human,OPRD1,MMAmay2016_0921,Analgesics; opioid addiction,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"ox219, buprenorphine + naloxone sublingual tablet",P41143,antagonist,
2060,1982,Class A (Rhodopsin),small molecule,oxyphenonium,acm3_human,CHRM3,ASH_Sep2016_76,digestive system disease,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,oxyphenonium,P20309,antagonist,
2061,2006,Class A (Rhodopsin),small molecule,paliperidone,drd2_human,DRD2,1558,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"paliperidone er, paliperidone palmitate",P14416,antagonist,
2062,2006,Class A (Rhodopsin),small molecule,paliperidone,5ht2a_human,HTR2A,1558,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"paliperidone er, paliperidone palmitate",P28223,antagonist,
2063,1984,Class A (Rhodopsin),small molecule,pentoxifylline,aa2br_human,ADORA2B,ASH_Sep2016_316,irritable bowel syndrome,Nucleotide ,4,,-,approved,Adenosine receptors,GPCR;Rhodopsin,established,pentoxifylline,P29275,antagonist,
2064,1984,Class A (Rhodopsin),small molecule,pentoxifylline,aa1r_human,ADORA1,1586,amyotrophic lateral sclerosis (ALS),Nucleotide ,4,,-,approved,Adenosine receptors,GPCR;Rhodopsin,established,"pentoxifylline, eht0201",P30542,antagonist,
2065,1984,Class A (Rhodopsin),small molecule,pentoxifylline,aa2ar_human,ADORA2B,1586,amyotrophic lateral sclerosis (ALS),Nucleotide ,4,,-,approved,Adenosine receptors,GPCR;Rhodopsin,established,"pentoxifylline, eht0201",P29274,antagonist,
2066,1953,Class A (Rhodopsin),small molecule,phenoxybenzamine,ada1b_human,ADRA1B,ASH_Sep2016_95,adrenal gland pheochromocytoma,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,phenoxybenzamine,P35368,antagonist,
2067,1953,Class A (Rhodopsin),small molecule,phenoxybenzamine,ada1d_human,ADRA1D,ASH_Sep2016_114,adrenal gland pheochromocytoma,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,phenoxybenzamine,P25100,antagonist,
2068,1953,Class A (Rhodopsin),small molecule,phenoxybenzamine,ada2a_human,ADRA2A,ASH_Sep2016_127,cardiovascular disease,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,phenoxybenzamine,P08913,antagonist,
2069,1953,Class A (Rhodopsin),small molecule,phenoxybenzamine,ada2b_human,ADRA2B,ASH_Sep2016_136,cardiovascular disease,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,phenoxybenzamine,P18089,antagonist,
2070,1953,Class A (Rhodopsin),small molecule,phenoxybenzamine,ada2c_human,ADRA2C,ASH_Sep2016_153,adrenal gland pheochromocytoma,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,phenoxybenzamine,P18825,antagonist,
2071,1952,Class A (Rhodopsin),small molecule,phentolamine,ada1b_human,ADRA1B,ASH_Sep2016_102,cardiovascular disease,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,phentolamine,P35368,antagonist,
2072,1952,Class A (Rhodopsin),small molecule,phentolamine,ada1d_human,ADRA1D,ASH_Sep2016_117,cardiovascular disease,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,phentolamine,P25100,antagonist,
2073,1952,Class A (Rhodopsin),small molecule,phentolamine,ada2b_human,ADRA2B,ASH_Sep2016_137,cardiovascular disease,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,phentolamine,P18089,antagonist,
2074,1952,Class A (Rhodopsin),small molecule,phentolamine,ada2c_human,ADRA2C,ASH_Sep2016_163,cardiovascular disease,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,phentolamine,P18825,antagonist,
2075,1984,Class A (Rhodopsin),small molecule,pimozide,5ht2a_human,HTR2A,ASH_Sep2016_20,psychosis,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,pimozide,P28223,antagonist,
2076,1984,Class A (Rhodopsin),small molecule,pimozide,drd1_human,DRD1,ASH_Sep2016_199,psychosis,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,pimozide,P21728,antagonist,
2077,1984,Class A (Rhodopsin),small molecule,pimozide,drd3_human,DRD3,ASH_Sep2016_211,psychosis,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,pimozide,P35462,antagonist,
2078,1984,Class A (Rhodopsin),small molecule,pimozide,drd4_human,DRD4,ASH_Sep2016_222,psychosis,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,pimozide,P21917,antagonist,
2079,1984,Class A (Rhodopsin),small molecule,pimozide,drd5_human,DRD5,ASH_Sep2016_230,psychosis,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,pimozide,P21918,antagonist,
2080,1997,Class A (Rhodopsin),small molecule,clopidogrel,p2y12_human,P2RY12,1619,antithrombotic,Nucleotide ,4,,-,approved,P2Y receptors,GPCR;Rhodopsin,established,plavix,Q9H244,antagonist,
2081,2009,Class A (Rhodopsin),small molecule,prasugrel,p2y12_human,P2RY12,1640,antithrombotic,Nucleotide ,4,,-,approved,P2Y receptors,GPCR;Rhodopsin,established,"prasugrel, cs-747,efient",Q9H244,antagonist,
2082,1956,Class A (Rhodopsin),small molecule,promazine,drd3_human,DRD3,ASH_Sep2016_208,psychosis,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,promazine,P35462,antagonist,
2083,1989,Class A (Rhodopsin),small molecule,propafenone,adrb1_human,ADRB1,ASH_Sep2016_170,cardiac arrhythmia,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,propafenone,P08588,antagonist,
2084,1989,Class A (Rhodopsin),small molecule,propafenone,adrb2_human,ADRB2,ASH_Sep2016_177,atrial fibrillation,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,propafenone,P07550,antagonist,
2085,1953,Class A (Rhodopsin),small molecule,propantheline,acm2_human,CHRM2,ASH_Sep2016_55,digestive system disease,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,propantheline,P08172,antagonist,
2086,1953,Class A (Rhodopsin),small molecule,propantheline,acm3_human,CHRM3,ASH_Sep2016_69,digestive system disease,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,propantheline,P20309,antagonist,
2087,1967,Class A (Rhodopsin),small molecule,propranolol,adrb2_human,ADRB2,ASH_Sep2016_178,Antihypertensive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,propranolol,P07550,antagonist,
2088,1961,Class A (Rhodopsin),small molecule,glycopyrrolate,acm1_human,CHRM1,1680,chronic obstructive pulmonary disease (COPD),Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,pt001,P11229,antagonist,
2089,1961,Class A (Rhodopsin),small molecule,glycopyrrolate,acm1_human,CHRM1,1681,chronic obstructive pulmonary disease (COPD),Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"pt003, glycopyrrolate + formoterol inhalation aerosol",P11229,antagonist,
2090,1998,Class A (Rhodopsin),small molecule,naltrexone,oprd_human,OPRD1,1685,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,pti-601,P41143,antagonist,
2091,1998,Class A (Rhodopsin),small molecule,naltrexone,oprk_human,OPRK1,1685,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,pti-601,P41145,antagonist,
2092,1998,Class A (Rhodopsin),small molecule,naltrexone,oprm_human,OPRM1,1685,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,pti-601,P35372,antagonist,
2093,1998,Class A (Rhodopsin),small molecule,naltrexone,oprd_human,OPRD1,1686,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,pti-701,P41143,antagonist,
2094,1998,Class A (Rhodopsin),small molecule,naltrexone,oprk_human,OPRK1,1686,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,pti-701,P41145,antagonist,
2095,1998,Class A (Rhodopsin),small molecule,naltrexone,oprm_human,OPRM1,1686,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,pti-701,P35372,antagonist,
2096,1998,Class A (Rhodopsin),small molecule,naltrexone,oprd_human,OPRD1,1687,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"pti-801,oxytrex",P41143,antagonist,
2097,1998,Class A (Rhodopsin),small molecule,naltrexone,oprk_human,OPRK1,1687,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"pti-801,oxytrex",P41145,antagonist,
2098,1998,Class A (Rhodopsin),small molecule,naltrexone,oprm_human,OPRM1,1687,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"pti-801,oxytrex",P35372,antagonist,
2099,1998,Class A (Rhodopsin),small molecule,naltrexone,oprd_human,OPRD1,1688,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,pti-901,P41143,antagonist,
2100,1998,Class A (Rhodopsin),small molecule,naltrexone,oprk_human,OPRK1,1688,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,pti-901,P41145,antagonist,
2101,1998,Class A (Rhodopsin),small molecule,naltrexone,oprm_human,OPRM1,1688,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,pti-901,P35372,antagonist,
2102,1998,Class A (Rhodopsin),small molecule,naltrexone,oprm_human,OPRM1,MMAmay2016_0073,Analgesics; for type 1A Charcot-Marie-Tooth disease,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"pxt3003, baclofen + naltrexone + sorbitol",P35372,antagonist,
2103,1998,Class A (Rhodopsin),small molecule,naltrexone,oprd_human,OPRD1,MMAmay2016_0074,Analgesics; for type 1A Charcot-Marie-Tooth disease,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"pxt3003, baclofen + naltrexone + sorbitol",P41143,antagonist,
2104,1998,Class A (Rhodopsin),small molecule,naltrexone,oprk_human,OPRK1,MMAmay2016_0075,Analgesics; for type 1A Charcot-Marie-Tooth disease,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"pxt3003, baclofen + naltrexone + sorbitol",P41145,antagonist,
2105,1973,Class A (Rhodopsin),small molecule,pyrilamine,hrh1_human,HRH1,ASH_Sep2016_236,pruritus,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,pyrilamine,P35367,antagonist,
2106,1961,Class A (Rhodopsin),small molecule,glycopyrronium,adrb2_human,ADRB2,1702,chronic obstructive pulmonary disease (COPD),Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"qva149, glycopyrronium + i/",P07550,antagonist,
2107,1977,Class A (Rhodopsin),small molecule,ranitidine,hrh2_human,HRH2,1716,antiulcer,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,"ranitidine bismuth citrate,tritec",P25021,antagonist,
2108,0,Class A (Rhodopsin),small molecule,rauwolfia serpentina,ada1a_human,ADRA1A,ASH_Sep2016_84,Antihypertensive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,rauwolfia serpentina,P35348,antagonist,
2109,0,Class A (Rhodopsin),small molecule,rauwolfia serpentina,ada1b_human,ADRA1B,ASH_Sep2016_93,Antihypertensive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,rauwolfia serpentina,P35368,antagonist,
2110,0,Class A (Rhodopsin),small molecule,rauwolfia serpentina,ada1d_human,ADRA1D,ASH_Sep2016_108,Antihypertensive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,rauwolfia serpentina,P25100,antagonist,
2111,0,Class A (Rhodopsin),small molecule,rauwolfia serpentina,ada2a_human,ADRA2A,ASH_Sep2016_121,Antihypertensive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,rauwolfia serpentina,P08913,antagonist,
2112,0,Class A (Rhodopsin),small molecule,rauwolfia serpentina,ada2b_human,ADRA2B,ASH_Sep2016_144,Antihypertensive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,rauwolfia serpentina,P18089,antagonist,
2113,0,Class A (Rhodopsin),small molecule,rauwolfia serpentina,ada2c_human,ADRA2C,ASH_Sep2016_160,Antihypertensive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,rauwolfia serpentina,P18825,antagonist,
2114,1971,Class A (Rhodopsin),small molecule,naloxone,oprd_human,OPRD1,1733,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,ren-213,P41143,antagonist,
2115,1971,Class A (Rhodopsin),small molecule,naloxone,oprk_human,OPRK1,1733,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,ren-213,P41145,antagonist,
2116,1971,Class A (Rhodopsin),small molecule,naloxone,oprm_human,OPRM1,1733,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,ren-213,P35372,antagonist,
2117,1993,Class A (Rhodopsin),small molecule,risperidone,drd2_human,DRD2,1770,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,risperdal,P14416,antagonist,
2118,1993,Class A (Rhodopsin),small molecule,risperidone,5ht2a_human,HTR2A,1770,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,risperdal,P28223,antagonist,
2119,1993,Class A (Rhodopsin),small molecule,risperidone,5ht2c_human,HTR2C,ASH_Sep2016_28,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,risperidone,P28335,antagonist,
2120,2008,Class A (Rhodopsin),small molecule,rocuronium,acm2_human,CHRM2,1776,Muscle Relaxants,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"rocuronium bromide,esmeron, zemuron, eslax",P08172,antagonist,
2121,2012,Class A (Rhodopsin),small molecule,valsartan,agtr1_human,AGTR1,MMAmay2016_0742,Antihypertensive,Peptide ,4,,-,approved,Angiotensin receptors,GPCR;Rhodopsin,established,sacubitril + valsartan,P30556,antagonist,
2122,2015,Class A (Rhodopsin),small molecule,rolapitant,nk1r_human,TACR1,MMAmay2016_0753,Antiemetics,Peptide ,4,,-,approved,Tachykinin receptors,GPCR;Rhodopsin,established,"sch 619734, rolapitant",P25103,antagonist,
2123,2007,Class A (Rhodopsin),small molecule,maraviroc,ccr5_human,CCR5,1834,antiviral ; HIV,Protein ,4,,-,approved,Chemokine receptors,GPCR;Rhodopsin,established,selzentry,P51681,antagonist,
2124,1997,Class A (Rhodopsin),small molecule,quetiapine,drd2_human,DRD2,1840,Antipsychotic ; Anti-depressant,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,seroquel,P14416,antagonist,
2125,1997,Class A (Rhodopsin),small molecule,quetiapine,5ht2a_human,HTR2A,1840,Antipsychotic ; Anti-depressant,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,seroquel,P28223,antagonist,
2126,1997,Class A (Rhodopsin),small molecule,quetiapine,5ht2b_human,HTR2B,1840,Antipsychotic ; Anti-depressant,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,seroquel,P41595,antagonist,
2127,1997,Class A (Rhodopsin),small molecule,quetiapine,5ht2c_human,HTR2C,1840,Antipsychotic ; Anti-depressant,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,seroquel,P28335,antagonist,
2128,2008,Class A (Rhodopsin),small molecule,silodosin,ada1a_human,ADRA1A,1852,BPH-related urinary symptoms,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,silodosin,P35348,antagonist,
2129,2004,Class A (Rhodopsin),small molecule,solifenacin,acm1_human,CHRM1,1876,incontinence,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"solifenacin succinate, ym-905,vesicare",P11229,antagonist,
2130,2004,Class A (Rhodopsin),small molecule,solifenacin,acm2_human,CHRM2,1876,incontinence,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"solifenacin succinate, ym-905,vesicare",P08172,antagonist,
2131,2004,Class A (Rhodopsin),small molecule,solifenacin,acm3_human,CHRM3,1876,incontinence,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"solifenacin succinate, ym-905,vesicare",P20309,antagonist,
2132,2004,Class A (Rhodopsin),small molecule,solifenacin,acm4_human,CHRM4,1876,incontinence,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"solifenacin succinate, ym-905,vesicare",P08173,antagonist,
2133,2004,Class A (Rhodopsin),small molecule,solifenacin,acm5_human,CHRM5,1876,incontinence,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"solifenacin succinate, ym-905,vesicare",P08912,antagonist,
2134,1992,Class A (Rhodopsin),small molecule,sotalol,adrb1_human,ADRB1,ASH_Sep2016_168,atrial fibrillation,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,sotalol,P08588,antagonist,
2135,1992,Class A (Rhodopsin),small molecule,sotalol,adrb2_human,ADRB2,ASH_Sep2016_180,cardiovascular disease,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,sotalol,P07550,antagonist,
2136,1974,Class A (Rhodopsin),small molecule,molindone,drd2_human,DRD2,2425,ADHD,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"spn810 ,zalvari",P14416,antagonist,
2137,1995,Class A (Rhodopsin),small molecule,nalmefene,oprd_human,OPRD1,2766,pruritus,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,srd174,P41143,antagonist,
2138,1995,Class A (Rhodopsin),small molecule,nalmefene,oprk_human,OPRK1,2766,pruritus,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,srd174,P41145,antagonist,
2139,1995,Class A (Rhodopsin),small molecule,nalmefene,oprm_human,OPRM1,2766,pruritus,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,srd174,P35372,antagonist,
2140,1997,Class A (Rhodopsin),small molecule,tamsulosin,ada1a_human,ADRA1A,1946,urinary symptoms associated with BPH,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"tamsulosin, ym-617,harnal, flomax",P35348,antagonist,
2141,1997,Class A (Rhodopsin),small molecule,tamsulosin,ada1b_human,ADRA1B,1946,urinary symptoms associated with BPH,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"tamsulosin, ym-617,harnal, flomax",P35368,antagonist,
2142,1997,Class A (Rhodopsin),small molecule,tamsulosin,ada1d_human,ADRA1D,1946,urinary symptoms associated with BPH,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"tamsulosin, ym-617,harnal, flomax",P25100,antagonist,
2143,1971,Class A (Rhodopsin),small molecule,naloxone,oprm_human,OPRM1,MMAmay2016_0709,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"targin,  targinac, targiniq er,  oxycodone hydrochloride + naloxone hydrochloride extended-release tablets",P35372,antagonist,
2144,1971,Class A (Rhodopsin),small molecule,naloxone,oprd_human,OPRD1,MMAmay2016_0710,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"targin,  targinac, targiniq er,  oxycodone hydrochloride + naloxone hydrochloride extended-release tablets",P41143,antagonist,
2145,1971,Class A (Rhodopsin),small molecule,naloxone,oprk_human,OPRK1,MMAmay2016_0711,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,"targin,  targinac, targiniq er,  oxycodone hydrochloride + naloxone hydrochloride extended-release tablets",P41145,antagonist,
2146,1998,Class A (Rhodopsin),small molecule,telmisartan,agtr1_human,AGTR1,1977,Antihypertensive,Peptide ,4,,-,approved,Angiotensin receptors,GPCR;Rhodopsin,established,"telmisartan,micardis, micardis hct",P30556,antagonist,
2147,1962,Class A (Rhodopsin),small molecule,thioridazine,5ht2c_human,HTR2C,ASH_Sep2016_34,psychosis,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,thioridazine,P28335,antagonist,
2148,1962,Class A (Rhodopsin),small molecule,thioridazine,drd3_human,DRD3,ASH_Sep2016_205,psychosis,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,thioridazine,P35462,antagonist,
2149,1962,Class A (Rhodopsin),small molecule,thioridazine,drd4_human,DRD4,ASH_Sep2016_219,psychosis,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,thioridazine,P21917,antagonist,
2150,1967,Class A (Rhodopsin),small molecule,thiothixene,5ht2a_human,HTR2A,ASH_Sep2016_19,psychosis,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,thiothixene,P28223,antagonist,
2151,1967,Class A (Rhodopsin),small molecule,thiothixene,drd2_human,DRD2,ASH_Sep2016_67,psychosis,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,thiothixene,P14416,antagonist,
2152,1998,Class A (Rhodopsin),small molecule,tolterodine,acm1_human,CHRM1,2013,incontinence,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,thvd-201,P11229,antagonist,
2153,1998,Class A (Rhodopsin),small molecule,tolterodine,acm2_human,CHRM2,2013,incontinence,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,thvd-201,P08172,antagonist,
2154,1998,Class A (Rhodopsin),small molecule,tolterodine,acm3_human,CHRM3,2013,incontinence,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,thvd-201,P20309,antagonist,
2155,1998,Class A (Rhodopsin),small molecule,tolterodine,acm4_human,CHRM4,2013,incontinence,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,thvd-201,P08173,antagonist,
2156,1998,Class A (Rhodopsin),small molecule,tolterodine,acm5_human,CHRM5,2013,incontinence,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,thvd-201,P08912,antagonist,
2157,2004,Class A (Rhodopsin),small molecule,tiotropium,acm2_human,CHRM2,MMAmay2016_0589,chronic obstructive pulmonary disease (COPD),Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,tiotropium + olodaterol,P08172,antagonist,
2158,2004,Class A (Rhodopsin),small molecule,tiotropium,acm1_human,CHRM1,MMAmay2016_0590,chronic obstructive pulmonary disease (COPD),Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,tiotropium + olodaterol,P11229,antagonist,
2159,2004,Class A (Rhodopsin),small molecule,tiotropium,acm3_human,CHRM3,MMAmay2016_0591,chronic obstructive pulmonary disease (COPD),Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,tiotropium + olodaterol,P20309,antagonist,
2160,2004,Class A (Rhodopsin),small molecule,tiotropium,acm1_human,CHRM1,2019,cystic fibrosis; chronic obstructive pulmonary disorder (COPD),Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"tiotropium bromide,spiriva",P11229,antagonist,
2161,2004,Class A (Rhodopsin),small molecule,tiotropium,acm2_human,CHRM2,2019,cystic fibrosis; chronic obstructive pulmonary disorder (COPD),Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"tiotropium bromide,spiriva",P08172,antagonist,
2162,2004,Class A (Rhodopsin),small molecule,tiotropium,acm3_human,CHRM3,2019,cystic fibrosis; chronic obstructive pulmonary disorder (COPD),Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"tiotropium bromide,spiriva",P20309,antagonist,
2163,1977,Class A (Rhodopsin),small molecule,cimetidine,hrh2_human,HRH2,MMAmay2016_0601,Antihistamines,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,"tl-118, hamsa-1, cyclophosphamide + diclofenac + sulfasalazine + cimetidine",P25021,antagonist,
2164,1977,Class A (Rhodopsin),small molecule,cyclobenzaprine,5ht2a_human,HTR2A,MMAmay2016_0082,fibromyalgia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,tnx-102,P28223,antagonist,
2165,1998,Class A (Rhodopsin),small molecule,tolterodine,acm1_human,CHRM1,2036,incontinence,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"tolterodine extended release capsules,detrol la",P11229,antagonist,
2166,1998,Class A (Rhodopsin),small molecule,tolterodine,acm2_human,CHRM2,2036,incontinence,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"tolterodine extended release capsules,detrol la",P08172,antagonist,
2167,1998,Class A (Rhodopsin),small molecule,tolterodine,acm3_human,CHRM3,2036,incontinence,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"tolterodine extended release capsules,detrol la",P20309,antagonist,
2168,1998,Class A (Rhodopsin),small molecule,tolterodine,acm4_human,CHRM4,2036,incontinence,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"tolterodine extended release capsules,detrol la",P08173,antagonist,
2169,1998,Class A (Rhodopsin),small molecule,tolterodine,acm5_human,CHRM5,2036,incontinence,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"tolterodine extended release capsules,detrol la",P08912,antagonist,
2170,2009,Class A (Rhodopsin),small molecule,tolvaptan,v2r_human,AVPR2,2037,Antihypertensive,Peptide ,4,,-,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,"tolvaptan, opc-41061,samsca",P30518,antagonist,
2171,2001,Class A (Rhodopsin),small molecule,bosentan,ednra_human,EDNRA,2053,Antihypertensive,Peptide ,4,,-,approved,Endothelin receptors,GPCR;Rhodopsin,established,tracleer,P25101,antagonist,
2172,2001,Class A (Rhodopsin),small molecule,bosentan,ednrb_human,EDNRB,2053,Antihypertensive,Peptide ,4,,-,approved,Endothelin receptors,GPCR;Rhodopsin,established,tracleer,P24530,antagonist,
2173,1975,Class A (Rhodopsin),small molecule,oxybutynin,acm1_human,CHRM1,2067,incontinence,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"transdermal oxybutynin patch, oxybutynin topical gel,oxytrol, kentera, gelnique",P11229,antagonist,
2174,1975,Class A (Rhodopsin),small molecule,oxybutynin,acm2_human,CHRM2,2067,incontinence,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"transdermal oxybutynin patch, oxybutynin topical gel,oxytrol, kentera, gelnique",P08172,antagonist,
2175,1975,Class A (Rhodopsin),small molecule,oxybutynin,acm3_human,CHRM3,2067,incontinence,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"transdermal oxybutynin patch, oxybutynin topical gel,oxytrol, kentera, gelnique",P20309,antagonist,
2176,1981,Class A (Rhodopsin),small molecule,timolol,adrb1_human,ADRB1,2071,Antiglaucomic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"travoprost + timolol,extravan, duotrav",P08588,antagonist,
2177,1981,Class A (Rhodopsin),small molecule,timolol,adrb2_human,ADRB2,2071,Antiglaucomic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"travoprost + timolol,extravan, duotrav",P07550,antagonist,
2178,2002,Class A (Rhodopsin),small molecule,olmesartan medoxomil,agtr1_human,AGTR1,2080,Antihypertensive,Peptide ,4,,-,approved,Angiotensin receptors,GPCR;Rhodopsin,established,tribenzor,P30556,antagonist,
2179,1959,Class A (Rhodopsin),small molecule,trifluoperazine,5ht2a_human,HTR2A,ASH_Sep2016_18,psychosis,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,trifluoperazine,P28223,antagonist,
2180,1959,Class A (Rhodopsin),small molecule,trifluoperazine,5ht2c_human,HTR2C,ASH_Sep2016_36,psychosis,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,trifluoperazine,P28335,antagonist,
2181,1959,Class A (Rhodopsin),small molecule,trifluoperazine,drd3_human,DRD3,ASH_Sep2016_203,psychosis,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,trifluoperazine,P35462,antagonist,
2182,1959,Class A (Rhodopsin),small molecule,trifluoperazine,drd4_human,DRD4,ASH_Sep2016_217,psychosis,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,trifluoperazine,P21917,antagonist,
2183,1979,Class A (Rhodopsin),small molecule,trimipramine,5ht2a_human,HTR2A,ASH_Sep2016_15,unipolar depression,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,trimipramine,P28223,antagonist,
2184,1979,Class A (Rhodopsin),small molecule,trimipramine,5ht2c_human,HTR2C,ASH_Sep2016_37,unipolar depression,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,trimipramine,P28335,antagonist,
2185,1979,Class A (Rhodopsin),small molecule,trimipramine,drd2_human,DRD2,ASH_Sep2016_62,unipolar depression,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,trimipramine,P14416,antagonist,
2186,1979,Class A (Rhodopsin),small molecule,trimipramine,ada1a_human,ADRA1A,ASH_Sep2016_89,unipolar depression,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,trimipramine,P35348,antagonist,
2187,1979,Class A (Rhodopsin),small molecule,trimipramine,ada1b_human,ADRA1B,ASH_Sep2016_101,unipolar depression,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,trimipramine,P35368,antagonist,
2188,1979,Class A (Rhodopsin),small molecule,trimipramine,ada1d_human,ADRA1D,ASH_Sep2016_118,unipolar depression,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,trimipramine,P25100,antagonist,
2189,1979,Class A (Rhodopsin),small molecule,trimipramine,hrh1_human,HRH1,ASH_Sep2016_234,unipolar depression,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,trimipramine,P35367,antagonist,
2190,1960,Class A (Rhodopsin),small molecule,tropicamide,acm3_human,CHRM3,ASH_Sep2016_70,myopia,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,tropicamide,P20309,antagonist,
2191,2004,Class A (Rhodopsin),small molecule,trospium,acm1_human,CHRM1,2086,incontinence,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"trospium chloride,sanctura",P11229,antagonist,
2192,2004,Class A (Rhodopsin),small molecule,trospium,acm2_human,CHRM2,2086,incontinence,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"trospium chloride,sanctura",P08172,antagonist,
2193,2004,Class A (Rhodopsin),small molecule,trospium,acm3_human,CHRM3,2086,incontinence,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"trospium chloride,sanctura",P20309,antagonist,
2194,2004,Class A (Rhodopsin),small molecule,trospium,acm4_human,CHRM4,2086,incontinence,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"trospium chloride,sanctura",P08173,antagonist,
2195,2004,Class A (Rhodopsin),small molecule,trospium,acm5_human,CHRM5,2086,incontinence,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"trospium chloride,sanctura",P08912,antagonist,
2196,2013,Class A (Rhodopsin),small molecule,umeclidinium,acm2_human,CHRM2,MMAmay2016_0618,Bronchodilator ; COPD,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,umeclidinium + vilanterol,P08172,antagonist,
2197,2013,Class A (Rhodopsin),small molecule,umeclidinium,acm3_human,CHRM3,MMAmay2016_0618,Bronchodilator ; COPD,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,umeclidinium + vilanterol,P20309,antagonist,
2198,2012,Class A (Rhodopsin),small molecule,valsartan,agtr1_human,AGTR1,2122,Antihypertensive,Peptide ,4,,-,approved,Angiotensin receptors,GPCR;Rhodopsin,established,"valsartan,diovan",P30556,antagonist,
2199,1998,Class A (Rhodopsin),small molecule,naltrexone,oprd_human,OPRD1,2168,substance abuse,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,vivitrol,P41143,antagonist,
2200,1998,Class A (Rhodopsin),small molecule,naltrexone,oprk_human,OPRK1,2168,substance abuse,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,vivitrol,P41145,antagonist,
2201,1998,Class A (Rhodopsin),small molecule,naltrexone,oprm_human,OPRM1,2168,substance abuse,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,vivitrol,P35372,antagonist,
2202,2014,Class A (Rhodopsin),small molecule,vorapaxar,par1_human,F2R,2175,cardiovascular disease,Peptide ,4,,-,approved,Proteinase-activated receptors,GPCR;Rhodopsin,established,"vorapaxar , sch-530348",P25116,antagonist,
2203,2014,Class A (Rhodopsin),small molecule,vorapaxar,par3_human,F2RL2,2175,cardiovascular disease,Peptide ,4,,-,approved,Proteinase-activated receptors,GPCR;Rhodopsin,established,"vorapaxar , sch-530348",O00254,antagonist,
2204,2014,Class A (Rhodopsin),small molecule,vorapaxar,par4_human,F2RL3,2175,cardiovascular disease,Peptide ,4,,-,approved,Proteinase-activated receptors,GPCR;Rhodopsin,established,"vorapaxar , sch-530348",Q96RI0,antagonist,
2205,1967,Class A (Rhodopsin),small molecule,propranolol,adrb1_human,ADRB1,2183,cancer cachexia,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,vt-122,P08588,antagonist,
2206,1996,Class A (Rhodopsin),small molecule,zafirlukast,cltr1_human,CYSLTR1,2235,Anti-Asthmatic,Lipid ,4,,-,approved,Leukotriene receptors,GPCR;Rhodopsin,established,"zafirlukast,accolate",Q9Y271,antagonist,
2207,1977,Class A (Rhodopsin),small molecule,ranitidine,hrh2_human,HRH2,2238,antiulcer,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,"zantac,ranitidine hydrochloride",P25021,antagonist,
2208,2001,Class A (Rhodopsin),small molecule,ziprasidone,5ht2c_human,HTR2C,ASH_Sep2016_30,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,ziprasidone,P28335,antagonist,
2209,2001,Class A (Rhodopsin),small molecule,ziprasidone,drd2_human,DRD2,2243,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"ziprasidone hcl, ziprasidone mesylate,geodon, zeldox",P14416,antagonist,
2210,2001,Class A (Rhodopsin),small molecule,ziprasidone,5ht2a_human,HTR2A,2243,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"ziprasidone hcl, ziprasidone mesylate,geodon, zeldox",P28223,antagonist,
2211,2009,Class A (Rhodopsin),small molecule,dronedarone,ada1a_human,ADRA1A,NRDD190,Anti-Arrhythmia,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,blocker,
2212,2009,Class A (Rhodopsin),small molecule,dronedarone,adrb1_human,ADRB1,NRDD190,Anti-Arrhythmia,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588,blocker,
2213,1985,Class A (Rhodopsin),small molecule,amiodarone,ada1a_human,ADRA1A,160,Anti-Arrhythmia,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"amiodarone hcl,amio-aqueous iv",P35348,blocker,
2214,1985,Class A (Rhodopsin),small molecule,amiodarone,adrb1_human,ADRB1,160,Anti-Arrhythmia,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"amiodarone hcl,amio-aqueous iv",P08588,blocker,
2215,2009,Class A (Rhodopsin),small molecule,dronedarone,ada1a_human,ADRA1A,2270,Anti-Arrhythmia,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,dronedarone,P35348,blocker,
2216,2009,Class A (Rhodopsin),small molecule,dronedarone,adrb1_human,ADRB1,2270,Anti-Arrhythmia,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,dronedarone,P08588,blocker,
2217,2015,Class A (Rhodopsin),enzyme,asfotase alfa,s1pr1_human,S1PR1,ASH_Sep2016_303,hypophosphatasia,Lipid ,4,,-,approved,Lysophospholipid (S1P) receptors,GPCR;Rhodopsin,established,asfotase alfa,P21453,hydrolytic enzyme,
2218,1964,Class A (Rhodopsin),small molecule,desipramine,adrb1_human,ADRB1,NRDD148,Anti-depressant,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588,inhibitor,
2219,1964,Class A (Rhodopsin),small molecule,desipramine,adrb2_human,ADRB2,NRDD148,Anti-depressant,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P07550,inhibitor,
2220,1964,Class A (Rhodopsin),small molecule,desipramine,acm1_human,CHRM1,NRDD148,Anti-depressant,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,inhibitor,
2221,1964,Class A (Rhodopsin),small molecule,desipramine,acm2_human,CHRM2,NRDD148,Anti-depressant,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172,inhibitor,
2222,1964,Class A (Rhodopsin),small molecule,desipramine,hrh1_human,HRH1,NRDD148,Anti-depressant,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,inhibitor,
2223,1970,Class A (Rhodopsin),small molecule,flavoxate,acm1_human,CHRM1,NRDD230,Antispasmodics,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,inhibitor,
2224,1970,Class A (Rhodopsin),small molecule,flavoxate,acm2_human,CHRM2,NRDD230,Antispasmodics,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172,inhibitor,
2225,1994,Class A (Rhodopsin),small molecule,nefazodone,ada1a_human,ADRA1A,NRDD380,Anti-depressant,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,inhibitor,
2226,1994,Class A (Rhodopsin),small molecule,nefazodone,ada1b_human,ADRA1B,NRDD380,Anti-depressant,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35368,inhibitor,
2227,1994,Class A (Rhodopsin),small molecule,nefazodone,5ht2a_human,HTR2A,NRDD380,Anti-depressant,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28223,inhibitor,
2228,1976,Class A (Rhodopsin),small molecule,phendimetrazine,ada1a_human,ADRA1A,NRDD427,Appetite suppressant,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,inhibitor,
2229,1976,Class A (Rhodopsin),small molecule,phendimetrazine,ada1b_human,ADRA1B,NRDD427,Appetite suppressant,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35368,inhibitor,
2230,1980,Class A (Rhodopsin),small molecule,amoxapine,drd2_human,DRD2,ASH_Sep2016_64,unipolar depression,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,amoxapine,P14416,inhibitor,
2231,1980,Class A (Rhodopsin),small molecule,amoxapine,drd1_human,DRD1,ASH_Sep2016_200,unipolar depression,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,amoxapine,P21728,inhibitor,
2232,1980,Class A (Rhodopsin),small molecule,amoxapine,drd3_human,DRD3,ASH_Sep2016_210,unipolar depression,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,amoxapine,P35462,inhibitor,
2233,1980,Class A (Rhodopsin),small molecule,amoxapine,drd4_human,DRD4,ASH_Sep2016_221,unipolar depression,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,amoxapine,P21917,inhibitor,
2234,1980,Class A (Rhodopsin),small molecule,amoxapine,drd5_human,DRD5,ASH_Sep2016_228,unipolar depression,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,amoxapine,P21918,inhibitor,
2235,2012,Class F (Frizzled),small molecule,vismodegib,smo_human,SMO,2822,Antineoplastic,Protein ,4,,-,approved,Frizzled,GPCR;Frizzled,established,"gdc-0449, hedgehog pathway inhibitor",Q99835,inhibitor,
2236,2015,Class F (Frizzled),small molecule,sonidegib,smo_human,SMO,1101,Antineoplastic,Protein ,4,,-,approved,Frizzled,GPCR;Frizzled,established,lde225,Q99835,inhibitor,
2237,1981,Class A (Rhodopsin),small molecule,trazodone,5ht1a_human,HTR1A,MMAmay2016_0460,Anti-depressant; for Hypoactive Sexual Desire Disorder and Female Sexual Dysfunction,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"lorexys, sip-104, bupropion/trazodone",P08908,inhibitor,
2238,1981,Class A (Rhodopsin),small molecule,trazodone,5ht2a_human,HTR2A,MMAmay2016_0461,Anti-depressant; for Hypoactive Sexual Desire Disorder and Female Sexual Dysfunction,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"lorexys, sip-104, bupropion/trazodone",P28223,inhibitor,
2239,1981,Class A (Rhodopsin),small molecule,trazodone,5ht2c_human,HTR2C,MMAmay2016_0462,Anti-depressant; for Hypoactive Sexual Desire Disorder and Female Sexual Dysfunction,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"lorexys, sip-104, bupropion/trazodone",P28335,inhibitor,
2240,1943,Class A (Rhodopsin),small molecule,methamphetamine,ada2a_human,ADRA2A,1167,neuroprotectant,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,low dose intravenous methamphetamine,P08913,inhibitor,
2241,1943,Class A (Rhodopsin),small molecule,methamphetamine,ada2b_human,ADRA2B,1167,neuroprotectant,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,low dose intravenous methamphetamine,P18089,inhibitor,
2242,1943,Class A (Rhodopsin),small molecule,methamphetamine,ada2c_human,ADRA2C,1167,neuroprotectant,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,low dose intravenous methamphetamine,P18825,inhibitor,
2243,1943,Class A (Rhodopsin),small molecule,methamphetamine,taar1_human,TAAR1,1167,neuroprotectant,Aminergic ,4,,-,approved,Trace amine receptors,GPCR;Rhodopsin,established,low dose intravenous methamphetamine,Q96RJ0,inhibitor,
2244,1994,Class A (Rhodopsin),small molecule,nefazodone,5ht2c_human,HTR2C,ASH_Sep2016_33,unipolar depression,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,nefazodone,P28335,inhibitor,
2245,1987,Class A (Rhodopsin),small molecule,fluoxetine,5ht2a_human,HTR2A,1440,autism,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"npl-2008, fluoxetine",P28223,inhibitor,
2246,1961,Class A (Rhodopsin),small molecule,amitriptyline,5ht2a_human,HTR2A,1491,Analgesics,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,oms-103hp,P28223,inhibitor,
2247,1969,Class A (Rhodopsin),small molecule,doxepin,acm1_human,CHRM1,1851,Hypnotics and Sedatives,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,silenor (so-101),P11229,inhibitor,
2248,1969,Class A (Rhodopsin),small molecule,doxepin,acm2_human,CHRM2,1851,Hypnotics and Sedatives,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,silenor (so-101),P08172,inhibitor,
2249,1969,Class A (Rhodopsin),small molecule,doxepin,acm3_human,CHRM3,1851,Hypnotics and Sedatives,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,silenor (so-101),P20309,inhibitor,
2250,1969,Class A (Rhodopsin),small molecule,doxepin,acm4_human,CHRM4,1851,Hypnotics and Sedatives,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,silenor (so-101),P08173,inhibitor,
2251,1969,Class A (Rhodopsin),small molecule,doxepin,acm5_human,CHRM5,1851,Hypnotics and Sedatives,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,silenor (so-101),P08912,inhibitor,
2252,1969,Class A (Rhodopsin),small molecule,doxepin,hrh1_human,HRH1,1851,Hypnotics and Sedatives,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,silenor (so-101),P35367,inhibitor,
2253,1969,Class A (Rhodopsin),small molecule,doxepin,hrh2_human,HRH2,1851,Hypnotics and Sedatives,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,silenor (so-101),P25021,inhibitor,
2254,1969,Class A (Rhodopsin),small molecule,doxepin,5ht2a_human,HTR2A,1851,Hypnotics and Sedatives,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,silenor (so-101),P28223,inhibitor,
2255,1969,Class A (Rhodopsin),small molecule,doxepin,5ht2b_human,HTR2B,1851,Hypnotics and Sedatives,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,silenor (so-101),P41595,inhibitor,
2256,1969,Class A (Rhodopsin),small molecule,doxepin,5ht2c_human,HTR2C,1851,Hypnotics and Sedatives,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,silenor (so-101),P28335,inhibitor,
2257,1992,Class F (Frizzled),small molecule,itraconazole,smo_human,SMO,MMAmar2016_0140,Antineoplastic,Protein ,4,,-,approved,Frizzled,GPCR;Frizzled,established,suba-itraconazole,Q99835,inhibitor,
2258,1981,Class A (Rhodopsin),small molecule,trazodone,5ht1a_human,HTR1A,2072,Anti-depressant,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"trazodone extended release, dds-04a,oleptro",P08908,inhibitor,
2259,1981,Class A (Rhodopsin),small molecule,trazodone,5ht2a_human,HTR2A,2072,Anti-depressant,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"trazodone extended release, dds-04a,oleptro",P28223,inhibitor,
2260,1981,Class A (Rhodopsin),small molecule,trazodone,5ht2c_human,HTR2C,2072,Anti-depressant,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"trazodone extended release, dds-04a,oleptro",P28335,inhibitor,
2261,2009,Class C (Glutamate) ,small molecule,vigabatrin,gabr1_human,GABBR1,2159,addiction,Amino acid ,4,,-,approved,GABAB receptors,GPCR;Glutamate,established,"vigabatrin is a selective, irreversible enzyme-activated gaba transaminase inhibitor. gaba (gamma-aminobutyric acid) is a n/",Q9UBS5,inhibitor,
2262,2011,Class A (Rhodopsin),small molecule,vilazodone ,5ht1a_human,HTR1A,2160,Anti-depressant,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"vilazodone hydrochloride, sb 659746a",P08908,inhibitor,
2263,2016,Class A (Rhodopsin),small molecule,pimavanserin,5ht2a_human,HTR2A,1610,Antiparkinson,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,pimavanserin,P28223,inverse agonist,
2264,1974,Class A (Rhodopsin),small molecule,benzquinamide,acm1_human,CHRM1,NRDD047,Antiemetics; Antipsychotic,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,modulator,
2265,1974,Class A (Rhodopsin),small molecule,benzquinamide,acm2_human,CHRM2,NRDD047,Antiemetics; Antipsychotic,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172,modulator,
2266,1974,Class A (Rhodopsin),small molecule,benzquinamide,acm3_human,CHRM3,NRDD047,Antiemetics; Antipsychotic,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P20309,modulator,
2267,1974,Class A (Rhodopsin),small molecule,benzquinamide,acm4_human,CHRM4,NRDD047,Antiemetics; Antipsychotic,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08173,modulator,
2268,1974,Class A (Rhodopsin),small molecule,benzquinamide,acm5_human,CHRM5,NRDD047,Antiemetics; Antipsychotic,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08912,modulator,
2269,1974,Class A (Rhodopsin),small molecule,benzquinamide,hrh1_human,HRH1,NRDD047,Antiemetics; Antipsychotic,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,modulator,
2270,2015,Class A (Rhodopsin),small molecule,cariprazine,drd2_human,DRD2,433,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"cariprazine, rgh-188",P14416,modulator,
2271,2015,Class A (Rhodopsin),small molecule,cariprazine,drd3_human,DRD3,433,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"cariprazine, rgh-188",P35462,modulator,
2272,1970,Class A (Rhodopsin),small molecule,betanechol,acm2_human,CHRM2,648,Antidiabetic,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,dm-71,P08172,agonist,
2273,2015,Class B1 (Secretin),protein,parathyroid horomone,pth1r_human,PTHR1,MMAmay2016_0745,Control hypocalcemia,Peptide ,4,,-,approved,Parathyroid hormone receptors,GPCR;Secretin,established,"natpara, npsp558, parathyroid horomone",Q03431,agonist,
2274,0,Class A (Rhodopsin),small molecule,ridogrelum,ta2r_human,TBXA2R,MMAjun2016_0002,for the prevention of systemic thrombo-embolism; adjunctive  to thrombolytic therapy,Lipid ,4,,-,approved,Prostanoid receptors,GPCR;Rhodopsin,established,ridogrel,P21731,antagonist,
2275,2010,Class A (Rhodopsin),small molecule,ticagrelor,p2y12_human,P2RY12,2015,antithrombotic,Nucleotide ,4,,-,approved,P2Y receptors,GPCR;Rhodopsin,established,ticagrelor,Q9H244,nam,
2276,1997,Class A (Rhodopsin),small molecule,arbutamine,adrb1_human,ADRB1,NRDD034,Cardiotonic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588,unknown,
2277,1960,Class A (Rhodopsin),small molecule,benzphetamine,ada1a_human,ADRA1A,NRDD046,Central Nervous System Stimulants,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,unknown,
2278,1960,Class A (Rhodopsin),small molecule,benzphetamine,ada2a_human,ADRA2A,NRDD046,Central Nervous System Stimulants,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08913,unknown,
2279,1989,Class A (Rhodopsin),small molecule,cinnarizine,hrh1_human,HRH1,NRDD107,Anti-Allergic,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,unknown,
2280,1982,Class A (Rhodopsin),small molecule,cocaine,drd3_human,DRD3,NRDD123,local anesthetic,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P35462,unknown,
2281,1982,Class A (Rhodopsin),small molecule,cocaine,oprk_human,OPRK1,NRDD123,local anesthetic,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P41145,unknown,
2282,1963,Class A (Rhodopsin),small molecule,ephedrine,ada1a_human,ADRA1A,NRDD204,Central Nervous System Stimulants,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,unknown,
2283,1977,Class A (Rhodopsin),small molecule,fluspirilene,drd2_human,DRD2,NRDD244,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,unknown,
2284,1982,Class A (Rhodopsin),small molecule,homatropine methylbromide,acm1_human,CHRM1,NRDD271,GI Anti-Ulcer ; Antimuscarinics,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,unknown,
2285,1982,Class A (Rhodopsin),small molecule,homatropine methylbromide,acm2_human,CHRM2,NRDD271,GI Anti-Ulcer ; Antimuscarinics,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172,unknown,
2286,1982,Class A (Rhodopsin),small molecule,homatropine methylbromide,acm3_human,CHRM3,NRDD271,GI Anti-Ulcer ; Antimuscarinics,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P20309,unknown,
2287,1982,Class A (Rhodopsin),small molecule,homatropine methylbromide,acm4_human,CHRM4,NRDD271,GI Anti-Ulcer ; Antimuscarinics,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08173,unknown,
2288,1982,Class A (Rhodopsin),small molecule,homatropine methylbromide,acm5_human,CHRM5,NRDD271,GI Anti-Ulcer ; Antimuscarinics,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08912,unknown,
2289,2011,Class A (Rhodopsin),small molecule,lisuride,drd1_human,DRD1,NRDD307,Antiparkinson,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21728,unknown,
2290,2011,Class A (Rhodopsin),small molecule,lisuride,drd2_human,DRD2,NRDD307,Antiparkinson,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,unknown,
2291,2011,Class A (Rhodopsin),small molecule,lisuride,5ht1a_human,HTR1A,NRDD307,Antiparkinson,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P08908,unknown,
2292,2005,Class A (Rhodopsin),small molecule,melatonin,mtr1a_human,MTNR1A,NRDD320,Hypnotics and Sedatives,Melatonin ,4,,-,approved,Melatonin,GPCR;Rhodopsin,established,-,P48039,unknown,
2293,2005,Class A (Rhodopsin),small molecule,melatonin,mtr1b_human,MTNR1B,NRDD320,Hypnotics and Sedatives,Melatonin ,4,,-,approved,Melatonin,GPCR;Rhodopsin,established,-,P49286,unknown,
2294,1993,Class A (Rhodopsin),small molecule,methadyl acetate,oprm_human,OPRM1,NRDD335,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P35372,unknown,
2295,1953,Class A (Rhodopsin),small molecule,methylscopolamine,acm1_human,CHRM1,NRDD351,Antispasmodics,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,unknown,
2296,1992,Class A (Rhodopsin),small molecule,nedocromil,cltr1_human,CYSLTR1,NRDD379,Anti-Allergic ; Anti-Asthmatic,Lipid ,4,,-,approved,Leukotriene receptors,GPCR;Rhodopsin,established,-,Q9Y271,unknown,
2297,1999,Class A (Rhodopsin),small molecule,pemirolast,hrh1_human,HRH1,NRDD416,Anti-Allergic,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,unknown,
2298,1974,Class A (Rhodopsin),small molecule,pentagastrin,gasr_human,CCKBR,NRDD418,Diagnostic,Peptide ,4,,-,approved,Cholecystokinin receptors,GPCR;Rhodopsin,established,-,P32239,unknown,
2299,1974,Class A (Rhodopsin),small molecule,pentagastrin,gasr_human,CCKBR,NRDD418,Diagnostic,Peptide ,4,,-,approved,Cholecystokinin receptors,GPCR;Rhodopsin,established,-,P32239,unknown,
2300,1967,Class A (Rhodopsin),small molecule,pentazocine,oprk_human,OPRK1,NRDD419,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P41145,unknown,
2301,1967,Class A (Rhodopsin),small molecule,pentazocine,oprm_human,OPRM1,NRDD419,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P35372,unknown,
2302,1985,Class A (Rhodopsin),small molecule,terfenadine,hrh1_human,HRH1,NRDD516,Anti-Allergic,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,unknown,
2303,1962,Class A (Rhodopsin),small molecule,zuclopenthixol,drd1_human,DRD1,NRDD567,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21728,unknown,
2304,1962,Class A (Rhodopsin),small molecule,zuclopenthixol,drd2_human,DRD2,NRDD567,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,unknown,
2305,1962,Class A (Rhodopsin),small molecule,zuclopenthixol,drd5_human,DRD5,NRDD567,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21918,unknown,
2306,0,Class A (Rhodopsin),small molecule,acepromazine,5ht2a_human,HTR2A,ASH_Oct2016_379,Antipsychotic,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,acepromazine,P28223,unknown,
2307,0,Class A (Rhodopsin),small molecule,acepromazine,drd1_human,DRD1,ASH_Oct2016_383,Antipsychotic,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,acepromazine,P21728,unknown,
2308,0,Class A (Rhodopsin),small molecule,acepromazine,drd2_human,DRD2,ASH_Oct2016_387,Antipsychotic,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,acepromazine,P14416,unknown,
2309,0,Class A (Rhodopsin),small molecule,acepromazine,5ht1a_human,HTR1A,ASH_Oct2016_391,Antipsychotic,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,acepromazine,P08908,unknown,
2310,2003,Class A (Rhodopsin),small molecule,acipimox,hcar2_human,HCAR2,ASH_Oct2016_428,lipid-lowering,Alicarboxylic acid ,4,,-,approved,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,acipimox,Q8TDS4,unknown,
2311,1976,Class A (Rhodopsin),small molecule,theophylline,aa1r_human,ADORA1,53,Bronchodilator,Nucleotide ,4,,-,approved,Adenosine receptors,GPCR;Rhodopsin,established,"adc4022, low-dose inhaled theophylline",P30542,unknown,
2312,1976,Class A (Rhodopsin),small molecule,theophylline,aa2ar_human,ADORA2A,53,Bronchodilator,Nucleotide ,4,,-,approved,Adenosine receptors,GPCR;Rhodopsin,established,"adc4022, low-dose inhaled theophylline",P29274,unknown,
2313,1976,Class A (Rhodopsin),small molecule,theophylline,aa2br_human,ADORA2B,53,Bronchodilator,Nucleotide ,4,,-,approved,Adenosine receptors,GPCR;Rhodopsin,established,"adc4022, low-dose inhaled theophylline",P29275,unknown,
2314,2009,Class A (Rhodopsin),small molecule,agomelatine,mtr1b_human,MTNR1B,86,Anti-depressant,Melatonin ,4,,-,approved,Melatonin,GPCR;Rhodopsin,established,"agomelatine , ago178c, s-20098,valdoxan, thymanax",P49286,unknown,
2315,2009,Class A (Rhodopsin),small molecule,agomelatine,mtr1b_human,MTNR1B,86,Anti-depressant,Melatonin ,4,,-,approved,Melatonin,GPCR;Rhodopsin,established,"agomelatine , ago178c, s-20098,valdoxan, thymanax",P49286,unknown,
2316,2009,Class A (Rhodopsin),small molecule,agomelatine,5ht2b_human,HTR2B,87,Anti-depressant,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"agomelatine, ago178c, s-20098,valdoxan, thymanax",P41595,unknown,
2317,2009,Class A (Rhodopsin),small molecule,agomelatine,5ht2c_human,HTR2C,87,Anti-depressant,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"agomelatine, ago178c, s-20098,valdoxan, thymanax",P28335,unknown,
2318,2009,Class A (Rhodopsin),small molecule,agomelatine,mtr1a_human,MTNR1A,87,Anti-depressant,Melatonin ,4,,-,approved,Melatonin,GPCR;Rhodopsin,established,"agomelatine, ago178c, s-20098,valdoxan, thymanax",P48039,unknown,
2319,2009,Class A (Rhodopsin),small molecule,agomelatine,mtr1a_human,MTNR1A,87,Anti-depressant,Melatonin ,4,,-,approved,Melatonin,GPCR;Rhodopsin,established,"agomelatine, ago178c, s-20098,valdoxan, thymanax",P48039,unknown,
2320,1981,Class A (Rhodopsin),small molecule,alprostadil,pe2r1_human,PTGER1,128,sexual dysfunction,Lipid ,4,,-,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"alprostadil,alista",P34995,unknown,
2321,1981,Class A (Rhodopsin),small molecule,alprostadil,pe2r2_human,PTGER2,128,sexual dysfunction,Lipid ,4,,-,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"alprostadil,alista",P43116,unknown,
2322,1981,Class A (Rhodopsin),small molecule,alprostadil,pe2r1_human,PTGER1,129,sexual dysfunction,Lipid ,4,,-,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"alprostadil,femprox",P34995,unknown,
2323,1981,Class A (Rhodopsin),small molecule,alprostadil,pe2r2_human,PTGER2,129,sexual dysfunction,Lipid ,4,,-,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"alprostadil,femprox",P43116,unknown,
2324,1981,Class A (Rhodopsin),small molecule,alprostadil,pe2r1_human,PTGER1,130,sexual dysfunction,Lipid ,4,,-,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"alprostadil,topiglan",P34995,unknown,
2325,1981,Class A (Rhodopsin),small molecule,alprostadil,pe2r2_human,PTGER2,130,sexual dysfunction,Lipid ,4,,-,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"alprostadil,topiglan",P43116,unknown,
2326,2014,Class A (Rhodopsin),small molecule,alverine,5ht1a_human,HTR1A,ASH_Oct2016_395,Antispasmodics,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,alverine,P08908,unknown,
2327,2013,Class A (Rhodopsin),small molecule,atosiban,oxyr_human,OXTR,ASH_Oct2016_425,labor repressant,Protein ,4,,-,approved,Chemokine receptors,GPCR;Rhodopsin,established,atosiban,P30559,unknown,
2328,2006,Class A (Rhodopsin),small molecule,benperidol,ada1a_human,ADRA1A,ASH_Oct2016_375,Antipsychotic,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,benperidol,P35348,unknown,
2329,2006,Class A (Rhodopsin),small molecule,benperidol,drd2_human,DRD2,ASH_Oct2016_384,Antipsychotic,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,benperidol,P14416,unknown,
2330,1970,Class A (Rhodopsin),small molecule,betahistine,hrh1_human,HRH1,MMAmay2016_0919,vertigo,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,betahistine,P35367,unknown,
2331,1970,Class A (Rhodopsin),small molecule,betahistine,hrh3_human,HRH3,MMAmay2016_0920,vertigo,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,betahistine,Q9Y5N1,unknown,
2332,2010,Class A (Rhodopsin),small molecule,bilastine,hrh1_human,HRH1,ASH_Oct2016_359,Anti-Allergic,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,bilastine,P35367,unknown,
2333,0,Class A (Rhodopsin),small molecule,bopindolol,adrb1_human,ADRB1,ASH_Oct2016_371,Antihypertensive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,bopindolol,P08588,unknown,
2334,0,Class A (Rhodopsin),small molecule,bromopride,drd2_human,DRD2,ASH_Oct2016_366,Antiemetics,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,bromopride,P14416,unknown,
2335,0,Class A (Rhodopsin),small molecule,bupranolol,adrb1_human,ADRB1,ASH_Oct2016_369,Antihypertensive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,bupranolol,P08588,unknown,
2336,0,Class A (Rhodopsin),peptide,buserelin,gnrhr_human,GNRHR,ASH_Oct2016_426,LHRH analogue,Alicarboxylic acid ,4,,-,approved,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,buserelin,P30968,unknown,
2337,0,Class A (Rhodopsin),peptide,buserelin,lshr_human,LHCGR,ASH_Oct2016_427,LHRH analogue,Protein ,4,,-,approved,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,buserelin,P22888,unknown,
2338,1974,Class A (Rhodopsin),small molecule,butriptyline,hrh1_human,HRH1,ASH_Oct2016_363,Anti-depressant,Peptide ,4,,-,approved,Endothelin receptors,GPCR;Rhodopsin,established,butriptyline,P35367,unknown,
2339,1974,Class A (Rhodopsin),small molecule,butriptyline,5ht2a_human,HTR2A,ASH_Oct2016_365,Anti-depressant,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,butriptyline,P28223,unknown,
2340,0,Class A (Rhodopsin),small molecule,captodiame,drd3_human,DRD3,ASH_Oct2016_399,anxiolytic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,captodiame,P35462,unknown,
2341,0,Class A (Rhodopsin),small molecule,captodiame,5ht2c_human,HTR2C,ASH_Oct2016_400,anxiolytic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,captodiame,P28335,unknown,
2342,0,Class A (Rhodopsin),small molecule,celiprolol,adrb1_human,ADRB1,ASH_Oct2016_370,Antihypertensive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,celiprolol,P08588,unknown,
2343,0,Class A (Rhodopsin),small molecule,celiprolol,adrb2_human,ADRB2,ASH_Oct2016_372,Antihypertensive,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,celiprolol,P07550,unknown,
2344,1997,Class A (Rhodopsin),small molecule,niacin,hcar2_human,HCAR2,467,Antidyslipidaemic,Alicarboxylic acid ,4,,-,approved,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,cer627,Q8TDS4,unknown,
2345,1997,Class A (Rhodopsin),small molecule,niacin,hcar3_human,HCAR3,467,Antidyslipidaemic,Alicarboxylic acid ,4,,-,approved,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,cer627,P49019,unknown,
2346,1997,Class A (Rhodopsin),small molecule: combination,niacin,hcar3_human,HCAR3,MMA2015_0071,Dyslipidemia with low HDL,Alicarboxylic acid ,4,,-,approved,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,cer627,P49019,unknown,
2347,1997,Class A (Rhodopsin),small molecule: combination,niacin,hcar2_human,HCAR2,MMA2015_0072,Dyslipidemia with low HDL,Alicarboxylic acid ,4,,-,approved,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,cer627,Q8TDS4,unknown,
2348,0,Class A (Rhodopsin),small molecule,chlorcyclizine,hrh1_human,HRH1,ASH_Oct2016_358,Anti-Allergic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,chlorcyclizine,P35367,unknown,
2349,0,Class A (Rhodopsin),small molecule,chloropyramine,hrh1_human,HRH1,ASH_Oct2016_356,Anti-Allergic,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,chloropyramine,P35367,unknown,
2350,0,Class A (Rhodopsin),small molecule,cinitapride,5ht2a_human,HTR2A,ASH_Oct2016_414,gastrointestinal disorders,Peptide ,4,,-,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,cinitapride,P28223,unknown,
2351,0,Class A (Rhodopsin),small molecule,cinitapride,5ht1a_human,HTR1A,ASH_Oct2016_415,gastrointestinal disorders,Peptide ,4,,-,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,cinitapride,P08908,unknown,
2352,1987,Class A (Rhodopsin),small molecule,clofedanol,hrh1_human,HRH1,ASH_Oct2016_397,antitussive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,clofedanol,P35367,unknown,
2353,0,Class A (Rhodopsin),small molecule,corticorelin ovine triflutate,crfr1_human,CRHR1,ASH_Oct2016_409,Diagnostic,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Secretin,established,corticorelin ovine triflutate,P34998,unknown,
2354,0,Class A (Rhodopsin),small molecule,dimetindene,hrh1_human,HRH1,ASH_Oct2016_357,Anti-Allergic,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,dimetindene,P35367,unknown,
2355,0,Class A (Rhodopsin),small molecule,dimetindene,acm2_human,CHRM2,ASH_Oct2016_360,Anti-Allergic,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,dimetindene,P08172,unknown,
2356,1946,Class A (Rhodopsin),small molecule,ergonovine,ada1a_human,ADRA1A,ASH_Oct2016_367,antihaemorrhagic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,ergonovine,P35348,unknown,
2357,0,Class A (Rhodopsin),small molecule,ethylmorphine,oprm_human,OPRM1,ASH_Oct2016_353,Analgesics,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,ethylmorphine,P35372,unknown,
2358,2015,Class A (Rhodopsin),small molecule,flibanserin,5ht1a_human,HTR1A,801,sexual dysfunction,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,flibanserin,P08908,unknown,
2359,2015,Class A (Rhodopsin),small molecule,flibanserin,5ht2a_human,HTR2A,801,sexual dysfunction,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,flibanserin,P28223,unknown,
2360,1965,Class A (Rhodopsin),small molecule,flupentixol,5ht2a_human,HTR2A,ASH_Oct2016_377,Antipsychotic,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,flupentixol,P28223,unknown,
2361,1965,Class A (Rhodopsin),small molecule,flupentixol,drd1_human,DRD1,ASH_Oct2016_381,Antipsychotic,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,flupentixol,P21728,unknown,
2362,1965,Class A (Rhodopsin),small molecule,flupentixol,drd2_human,DRD2,ASH_Oct2016_385,Antipsychotic,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,flupentixol,P14416,unknown,
2363,1965,Class A (Rhodopsin),small molecule,flupentixol,acm1_human,CHRM1,ASH_Oct2016_389,Antipsychotic,Aminergic ,4,,-,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,flupentixol,P11229,unknown,
2364,1965,Class A (Rhodopsin),small molecule,flupentixol,5ht2a_human,HTR2A,ASH_Oct2016_393,Antipsychotic,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,flupentixol,P28223,unknown,
2365,0,Class A (Rhodopsin),small molecule,hyoscyamine,acm1_human,CHRM1,ASH_Oct2016_394,Antispasmodics,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,hyoscyamine,P11229,unknown,
2366,0,Class A (Rhodopsin),small molecule,hyoscyamine,acm2_human,CHRM2,ASH_Oct2016_396,Antispasmodics,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,hyoscyamine,P08172,unknown,
2367,1993,Class A (Rhodopsin),small molecule,indoramin,ada1b_human,ADRA1B,ASH_Oct2016_431,Antihypertensive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,indoramin,P35368,unknown,
2368,1993,Class A (Rhodopsin),small molecule,indoramin,ada1a_human,ADRA1A,ASH_Oct2016_432,Antihypertensive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,indoramin,P35348,unknown,
2369,1993,Class A (Rhodopsin),small molecule,indoramin,ada1d_human,ADRA1D,ASH_Oct2016_433,Antihypertensive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,indoramin,P25100,unknown,
2370,0,Class A (Rhodopsin),small molecule,isometheptene,ada1a_human,ADRA1A,ASH_Oct2016_417,migraines,Alicarboxylic acid ,4,,-,approved,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,isometheptene,P35348,unknown,
2371,0,Class A (Rhodopsin),small molecule,isothipendyl,hrh1_human,HRH1,ASH_Oct2016_373,antipruritic,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,isothipendyl,P35367,unknown,
2372,0,Class A (Rhodopsin),small molecule,ketobemidone,oprk_human,OPRK1,ASH_Oct2016_351,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,ketobemidone,P41145,unknown,
2373,0,Class A (Rhodopsin),small molecule,ketobemidone,oprd_human,OPRD1,ASH_Oct2016_352,Analgesics,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,ketobemidone,P41143,unknown,
2374,0,Class A (Rhodopsin),small molecule,ketobemidone,oprm_human,OPRM1,ASH_Oct2016_354,Analgesics,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,ketobemidone,P35372,unknown,
2375,2016,Class B1 (Secretin),small molecule,lixisenatide,glp1r_human,GLP1R,MMAmar2016_0257,Antidiabetic,Peptide ,4,,-,approved,Glucagon receptor family,GPCR;Secretin,established,"lixilan, lantus (basal insulin) + lyxumia (lixisenatide)",P43220,unknown,
2376,2006,Class A (Rhodopsin),small molecule,lofexidine,ada2a_human,ADRA2A,1159,opiate withdrawal,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"lofexidine,britlofex",P08913,unknown,
2377,2006,Class A (Rhodopsin),small molecule,lofexidine,ada2b_human,ADRA2B,1159,opiate withdrawal,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"lofexidine,britlofex",P18089,unknown,
2378,2006,Class A (Rhodopsin),small molecule,lofexidine,ada2c_human,ADRA2C,1159,opiate withdrawal,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"lofexidine,britlofex",P18825,unknown,
2379,0,Class A (Rhodopsin),small molecule,methylscopolamine bromide,acm1_human,CHRM1,ASH_Oct2016_421,Anti-ulcer,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,methylscopolamine bromide,P11229,unknown,
2380,0,Class A (Rhodopsin),small molecule,methylscopolamine bromide,acm2_human,CHRM2,ASH_Oct2016_422,Anti-ulcer,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,methylscopolamine bromide,P08172,unknown,
2381,0,Class A (Rhodopsin),small molecule,metiamide,hrh2_human,HRH2,ASH_Oct2016_348,acid reducer,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,metiamide,P25021,unknown,
2382,0,Class A (Rhodopsin),small molecule,metiamide,hrh2_human,HRH2,ASH_Oct2016_349,acid reducer,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,metiamide,P25021,unknown,
2383,1997,Class A (Rhodopsin),small molecule,niacin,hcar2_human,HCAR2,1300,Antidyslipidaemic,Alicarboxylic acid ,4,,-,approved,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,"mk-0524a, er niacin/laropiprant,tredaptive, trevaclyn, pelzont",Q8TDS4,unknown,
2384,1997,Class A (Rhodopsin),small molecule,niacin,hcar3_human,HCAR3,1300,Antidyslipidaemic,Alicarboxylic acid ,4,,-,approved,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,"mk-0524a, er niacin/laropiprant,tredaptive, trevaclyn, pelzont",P49019,unknown,
2385,1997,Class A (Rhodopsin),small molecule,niacin,hcar2_human,HCAR2,1301,Antidyslipidaemic,Alicarboxylic acid ,4,,-,approved,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,"mk-0542b, extended release niacin + laropiprant +simvastatin",Q8TDS4,unknown,
2386,1997,Class A (Rhodopsin),small molecule,niacin,hcar3_human,HCAR3,1301,Antidyslipidaemic,Alicarboxylic acid ,4,,-,approved,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,"mk-0542b, extended release niacin + laropiprant +simvastatin",P49019,unknown,
2387,2012,Class A (Rhodopsin),antibody,mogamulizumab,ccr4_human,CCR4,ASH_Oct2016_436,Antineoplastic,Protein ,4,,-,approved,Chemokine receptors,GPCR;Rhodopsin,established,mogamulizumab,P51679,unknown,
2388,1997,Class A (Rhodopsin),small molecule,niacin,hcar2_human,HCAR2,2468,Antihyperlipidemic,Alicarboxylic acid ,4,,-,approved,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,"niacin extended-release tablets,niaspan",Q8TDS4,unknown,
2389,1997,Class A (Rhodopsin),small molecule,niacin,hcar3_human,HCAR3,2468,Antihyperlipidemic,Alicarboxylic acid ,4,,-,approved,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,"niacin extended-release tablets,niaspan",P49019,unknown,
2390,1978,Class A (Rhodopsin),peptide,desmopressin,v1ar_human,AVPR1A,MMAjun2016_0039,Antidiuretic,Peptide ,4,,-,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,"nocdurna,  desmopressin",P37288,unknown,
2391,1978,Class A (Rhodopsin),peptide,desmopressin,v1br_human,AVPR1B,MMAjun2016_0040,Antidiuretic,Peptide ,4,,-,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,"nocdurna,  desmopressin",P47901,unknown,
2392,1978,Class A (Rhodopsin),peptide,desmopressin,v2r_human,AVPR2,MMAjun2016_0041,Antidiuretic,Peptide ,4,,-,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,"nocdurna,  desmopressin",P30518,unknown,
2393,1970,Class A (Rhodopsin),small molecule,betahistine,hrh1_human,HRH1,1464,Anti-obesity,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,"obe101,histalean,anti-obesity ",P35367,unknown,
2394,1970,Class A (Rhodopsin),small molecule,betahistine,hrh3_human,HRH3,1464,Anti-obesity,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,"obe101,histalean,anti-obesity ",Q9Y5N1,unknown,
2395,1978,Class A (Rhodopsin),peptide,desmopressin,v1ar_human,AVPR1A,1537,incontinence,Peptide ,4,,-,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,"ox 19, sublingual desmopressin",P37288,unknown,
2396,1978,Class A (Rhodopsin),peptide,desmopressin,v1br_human,AVPR1B,1537,incontinence,Peptide ,4,,-,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,"ox 19, sublingual desmopressin",P47901,unknown,
2397,1978,Class A (Rhodopsin),peptide,desmopressin,v2r_human,AVPR2,1537,incontinence,Peptide ,4,,-,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,"ox 19, sublingual desmopressin",P30518,unknown,
2398,1978,Class A (Rhodopsin),peptide,desmopressin,v1br_human,AVPR1B,1537,incontinence,Peptide ,4,,-,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,"ox 19, sublingual desmopressin",P47901,unknown,
2399,1997,Class A (Rhodopsin),small molecule,niacin,hcar2_human,HCAR2,1546,substance abuse deterrant,Alicarboxylic acid ,4,,-,approved,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,"oxycodone hcl + niacin,acurox, oxyadf",Q8TDS4,unknown,
2400,1997,Class A (Rhodopsin),small molecule,niacin,hcar3_human,HCAR3,1546,substance abuse deterrant,Alicarboxylic acid ,4,,-,approved,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,"oxycodone hcl + niacin,acurox, oxyadf",P49019,unknown,
2401,2005,Class B1 (Secretin),peptide,exendin-4,glp1r_human,GLP1R,1572,Antidiabetic,Peptide ,4,,-,approved,Glucagon receptor family,GPCR;Secretin,established,pc-dac:exendin-4,P43220,unknown,
2402,1949,Class A (Rhodopsin),small molecule,phenindamine,hrh1_human,HRH1,ASH_Oct2016_355,Anti-Allergic,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,phenindamine,P35367,unknown,
2403,1980,Class A (Rhodopsin),small molecule,pipotiazine,5ht2a_human,HTR2A,ASH_Oct2016_378,Antipsychotic,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,pipotiazine,P28223,unknown,
2404,1980,Class A (Rhodopsin),small molecule,pipotiazine,drd1_human,DRD1,ASH_Oct2016_382,Antipsychotic,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,pipotiazine,P21728,unknown,
2405,1980,Class A (Rhodopsin),small molecule,pipotiazine,drd2_human,DRD2,ASH_Oct2016_386,Antipsychotic,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,pipotiazine,P14416,unknown,
2406,1980,Class A (Rhodopsin),small molecule,pipotiazine,5ht1a_human,HTR1A,ASH_Oct2016_390,Antipsychotic,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,pipotiazine,P08908,unknown,
2407,2009,Class A (Rhodopsin),small molecule,prucalopride,5ht4r_human,HTR4,1665,motilitant,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"prucalopride ,resolor",Q13639,unknown,
2408,1981,Class A (Rhodopsin),small molecule,alprostadil,pe2r1_human,PTGER1,MMAapril2016_0157,Raynaud's Disease,Lipid ,4,,-,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"rayva, alprostadil + ddaip.hcl",P34995,unknown,
2409,1981,Class A (Rhodopsin),small molecule,alprostadil,pe2r2_human,PTGER2,MMAapril2016_0158,Raynaud's Disease,Lipid ,4,,-,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"rayva, alprostadil + ddaip.hcl",P43116,unknown,
2410,2007,Class A (Rhodopsin),small molecule,rimonabant,cnr1_human,CNR1,1766,Anti-obesity,Lipid ,4,,-,approved,Cannabinoid receptors,GPCR;Rhodopsin,established,rimonabant,P21554,unknown,
2411,1985,Class A (Rhodopsin),plant extract,tetrahydrocannabinol,cnr1_human,CNR1,1812,Analgesics; neuropathic pain; restlegs legs syndrome,Lipid ,4,,-,approved,Cannabinoid receptors,GPCR;Rhodopsin,established,sativex,P21554,unknown,
2412,1985,Class A (Rhodopsin),plant extract,tetrahydrocannabinol,cnr2_human,CNR2,1812,Analgesics; neuropathic pain; restlegs legs syndrome,Lipid ,4,,-,approved,Cannabinoid receptors,GPCR;Rhodopsin,established,sativex,P34972,unknown,
2413,2006,Class A (Rhodopsin),small molecule,sitaxentan,ednra_human,EDNRA,ASH_Oct2016_368,Antihypertensive,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,sitaxentan,P25101,unknown,
2414,2002,Class C (Glutamate) ,small molecule,gamma hydroxybutyric acid,gabr1_human,GABBR1,1871,Hypnotics and Sedatives,Amino acid ,4,,-,approved,GABAB receptors,GPCR;Glutamate,established,sodium oxybate,Q9UBS5,unknown,
2415,2002,Class C (Glutamate) ,small molecule,gamma hydroxybutyric acid,gabr2_human,GABBR2,1871,Hypnotics and Sedatives,Amino acid ,4,,-,approved,GABAB receptors,GPCR;Glutamate,established,sodium oxybate,O75899,unknown,
2416,2002,Class A (Rhodopsin),small molecule,gamma hydroxybutyric acid,hcar1_human,HCAR1,ASH_Oct2016_437,Hypnotics and Sedatives,Alicarboxylic acid ,4,,-,approved,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,sodium oxybate,Q9BXC0,unknown,
2417,1916,Class A (Rhodopsin),small molecule,suramin,p2ry2_human,P2RY2,ASH_Oct2016_346,African trypanosomiasis,Nucleotide ,4,,-,approved,P2Y,GPCR;Rhodopsin,established,Suramin,P41231,unknown,
2418,2003,Class A (Rhodopsin),small molecule,terlipressin,v1ar_human,AVPR1A,1986,hepatorenal syndrome,Peptide ,4,,-,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,"terlipressin,lucassin",P37288,unknown,
2419,2003,Class A (Rhodopsin),small molecule,terlipressin,v1br_human,AVPR1B,1986,hepatorenal syndrome,Peptide ,4,,-,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,"terlipressin,lucassin",P47901,unknown,
2420,2003,Class A (Rhodopsin),small molecule,terlipressin,v2r_human,AVPR2,1986,hepatorenal syndrome,Peptide ,4,,-,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,"terlipressin,lucassin",P30518,unknown,
2421,2006,Class A (Rhodopsin),small molecule,sitaxentan,ednra_human,EDNRA,2010,Antihypertensive,Peptide ,4,,-,approved,Endothelin receptors,GPCR;Rhodopsin,established,thelin,P25101,unknown,
2422,1976,Class A (Rhodopsin),small molecule,theophylline,aa3r_human,ADORA3,ASH_Sep2016_318,Anti-Asthmatic,Nucleotide ,4,,-,approved,Adenosine receptors,GPCR;Rhodopsin,established,theophylline,P0DMS8,unknown,
2423,1962,Class A (Rhodopsin),small molecule,thioproperazine,ada1b_human,ADRA1B,ASH_Oct2016_374,Antipsychotic,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,thioproperazine,P35368,unknown,
2424,1962,Class A (Rhodopsin),small molecule,thioproperazine,ada1a_human,ADRA1A,ASH_Oct2016_376,Antipsychotic,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,thioproperazine,P35348,unknown,
2425,1962,Class A (Rhodopsin),small molecule,thioproperazine,5ht2a_human,HTR2A,ASH_Oct2016_380,Antipsychotic,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,thioproperazine,P28223,unknown,
2426,1962,Class A (Rhodopsin),small molecule,thioproperazine,drd2_human,DRD2,ASH_Oct2016_388,Antipsychotic,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,thioproperazine,P14416,unknown,
2427,1962,Class A (Rhodopsin),small molecule,thioproperazine,5ht1a_human,HTR1A,ASH_Oct2016_392,Antipsychotic,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,thioproperazine,P08908,unknown,
2428,1962,Class A (Rhodopsin),small molecule,isometheptene,ada1a_human,ADRA1A,MMAmar2016_0022,Anti-migraine,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,"tnx-201, single isomer isometheptene, imh",P35348,unknown,
2429,1981,Class A (Rhodopsin),small molecule,alprostadil,pe2r1_human,PTGER1,2039,sexual dysfunction,Lipid ,4,,-,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"topical alprostadil cream,alprox-td, befar, vitaros",P34995,unknown,
2430,1981,Class A (Rhodopsin),small molecule,alprostadil,pe2r2_human,PTGER2,2039,sexual dysfunction,Lipid ,4,,-,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"topical alprostadil cream,alprox-td, befar, vitaros",P43116,unknown,
2431,2000,Class A (Rhodopsin),small molecule,melevodopa,drd1_human,DRD1,2110,Antiparkinson,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"v-1512, chf-1512,levomet complex, sirio",P21728,unknown,
2432,2000,Class A (Rhodopsin),small molecule,melevodopa,drd2_human,DRD2,2110,Antiparkinson,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"v-1512, chf-1512,levomet complex, sirio",P14416,unknown,
2433,2000,Class A (Rhodopsin),small molecule,melevodopa,drd3_human,DRD3,2110,Antiparkinson,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"v-1512, chf-1512,levomet complex, sirio",P35462,unknown,
2434,2000,Class A (Rhodopsin),small molecule,melevodopa,drd4_human,DRD4,2110,Antiparkinson,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"v-1512, chf-1512,levomet complex, sirio",P21917,unknown,
2435,2000,Class A (Rhodopsin),small molecule,melevodopa,drd5_human,DRD5,2110,Antiparkinson,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,"v-1512, chf-1512,levomet complex, sirio",P21918,unknown,
2436,1959,Class A (Rhodopsin),small molecule,xylometazoline,ada1a_human,ADRA1A,ASH_Oct2016_404,decongestant,Aminergic ,4,,-,approved,Histamine receptors,GPCR;Rhodopsin,established,xylometazoline,P35348,unknown,
2437,1959,Class A (Rhodopsin),small molecule,xylometazoline,ada2b_human,ADRA2B,ASH_Oct2016_406,decongestant,Peptide ,4,,-,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,xylometazoline,P18089,unknown,
2438,1959,Class A (Rhodopsin),small molecule,xylometazoline,ada2a_human,ADRA2A,ASH_Oct2016_407,decongestant,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,xylometazoline,P08913,unknown,
2439,1986,Class A (Rhodopsin),small molecule,buspirone,drd2_human,DRD2,NRDD066,Anti-anxiety,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,partial agonist,
2440,1986,Class A (Rhodopsin),small molecule,buspirone,5ht1a_human,HTR1A,NRDD066,Anti-anxiety,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P08908,partial agonist,
2441,1978,Class A (Rhodopsin),small molecule,butorphanol,oprd_human,OPRD1,NRDD070,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P41143,partial agonist,
2442,1978,Class A (Rhodopsin),small molecule,butorphanol,oprk_human,OPRK1,NRDD070,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P41145,partial agonist,
2443,1978,Class A (Rhodopsin),small molecule,butorphanol,oprm_human,OPRM1,NRDD070,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P35372,partial agonist,
2444,1989,Class A (Rhodopsin),small molecule,dezocine,oprk_human,OPRK1,NRDD157,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P41145,partial agonist,
2445,1989,Class A (Rhodopsin),small molecule,dezocine,oprm_human,OPRM1,NRDD157,Analgesics,Peptide ,4,,-,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P35372,partial agonist,
2446,1946,Class A (Rhodopsin),small molecule,methylergonovine,drd1_human,DRD1,NRDD347,Abortifacient,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21728,partial agonist,
2447,1982,Class A (Rhodopsin),small molecule,pindolol,adrb1_human,ADRB1,NRDD444,Antihypertensive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588,partial agonist,
2448,1982,Class A (Rhodopsin),small molecule,pindolol,adrb2_human,ADRB2,NRDD444,Antihypertensive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P07550,partial agonist,
2449,2002,Class A (Rhodopsin),small molecule,aripiprazole,drd2_human,DRD2,22,schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,abilify,P14416,partial agonist,
2450,2002,Class A (Rhodopsin),small molecule,aripiprazole,5ht1a_human,HTR1A,22,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,abilify,P08908,partial agonist,
2451,2002,Class A (Rhodopsin),small molecule,aripiprazole,5ht2a_human,HTR2A,22,schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,abilify,P28223,partial agonist,
2452,2002,Class A (Rhodopsin),small molecule,aripiprazole,5ht1a_human,HTR1A,MMAmay2016_0260,Antipsychotic ; schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,alks 9070,P08908,partial agonist,
2453,2002,Class A (Rhodopsin),small molecule,aripiprazole,drd2_human,DRD2,MMAmay2016_0261,Antipsychotic ; schizophrenia,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,alks 9070,P14416,partial agonist,
2454,2002,Class A (Rhodopsin),small molecule,aripiprazole,5ht2a_human,HTR2A,MMAmay2016_0262,Antipsychotic ; schizophrenia,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,alks 9070,P28223,partial agonist,
2455,2015,Class A (Rhodopsin),unknown,aripiprazole,5ht1a_human,HTR1A,ASH_Sep2016_1,psychosis,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,aripiprazole lauroxil,P08908,partial agonist,
2456,2015,Class A (Rhodopsin),unknown,aripiprazole,5ht2a_human,HTR2A,ASH_Sep2016_14,psychosis,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,aripiprazole lauroxil,P28223,partial agonist,
2457,2015,Class A (Rhodopsin),unknown,aripiprazole,drd2_human,DRD2,ASH_Sep2016_58,psychosis,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,aripiprazole lauroxil,P14416,partial agonist,
2458,2015,Class A (Rhodopsin),small molecule,brexpiprazole,drd2_human,DRD2,1502,Anti-depressant,Aminergic ,4,,-,approved,Dopamine receptors,GPCR;Rhodopsin,established,brexpiprazole,P14416,partial agonist,
2459,2015,Class A (Rhodopsin),small molecule,brexpiprazole,5ht1a_human,HTR1A,1502,Anti-depressant,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,brexpiprazole,P08908,partial agonist,
2460,2015,Class A (Rhodopsin),small molecule,brexpiprazole,5ht2a_human,HTR2A,1502,Anti-depressant,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,brexpiprazole,P28223,partial agonist,
2461,2015,Class A (Rhodopsin),small molecule,brexpiprazole,5ht7r_human,HTR7,1502,Anti-depressant,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,brexpiprazole,P34969,partial agonist,
2462,1946,Class A (Rhodopsin),small molecule,methylergonovine,5ht2b_human,HTR2B,ASH_Sep2016_26,hemorrhage,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,methylergonovine,P41595,partial agonist,
2463,2008,Class A (Rhodopsin),small molecule,plerixafor,cxcr4_human,CXCR4,1342,Antineoplastic,Protein ,4,,-,approved,Chemokine receptors,GPCR;Rhodopsin,established,mozobil,P61073,partial agonist,
2464,2002,Class A (Rhodopsin),small molecule,tegaserod,5ht4r_human,HTR4,1975,motilitant,Aminergic ,4,,-,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"tegaserod,zelnorm, zelmac",Q13639,partial agonist,
2465,2004,Class C (Glutamate) ,small molecule,cinacalcet,casr_human,CASR,NRDD105,Calcimimetics,Ion ,4,,-,approved,Calcium-sensing receptors,GPCR;Glutamate,established,-,P41180,pam,
2466,2004,Class C (Glutamate) ,small molecule,cinacalcet,casr_human,CASR,NRDD105,Calcimimetics,Ion ,4,,-,approved,Calcium-sensing receptors,GPCR;Glutamate,established,-,P41180,pam,
2467,2004,Class C (Glutamate) ,small molecule,cinacalcet,casr_human,CASR,2327,hyperparathyroidism,Ion ,4,,-,approved,Calcium-sensing receptors,GPCR;Glutamate,established,"cinacalcet hcl, amg 073,sensipar",P41180,pam,
2468,1982,Class A (Rhodopsin),small molecule,etomidate,ada2b_human,ADRA2B,NRDD222,Anesthetics; Intravenous,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P18089,positive modulator,
2469,2007,Class A (Rhodopsin),small molecule,lisdexamfetamine,ada1a_human,ADRA1A,NRDD306,Central Nervous System Stimulants,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,releasing agent,
2470,2007,Class A (Rhodopsin),small molecule,lisdexamfetamine,ada1b_human,ADRA1B,NRDD306,Central Nervous System Stimulants,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35368,releasing agent,
2471,1976,Class A (Rhodopsin),small molecule,amphetamine,taar1_human,TAAR1,413,cognitive dysfunction; ADHD,Aminergic ,4,,-,approved,Trace amine receptors,GPCR;Rhodopsin,established,"c105, levo-amphetamine sulfate",Q96RJ0,releasing agent,
2472,1976,Class A (Rhodopsin),small molecule,amphetamine,taar1_human,TAAR1,413,cognitive dysfunction; ADHD,Aminergic ,4,,-,approved,Trace amine receptors,GPCR;Rhodopsin,established,"c105, levo-amphetamine sulfate",Q96RJ0,releasing agent,
2473,1976,Class A (Rhodopsin),small molecule,amphetamine,taar1_human,TAAR1,MMAmay2016_0357,cognitive dysfunction; ADHD,Aminergic ,4,,-,approved,Trace amine receptors,GPCR;Rhodopsin,established,d-amphetamine transdermal system (d-ats),Q96RJ0,releasing agent,
2474,1975,Class A (Rhodopsin),small molecule,pseudoephedrine,ada1a_human,ADRA1A,789,Anti-Allergic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,fexofenadine + ps/,P35348,releasing agent,
2475,1975,Class A (Rhodopsin),small molecule,pseudoephedrine,ada2a_human,ADRA2A,789,Anti-Allergic,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,fexofenadine + ps/,P08913,releasing agent,
2476,1976,Class A (Rhodopsin),small molecule,amphetamine,taar1_human,TAAR1,MMAmay2016_0658,cognitive dysfunction; ADHD,Aminergic ,4,,-,approved,Trace amine receptors,GPCR;Rhodopsin,established,"hld-100, reformulated amphetamine",Q96RJ0,releasing agent,
2477,1976,Class A (Rhodopsin),small molecule,amphetamine,taar1_human,TAAR1,1862,cognitive dysfunction; ADHD,Aminergic ,4,,-,approved,Trace amine receptors,GPCR;Rhodopsin,established,"sli 381, spd 465,adderall, adderall xr, adderall ir",Q96RJ0,releasing agent,
2478,1982,Class A (Rhodopsin),small molecule,bethanidine,ada1a_human,ADRA1A,NRDD055,Antihypertensive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,substrate,
2479,1982,Class A (Rhodopsin),small molecule,bethanidine,ada1b_human,ADRA1B,NRDD055,Antihypertensive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35368,substrate,
2480,1982,Class A (Rhodopsin),small molecule,bethanidine,ada1d_human,ADRA1D,NRDD055,Antihypertensive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P25100,substrate,
2481,1982,Class A (Rhodopsin),small molecule,bethanidine,ada2a_human,ADRA2A,NRDD055,Antihypertensive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08913,substrate,
2482,1982,Class A (Rhodopsin),small molecule,bethanidine,ada2b_human,ADRA2B,NRDD055,Antihypertensive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P18089,substrate,
2483,1982,Class A (Rhodopsin),small molecule,bethanidine,ada2c_human,ADRA2C,NRDD055,Antihypertensive,Aminergic ,4,,-,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P18825,substrate,
